data_2ro4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ro4 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.818 -0.808 . . . . 0.92000000000000004 108.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.694 HG22 ' HD1' ' B' ' 37' ' ' TYR . 59.4 m 63.32 75.41 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.813 0.815 . . . . 1.2 111.311 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.61 35.97 12.82 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 111.339 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 134.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.745 -0.465 . . . . 1.3300000000000001 109.745 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -86.99 125.66 40.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 120.988 0.423 . . . . 1.1599999999999999 111.384 -173.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.44 155.86 36.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 2.6600000000000001 110.863 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -82.34 162.57 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.881 -0.414 . . . . 1.9299999999999999 109.881 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 11' ' ' ASP . 2.5 t -85.05 -108.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.772 -0.371 . . . . 1.0600000000000001 110.231 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t70 177.26 -74.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.98 -0.748 . . . . 1.3200000000000001 108.98 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.905 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.9 OUTLIER -161.57 -80.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.942 -1.026 . . . . 1.3899999999999999 109.686 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.556 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -68.4 -32.78 73.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.774 -1.103 . . . . 1.22 111.302 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.78 -16.31 0.11 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.879 -1.153 . . . . 0.34000000000000002 113.947 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.36 103.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.584 0.692 . . . . 1.54 111.867 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.71 HG12 HD11 ' B' ' 45' ' ' LEU . 13.4 p -96.55 140.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.866 -0.42 . . . . 1.6899999999999999 109.866 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.506 HG23 ' HG3' ' B' ' 15' ' ' ARG . 48.4 t -77.76 101.75 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.267 -0.424 . . . . 1.1599999999999999 111.323 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.7 129.06 88.89 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.818 -0.628 . . . . 1.3300000000000001 110.229 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 57.2 Cg_exo -45.5 139.09 10.08 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.387 2.725 . . . . 0.34999999999999998 113.407 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 8.6 tt -57.03 -33.26 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 110.827 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -73.2 -24.86 60.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.098 0.475 . . . . 1.73 110.472 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 10.5 mt -81.49 -48.09 12.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.402 -0.592 . . . . 1.1100000000000001 109.402 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 20' ' ' ILE . 12.2 ptt180 -64.7 -33.81 76.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.083 -0.71 . . . . 2.4100000000000001 109.083 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.76 -40.38 94.96 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.281 -0.872 . . . . 3.4100000000000001 110.677 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.6 m -61.12 -38.36 86.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.205 0.526 . . . . 1.1299999999999999 110.634 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.2 mt -87.14 -10.67 52.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 1.1000000000000001 109.704 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.98 25.83 71.02 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.377 -0.829 . . . . 0.28000000000000003 112.466 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.5 pt -106.71 167.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 1.24 111.606 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -177.32 152.84 0.88 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.883 -1.053 . . . . 1.03 109.549 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.791 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.0 pt-20 32.4 -89.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.779 1.77 . . . . 1.22 115.779 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.523 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.7 mmpt? -77.27 -0.43 25.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.746 0.647 . . . . 1.51 112.746 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -81.94 174.67 11.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.007 0.432 . . . . 1.54 110.535 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' B' ' 7' ' ' VAL . . . -123.93 152.59 42.28 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.405 0.621 . . . . 1.0600000000000001 112.499 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.3 mp -120.04 152.51 37.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.91 -1.041 . . . . 1.72 109.204 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.53 100.14 10.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -91.13 123.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.347 0.594 . . . . 1.1000000000000001 111.352 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.684 ' HD1' HG23 ' B' ' 4' ' ' THR . 3.4 t80 -126.24 163.4 23.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.317 -0.856 . . . . 4.8399999999999999 108.721 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.91 139.25 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.706 -0.398 . . . . 0.97999999999999998 110.686 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 81.26 2.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.345 -0.388 . . . . 1.1499999999999999 110.335 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 55.26 -80.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.637 -1.165 . . . . 1.8300000000000001 112.843 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 3.68 19.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.08 0.4 . . . . 2.54 112.08 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -143.38 170.79 15.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 1.5700000000000001 112.611 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.595 HD12 HD12 ' B' ' 18' ' ' ILE . 31.5 mt -106.58 139.06 29.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.973 -1.012 . . . . 1.1499999999999999 110.257 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.628 HD12 HD12 ' B' ' 44' ' ' ILE . 22.4 mm -121.64 107.07 19.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 1.05 109.458 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.615 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.6 118.55 28.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.912 0.863 . . . . 1.9299999999999999 111.362 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 32.9 ttpt -102.64 165.43 11.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.197 -1.365 . . . . 2.0 107.932 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.685 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 57.5 pttt -66.43 147.91 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.524 -0.917 . . . . 3.1099999999999999 108.524 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 t80 . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 120.173 -0.611 . . . . 3.9199999999999999 109.402 178.474 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.615 0.722 . . . . 0.88 112.255 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.684 HG23 ' HD1' ' A' ' 37' ' ' TYR . 60.9 m 78.79 72.61 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.283 -1.326 . . . . 1.1200000000000001 111.345 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.92 36.53 10.12 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.983 -1.008 . . . . 0.33000000000000002 111.28 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tp -107.3 137.6 37.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.102 0.477 . . . . 1.0700000000000001 109.931 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.556 ' CG2' ' HB2' ' A' ' 33' ' ' ALA . 6.6 p -88.17 129.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 116.278 -0.419 . . . . 1.0900000000000001 111.163 -173.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 2.5 mpt_? -126.43 155.91 41.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.729 -0.214 . . . . 2.3900000000000001 111.074 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' B' ' 9' ' ' LYS . 10.4 mmpt? -81.28 162.38 23.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.847 -0.427 . . . . 2.04 109.847 176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.16 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.117 0.484 . . . . 1.0700000000000001 110.513 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.471 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 6.6 t70 172.91 -76.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.794 -0.817 . . . . 1.6599999999999999 108.794 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.791 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.2 pt-20 -166.65 -76.8 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.693 -1.14 . . . . 1.9099999999999999 108.754 170.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.677 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.3 pp -76.8 -6.16 51.16 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.435 -1.711 . . . . 1.4299999999999999 112.644 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.35 -16.02 3.89 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.317 -1.421 . . . . 0.31 113.692 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.4 ttt180 -56.17 99.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.334 0.567 . . . . 0.93999999999999995 111.6 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.0 p -93.83 139.89 17.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.159 -0.473 . . . . 1.6499999999999999 109.955 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.427 HG23 ' HG3' ' A' ' 15' ' ' ARG . 25.6 t -79.99 100.52 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.903 0.383 . . . . 1.1000000000000001 111.63 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.595 HD12 HD12 ' A' ' 43' ' ' ILE . 36.8 mm -68.74 131.94 91.02 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 1.3100000000000001 110.79 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.541 ' HD2' HD12 ' B' ' 22' ' ' LEU . 93.5 Cg_exo -48.23 139.03 22.23 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.269 2.646 . . . . 0.34000000000000002 113.279 173.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.03 -32.17 43.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 1.3600000000000001 110.851 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -72.43 -25.05 61.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.499 . . . . 1.3500000000000001 110.037 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.763 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -81.81 -48.41 11.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.1000000000000001 109.537 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -30.34 71.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.847 -0.797 . . . . 1.9099999999999999 108.847 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.04 -39.34 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.264 -0.88 . . . . 3.1800000000000002 111.217 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.71 -38.09 83.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.391 0.615 . . . . 1.04 110.417 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -87.44 -10.71 51.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 1.1100000000000001 109.742 -174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 30.52 75.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.217 -0.901 . . . . 0.34000000000000002 112.647 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.648 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.9 pt -110.75 166.91 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.094 0.474 . . . . 1.25 111.141 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.41 150.71 1.47 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.978 -1.01 . . . . 1.05 110.391 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.905 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.6 pt-20 34.65 -87.3 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.43 1.641 . . . . 1.1200000000000001 115.43 171.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.41 -11.88 61.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.485 0.55 . . . . 1.28 112.485 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -78.75 177.13 8.91 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.165 0.507 . . . . 1.3700000000000001 111.443 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -125.18 155.47 39.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.675 0.75 . . . . 1.05 112.577 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.8 mp -121.99 154.85 36.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.63 -1.168 . . . . 1.8500000000000001 108.8 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.826 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 40.6 mt-10 -102.48 104.3 14.73 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.169 -0.678 . . . . 1.3999999999999999 109.169 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.981 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -89.83 123.29 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.857 -0.61 . . . . 1.0900000000000001 110.953 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.694 ' HD1' HG22 ' A' ' 4' ' ' THR . 3.8 t80 -124.3 158.82 31.67 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.115 -0.698 . . . . 4.8300000000000001 109.115 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.29 137.18 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.811 -0.356 . . . . 1.05 110.495 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' B' ' 42' ' ' LYS . 37.0 t70 -128.76 82.46 2.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 1.1200000000000001 111.108 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 61.19 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.949 -1.023 . . . . 1.6399999999999999 112.322 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.44 9.46 15.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.579 -0.737 . . . . 2.8100000000000001 111.042 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.642 ' HD2' HD13 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -138.41 169.16 18.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.139 -0.482 . . . . 1.71 111.206 -177.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.595 HD12 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -115.26 139.47 41.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 1.1299999999999999 110.625 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' B' ' 42' ' ' LYS . 19.6 mm -117.71 116.0 50.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.527 -0.545 . . . . 1.1000000000000001 109.527 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.981 HD22 HG13 ' B' ' 36' ' ' ILE . 1.0 OUTLIER -115.89 110.41 18.97 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.287 -0.565 . . . . 1.95 109.806 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -95.83 162.06 13.75 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.0 -1.111 . . . . 1.73 108.0 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 56.5 pttt -66.82 148.27 52.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.813 -0.81 . . . . 2.8700000000000001 108.813 169.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.826 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 76.3 t80 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.673 -0.862 . . . . 3.6899999999999999 108.673 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.35 0.595 . . . . 0.92000000000000004 111.066 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.0 m 68.86 56.18 0.43 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.18 -0.918 . . . . 1.2 110.931 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.58 34.32 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.462 -0.79 . . . . 0.34000000000000002 112.362 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 tp -105.19 136.68 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 120.928 0.394 . . . . 1.3300000000000001 110.086 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -90.67 128.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.946 0.403 . . . . 1.1599999999999999 110.691 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpt_? -125.96 157.12 38.59 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.171 -0.33 . . . . 2.6600000000000001 110.497 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.35 158.39 15.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.123 -0.325 . . . . 1.9299999999999999 110.123 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -82.93 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.031 -0.729 . . . . 1.0600000000000001 109.031 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 14.7 t0 -153.96 -62.5 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.443 -0.577 . . . . 1.3200000000000001 109.443 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.583 ' HG3' ' H ' ' A' ' 13' ' ' LEU . 1.3 pt-20 -157.2 -85.34 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.131 -0.94 . . . . 1.3899999999999999 109.775 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.583 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -74.18 -15.47 61.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.768 -1.105 . . . . 1.22 111.759 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.68 -20.74 0.8 Allowed Glycine 0 C--O 1.222 -0.647 0 C-N-CA 119.853 -1.165 . . . . 0.34000000000000002 114.063 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 4.3 ttt180 -52.9 106.41 0.16 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.104 0.952 . . . . 1.54 111.976 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -101.84 141.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.82 . . . . 1.6899999999999999 109.433 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.562 HG21 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.55 100.08 3.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 1.1599999999999999 111.452 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.07 133.43 89.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 1.3300000000000001 110.582 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 76.7 Cg_exo -46.61 140.67 11.99 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.297 2.664 . . . . 0.34999999999999998 113.243 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.21 -30.09 48.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.028 -0.533 . . . . 1.6399999999999999 110.129 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.142 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.751 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 9.3 mt -82.74 -47.99 11.35 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.883 -0.599 . . . . 1.1100000000000001 109.657 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -33.94 76.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.432 -0.951 . . . . 2.4100000000000001 108.432 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -61.37 -42.94 99.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.121 -0.945 . . . . 3.4100000000000001 111.653 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -33.75 74.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.132 0.491 . . . . 1.1299999999999999 110.829 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.6 mt -89.55 -9.1 51.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 1.1000000000000001 109.744 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.7 76.96 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.419 -0.81 . . . . 0.28000000000000003 112.52 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 26' ' ' LEU . 21.8 pt -113.55 166.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.985 0.422 . . . . 1.24 111.403 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.4 152.01 3.19 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.11 -0.95 . . . . 1.03 109.863 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.747 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 4.3 pt-20 31.05 -89.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.901 1.815 . . . . 1.22 115.901 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.484 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.9 mmpt? -78.76 6.73 8.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.468 0.914 . . . . 1.51 113.468 -171.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' B' ' 9' ' ' LYS . 10.9 m-20 -87.39 175.16 8.12 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.071 -0.393 . . . . 1.54 110.494 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.464 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.59 154.05 41.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.653 0.739 . . . . 1.0600000000000001 112.72 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.6 mp -122.94 154.97 37.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.461 -1.245 . . . . 1.72 108.28 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -106.35 104.22 13.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.269 -0.641 . . . . 1.28 109.269 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.55 122.98 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.341 0.591 . . . . 1.1000000000000001 111.561 -174.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 2.2 m-85 -113.1 171.89 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.821 -1.177 . . . . 4.8399999999999999 107.821 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.0 p -124.59 142.9 39.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.519 -0.472 . . . . 0.97999999999999998 110.651 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -133.48 90.96 2.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.285 -0.416 . . . . 1.1499999999999999 110.115 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 56.88 -96.45 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.606 -0.725 . . . . 1.8300000000000001 111.393 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -116.02 11.81 15.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.412 -0.813 . . . . 2.54 110.229 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -113.99 156.39 24.16 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.304 -0.407 . . . . 1.5700000000000001 110.03 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 HD11 ' B' ' 18' ' ' ILE . 46.4 mt -108.36 138.36 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.221 -0.659 . . . . 1.1499999999999999 109.221 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.539 HD12 HD11 ' B' ' 44' ' ' ILE . 17.4 mm -124.55 107.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.421 -0.585 . . . . 1.05 109.421 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.899 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.33 110.99 16.79 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.225 1.012 . . . . 1.9299999999999999 111.057 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -93.36 165.86 12.57 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.74 -1.573 . . . . 2.0 108.156 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 61.5 pttt -63.75 148.37 49.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.394 -0.595 . . . . 3.1099999999999999 109.394 169.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.325 -0.499 0 N-CA-C 109.458 -0.571 . . . . 3.9199999999999999 109.458 176.468 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.562 0.696 . . . . 0.88 111.732 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 9.2 m 69.59 63.94 0.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.61 -1.177 . . . . 1.1200000000000001 111.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 37.45 4.13 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.269 -0.878 . . . . 0.33000000000000002 112.196 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -106.2 135.47 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.053 0.454 . . . . 1.0700000000000001 109.898 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.464 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.3 p -87.74 126.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.923 0.392 . . . . 1.0900000000000001 111.066 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 2.1 mpt_? -123.3 154.08 39.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.282 -0.261 . . . . 2.3900000000000001 110.514 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 32' ' ' ASP . 2.0 tpmt? -89.51 159.99 16.95 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.639 -0.504 . . . . 2.04 109.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.0 t -82.85 -117.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.067 -0.345 . . . . 1.0700000000000001 110.067 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.47 ' H ' ' HB ' ' B' ' 10' ' ' VAL . 35.9 t0 -178.25 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.558 -0.534 . . . . 1.6599999999999999 109.558 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.747 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.7 pt-20 -161.18 -84.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.253 -0.885 . . . . 1.9099999999999999 110.381 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.534 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -68.52 -33.42 74.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.42 -0.809 . . . . 1.4299999999999999 111.459 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.74 -9.8 0.08 OUTLIER Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.654 -1.26 . . . . 0.31 113.393 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.0 mtt180 -54.65 104.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.183 0.492 . . . . 0.93999999999999995 111.967 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.7 p -100.3 141.02 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.341 -0.614 . . . . 1.6499999999999999 109.341 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 39.3 t -79.6 101.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.968 0.413 . . . . 1.1000000000000001 111.206 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 43' ' ' ILE . 26.1 mm -66.64 136.67 94.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 1.3100000000000001 110.175 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.553 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.2 138.42 28.88 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.633 2.222 . . . . 0.34000000000000002 112.321 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -61.6 -30.6 48.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.004 -0.544 . . . . 1.3600000000000001 110.143 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.11 -28.07 65.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 1.3500000000000001 110.55 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 6.4 mt -80.02 -46.83 15.9 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.38 0.609 . . . . 1.1000000000000001 109.515 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 32.8 ptt85 -66.49 -33.0 74.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.622 -0.881 . . . . 1.9099999999999999 108.622 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 11.8 ttm180 -61.5 -38.61 87.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.684 -0.689 . . . . 3.1800000000000002 110.781 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 99.2 m -63.42 -35.94 82.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.39 0.614 . . . . 1.04 110.629 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.755 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 2.7 mt -88.71 -5.96 57.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.506 -0.77 . . . . 1.1100000000000001 109.364 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.62 28.64 65.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.028 -0.987 . . . . 0.34000000000000002 112.47 -174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.692 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.0 pt -109.9 167.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.593 . . . . 1.25 111.504 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -173.51 151.62 1.98 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.782 -1.099 . . . . 1.05 109.468 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.1 pt-20 36.11 -86.76 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.415 1.635 . . . . 1.1200000000000001 115.415 171.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -79.86 5.05 14.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.156 0.799 . . . . 1.28 113.156 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -89.28 173.21 8.52 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.496 -0.482 . . . . 1.3700000000000001 110.486 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.5 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.81 154.38 38.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.335 0.588 . . . . 1.05 112.099 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.6 mp -122.25 153.74 38.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.946 -1.025 . . . . 1.8500000000000001 108.996 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 21.7 mt-10 -101.74 108.01 19.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.4 -0.593 . . . . 1.3999999999999999 109.4 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.522 ' N ' HD12 ' B' ' 36' ' ' ILE . 1.9 mp -95.08 122.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.641 0.734 . . . . 1.0900000000000001 111.546 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 14.5 m-85 -113.07 171.94 7.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.613 -1.255 . . . . 4.8300000000000001 107.613 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . 0.436 HG11 ' OG1' ' A' ' 4' ' ' THR . 10.5 p -128.18 142.96 42.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.161 -0.616 . . . . 1.05 110.68 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -134.0 91.04 2.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.126 -0.488 . . . . 1.1200000000000001 110.053 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.99 -91.28 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.62 -0.718 . . . . 1.6399999999999999 111.817 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.2 10.84 8.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.808 -0.633 . . . . 2.8100000000000001 110.281 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -114.57 154.16 28.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.125 -0.695 . . . . 1.71 109.125 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.864 ' HB ' HD13 ' A' ' 45' ' ' LEU . 46.5 mt -107.58 137.84 36.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.996 -0.372 . . . . 1.1299999999999999 109.996 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 44' ' ' ILE . 17.5 mm -113.52 118.24 57.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.176 -0.675 . . . . 1.1000000000000001 109.176 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.504 ' N ' HD12 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -123.99 107.82 11.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.546 0.689 . . . . 1.95 109.933 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 31.9 ttpt -96.62 163.13 13.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.731 -1.211 . . . . 1.73 107.731 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.755 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 24.4 pttm -71.11 150.24 45.67 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.855 -0.795 . . . . 2.8700000000000001 108.855 171.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.441 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 46.2 t80 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.629 . . . . 3.6899999999999999 109.3 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . 0.436 ' OG ' HD11 ' A' ' 22' ' ' LEU . 72.3 m . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.92000000000000004 111.436 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 ' HD1' ' B' ' 37' ' ' TYR . 5.8 m 62.27 55.55 2.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.091 -0.959 . . . . 1.2 110.776 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.89 35.89 4.69 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.489 -0.778 . . . . 0.34000000000000002 112.159 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 10.2 tp -93.43 160.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.946 -1.131 . . . . 1.3300000000000001 107.946 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -124.67 126.65 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.792 -0.447 . . . . 1.1599999999999999 109.792 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' CZ ' ' HG3' ' A' ' 19' ' ' PRO . 9.7 mtt-85 -137.17 170.73 15.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.758 0.314 . . . . 2.6600000000000001 110.806 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.9 mmpt? -91.8 162.6 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 1.9299999999999999 111.273 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' B' ' 30' ' ' GLU . 1.4 t -85.08 -133.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 1.0600000000000001 108.051 168.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.92 -67.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.698 -0.482 . . . . 1.3200000000000001 109.698 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 3.0 pt-20 -140.9 -94.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 1.3899999999999999 111.515 169.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.579 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -66.1 -28.22 68.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.397 0.518 . . . . 1.22 112.397 -172.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.51 -5.56 0.05 OUTLIER Glycine 0 C--O 1.222 -0.616 0 C-N-CA 119.782 -1.199 . . . . 0.34000000000000002 114.158 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 31.9 mtt180 -58.56 104.94 0.25 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.073 0.936 . . . . 1.54 111.708 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.678 HG11 HD23 ' B' ' 45' ' ' LEU . 7.2 p -96.14 138.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.995 -0.743 . . . . 1.6899999999999999 108.995 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' B' ' 15' ' ' ARG . 25.5 t -79.0 100.62 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.47 -0.332 . . . . 1.1599999999999999 111.263 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.1 mm -67.67 128.71 93.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 1.3300000000000001 110.147 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.801 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 87.8 Cg_exo -47.72 141.92 15.07 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.256 2.637 . . . . 0.34999999999999998 113.17 173.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 10.5 tt -59.28 -34.67 54.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.19 -0.459 . . . . 1.6399999999999999 110.795 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.45 -27.93 64.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.384 0.611 . . . . 1.73 110.256 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.801 ' HG ' ' HB2' ' A' ' 19' ' ' PRO . 5.0 mt -80.45 -46.93 15.11 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.537 -0.756 . . . . 1.1100000000000001 109.141 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' HG13 ' A' ' 28' ' ' ILE . 13.3 ptt180 -65.37 -32.38 73.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.31 -0.996 . . . . 2.4100000000000001 108.31 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 2.3 tmt_? -65.05 -35.81 82.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.077 -0.965 . . . . 3.4100000000000001 110.272 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -64.73 -37.02 86.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.337 0.589 . . . . 1.1299999999999999 110.463 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -89.25 -14.11 36.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 1.1000000000000001 109.886 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.4 30.73 77.1 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.262 -0.881 . . . . 0.28000000000000003 112.387 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 23' ' ' ARG . 14.0 pt -103.98 165.97 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.984 0.421 . . . . 1.24 111.229 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.45 146.87 0.49 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.929 -1.032 . . . . 1.03 109.773 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.416 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 2.9 pt-20 35.0 -89.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.447 1.647 . . . . 1.22 115.447 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -80.86 5.49 15.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.28 0.845 . . . . 1.51 113.28 -172.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.72 176.75 9.09 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.14 -0.624 . . . . 1.54 110.429 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -123.19 146.12 48.06 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.111 -0.95 . . . . 1.0600000000000001 112.213 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.5 mp -121.48 151.54 40.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.088 -0.96 . . . . 1.72 108.793 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 11.2 tt0 -108.31 106.45 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.994 -0.743 . . . . 1.28 108.994 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.72 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.1 126.59 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 112.023 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.593 ' HD1' ' HA ' ' B' ' 4' ' ' THR . 8.0 t80 -119.14 159.87 23.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.074 -1.084 . . . . 4.8399999999999999 108.074 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.95 143.09 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 121.833 -0.542 . . . . 0.97999999999999998 110.731 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -134.67 82.32 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 1.1499999999999999 110.653 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.0 t70 55.8 -90.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.573 -1.194 . . . . 1.8300000000000001 112.641 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -88.86 -23.03 22.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.54 110.349 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.775 ' HE2' HD13 ' A' ' 44' ' ' ILE . 20.1 pttm -119.32 158.12 26.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.463 -0.79 . . . . 1.5700000000000001 112.236 -167.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.611 HD11 HD11 ' B' ' 26' ' ' LEU . 49.7 mt -110.36 139.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.265 -0.879 . . . . 1.1499999999999999 109.547 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.775 HD13 ' HE2' ' A' ' 42' ' ' LYS . 13.4 mm -118.26 120.41 64.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.013 -0.54 . . . . 1.05 109.593 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.72 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -130.46 123.94 30.9 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.44 -0.904 . . . . 1.9299999999999999 111.886 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 41' ' ' GLU . 38.6 ttpt -115.59 170.23 8.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.011 -1.107 . . . . 2.0 108.011 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HG3' ' CG2' ' A' ' 28' ' ' ILE . 44.5 tttm -63.81 146.05 54.65 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.496 -0.557 . . . . 3.1099999999999999 109.496 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.423 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 67.0 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.563 -0.29 . . . . 3.9199999999999999 110.764 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.0 -0.37 . . . . 0.88 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.593 ' HA ' ' HD1' ' A' ' 37' ' ' TYR . 25.7 m 62.84 63.26 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.865 0.84 . . . . 1.1200000000000001 110.783 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.95 38.37 5.77 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.188 -0.915 . . . . 0.33000000000000002 111.95 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 tp -108.91 138.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 1.0700000000000001 110.547 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 33' ' ' ALA . 7.8 p -94.64 134.21 32.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.109 0.481 . . . . 1.0900000000000001 112.028 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' B' ' 8' ' ' ARG . 0.6 OUTLIER -136.6 174.46 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 2.3900000000000001 110.178 171.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -98.27 160.29 14.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.211 -0.45 . . . . 2.04 110.363 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -82.36 -133.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.686 -1.598 . . . . 1.0700000000000001 106.686 166.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 28.2 t70 -177.95 -51.47 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.301 0.572 . . . . 1.6599999999999999 110.883 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -125.32 -124.85 0.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.354 -0.839 . . . . 1.9099999999999999 111.408 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -70.45 -8.65 52.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 1.4299999999999999 112.377 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.41 -8.86 0.32 Allowed Glycine 0 C--O 1.219 -0.804 0 C-N-CA 119.749 -1.215 . . . . 0.31 112.535 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 39.4 mtt180 -58.96 100.24 0.06 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.918 0.39 . . . . 0.93999999999999995 111.595 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.9 p -94.33 137.85 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 1.6499999999999999 109.092 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 15' ' ' ARG . 44.0 t -79.66 101.15 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.246 -0.434 . . . . 1.1000000000000001 111.535 -172.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.69 132.16 91.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 1.3100000000000001 110.512 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.585 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 91.0 Cg_exo -47.88 140.41 18.18 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.155 2.57 . . . . 0.34000000000000002 113.125 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 8.9 tt -57.91 -35.15 50.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.978 -0.555 . . . . 1.3600000000000001 110.73 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.05 -23.91 60.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.219 0.533 . . . . 1.3500000000000001 110.506 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.748 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 10.6 mt -82.68 -47.75 11.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.299 -0.63 . . . . 1.1000000000000001 109.299 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 4.4 ppt_? -65.81 -28.21 68.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.433 -0.951 . . . . 1.9099999999999999 108.433 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -62.48 -47.65 83.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.979 -1.009 . . . . 3.1800000000000002 111.027 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -57.17 -37.84 72.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.522 0.677 . . . . 1.04 110.874 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.7 mt -85.91 -19.77 30.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.415 -0.811 . . . . 1.1100000000000001 109.922 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.46 33.07 71.95 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.704 -0.68 . . . . 0.34000000000000002 112.249 -171.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.2 pt -110.91 166.38 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-O 120.685 0.279 . . . . 1.25 110.84 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.35 150.69 0.58 Allowed 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.29 0.994 . . . . 1.05 110.192 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.15 -89.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.549 1.685 . . . . 1.1200000000000001 115.549 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.5 mmpt? -82.43 4.98 22.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.978 0.733 . . . . 1.28 112.978 -172.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.63 171.15 15.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 1.3700000000000001 110.83 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.75 144.72 46.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.366 0.603 . . . . 1.05 111.882 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.4 mp -118.55 149.74 40.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.179 -0.919 . . . . 1.8500000000000001 108.917 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 7.5 tt0 -104.45 101.44 11.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.544 -0.753 . . . . 1.3999999999999999 108.99 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.533 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.0 mp -90.71 126.39 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.671 0.748 . . . . 1.0900000000000001 112.016 -175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.538 ' HD1' HG22 ' A' ' 4' ' ' THR . 2.1 t80 -118.04 160.42 21.52 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.836 -1.172 . . . . 4.8300000000000001 107.836 171.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.92 140.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.53 -0.468 . . . . 1.05 110.301 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -136.88 86.84 2.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.123 0.487 . . . . 1.1200000000000001 110.592 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.17 -97.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.026 -0.988 . . . . 1.6399999999999999 112.402 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 36.1 mt-10 -102.88 -4.6 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 2.8100000000000001 110.417 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.467 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 26.0 pttm -124.03 159.09 30.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.361 0.6 . . . . 1.71 112.0 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.694 ' HB ' HD13 ' A' ' 45' ' ' LEU . 60.2 mt -111.31 138.98 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.254 -0.885 . . . . 1.1299999999999999 109.725 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.749 HD13 HD12 ' A' ' 44' ' ' ILE . 18.7 mm -115.05 121.43 67.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.621 -0.718 . . . . 1.1000000000000001 109.3 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.678 HD23 HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.05 111.46 14.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.077 0.942 . . . . 1.95 110.937 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 34.1 ttpt -104.75 169.75 8.27 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.826 -1.534 . . . . 1.73 107.806 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.418 ' N ' ' HG2' ' B' ' 46' ' ' LYS . 60.3 tttm -73.85 145.26 45.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.591 -0.522 . . . . 2.8700000000000001 109.591 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 3.6899999999999999 110.145 178.919 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 108.847 -0.798 . . . . 0.92000000000000004 108.847 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.637 HG23 ' HD1' ' B' ' 37' ' ' TYR . 15.2 m 66.85 69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 1.2 111.692 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.62 42.07 5.87 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.705 -0.759 . . . . 0.34000000000000002 111.638 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tp -115.64 141.93 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 1.3300000000000001 110.514 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.3 p -88.35 129.59 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.042 -0.526 . . . . 1.1599999999999999 111.303 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -127.26 163.34 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.65 -0.25 . . . . 2.6600000000000001 110.378 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.9 mmpt? -89.54 162.09 15.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.501 -0.318 . . . . 1.9299999999999999 110.654 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.77 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.757 -0.831 . . . . 1.0600000000000001 108.757 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.552 ' HB2' ' HE ' ' B' ' 15' ' ' ARG . 25.4 t70 -159.6 -66.14 0.08 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.699 -0.852 . . . . 1.3200000000000001 108.699 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.842 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.7 pt-20 -153.47 -84.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.02 -0.991 . . . . 1.3899999999999999 110.254 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.565 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -75.98 -14.92 60.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.89 -1.05 . . . . 1.22 112.492 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.595 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 157.46 -11.2 0.25 Allowed Glycine 0 C--O 1.22 -0.778 0 C-N-CA 119.513 -1.327 . . . . 0.34000000000000002 114.546 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.7 ttt180 -66.13 99.66 0.54 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.54 1.17 . . . . 1.54 112.131 -177.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 20.8 m -95.97 141.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 1.6899999999999999 110.428 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.505 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.29 103.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.379 -0.373 . . . . 1.1599999999999999 110.777 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.669 HG22 HD11 ' B' ' 43' ' ' ILE . 21.0 mt -85.38 133.89 41.51 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 1.3300000000000001 110.335 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 43.9 Cg_exo -40.87 138.32 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.094 3.196 . . . . 0.34999999999999998 114.405 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -58.42 -31.41 42.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 1.6399999999999999 110.285 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.67 -26.76 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 1.73 110.238 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.2 mt -81.11 -47.34 13.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.995 -0.548 . . . . 1.1100000000000001 109.774 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.594 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 1.9 ptt180 -63.28 -35.78 81.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.051 -1.092 . . . . 2.4100000000000001 108.051 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.594 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 3.1 tmt_? -61.94 -37.31 84.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.731 -1.122 . . . . 3.4100000000000001 110.893 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.58 -34.8 78.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.344 0.592 . . . . 1.1299999999999999 110.549 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.6 mt -87.89 -9.05 54.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 1.1000000000000001 109.793 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.89 66.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.275 -0.875 . . . . 0.28000000000000003 112.269 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.575 HD13 HD11 ' A' ' 34' ' ' LEU . 2.4 pp -112.07 169.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 1.24 111.257 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 179.67 157.31 0.63 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.441 -0.8 . . . . 1.03 110.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.867 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 35.22 -90.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.378 1.621 . . . . 1.22 115.378 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.454 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -75.56 -4.5 40.29 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.882 0.697 . . . . 1.51 112.882 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 -178.44 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.508 -0.477 . . . . 1.54 111.409 -172.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.526 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -125.91 152.46 45.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.704 0.764 . . . . 1.0600000000000001 112.842 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 28' ' ' ILE . 7.1 mp -127.94 156.89 41.92 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.477 -1.238 . . . . 1.72 107.855 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -105.83 107.6 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.117 -0.697 . . . . 1.28 109.117 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.502 HG13 HD23 ' A' ' 45' ' ' LEU . 1.8 mp -92.79 122.85 44.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.639 -0.71 . . . . 1.1000000000000001 111.217 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.722 ' HD1' HG21 ' B' ' 4' ' ' THR . 0.8 OUTLIER -124.44 159.94 29.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.207 -0.906 . . . . 4.8399999999999999 108.79 175.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.1 135.66 55.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.754 -0.379 . . . . 0.97999999999999998 110.524 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.04 96.07 3.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.977 -0.379 . . . . 1.1499999999999999 109.977 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 64.71 -97.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.13 -0.941 . . . . 1.8300000000000001 110.783 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.04 10.86 8.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.085 -0.961 . . . . 2.54 109.489 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -111.17 156.52 21.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.382 -0.826 . . . . 1.5700000000000001 109.586 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' B' ' 45' ' ' LEU . 38.0 mt -110.21 133.4 55.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.115 -0.493 . . . . 1.1499999999999999 109.838 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.786 HD11 HD12 ' B' ' 44' ' ' ILE . 15.8 mm -117.45 112.71 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.406 -0.59 . . . . 1.05 109.406 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.588 HD21 HG23 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -121.19 108.97 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.266 -0.573 . . . . 1.9299999999999999 109.505 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -107.05 141.18 38.69 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.012 -1.107 . . . . 2.0 108.012 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 20.9 ptmt -47.8 139.16 7.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.914 0.324 . . . . 3.1099999999999999 110.375 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.899 -0.778 . . . . 3.9199999999999999 108.899 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.31 -0.626 . . . . 0.88 109.31 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.722 HG21 ' HD1' ' A' ' 37' ' ' TYR . 20.6 m 64.78 67.07 0.56 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.703 0.763 . . . . 1.1200000000000001 111.466 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.95 38.53 5.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.284 -0.871 . . . . 0.33000000000000002 111.975 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.16 139.03 28.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.493 -0.558 . . . . 1.0700000000000001 109.493 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.526 ' CG2' ' HB3' ' A' ' 33' ' ' ALA . 7.7 p -90.1 125.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 120.971 0.415 . . . . 1.0900000000000001 110.81 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 1.2 tpt180 -124.18 160.06 28.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 2.3900000000000001 110.345 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' B' ' 9' ' ' LYS . 10.2 mmpt? -87.26 163.12 17.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.415 -0.357 . . . . 2.04 110.65 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.42 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.049 -0.352 . . . . 1.0700000000000001 110.049 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.498 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 26.9 t70 173.11 -68.97 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.969 -0.752 . . . . 1.6599999999999999 108.969 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.867 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.8 pt-20 -166.56 -85.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.751 -1.113 . . . . 1.9099999999999999 109.872 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.691 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.318 -0.856 . . . . 1.4299999999999999 112.155 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 18' ' ' ILE . . . 164.35 -3.13 0.06 OUTLIER Glycine 0 C--O 1.224 -0.475 0 C-N-CA 119.617 -1.278 . . . . 0.31 113.442 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 1.7 ttt180 -65.67 97.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.101 0.451 . . . . 0.93999999999999995 111.764 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 18.5 m -94.12 144.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 1.6499999999999999 110.32 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 40.8 t -81.84 104.53 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.36 -0.382 . . . . 1.1000000000000001 110.873 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.705 HG22 HD12 ' A' ' 43' ' ' ILE . 2.3 mt -80.68 138.96 50.6 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.308 -0.256 . . . . 1.3100000000000001 110.308 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.614 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 59.1 Cg_exo -42.96 135.3 5.33 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.449 2.766 . . . . 0.34000000000000002 113.809 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.69 -32.22 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.471 -0.786 . . . . 1.3600000000000001 110.727 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.96 -23.46 60.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.132 0.492 . . . . 1.3500000000000001 110.499 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.706 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -81.9 -46.99 13.32 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.161 -0.472 . . . . 1.1000000000000001 109.769 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 6.9 ptt180 -63.41 -35.47 80.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.174 -1.047 . . . . 1.9099999999999999 108.174 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.587 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 51.2 ttt180 -56.98 -44.92 83.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.555 -1.202 . . . . 3.1800000000000002 110.821 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 89.7 m -59.29 -37.31 77.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 1.04 110.615 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.838 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 3.2 mt -86.74 -8.41 57.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 1.1100000000000001 109.759 -175.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 31.96 81.3 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.311 -0.859 . . . . 0.34000000000000002 112.133 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.791 HG12 ' HB2' ' B' ' 26' ' ' LEU . 10.9 pt -120.43 169.09 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 1.25 111.007 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.77 157.46 1.21 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.951 -1.022 . . . . 1.05 110.172 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pt-20 39.65 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.381 1.623 . . . . 1.1200000000000001 115.381 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -81.49 6.79 13.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.681 0.622 . . . . 1.28 112.681 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -86.02 176.67 7.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.373 . . . . 1.3700000000000001 110.951 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.548 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -124.38 152.98 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.656 0.741 . . . . 1.05 112.936 -175.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.4 mp -124.53 157.09 36.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.69 -1.141 . . . . 1.8500000000000001 109.143 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.56 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 46.5 mt-10 -102.9 105.47 15.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.874 -0.603 . . . . 1.3999999999999999 109.392 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.734 HG13 ' HB3' ' B' ' 45' ' ' LEU . 1.9 mp -91.89 122.51 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.282 0.563 . . . . 1.0900000000000001 111.207 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.637 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.4 OUTLIER -124.38 161.04 26.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 4.8300000000000001 108.961 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.56 136.26 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.845 -0.342 . . . . 1.05 110.605 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -128.23 89.21 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.828 0.347 . . . . 1.1200000000000001 110.077 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 60.42 -90.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.334 -0.848 . . . . 1.6399999999999999 111.041 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.51 7.34 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.867 -0.606 . . . . 2.8100000000000001 110.427 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -104.31 158.23 16.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.648 -0.501 . . . . 1.71 109.648 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 18' ' ' ILE . 28.5 mt -109.13 134.49 50.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.059 -0.719 . . . . 1.1299999999999999 109.059 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.786 HD12 HD11 ' A' ' 44' ' ' ILE . 15.6 mm -123.23 108.73 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.373 -0.603 . . . . 1.1000000000000001 109.373 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.953 HD11 ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -120.88 110.96 16.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.177 0.989 . . . . 1.95 111.03 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' B' ' 47' ' ' LYS . 30.0 ttpt -90.71 161.33 15.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.747 -1.57 . . . . 1.73 107.843 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 45.9 pttt -64.19 137.99 58.22 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.849 -0.426 . . . . 2.8700000000000001 109.849 171.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.56 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 88.0 t80 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.183 -0.673 . . . . 3.6899999999999999 109.183 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.454 0.645 . . . . 0.92000000000000004 111.741 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 3.9 m 65.88 65.26 0.53 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.019 -0.991 . . . . 1.2 111.452 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.42 37.2 3.84 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 114.944 -1.026 . . . . 0.34000000000000002 111.932 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tp -107.29 138.89 31.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.969 -0.382 . . . . 1.3300000000000001 109.969 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' B' ' 33' ' ' ALA . 7.4 p -89.13 127.78 41.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.898 0.38 . . . . 1.1599999999999999 111.0 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -123.57 164.8 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 2.6600000000000001 110.492 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HZ2' ' HB1' ' B' ' 33' ' ' ALA . 29.6 mmmt -98.95 158.62 15.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.447 -0.342 . . . . 1.9299999999999999 110.317 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.58 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.988 -0.745 . . . . 1.0600000000000001 108.988 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.559 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 20.8 t70 -155.6 -66.01 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.957 -0.757 . . . . 1.3200000000000001 108.957 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.9 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.4 pt-20 -156.01 -82.82 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.698 -1.137 . . . . 1.3899999999999999 109.098 168.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.526 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -60.16 -38.13 82.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 1.22 111.62 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -15.19 0.08 OUTLIER Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.572 -1.299 . . . . 0.34000000000000002 114.552 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.96 104.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.251 1.025 . . . . 1.54 111.637 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.6 p -101.38 141.7 17.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 1.6899999999999999 109.692 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' B' ' 15' ' ' ARG . 45.1 t -78.84 108.65 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.262 -0.426 . . . . 1.1599999999999999 111.39 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.1 mm -74.26 132.94 78.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 1.3300000000000001 110.89 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' A' ' 22' ' ' LEU . 77.8 Cg_exo -46.93 140.83 12.8 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.403 2.735 . . . . 0.34999999999999998 113.298 173.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.937 HD12 ' HD2' ' A' ' 23' ' ' ARG . 4.2 tp -60.49 -32.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.606 -0.724 . . . . 1.6399999999999999 110.132 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.67 -26.29 63.37 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.128 0.489 . . . . 1.73 109.934 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.758 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 12.3 mt -82.1 -47.96 11.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.321 -0.622 . . . . 1.1100000000000001 109.321 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.937 ' HD2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -64.31 -32.12 73.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.606 -0.887 . . . . 2.4100000000000001 108.606 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -63.74 -42.7 97.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.314 -0.857 . . . . 3.4100000000000001 111.397 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.3 m -61.41 -35.28 77.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.383 0.611 . . . . 1.1299999999999999 110.75 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.758 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -91.09 -10.53 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.452 -0.795 . . . . 1.1000000000000001 109.446 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.2 34.7 81.12 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.449 -0.796 . . . . 0.28000000000000003 112.22 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' HB2' ' A' ' 26' ' ' LEU . 13.9 pt -106.86 163.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.372 0.606 . . . . 1.24 111.665 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.97 148.96 1.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.462 -1.245 . . . . 1.03 109.373 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.868 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 2.5 pt-20 33.07 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.62 1.711 . . . . 1.22 115.62 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -76.04 4.9 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.509 0.929 . . . . 1.51 113.509 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.78 171.47 11.54 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.578 -0.449 . . . . 1.54 110.112 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.466 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -124.03 153.26 41.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.527 0.68 . . . . 1.0600000000000001 112.16 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.4 mp -123.09 153.38 40.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.813 -1.085 . . . . 1.72 108.22 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.6 106.16 16.38 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.717 -0.846 . . . . 1.28 108.717 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.801 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -89.8 124.42 42.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.292 -0.867 . . . . 1.1000000000000001 111.365 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.7 m-85 -115.06 172.8 6.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.471 -1.307 . . . . 4.8399999999999999 107.471 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.55 141.19 46.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 120.693 -0.403 . . . . 0.97999999999999998 110.173 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -129.32 76.84 1.75 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.491 . . . . 1.1499999999999999 110.19 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 54.03 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.254 -1.339 . . . . 1.8300000000000001 113.001 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -105.03 -13.43 15.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.978 -0.556 . . . . 2.54 110.777 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -115.25 158.73 21.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 1.5700000000000001 110.932 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HD12 ' B' ' 26' ' ' LEU . 59.0 mt -104.37 137.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.842 -0.799 . . . . 1.1499999999999999 108.842 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.565 HD11 HD12 ' B' ' 44' ' ' ILE . 15.9 mm -123.88 105.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.614 -0.513 . . . . 1.05 109.614 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.881 HD13 ' HB ' ' B' ' 43' ' ' ILE . 0.4 OUTLIER -119.62 118.71 31.69 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.316 -0.953 . . . . 1.9299999999999999 111.185 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 ttpt -102.88 165.13 11.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.97 -1.468 . . . . 2.0 107.882 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 81.8 tttt -65.22 137.02 57.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.064 -0.717 . . . . 3.1099999999999999 109.064 171.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 t80 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 109.371 -0.603 . . . . 3.9199999999999999 109.371 176.789 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.457 0.646 . . . . 0.88 112.002 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 3.9 m 69.33 59.37 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.703 -1.135 . . . . 1.1200000000000001 111.337 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.76 35.89 3.14 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.33000000000000002 112.282 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -109.52 136.92 43.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.975 0.417 . . . . 1.0700000000000001 110.761 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.3 p -88.94 125.37 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.982 0.42 . . . . 1.0900000000000001 111.688 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.94 165.93 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.509 -0.314 . . . . 2.3900000000000001 110.321 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -96.04 162.54 13.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.974 -0.38 . . . . 2.04 109.974 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.34 -108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.798 -0.361 . . . . 1.0700000000000001 110.293 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.487 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 7.0 t70 175.17 -77.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.107 -0.701 . . . . 1.6599999999999999 109.107 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.868 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -159.27 -71.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.045 -0.979 . . . . 1.9099999999999999 108.832 168.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.577 ' H ' HD21 ' B' ' 13' ' ' LEU . 2.4 pt? -77.74 -29.07 50.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.58 -1.191 . . . . 1.4299999999999999 111.271 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.46 -11.86 0.18 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 119.206 -1.473 . . . . 0.31 114.011 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.9 ttt180 -56.61 99.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.628 0.714 . . . . 0.93999999999999995 111.741 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.6 p -95.01 141.83 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.777 -0.453 . . . . 1.6499999999999999 109.777 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.38 109.44 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.406 . . . . 1.1000000000000001 111.071 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.491 HD11 HD12 ' A' ' 43' ' ' ILE . 30.8 mm -75.34 134.48 73.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.155 -0.475 . . . . 1.3100000000000001 110.701 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.635 ' HD2' HD13 ' B' ' 22' ' ' LEU . 92.9 Cg_exo -48.46 141.12 20.08 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.087 2.525 . . . . 0.34000000000000002 113.044 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.556 HD12 ' HD2' ' B' ' 23' ' ' ARG . 6.5 tp -59.93 -32.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.937 -0.574 . . . . 1.3600000000000001 110.222 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.47 -23.62 60.1 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.172 0.51 . . . . 1.3500000000000001 110.328 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.8 mt -81.36 -48.19 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.417 -0.586 . . . . 1.1000000000000001 109.417 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.556 ' HD2' HD12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -64.15 -33.48 75.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 1.9099999999999999 108.154 177.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.45 -47.11 85.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.191 -0.913 . . . . 3.1800000000000002 111.289 171.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -60.77 -35.14 75.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.358 0.599 . . . . 1.04 111.045 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 2.5 mt -90.36 -10.9 42.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 1.1100000000000001 109.785 -176.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 24.72 64.66 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 112.298 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.3 pt -96.98 166.53 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-O 121.293 0.568 . . . . 1.25 111.048 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.87 152.69 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.548 -1.206 . . . . 1.05 109.111 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.9 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.5 pt-20 33.78 -90.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.778 1.77 . . . . 1.1200000000000001 115.778 169.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.48 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.0 mmpt? -83.98 7.19 19.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.01 0.744 . . . . 1.28 113.01 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.48 174.54 9.96 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.129 -0.357 . . . . 1.3700000000000001 110.57 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.464 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -122.7 152.97 40.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.481 0.658 . . . . 1.05 112.453 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.5 mp -120.92 151.88 39.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.935 -1.03 . . . . 1.8500000000000001 108.979 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -104.18 102.35 12.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.652 -0.869 . . . . 1.3999999999999999 108.652 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.414 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.8 mp -90.07 124.88 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.391 0.615 . . . . 1.0900000000000001 111.68 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 7.3 m-85 -114.16 175.13 5.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.012 -1.107 . . . . 4.8300000000000001 108.012 171.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.25 143.11 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 110.008 -0.367 . . . . 1.05 110.008 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -132.94 77.13 1.72 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.827 0.346 . . . . 1.1200000000000001 110.628 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 t70 56.14 -75.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.565 -1.198 . . . . 1.6399999999999999 113.05 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -103.17 -25.44 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 2.8100000000000001 110.81 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' B' ' 42' ' ' LYS . 1.0 OUTLIER -111.62 160.06 17.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.857 -0.611 . . . . 1.71 111.127 -173.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.881 ' HB ' HD13 ' A' ' 45' ' ' LEU . 68.0 mt -105.58 138.16 32.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.459 -0.792 . . . . 1.1299999999999999 109.351 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.565 HD12 HD11 ' A' ' 44' ' ' ILE . 16.9 mm -114.64 112.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.491 -0.559 . . . . 1.1000000000000001 109.491 -175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.5 HD13 ' N ' ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.92 108.97 15.43 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.938 -0.705 . . . . 1.95 110.247 -178.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 35.4 ttpt -96.23 164.96 12.44 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.087 -1.079 . . . . 1.73 108.087 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 82.9 tttt -70.48 139.06 51.6 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.769 -0.826 . . . . 2.8700000000000001 108.769 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 56.0 t80 . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 108.823 -0.806 . . . . 3.6899999999999999 108.823 175.507 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.203 0.525 . . . . 0.92000000000000004 111.539 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.637 HG23 ' HD1' ' B' ' 37' ' ' TYR . 49.2 m 72.15 72.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.999 -1.0 . . . . 1.2 112.574 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 40.02 7.13 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.405 -0.816 . . . . 0.34000000000000002 111.756 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 tp -111.47 139.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.052 0.453 . . . . 1.3300000000000001 110.1 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' CG2' ' HB3' ' B' ' 33' ' ' ALA . 10.9 p -94.04 132.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.306 -0.406 . . . . 1.1599999999999999 111.205 -174.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 3.2 mpt_? -134.14 164.85 26.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.251 -0.431 . . . . 2.6600000000000001 110.498 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 0.8 OUTLIER -83.69 161.12 21.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.923 -0.58 . . . . 1.9299999999999999 109.611 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.35 -102.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 110.022 -0.362 . . . . 1.0600000000000001 110.022 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 17.2 t0 174.48 -73.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.712 -0.847 . . . . 1.3200000000000001 108.712 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.855 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.3 pt-20 -164.78 -80.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.398 -1.274 . . . . 1.3899999999999999 109.43 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.705 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.7 pt? -65.81 -31.48 72.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.053 -0.976 . . . . 1.22 112.032 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.62 -19.81 0.38 Allowed Glycine 0 C--O 1.221 -0.719 0 C-N-CA 119.783 -1.198 . . . . 0.34000000000000002 113.816 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.3 ttt180 -49.49 105.8 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.386 0.593 . . . . 1.54 112.385 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -97.39 141.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.175 -0.466 . . . . 1.6899999999999999 109.941 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.19 110.92 14.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 1.1599999999999999 111.8 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.512 HD13 HG21 ' B' ' 43' ' ' ILE . 40.7 mm -80.95 134.49 52.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 1.3300000000000001 110.597 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.653 ' HD2' HD12 ' A' ' 22' ' ' LEU . 80.4 Cg_exo -49.99 141.11 30.33 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.275 2.65 . . . . 0.34999999999999998 113.533 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.59 -33.3 54.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.651 -0.704 . . . . 1.6399999999999999 110.689 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.89 -23.54 62.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.155 0.503 . . . . 1.73 109.747 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.7 mt -82.22 -49.51 10.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.838 -0.619 . . . . 1.1100000000000001 109.875 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -65.29 -31.31 72.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.73 -0.841 . . . . 2.4100000000000001 108.73 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -39.54 94.66 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.525 -0.761 . . . . 3.4100000000000001 110.895 173.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -62.59 -33.28 74.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 1.1299999999999999 110.254 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.829 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.9 mt -88.43 -11.25 46.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.422 -0.808 . . . . 1.1000000000000001 109.573 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.03 24.39 66.92 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.252 -0.886 . . . . 0.28000000000000003 112.401 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.8 HG12 ' HB2' ' A' ' 26' ' ' LEU . 18.5 pt -107.71 166.55 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 1.24 111.467 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.38 146.39 0.63 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.812 -1.085 . . . . 1.03 109.807 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.961 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 37.5 -85.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 115.33 1.604 . . . . 1.22 115.33 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 30' ' ' GLU . 11.0 mmpt? -71.51 -1.42 13.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.91 0.707 . . . . 1.51 112.91 -173.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 175.98 8.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.99 0.424 . . . . 1.54 111.428 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -122.8 152.33 40.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.626 -0.715 . . . . 1.0600000000000001 112.59 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.8 mp -124.69 156.95 36.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.344 -1.354 . . . . 1.72 107.344 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 26.4 tt0 -108.03 107.96 18.87 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.204 -0.665 . . . . 1.28 109.204 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.611 HG13 HD11 ' A' ' 45' ' ' LEU . 2.0 mp -92.8 123.21 44.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.618 -0.719 . . . . 1.1000000000000001 111.282 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.65 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.05 162.56 25.75 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.201 -0.909 . . . . 4.8399999999999999 109.092 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.42 139.89 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.989 0.423 . . . . 0.97999999999999998 110.611 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.06 80.17 1.96 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.233 0.539 . . . . 1.1499999999999999 110.243 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.94 -77.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.353 -1.294 . . . . 1.8300000000000001 111.459 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.28 -31.47 6.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 2.54 110.639 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.694 ' HE2' HD11 ' A' ' 44' ' ' ILE . 25.2 pttm -96.8 156.34 16.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.196 -0.601 . . . . 1.5700000000000001 111.46 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.707 HD12 HD12 ' B' ' 26' ' ' LEU . 13.8 mt -107.06 137.67 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.462 -0.79 . . . . 1.1499999999999999 109.575 -176.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.694 HD11 ' HE2' ' A' ' 42' ' ' LYS . 15.1 mm -124.24 109.62 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 1.05 110.112 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.72 HD23 HD12 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -117.77 113.84 22.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.897 -0.721 . . . . 1.9299999999999999 109.51 176.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 35' ' ' GLU . 12.7 ptpt -91.98 162.57 14.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.647 -1.242 . . . . 2.0 107.647 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 51.4 pttt -65.97 148.01 52.46 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.82 -0.807 . . . . 3.1099999999999999 108.82 168.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 107.712 -1.218 . . . . 3.9199999999999999 107.712 173.239 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 121.137 0.494 . . . . 0.88 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.575 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.8 m 74.16 71.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.269 -0.878 . . . . 1.1200000000000001 111.98 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.73 39.13 7.22 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.199 -0.91 . . . . 0.33000000000000002 111.812 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.67 138.71 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.164 0.506 . . . . 1.0700000000000001 110.029 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 33' ' ' ALA . 7.4 p -93.37 129.34 43.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.114 -0.494 . . . . 1.0900000000000001 111.244 -173.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 1.5 mpt_? -131.03 163.54 27.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 2.3900000000000001 110.574 176.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -82.67 161.22 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.364 -0.606 . . . . 2.04 109.364 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.99 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.806 -0.357 . . . . 1.0700000000000001 110.251 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.556 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 17.4 t70 175.42 -77.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.173 -0.677 . . . . 1.6599999999999999 109.173 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.961 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -160.57 -73.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.965 -1.016 . . . . 1.9099999999999999 108.626 172.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.407 ' H ' HD22 ' B' ' 13' ' ' LEU . 2.5 pt? -80.12 -23.1 41.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.394 -1.275 . . . . 1.4299999999999999 111.534 -174.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.9 -18.95 0.66 Allowed Glycine 0 C--O 1.221 -0.665 0 C-N-CA 119.557 -1.306 . . . . 0.31 113.553 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.4 ttt180 -50.12 105.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.312 0.486 . . . . 0.93999999999999995 112.312 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 11.5 p -97.94 142.98 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 1.6499999999999999 109.906 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.47 111.46 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.025 0.44 . . . . 1.1000000000000001 111.889 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.621 HD13 HD13 ' A' ' 43' ' ' ILE . 25.1 mm -78.34 132.51 65.93 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.642 -0.708 . . . . 1.3100000000000001 110.777 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.59 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 88.8 Cg_exo -48.73 140.27 22.95 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.233 2.622 . . . . 0.34000000000000002 113.291 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.11 -33.01 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 1.3600000000000001 110.961 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.83 -25.49 62.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.264 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.757 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -80.54 -48.79 12.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.808 -0.633 . . . . 1.1000000000000001 109.608 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -65.44 -33.22 75.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.381 -0.97 . . . . 1.9099999999999999 108.381 178.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.5 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 5.7 tmm_? -59.57 -42.4 92.36 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.261 -0.881 . . . . 3.1800000000000002 109.844 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 80.3 m -60.96 -38.15 84.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.677 0.751 . . . . 1.04 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.814 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 4.9 mt -85.72 -11.26 54.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.994 -1.003 . . . . 1.1100000000000001 109.789 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.86 86.71 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.294 -0.866 . . . . 0.34000000000000002 111.782 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' B' ' 26' ' ' LEU . 2.7 pp -122.15 167.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.917 0.389 . . . . 1.25 111.345 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -174.13 154.93 2.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.164 -0.926 . . . . 1.05 109.432 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.855 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.4 pt-20 36.2 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.419 1.637 . . . . 1.1200000000000001 115.419 170.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.463 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.8 mmpt? -79.45 6.91 9.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.28 112.822 -173.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -92.9 176.73 6.32 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 122.223 -0.298 . . . . 1.3700000000000001 110.94 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . . . -123.01 153.33 39.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.168 0.803 . . . . 1.05 113.168 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -124.71 155.94 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.377 -1.283 . . . . 1.8500000000000001 107.557 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -108.16 107.37 17.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 1.3999999999999999 109.768 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.718 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.3 124.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.259 -0.882 . . . . 1.0900000000000001 111.432 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.637 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.7 OUTLIER -127.0 164.49 21.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.195 -0.911 . . . . 4.8300000000000001 108.827 176.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.38 139.91 48.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.988 -0.285 . . . . 1.05 110.874 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.73 89.37 2.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.642 -0.423 . . . . 1.1200000000000001 110.333 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 t70 63.88 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.001 -1.0 . . . . 1.6399999999999999 111.396 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.14 4.77 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.274 -0.876 . . . . 2.8100000000000001 110.604 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -103.79 155.13 18.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.704 -0.48 . . . . 1.71 109.704 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.64 HD12 HD12 ' A' ' 26' ' ' LEU . 13.0 mt -109.6 134.13 52.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.454 -0.573 . . . . 1.1299999999999999 109.454 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.688 HD13 HD13 ' A' ' 44' ' ' ILE . 11.7 mm -125.65 106.13 15.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.322 -0.399 . . . . 1.1000000000000001 110.382 -172.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.72 HD12 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.08 116.04 24.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.758 -0.777 . . . . 1.95 110.067 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.42 163.47 13.4 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.087 -1.079 . . . . 1.73 108.087 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.814 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 62.1 pttt -63.18 151.32 40.62 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.179 -0.674 . . . . 2.8700000000000001 109.179 169.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 t80 . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 108.131 -1.062 . . . . 3.6899999999999999 108.131 172.504 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.797 0.808 . . . . 0.92000000000000004 112.854 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.633 HG22 ' HD1' ' B' ' 37' ' ' TYR . 17.8 m 72.11 67.74 0.14 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.28 -1.327 . . . . 1.2 111.409 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.88 43.85 4.97 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.349 -0.841 . . . . 0.34000000000000002 111.438 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -108.15 137.63 38.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.587 -0.445 . . . . 1.3300000000000001 109.968 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.511 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 9.8 p -98.67 124.23 51.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.907 0.384 . . . . 1.1599999999999999 110.652 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 0.5 OUTLIER -128.7 163.84 24.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.497 -0.32 . . . . 2.6600000000000001 111.297 -178.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.86 162.98 23.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 1.9299999999999999 110.645 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HB ' ' H ' ' A' ' 11' ' ' ASP . 2.3 t -86.75 -109.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.272 -0.422 . . . . 1.0600000000000001 109.975 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.476 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 16.7 t0 179.11 -67.3 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.044 -0.725 . . . . 1.3200000000000001 109.044 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.608 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.1 pt-20 -168.15 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.92 -1.036 . . . . 1.3899999999999999 110.255 175.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.587 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.3 pt? -80.52 -0.64 38.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.555 -1.202 . . . . 1.22 112.326 -171.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 144.35 -22.75 2.05 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 119.744 -1.217 . . . . 0.34000000000000002 113.967 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.711 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.6 ttt180 -58.12 106.82 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.436 0.618 . . . . 1.54 112.466 -174.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.4 p -98.3 140.07 18.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.753 -0.462 . . . . 1.6899999999999999 109.753 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.585 HG22 ' HG3' ' B' ' 15' ' ' ARG . 40.7 t -79.8 101.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.8 0.333 . . . . 1.1599999999999999 110.867 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.638 HD12 HD13 ' B' ' 43' ' ' ILE . 10.4 mt -81.04 135.1 51.67 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 1.3300000000000001 110.264 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.471 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 54.4 Cg_exo -42.85 136.0 4.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.494 2.796 . . . . 0.34999999999999998 113.663 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.06 -29.3 41.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.612 -0.722 . . . . 1.6399999999999999 109.98 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.87 -27.38 65.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.047 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.712 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.3 mt -82.91 -47.01 12.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.01 -0.541 . . . . 1.1100000000000001 109.675 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -65.69 -30.65 71.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.604 -0.888 . . . . 2.4100000000000001 108.604 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -62.44 -42.18 99.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 3.4100000000000001 110.846 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.9 m -60.81 -35.64 77.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 111.039 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.808 HD13 HD12 ' B' ' 43' ' ' ILE . 1.3 mt -90.3 -9.71 46.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.818 -0.628 . . . . 1.1000000000000001 109.719 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.26 34.91 86.6 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.241 -0.89 . . . . 0.28000000000000003 112.099 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.6 pt -115.41 165.96 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.104 0.478 . . . . 1.24 111.096 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.1 154.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 1.03 109.593 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.579 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 4.6 pt-20 37.83 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.356 1.613 . . . . 1.22 115.356 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.579 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.8 mmpt? -76.15 -1.61 27.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.818 0.673 . . . . 1.51 112.818 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.87 174.05 9.56 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.672 -0.411 . . . . 1.54 110.307 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.18 153.38 40.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.746 0.784 . . . . 1.0600000000000001 113.061 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 47' ' ' LYS . 18.5 mt -124.47 153.34 42.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.398 -1.274 . . . . 1.72 107.598 173.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -106.82 105.39 15.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.324 -0.621 . . . . 1.28 109.324 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 45' ' ' LEU . 1.8 mp -90.37 123.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.473 -0.785 . . . . 1.1000000000000001 111.06 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.722 ' HD1' HG22 ' B' ' 4' ' ' THR . 0.2 OUTLIER -124.92 158.85 32.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.716 -0.846 . . . . 4.8399999999999999 108.716 175.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.42 HG13 ' OG1' ' B' ' 4' ' ' THR . 9.7 p -112.56 139.48 37.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.68 -0.408 . . . . 0.97999999999999998 110.795 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -135.48 82.15 1.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.381 -0.372 . . . . 1.1499999999999999 110.109 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.17 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.357 -0.838 . . . . 1.8300000000000001 111.511 -175.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -121.28 -15.35 8.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 2.54 110.038 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -85.21 144.45 28.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.642 . . . . 1.5700000000000001 110.344 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.881 HD12 HD12 ' B' ' 26' ' ' LEU . 18.4 mt -106.05 131.58 55.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.431 -0.804 . . . . 1.1499999999999999 108.929 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.654 HD13 HD11 ' B' ' 44' ' ' ILE . 17.9 mm -119.32 112.25 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.389 -0.369 . . . . 1.05 110.054 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.851 HD22 HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -117.03 108.74 16.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.483 -0.562 . . . . 1.9299999999999999 109.483 -178.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HB2' ' HG2' ' B' ' 42' ' ' LYS . 31.9 ttpt -103.18 134.89 45.84 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.813 -0.81 . . . . 2.0 108.813 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HA ' HD21 ' A' ' 34' ' ' LEU . 60.3 pttt -47.51 144.85 2.84 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 123.064 0.227 . . . . 3.1099999999999999 110.623 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 110.108 -0.33 . . . . 3.9199999999999999 110.108 -177.795 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.88 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.722 HG22 ' HD1' ' A' ' 37' ' ' TYR . 27.9 m 65.73 69.3 0.46 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.403 -0.817 . . . . 1.1200000000000001 111.005 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.75 41.54 4.38 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.021 -0.99 . . . . 0.33000000000000002 111.721 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tp -105.44 137.21 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.664 -0.495 . . . . 1.0700000000000001 109.664 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.462 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 12.5 p -96.99 128.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.967 0.413 . . . . 1.0900000000000001 110.356 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -134.45 156.59 48.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.29 -0.414 . . . . 2.3900000000000001 110.638 -178.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' B' ' 9' ' ' LYS . 10.8 mmpt? -82.0 161.01 23.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 2.04 110.624 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 1.7 t -84.3 -118.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.029 0.443 . . . . 1.0700000000000001 110.146 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.51 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 17.3 t0 -171.91 -63.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.194 -0.669 . . . . 1.6599999999999999 109.194 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.722 ' HG3' ' H ' ' B' ' 13' ' ' LEU . 4.2 pt-20 -169.59 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.909 . . . . 1.9099999999999999 110.41 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.722 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -61.01 -29.64 69.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.405 -0.816 . . . . 1.4299999999999999 112.564 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.88 -9.78 0.31 Allowed Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.992 -1.099 . . . . 0.31 112.974 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.1 mtt180 -60.78 106.0 0.52 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.02 0.378 . . . . 0.93999999999999995 112.02 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 9.7 p -100.99 142.1 16.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.146 -0.479 . . . . 1.6499999999999999 109.734 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.65 108.98 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.601 -0.272 . . . . 1.1000000000000001 111.162 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 14' ' ' GLY . 3.4 mt -85.17 138.31 36.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.092 -0.336 . . . . 1.3100000000000001 110.092 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.645 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 62.2 Cg_exo -43.16 136.6 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.395 2.73 . . . . 0.34000000000000002 113.89 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -56.03 -33.42 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 1.3600000000000001 110.813 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.73 -22.75 59.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.394 -0.366 . . . . 1.3500000000000001 110.38 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.712 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -82.04 -47.17 12.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.33 -0.619 . . . . 1.1000000000000001 109.33 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -64.98 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.723 -0.843 . . . . 1.9099999999999999 108.723 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.7 -36.65 81.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.737 -1.119 . . . . 3.1800000000000002 110.635 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 76.7 m -63.45 -36.03 82.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.529 0.68 . . . . 1.04 110.526 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.881 HD12 HD12 ' A' ' 43' ' ' ILE . 2.1 mt -89.7 -10.61 45.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.338 -0.846 . . . . 1.1100000000000001 109.777 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.22 15.77 68.12 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.34000000000000002 112.698 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' B' ' 26' ' ' LEU . 15.5 pt -98.15 168.81 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.818 0.342 . . . . 1.25 111.247 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.44 146.66 0.28 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.309 -0.86 . . . . 1.05 109.835 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.608 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.3 pt-20 37.47 -89.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.299 1.592 . . . . 1.1200000000000001 115.299 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.474 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 10.8 mmpt? -75.23 4.91 6.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.515 0.561 . . . . 1.28 112.515 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.25 -177.99 4.02 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.086 -0.646 . . . . 1.3700000000000001 110.896 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.511 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -126.47 153.61 44.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.235 1.198 . . . . 1.05 114.235 -171.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' B' ' 47' ' ' LYS . 19.5 mt -127.02 153.68 45.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.186 -1.37 . . . . 1.8500000000000001 108.024 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -106.41 104.76 14.53 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.204 -0.665 . . . . 1.3999999999999999 109.204 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.635 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.94 124.5 45.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.52 0.676 . . . . 1.0900000000000001 111.748 -175.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.633 ' HD1' HG22 ' A' ' 4' ' ' THR . 0.3 OUTLIER -126.46 162.95 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.079 -0.964 . . . . 4.8300000000000001 108.658 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.27 140.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.019 0.437 . . . . 1.05 111.338 -171.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.31 78.87 1.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.588 . . . . 1.1200000000000001 109.59 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.71 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.504 -1.225 . . . . 1.6399999999999999 111.216 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -128.71 -13.62 4.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 2.8100000000000001 110.391 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 24.0 mtpt -85.27 143.87 28.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.504 . . . . 1.71 109.748 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.808 HD12 HD13 ' A' ' 26' ' ' LEU . 26.5 mt -104.25 132.5 50.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.927 -0.768 . . . . 1.1299999999999999 108.927 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.654 HD11 HD13 ' A' ' 44' ' ' ILE . 15.5 mm -120.53 108.89 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.1 -0.333 . . . . 1.1000000000000001 110.1 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.635 ' HB3' HG13 ' B' ' 36' ' ' ILE . 0.1 OUTLIER -118.81 108.79 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.352 0.596 . . . . 1.95 110.629 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -90.34 156.06 18.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.776 -1.194 . . . . 1.73 107.776 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD22 ' B' ' 34' ' ' LEU . 24.1 pttm -63.53 159.67 18.15 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.023 -0.671 . . . . 2.8700000000000001 109.338 173.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.379 -0.373 . . . . 3.6899999999999999 110.026 178.211 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.461 0.648 . . . . 0.92000000000000004 112.102 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.7 m 71.73 60.58 0.15 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.749 -1.114 . . . . 1.2 111.382 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.09 36.29 3.2 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.439 -0.8 . . . . 0.34000000000000002 112.131 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tp -105.15 134.92 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.905 0.383 . . . . 1.3300000000000001 110.128 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 13.1 p -93.41 129.51 43.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.112 0.482 . . . . 1.1599999999999999 111.36 -176.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.416 HH12 ' HA ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -129.81 165.82 21.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 2.6600000000000001 110.814 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' B' ' 32' ' ' ASP . 7.5 tppt? -87.84 159.79 18.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.629 -0.714 . . . . 1.9299999999999999 109.825 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' B' ' 30' ' ' GLU . 2.0 t -82.05 -118.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.716 -0.846 . . . . 1.0600000000000001 108.716 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.553 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 20.3 t0 -174.79 -69.3 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.647 -0.501 . . . . 1.3200000000000001 109.647 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.879 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.2 OUTLIER -154.98 -78.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.393 -0.821 . . . . 1.3899999999999999 110.349 174.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 13' ' ' LEU . 2.6 pt? -81.85 0.02 41.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.827 -1.079 . . . . 1.22 112.511 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.81 -21.05 3.59 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 120.076 -1.059 . . . . 0.34000000000000002 113.143 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.1 mtt180 -53.49 106.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.066 0.433 . . . . 1.54 111.961 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 12.1 p -102.3 142.83 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 110.063 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.496 HG21 ' HG3' ' B' ' 15' ' ' ARG . 51.9 t -76.87 102.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.415 . . . . 1.1599999999999999 111.939 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -70.67 132.36 87.26 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 1.3300000000000001 110.414 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.579 ' HD2' HD11 ' A' ' 22' ' ' LEU . 99.3 Cg_exo -47.76 141.92 15.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.019 2.479 . . . . 0.34999999999999998 113.016 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.35 -32.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.681 . . . . 1.6399999999999999 110.117 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.53 -24.45 61.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.02 0.438 . . . . 1.73 110.146 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.6 mt -83.12 -48.69 10.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.504 -0.554 . . . . 1.1100000000000001 109.504 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 22.6 ptt85 -64.5 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.408 -0.96 . . . . 2.4100000000000001 108.408 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 14.4 ttt180 -58.88 -43.62 90.94 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.14 -0.936 . . . . 3.4100000000000001 110.75 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -61.05 -32.76 72.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 1.1299999999999999 110.31 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.802 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 2.5 mt -92.98 -9.53 39.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.472 -0.785 . . . . 1.1000000000000001 110.003 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 28.01 69.61 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.28000000000000003 112.635 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.695 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.2 pt -107.0 167.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.117 0.484 . . . . 1.24 111.626 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.54 150.89 1.44 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.1 -0.955 . . . . 1.03 110.2 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.2 pt-20 35.12 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.723 1.749 . . . . 1.22 115.723 173.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.3 mmpt? -80.01 5.63 13.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.022 0.749 . . . . 1.51 113.022 -171.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.73 177.81 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.866 0.365 . . . . 1.54 111.422 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -123.36 151.33 42.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.993 -0.549 . . . . 1.0600000000000001 112.151 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.7 mp -126.63 157.28 39.34 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.433 -0.951 . . . . 1.72 108.433 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -111.37 105.86 14.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.295 -0.632 . . . . 1.28 109.295 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.721 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -90.09 125.14 42.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.201 -0.909 . . . . 1.1000000000000001 111.484 -176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.9 m-85 -114.55 173.97 6.19 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.459 -1.311 . . . . 4.8399999999999999 107.459 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.85 142.2 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.563 -0.455 . . . . 0.97999999999999998 110.294 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.85 77.23 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.885 -0.326 . . . . 1.1499999999999999 110.435 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t70 57.79 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.619 1.199 . . . . 1.8300000000000001 112.655 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.432 ' OE2' ' HG3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -117.19 7.16 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.52 -0.309 . . . . 2.54 111.351 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.674 ' HG2' ' HB2' ' B' ' 46' ' ' LYS . 35.6 mtmm -127.04 162.87 25.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.138 0.494 . . . . 1.5700000000000001 111.41 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.649 HD12 HD12 ' B' ' 18' ' ' ILE . 54.0 mt -106.68 138.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.428 -0.805 . . . . 1.1499999999999999 109.294 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.602 HD12 HD12 ' B' ' 44' ' ' ILE . 16.8 mm -125.78 106.13 15.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 109.705 -0.48 . . . . 1.05 109.705 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.824 HD11 ' HB ' ' B' ' 43' ' ' ILE . 0.5 OUTLIER -123.04 128.09 49.68 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.293 -0.963 . . . . 1.9299999999999999 111.474 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' B' ' 42' ' ' LYS . 38.1 ttpt -121.96 145.94 47.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.999 -1.001 . . . . 2.0 108.328 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.802 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 60.2 pttt -48.41 143.04 5.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.114 0.259 . . . . 3.1099999999999999 110.847 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.3 t80 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.865 -0.791 . . . . 3.9199999999999999 108.865 177.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.665 0.745 . . . . 0.88 112.128 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 7.8 m 66.82 66.16 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.651 -1.159 . . . . 1.1200000000000001 111.302 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.64 34.45 4.97 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.606 -0.725 . . . . 0.33000000000000002 112.403 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 tp -102.39 134.12 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.967 0.413 . . . . 1.0700000000000001 110.342 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.2 p -94.66 127.03 46.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.129 0.49 . . . . 1.0900000000000001 111.614 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.54 166.96 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.141 -0.481 . . . . 2.3900000000000001 110.52 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.83 161.85 16.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.04 109.79 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 2.2 t -81.06 -109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.59 -0.522 . . . . 1.0700000000000001 109.59 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.5 ' HB2' ' NE ' ' A' ' 15' ' ' ARG . 24.5 t70 176.65 -79.0 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.453 -0.573 . . . . 1.6599999999999999 109.453 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.842 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.6 pt-20 -154.92 -81.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.521 -0.763 . . . . 1.9099999999999999 110.024 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.596 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -65.49 -29.9 70.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.34 -0.845 . . . . 1.4299999999999999 112.102 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.72 -9.81 0.32 Allowed Glycine 0 C--O 1.223 -0.587 0 C-N-CA 119.685 -1.245 . . . . 0.31 112.888 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 9.6 mtt180 -54.9 105.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.0 0.37 . . . . 0.93999999999999995 112.0 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 12.7 p -98.72 141.44 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 1.6499999999999999 110.132 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 15' ' ' ARG . 42.4 t -77.28 101.1 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 1.1000000000000001 111.74 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 43' ' ' ILE . 26.0 mm -67.17 135.51 93.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.876 -0.602 . . . . 1.3100000000000001 110.708 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' B' ' 22' ' ' LEU . 89.2 Cg_exo -49.85 137.64 35.02 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.846 2.364 . . . . 0.34000000000000002 112.62 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 tt -57.86 -33.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 110.344 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.94 -27.34 64.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 1.3500000000000001 110.276 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.734 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.3 mt -82.03 -48.41 11.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 1.1000000000000001 109.457 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -68.29 -25.84 65.34 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.225 -1.028 . . . . 1.9099999999999999 108.225 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.91 -37.48 75.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.619 -0.719 . . . . 3.1800000000000002 110.742 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 98.2 m -61.35 -35.59 77.87 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.419 0.628 . . . . 1.04 110.503 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -89.27 -11.11 44.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.395 -0.82 . . . . 1.1100000000000001 109.864 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.18 22.59 69.16 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.551 -0.75 . . . . 0.34000000000000002 112.872 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.4 pt -101.95 167.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.173 0.511 . . . . 1.25 111.579 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.25 150.77 1.54 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.871 -1.059 . . . . 1.05 110.262 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.879 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.0 -89.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.725 1.75 . . . . 1.1200000000000001 115.725 172.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . 0.419 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.7 mmpt? -79.58 7.98 7.29 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.225 0.824 . . . . 1.28 113.225 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 71.6 m-20 -88.96 176.6 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.036 0.38 . . . . 1.3700000000000001 111.06 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.457 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . . . -121.43 150.91 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.536 0.684 . . . . 1.05 112.632 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.8 mp -123.02 156.21 35.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.964 -1.016 . . . . 1.8500000000000001 109.256 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 43.7 mt-10 -108.77 105.42 14.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.805 -0.634 . . . . 1.3999999999999999 109.385 175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.02 124.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.301 -0.863 . . . . 1.0900000000000001 111.351 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 17.0 m-85 -113.57 174.78 5.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.517 -1.29 . . . . 4.8300000000000001 107.517 172.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.45 142.96 42.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.598 -0.441 . . . . 1.05 110.158 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.58 78.12 1.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 60.02 -75.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.627 -1.169 . . . . 1.6399999999999999 112.618 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -107.43 -25.58 11.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.957 0.408 . . . . 2.8100000000000001 111.033 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 24.8 pttm -116.3 162.45 17.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.167 0.508 . . . . 1.71 111.919 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.824 ' HB ' HD11 ' A' ' 45' ' ' LEU . 59.9 mt -106.04 139.03 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.39 -0.823 . . . . 1.1299999999999999 110.169 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -118.11 109.66 27.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 116.081 -0.509 . . . . 1.1000000000000001 109.754 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.496 HD13 ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.39 116.88 28.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.433 -0.507 . . . . 1.95 110.146 -176.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.674 ' HB2' ' HG2' ' A' ' 42' ' ' LYS . 38.5 ttpt -116.88 139.8 50.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.702 -0.851 . . . . 1.73 108.702 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 63.2 pttt -47.69 147.59 1.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.202 0.314 . . . . 2.8700000000000001 110.939 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . 0.509 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 78.6 t80 . . . . . 0 C--N 1.324 -0.504 0 N-CA-C 109.112 -0.699 . . . . 3.6899999999999999 109.112 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.592 0.71 . . . . 0.92000000000000004 112.32 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.668 HG23 ' HD1' ' B' ' 37' ' ' TYR . 25.1 m 72.0 71.6 0.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.573 -1.194 . . . . 1.2 111.313 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.42 38.99 6.09 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.332 -0.849 . . . . 0.34000000000000002 111.879 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.51 136.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.706 -0.479 . . . . 1.3300000000000001 109.706 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' B' ' 33' ' ' ALA . 11.2 p -95.84 127.3 48.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.902 0.382 . . . . 1.1599999999999999 110.938 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -125.96 161.13 28.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.344 -0.389 . . . . 2.6600000000000001 110.671 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.45 161.09 23.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.218 -0.66 . . . . 1.9299999999999999 109.218 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 11' ' ' ASP . 3.0 t -80.21 -108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.564 -0.532 . . . . 1.0600000000000001 109.564 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 26.9 t70 175.26 -67.29 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.02 -0.733 . . . . 1.3200000000000001 109.02 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.823 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.4 pt-20 -158.47 -86.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.939 -1.028 . . . . 1.3899999999999999 109.986 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.606 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -77.24 -27.73 53.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 1.22 112.112 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.49 -0.33 0.06 OUTLIER Glycine 0 C--O 1.225 -0.464 0 C-N-CA 119.483 -1.342 . . . . 0.34000000000000002 114.461 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.695 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.9 ttt180 -66.81 99.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.495 1.148 . . . . 1.54 111.578 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 19.0 m -96.46 144.58 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 1.6899999999999999 110.386 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.572 HG21 ' HG3' ' B' ' 15' ' ' ARG . 41.4 t -82.0 107.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.302 -0.408 . . . . 1.1599999999999999 111.178 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.554 HG13 ' O ' ' B' ' 14' ' ' GLY . 3.6 mt -79.9 139.24 53.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 110.186 -0.302 . . . . 1.3300000000000001 110.186 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.541 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 70.8 Cg_exo -46.33 140.03 11.82 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.422 2.748 . . . . 0.34999999999999998 113.839 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.468 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 6.7 tp -58.19 -32.84 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 110.443 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -72.81 -23.03 60.73 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.406 -0.361 . . . . 1.73 110.419 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.698 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.3 mt -83.37 -46.48 12.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.297 0.57 . . . . 1.1100000000000001 109.858 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.503 HH11 ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -64.13 -31.37 72.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 2.4100000000000001 108.011 176.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -38.48 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.966 -1.016 . . . . 3.4100000000000001 111.605 173.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -60.66 -36.54 78.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.542 0.687 . . . . 1.1299999999999999 110.473 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.891 HD13 HD11 ' B' ' 43' ' ' ILE . 1.9 mt -89.28 -9.22 51.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.464 -0.789 . . . . 1.1000000000000001 109.713 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.13 29.37 70.91 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.257 -0.883 . . . . 0.28000000000000003 112.118 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.3 pt -110.12 167.29 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.189 0.518 . . . . 1.24 111.124 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . 0.503 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -179.68 154.87 0.62 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.727 -1.124 . . . . 1.03 109.22 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.626 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.1 pt-20 37.82 -89.46 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.904 1.446 . . . . 1.22 114.904 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.432 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.1 5.11 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.493 0.553 . . . . 1.51 112.493 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 2.7 m-20 -87.67 172.73 9.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.81 0.338 . . . . 1.54 110.419 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -117.37 149.04 41.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.353 0.597 . . . . 1.0600000000000001 111.692 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.837 HD13 ' HA ' ' A' ' 47' ' ' LYS . 14.1 tp -126.21 149.33 49.12 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.984 -1.117 . . . . 1.72 107.984 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -107.03 106.03 16.35 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.209 0.528 . . . . 1.28 110.049 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 1.015 HG13 HD22 ' A' ' 45' ' ' LEU . 1.7 mp -94.14 125.73 46.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 1.1000000000000001 111.312 -173.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.726 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -126.97 160.97 29.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.453 -0.794 . . . . 4.8399999999999999 109.555 175.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.83 138.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.84 0.352 . . . . 0.97999999999999998 110.794 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.59 81.69 2.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.788 -0.449 . . . . 1.1499999999999999 109.788 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 2.5 t70 58.55 -82.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.704 -1.135 . . . . 1.8300000000000001 111.454 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 24.3 mt-10 -114.08 -19.62 11.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 2.54 111.018 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -92.73 159.03 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 1.5700000000000001 110.242 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.829 HD11 HD13 ' B' ' 26' ' ' LEU . 26.7 mt -110.28 133.54 55.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.843 -0.617 . . . . 1.1499999999999999 109.367 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.726 ' HB ' ' HD1' ' A' ' 37' ' ' TYR . 17.9 mm -121.21 115.44 46.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.829 -0.434 . . . . 1.05 109.829 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 1.077 HD11 HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.03 118.91 35.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.546 -0.538 . . . . 1.9299999999999999 109.546 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 30.7 ttpt -112.35 148.65 33.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.117 -1.438 . . . . 2.0 107.117 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.837 ' HA ' HD13 ' A' ' 34' ' ' LEU . 84.5 tttt -56.69 149.66 17.44 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.491 -0.559 . . . . 3.1099999999999999 109.491 174.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 33' ' ' ALA . 17.3 p90 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.38 -0.97 . . . . 3.9199999999999999 108.38 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.488 0.661 . . . . 0.88 112.497 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.649 HG22 ' HD2' ' A' ' 37' ' ' TYR . 25.0 m 71.94 70.58 0.16 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.638 -1.164 . . . . 1.1200000000000001 111.79 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.39 39.18 6.05 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.33000000000000002 111.796 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.41 137.23 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.374 -0.602 . . . . 1.0700000000000001 109.374 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.477 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 10.0 p -95.61 127.99 47.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 120.958 0.408 . . . . 1.0900000000000001 110.41 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.66 159.93 30.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.155 -0.475 . . . . 2.3900000000000001 110.316 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -81.42 157.55 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.926 -0.768 . . . . 2.04 108.926 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.73 -104.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.577 -0.527 . . . . 1.0700000000000001 109.577 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.412 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 23.5 t0 170.2 -71.04 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.879 -0.786 . . . . 1.6599999999999999 108.879 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.626 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.1 pt-20 -154.45 -83.51 0.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 1.9099999999999999 110.173 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.559 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.5 pt? -84.13 -22.33 31.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.38 -0.827 . . . . 1.4299999999999999 112.434 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 159.42 -4.74 0.11 Allowed Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.477 -1.344 . . . . 0.31 113.871 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 2.1 ttt180 -66.77 96.98 0.43 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.926 0.863 . . . . 0.93999999999999995 111.513 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 24.7 m -94.42 144.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.012 -0.54 . . . . 1.6499999999999999 110.43 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.472 HG21 ' HG3' ' A' ' 15' ' ' ARG . 46.4 t -81.75 107.75 14.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.342 -0.39 . . . . 1.1000000000000001 111.073 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.464 HD13 HD12 ' A' ' 43' ' ' ILE . 8.6 mt -82.14 138.16 45.83 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.485 -0.325 . . . . 1.3100000000000001 110.611 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.477 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 70.6 Cg_exo -44.67 140.44 6.48 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.61 2.873 . . . . 0.34000000000000002 113.969 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.421 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 5.3 tp -57.68 -34.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.105 -0.952 . . . . 1.3600000000000001 110.611 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 7.8 pt-20 -71.11 -24.29 62.26 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 109.962 -0.384 . . . . 1.3500000000000001 109.962 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.721 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.0 mt -83.51 -46.35 12.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.004 -0.544 . . . . 1.1000000000000001 109.708 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' B' ' 28' ' ' ILE . 2.9 ppt_? -64.73 -31.57 72.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.866 -1.161 . . . . 1.9099999999999999 107.866 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 31.3 ttt180 -59.29 -46.73 87.76 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 114.81 -1.086 . . . . 3.1800000000000002 111.164 170.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.1 m -58.49 -35.33 72.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.313 0.578 . . . . 1.04 111.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.829 HD13 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -90.22 -10.33 44.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.488 -0.778 . . . . 1.1100000000000001 109.917 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.22 63.66 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.531 -0.758 . . . . 0.34000000000000002 112.768 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' B' ' 26' ' ' LEU . 13.3 pt -101.49 167.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.408 . . . . 1.25 111.126 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . 0.422 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -178.03 152.71 0.75 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.102 -0.953 . . . . 1.05 109.548 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.823 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.8 pt-20 34.36 -90.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.126 1.528 . . . . 1.1200000000000001 115.126 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -75.89 5.07 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.985 0.735 . . . . 1.28 112.985 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 16.0 m-20 -91.76 176.41 6.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.891 -0.506 . . . . 1.3700000000000001 111.335 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -116.65 150.68 37.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.639 -0.709 . . . . 1.05 112.167 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.839 HD11 ' HA ' ' B' ' 47' ' ' LYS . 14.0 tp -128.36 150.67 50.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.219 -1.03 . . . . 1.8500000000000001 108.219 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -106.35 107.25 18.16 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.607 -0.516 . . . . 1.3999999999999999 109.607 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 1.054 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -94.53 124.1 46.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.992 -0.549 . . . . 1.0900000000000001 111.291 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.815 ' HD2' ' HB ' ' B' ' 44' ' ' ILE . 0.3 OUTLIER -123.58 159.61 28.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.639 -0.71 . . . . 4.8300000000000001 109.513 175.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.89 136.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.954 0.407 . . . . 1.05 110.622 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.47 79.9 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 1.1200000000000001 109.557 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 57.02 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.858 -1.064 . . . . 1.6399999999999999 111.507 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.63 -3.33 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.964 -0.562 . . . . 2.8100000000000001 111.104 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -102.82 158.76 16.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.58 -0.526 . . . . 1.71 109.58 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.891 HD11 HD13 ' A' ' 26' ' ' LEU . 22.7 mt -111.8 133.51 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.431 -0.581 . . . . 1.1299999999999999 109.431 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.815 ' HB ' ' HD2' ' B' ' 37' ' ' TYR . 18.3 mm -123.99 116.1 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.765 -0.458 . . . . 1.1000000000000001 109.765 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 1.077 HD11 HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.71 117.57 30.65 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.565 -0.454 . . . . 1.95 109.942 -177.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . 0.667 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 18.8 ttpt -111.25 142.03 44.0 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.224 -1.028 . . . . 1.73 108.224 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.839 ' HA ' HD11 ' B' ' 34' ' ' LEU . 79.3 tttt -49.97 141.95 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.227 -0.286 . . . . 2.8700000000000001 110.227 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 11.8 p90 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 109.614 -0.513 . . . . 3.6899999999999999 109.614 -177.482 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.456 0.646 . . . . 0.92000000000000004 111.065 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.645 HG23 ' HD1' ' B' ' 37' ' ' TYR . 11.5 m 70.79 68.22 0.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.903 -1.044 . . . . 1.2 111.683 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.89 37.66 5.99 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.31 -0.859 . . . . 0.34000000000000002 111.894 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tp -104.14 135.76 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.767 -0.457 . . . . 1.3300000000000001 109.767 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.616 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.8 p -90.67 124.79 43.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.996 0.427 . . . . 1.1599999999999999 110.797 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.69 159.58 27.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.277 -0.419 . . . . 2.6600000000000001 110.525 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 1.1 tpmt? -83.58 158.32 21.98 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.89 -0.781 . . . . 1.9299999999999999 108.89 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.61 -105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 120.615 -0.434 . . . . 1.0600000000000001 110.055 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.444 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 14.4 t70 175.32 -78.03 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.448 -0.575 . . . . 1.3200000000000001 109.448 -173.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.869 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER -161.59 -77.71 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 1.3899999999999999 109.679 172.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.423 ' H ' HD22 ' A' ' 13' ' ' LEU . 2.7 pt? -72.66 -18.37 61.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.036 -0.984 . . . . 1.22 112.358 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.86 -21.32 1.0 Allowed Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.018 -1.087 . . . . 0.34000000000000002 113.76 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.689 ' HD3' ' HB2' ' B' ' 11' ' ' ASP . 6.8 ttm180 -51.92 104.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.381 0.591 . . . . 1.54 112.433 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 14.9 p -97.11 143.22 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.951 -0.389 . . . . 1.6899999999999999 109.951 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.2 t -77.14 105.9 6.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 1.1599999999999999 111.597 -175.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 HG22 ' B' ' 43' ' ' ILE . 35.8 mm -77.42 134.82 65.93 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 1.3300000000000001 110.218 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.623 ' HD2' HD11 ' A' ' 22' ' ' LEU . 87.3 Cg_exo -48.81 140.45 23.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.122 2.548 . . . . 0.34999999999999998 113.199 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.4 tt -60.76 -33.3 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 1.6399999999999999 110.339 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.04 -24.41 63.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.166 0.508 . . . . 1.73 109.725 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.767 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mt -82.05 -49.81 9.79 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.792 -0.64 . . . . 1.1100000000000001 109.415 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -64.88 -34.6 78.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.624 -0.88 . . . . 2.4100000000000001 108.624 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -44.36 85.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.241 -0.89 . . . . 3.4100000000000001 111.129 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.2 m -63.14 -33.15 74.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.309 0.576 . . . . 1.1299999999999999 110.956 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.82 HD12 HD13 ' B' ' 43' ' ' ILE . 3.1 mt -88.09 -12.91 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.918 -0.583 . . . . 1.1000000000000001 110.036 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.56 76.71 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.28000000000000003 112.17 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.3 pt -108.13 167.34 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.993 0.425 . . . . 1.24 111.26 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.55 152.67 0.66 Allowed 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 1.03 109.674 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.805 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.3 pt-20 37.65 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.566 1.691 . . . . 1.22 115.566 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.17 7.02 12.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.704 0.631 . . . . 1.51 112.704 -172.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.27 177.89 7.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 1.54 111.433 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.547 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -121.57 146.89 46.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.226 0.824 . . . . 1.0600000000000001 113.226 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.0 mp -124.16 156.48 36.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 1.72 108.455 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.69 107.61 18.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.583 -0.525 . . . . 1.28 109.583 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.965 HG13 HD13 ' A' ' 45' ' ' LEU . 1.8 mp -90.3 120.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.599 0.714 . . . . 1.1000000000000001 110.698 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.798 ' HD1' HG22 ' B' ' 4' ' ' THR . 1.0 OUTLIER -123.14 158.13 31.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.094 -0.957 . . . . 4.8399999999999999 109.012 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.73 137.72 45.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.97999999999999998 110.779 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 83.04 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 1.1499999999999999 110.857 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 4.4 t70 63.53 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.793 -1.094 . . . . 1.8300000000000001 111.817 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 0.8 OUTLIER -128.33 9.62 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.006 -0.543 . . . . 2.54 111.255 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -118.84 158.64 25.25 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.322 -0.399 . . . . 1.5700000000000001 109.978 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.744 HD13 HD12 ' B' ' 26' ' ' LEU . 15.9 mt -110.06 138.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.263 -0.426 . . . . 1.1499999999999999 109.89 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.762 HD12 HD13 ' B' ' 44' ' ' ILE . 11.4 mm -122.79 115.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.443 -0.344 . . . . 1.05 110.268 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.965 HD13 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -114.36 117.08 30.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.876 -0.73 . . . . 1.9299999999999999 109.092 176.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -107.62 126.8 53.02 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.028 -0.73 . . . . 2.0 109.028 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.625 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 59.3 pttt -44.71 139.48 2.92 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.255 0.347 . . . . 3.1099999999999999 111.148 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 108.71 -0.848 . . . . 3.9199999999999999 108.71 173.147 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.88 108.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' THR . . . . . 0.798 HG22 ' HD1' ' A' ' 37' ' ' TYR . 35.4 m 64.68 70.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.594 0.711 . . . . 1.1200000000000001 111.317 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.08 38.15 5.49 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.773 -0.727 . . . . 0.33000000000000002 112.255 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tp -104.6 133.81 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.628 -0.508 . . . . 1.0700000000000001 109.628 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' VAL . . . . . 0.547 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 11.0 p -92.0 117.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.529 0.68 . . . . 1.0900000000000001 111.486 -172.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ARG . . . . . 0.447 ' HG2' ' HB ' ' B' ' 17' ' ' VAL . 1.0 OUTLIER -109.73 159.61 17.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 2.3900000000000001 110.209 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -86.64 155.93 20.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.233 -1.025 . . . . 2.04 108.233 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.2 t -78.24 -111.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.497 -0.557 . . . . 1.0700000000000001 109.497 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ASP . . . . . 0.689 ' HB2' ' HD3' ' A' ' 15' ' ' ARG . 26.4 t0 179.88 -68.94 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.4 -0.592 . . . . 1.6599999999999999 109.4 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' GLU . . . . . 0.805 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.3 pt-20 -160.38 -83.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.819 . . . . 1.9099999999999999 110.563 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' LEU . . . . . 0.544 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -74.45 -16.13 60.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.031 -0.986 . . . . 1.4299999999999999 112.198 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.22 -16.79 1.16 Allowed Glycine 0 C--O 1.221 -0.66 0 C-N-CA 119.911 -1.137 . . . . 0.31 113.05 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.9 mtt180 -52.48 111.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.788 0.294 . . . . 0.93999999999999995 111.75 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.5 p -105.14 142.09 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.721 -0.474 . . . . 1.6499999999999999 109.721 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' VAL . . . . . 0.447 ' HB ' ' HG2' ' B' ' 8' ' ' ARG . 48.6 t -77.65 108.53 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 1.1000000000000001 112.019 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 43' ' ' ILE . 19.9 mm -76.28 135.65 69.35 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.942 -0.572 . . . . 1.3100000000000001 110.422 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' PRO . . . . . 0.683 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.06 139.89 25.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.987 2.458 . . . . 0.34000000000000002 113.215 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.526 HG13 ' HE ' ' B' ' 23' ' ' ARG . 12.3 tt -59.87 -33.6 53.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.587 -0.733 . . . . 1.3600000000000001 110.707 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.55 -22.98 59.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.105 0.478 . . . . 1.3500000000000001 110.251 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.2 mt -80.38 -48.47 12.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.957 -0.757 . . . . 1.1000000000000001 108.957 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ARG . . . . . 0.526 ' HE ' HG13 ' B' ' 20' ' ' ILE . 15.0 ptt180 -65.58 -33.71 76.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.936 -0.765 . . . . 1.9099999999999999 108.936 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ARG . . . . . 0.454 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 33.9 ttp180 -64.78 -37.83 88.93 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.409 -0.814 . . . . 3.1800000000000002 110.495 175.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 95.7 m -63.83 -34.34 77.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 1.04 110.422 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -88.72 -10.36 48.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.48 0.657 . . . . 1.1100000000000001 109.572 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.27 77.06 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 114.889 -1.051 . . . . 0.34000000000000002 112.282 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.0 pt -111.67 166.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.932 0.396 . . . . 1.25 111.196 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.85 148.67 0.54 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.224 -0.898 . . . . 1.05 110.182 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' GLU . . . . . 0.869 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.0 pt-20 35.85 -87.23 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.293 1.59 . . . . 1.1200000000000001 115.293 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -75.04 5.11 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.075 0.769 . . . . 1.28 113.075 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ASP . . . . . 0.565 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 3.2 m-20 -86.67 173.74 9.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 1.3700000000000001 111.636 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' ALA . . . . . 0.616 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -118.28 144.86 45.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.621 -0.718 . . . . 1.05 112.401 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' B' ' 47' ' ' LYS . 15.9 mt -124.77 152.27 44.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.846 -1.168 . . . . 1.8500000000000001 107.846 174.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -106.78 104.84 14.62 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.167 -0.679 . . . . 1.3999999999999999 109.167 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ILE . . . . . 0.923 HG13 HD12 ' B' ' 45' ' ' LEU . 1.9 mp -90.26 121.39 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.346 0.593 . . . . 1.0900000000000001 110.971 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' TYR . . . . . 0.645 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -127.21 158.64 36.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.358 -0.837 . . . . 4.8300000000000001 109.498 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.0 p -110.94 138.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.626 -0.429 . . . . 1.05 111.221 -173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.47 77.94 1.78 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.1200000000000001 110.336 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 t70 58.56 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.504 -1.225 . . . . 1.6399999999999999 112.384 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' GLU . . . . . 0.426 ' H ' ' HG3' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -115.58 -10.74 11.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 2.8100000000000001 110.924 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -109.84 157.6 19.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 1.71 110.667 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.82 HD13 HD12 ' A' ' 26' ' ' LEU . 12.1 mt -109.84 137.5 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.016 -0.538 . . . . 1.1299999999999999 109.83 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' ILE . . . . . 0.762 HD13 HD12 ' A' ' 44' ' ' ILE . 10.1 mm -123.61 115.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.457 -0.338 . . . . 1.1000000000000001 110.214 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' LEU . . . . . 0.923 HD12 HG13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -112.9 111.94 23.05 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.95 108.886 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.31 128.65 47.37 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.084 -0.71 . . . . 1.73 109.084 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LYS . . . . . 0.808 ' HA ' HD22 ' B' ' 34' ' ' LEU . 55.0 pttt -44.86 138.92 3.29 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.281 0.363 . . . . 2.8700000000000001 111.407 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 108.853 -0.795 . . . . 3.6899999999999999 108.853 173.723 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.648 -0.501 . . . . 5.4100000000000001 109.648 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.909 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -131.26 -85.6 0.5 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.994 -0.282 . . . . 2.3399999999999999 111.585 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.909 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 75.7 m -147.51 -170.9 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.818 -0.808 . . . . 0.92000000000000004 108.818 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.694 HG22 ' HD1' ' B' ' 37' ' ' TYR . 59.4 m 63.32 75.41 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.813 0.815 . . . . 1.2 111.311 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.61 35.97 12.82 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.271 -0.877 . . . . 0.34000000000000002 111.339 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 134.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.745 -0.465 . . . . 1.3300000000000001 109.745 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -86.99 125.66 40.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 120.988 0.423 . . . . 1.1599999999999999 111.384 -173.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.44 155.86 36.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 2.6600000000000001 110.863 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -82.34 162.57 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.881 -0.414 . . . . 1.9299999999999999 109.881 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' H ' ' A' ' 11' ' ' ASP . 2.5 t -85.05 -108.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.772 -0.371 . . . . 1.0600000000000001 110.231 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.455 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t70 177.26 -74.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.98 -0.748 . . . . 1.3200000000000001 108.98 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.905 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.9 OUTLIER -161.57 -80.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.942 -1.026 . . . . 1.3899999999999999 109.686 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.556 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -68.4 -32.78 73.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.774 -1.103 . . . . 1.22 111.302 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.78 -16.31 0.11 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.879 -1.153 . . . . 0.34000000000000002 113.947 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.636 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.36 103.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.584 0.692 . . . . 1.54 111.867 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.71 HG12 HD11 ' B' ' 45' ' ' LEU . 13.4 p -96.55 140.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.866 -0.42 . . . . 1.6899999999999999 109.866 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.506 HG23 ' HG3' ' B' ' 15' ' ' ARG . 48.4 t -77.76 101.75 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.267 -0.424 . . . . 1.1599999999999999 111.323 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.7 129.06 88.89 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.818 -0.628 . . . . 1.3300000000000001 110.229 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 57.2 Cg_exo -45.5 139.09 10.08 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.387 2.725 . . . . 0.34999999999999998 113.407 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.597 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 8.6 tt -57.03 -33.26 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 110.827 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -73.2 -24.86 60.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.098 0.475 . . . . 1.73 110.472 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.694 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 10.5 mt -81.49 -48.09 12.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.402 -0.592 . . . . 1.1100000000000001 109.402 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.597 ' HE ' ' HA ' ' A' ' 20' ' ' ILE . 12.2 ptt180 -64.7 -33.81 76.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.083 -0.71 . . . . 2.4100000000000001 109.083 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.76 -40.38 94.96 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.281 -0.872 . . . . 3.4100000000000001 110.677 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.6 m -61.12 -38.36 86.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.205 0.526 . . . . 1.1299999999999999 110.634 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.694 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.2 mt -87.14 -10.67 52.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 1.1000000000000001 109.704 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.98 25.83 71.02 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.377 -0.829 . . . . 0.28000000000000003 112.466 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.5 pt -106.71 167.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 1.24 111.606 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.416 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -177.32 152.84 0.88 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.883 -1.053 . . . . 1.03 109.549 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.791 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.0 pt-20 32.4 -89.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.779 1.77 . . . . 1.22 115.779 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.523 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.7 mmpt? -77.27 -0.43 25.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.746 0.647 . . . . 1.51 112.746 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.416 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 0.9 OUTLIER -81.94 174.67 11.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.007 0.432 . . . . 1.54 110.535 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.556 ' HB2' ' CG2' ' B' ' 7' ' ' VAL . . . -123.93 152.59 42.28 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.405 0.621 . . . . 1.0600000000000001 112.499 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.3 mp -120.04 152.51 37.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.91 -1.041 . . . . 1.72 109.204 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.53 100.14 10.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.615 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -91.13 123.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.347 0.594 . . . . 1.1000000000000001 111.352 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.684 ' HD1' HG23 ' B' ' 4' ' ' THR . 3.4 t80 -126.24 163.4 23.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.317 -0.856 . . . . 4.8399999999999999 108.721 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.91 139.25 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.706 -0.398 . . . . 0.97999999999999998 110.686 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 81.26 2.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.345 -0.388 . . . . 1.1499999999999999 110.335 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 55.26 -80.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.637 -1.165 . . . . 1.8300000000000001 112.843 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 3.68 19.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.08 0.4 . . . . 2.54 112.08 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -143.38 170.79 15.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 1.5700000000000001 112.611 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.595 HD12 HD12 ' B' ' 18' ' ' ILE . 31.5 mt -106.58 139.06 29.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.973 -1.012 . . . . 1.1499999999999999 110.257 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.628 HD12 HD12 ' B' ' 44' ' ' ILE . 22.4 mm -121.64 107.07 19.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 1.05 109.458 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.615 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.6 118.55 28.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.912 0.863 . . . . 1.9299999999999999 111.362 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.481 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 32.9 ttpt -102.64 165.43 11.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.197 -1.365 . . . . 2.0 107.932 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.685 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 57.5 pttt -66.43 147.91 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.524 -0.917 . . . . 3.1099999999999999 108.524 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.2 137.57 57.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.173 -0.611 . . . . 3.9199999999999999 109.402 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.563 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.52 111.28 7.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.576 -0.527 . . . . 3.8399999999999999 109.576 -178.473 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.563 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 92.0 Cg_endo -74.33 119.13 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.505 2.137 . . . . 1.5800000000000001 112.211 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.71 77.69 9.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.46 0.648 . . . . 4.25 109.33 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.423 ' HG2' ' HB2' ' A' ' 50' ' ' PRO . 79.0 mmm -117.03 122.65 44.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.409 -0.814 . . . . 5.54 109.705 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 119.21 -0.424 . . . . 6.1299999999999999 110.133 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.803 0.335 . . . . 5.9000000000000004 111.461 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.469 ' HE3' ' HB2' ' B' ' 2' ' ' LYS . 15.1 ptmt -103.04 -163.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.027 -0.731 . . . . 1.8500000000000001 109.027 171.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -67.31 -177.67 0.73 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.615 0.722 . . . . 0.88 112.255 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.684 HG23 ' HD1' ' A' ' 37' ' ' TYR . 60.9 m 78.79 72.61 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.283 -1.326 . . . . 1.1200000000000001 111.345 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.92 36.53 10.12 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.983 -1.008 . . . . 0.33000000000000002 111.28 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tp -107.3 137.6 37.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.102 0.477 . . . . 1.0700000000000001 109.931 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.556 ' CG2' ' HB2' ' A' ' 33' ' ' ALA . 6.6 p -88.17 129.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 116.278 -0.419 . . . . 1.0900000000000001 111.163 -173.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 2.5 mpt_? -126.43 155.91 41.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.729 -0.214 . . . . 2.3900000000000001 111.074 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.665 ' HE2' ' HA ' ' B' ' 9' ' ' LYS . 10.4 mmpt? -81.28 162.38 23.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.847 -0.427 . . . . 2.04 109.847 176.052 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 t -86.16 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.117 0.484 . . . . 1.0700000000000001 110.513 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.471 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 6.6 t70 172.91 -76.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.794 -0.817 . . . . 1.6599999999999999 108.794 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.791 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.2 pt-20 -166.65 -76.8 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.693 -1.14 . . . . 1.9099999999999999 108.754 170.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.677 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.3 pp -76.8 -6.16 51.16 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.435 -1.711 . . . . 1.4299999999999999 112.644 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.35 -16.02 3.89 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.317 -1.421 . . . . 0.31 113.692 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.4 ttt180 -56.17 99.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.334 0.567 . . . . 0.93999999999999995 111.6 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.0 p -93.83 139.89 17.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.159 -0.473 . . . . 1.6499999999999999 109.955 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.427 HG23 ' HG3' ' A' ' 15' ' ' ARG . 25.6 t -79.99 100.52 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.903 0.383 . . . . 1.1000000000000001 111.63 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.595 HD12 HD12 ' A' ' 43' ' ' ILE . 36.8 mm -68.74 131.94 91.02 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 1.3100000000000001 110.79 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.541 ' HD2' HD12 ' B' ' 22' ' ' LEU . 93.5 Cg_exo -48.23 139.03 22.23 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.269 2.646 . . . . 0.34000000000000002 113.279 173.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.03 -32.17 43.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 1.3600000000000001 110.851 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.428 ' OE2' ' HE3' ' B' ' 2' ' ' LYS . 18.1 pt-20 -72.43 -25.05 61.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.499 . . . . 1.3500000000000001 110.037 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.763 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -81.81 -48.41 11.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 1.1000000000000001 109.537 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -30.34 71.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.847 -0.797 . . . . 1.9099999999999999 108.847 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.04 -39.34 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.264 -0.88 . . . . 3.1800000000000002 111.217 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.71 -38.09 83.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.391 0.615 . . . . 1.04 110.417 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.763 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -87.44 -10.71 51.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 1.1100000000000001 109.742 -174.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 30.52 75.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.217 -0.901 . . . . 0.34000000000000002 112.647 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.648 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.9 pt -110.75 166.91 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.094 0.474 . . . . 1.25 111.141 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.41 150.71 1.47 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.978 -1.01 . . . . 1.05 110.391 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.905 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.6 pt-20 34.65 -87.3 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.43 1.641 . . . . 1.1200000000000001 115.43 171.468 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.41 -11.88 61.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.485 0.55 . . . . 1.28 112.485 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -78.75 177.13 8.91 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.165 0.507 . . . . 1.3700000000000001 111.443 -173.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.497 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -125.18 155.47 39.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.675 0.75 . . . . 1.05 112.577 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.515 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.8 mp -121.99 154.85 36.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.63 -1.168 . . . . 1.8500000000000001 108.8 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.826 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 40.6 mt-10 -102.48 104.3 14.73 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.169 -0.678 . . . . 1.3999999999999999 109.169 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.981 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -89.83 123.29 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.857 -0.61 . . . . 1.0900000000000001 110.953 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.694 ' HD1' HG22 ' A' ' 4' ' ' THR . 3.8 t80 -124.3 158.82 31.67 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.115 -0.698 . . . . 4.8300000000000001 109.115 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.29 137.18 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.811 -0.356 . . . . 1.05 110.495 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . 0.501 ' HB3' ' HG3' ' B' ' 42' ' ' LYS . 37.0 t70 -128.76 82.46 2.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 1.1200000000000001 111.108 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 61.19 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.949 -1.023 . . . . 1.6399999999999999 112.322 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.44 9.46 15.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.579 -0.737 . . . . 2.8100000000000001 111.042 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.642 ' HD2' HD13 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -138.41 169.16 18.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.139 -0.482 . . . . 1.71 111.206 -177.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.595 HD12 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -115.26 139.47 41.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 1.1299999999999999 110.625 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.642 HD13 ' HD2' ' B' ' 42' ' ' LYS . 19.6 mm -117.71 116.0 50.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.527 -0.545 . . . . 1.1000000000000001 109.527 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.981 HD22 HG13 ' B' ' 36' ' ' ILE . 1.0 OUTLIER -115.89 110.41 18.97 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.287 -0.565 . . . . 1.95 109.806 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -95.83 162.06 13.75 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.0 -1.111 . . . . 1.73 108.0 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.61 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 56.5 pttt -66.82 148.27 52.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.813 -0.81 . . . . 2.8700000000000001 108.813 169.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.826 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 76.3 t80 -65.82 125.69 26.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.673 -0.862 . . . . 3.6899999999999999 108.673 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.833 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -68.4 112.5 11.21 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.722 -0.473 . . . . 3.8100000000000001 109.722 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.833 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 76.6 Cg_endo -73.35 124.41 9.41 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.695 2.263 . . . . 1.5600000000000001 112.375 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -89.87 76.95 7.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 4.3600000000000003 109.474 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -123.1 113.83 19.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.874 -0.603 . . . . 5.6500000000000004 110.458 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.247 0.927 0 CA-C-N 116.057 -0.52 . . . . 6.3399999999999999 110.233 -179.838 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 23.4 mmt . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.054 -0.35 . . . . 5.4100000000000001 110.054 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 1' ' ' MET . 11.2 tptm 69.9 144.6 0.05 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.866 0.729 . . . . 2.3399999999999999 110.879 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m -72.54 -163.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.506 -0.77 . . . . 0.92000000000000004 111.066 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.512 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.0 m 68.86 56.18 0.43 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.18 -0.918 . . . . 1.2 110.931 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.58 34.32 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.462 -0.79 . . . . 0.34000000000000002 112.362 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 tp -105.19 136.68 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 120.928 0.394 . . . . 1.3300000000000001 110.086 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.502 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -90.67 128.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.946 0.403 . . . . 1.1599999999999999 110.691 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.478 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpt_? -125.96 157.12 38.59 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.171 -0.33 . . . . 2.6600000000000001 110.497 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.35 158.39 15.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.123 -0.325 . . . . 1.9299999999999999 110.123 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.3 t -82.93 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.031 -0.729 . . . . 1.0600000000000001 109.031 174.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 14.7 t0 -153.96 -62.5 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.443 -0.577 . . . . 1.3200000000000001 109.443 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.583 ' HG3' ' H ' ' A' ' 13' ' ' LEU . 1.3 pt-20 -157.2 -85.34 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.131 -0.94 . . . . 1.3899999999999999 109.775 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.583 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -74.18 -15.47 61.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.768 -1.105 . . . . 1.22 111.759 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.68 -20.74 0.8 Allowed Glycine 0 C--O 1.222 -0.647 0 C-N-CA 119.853 -1.165 . . . . 0.34000000000000002 114.063 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.64 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 4.3 ttt180 -52.9 106.41 0.16 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.104 0.952 . . . . 1.54 111.976 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -101.84 141.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.82 . . . . 1.6899999999999999 109.433 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.562 HG21 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.55 100.08 3.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 1.1599999999999999 111.452 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.07 133.43 89.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 1.3300000000000001 110.582 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 76.7 Cg_exo -46.61 140.67 11.99 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.297 2.664 . . . . 0.34999999999999998 113.243 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.21 -30.09 48.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.028 -0.533 . . . . 1.6399999999999999 110.129 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.43 ' OE2' ' HD2' ' A' ' 2' ' ' LYS . 11.8 pt-20 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.142 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.751 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 9.3 mt -82.74 -47.99 11.35 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.883 -0.599 . . . . 1.1100000000000001 109.657 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -33.94 76.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.432 -0.951 . . . . 2.4100000000000001 108.432 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -61.37 -42.94 99.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.121 -0.945 . . . . 3.4100000000000001 111.653 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -33.75 74.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.132 0.491 . . . . 1.1299999999999999 110.829 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.751 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.6 mt -89.55 -9.1 51.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 1.1000000000000001 109.744 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.7 76.96 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.419 -0.81 . . . . 0.28000000000000003 112.52 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.662 HG12 ' HB2' ' A' ' 26' ' ' LEU . 21.8 pt -113.55 166.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.985 0.422 . . . . 1.24 111.403 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.4 152.01 3.19 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.11 -0.95 . . . . 1.03 109.863 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.747 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 4.3 pt-20 31.05 -89.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.901 1.815 . . . . 1.22 115.901 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.484 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.9 mmpt? -78.76 6.73 8.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.468 0.914 . . . . 1.51 113.468 -171.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' O ' ' HE2' ' B' ' 9' ' ' LYS . 10.9 m-20 -87.39 175.16 8.12 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.071 -0.393 . . . . 1.54 110.494 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.464 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.59 154.05 41.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.653 0.739 . . . . 1.0600000000000001 112.72 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.6 mp -122.94 154.97 37.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.461 -1.245 . . . . 1.72 108.28 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -106.35 104.22 13.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.269 -0.641 . . . . 1.28 109.269 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.899 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.55 122.98 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.341 0.591 . . . . 1.1000000000000001 111.561 -174.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 2.2 m-85 -113.1 171.89 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.821 -1.177 . . . . 4.8399999999999999 107.821 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.0 p -124.59 142.9 39.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.519 -0.472 . . . . 0.97999999999999998 110.651 177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -133.48 90.96 2.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.285 -0.416 . . . . 1.1499999999999999 110.115 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 56.88 -96.45 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.606 -0.725 . . . . 1.8300000000000001 111.393 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -116.02 11.81 15.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.412 -0.813 . . . . 2.54 110.229 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -113.99 156.39 24.16 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.304 -0.407 . . . . 1.5700000000000001 110.03 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.69 HD12 HD11 ' B' ' 18' ' ' ILE . 46.4 mt -108.36 138.36 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.221 -0.659 . . . . 1.1499999999999999 109.221 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.539 HD12 HD11 ' B' ' 44' ' ' ILE . 17.4 mm -124.55 107.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.421 -0.585 . . . . 1.05 109.421 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.899 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.33 110.99 16.79 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.225 1.012 . . . . 1.9299999999999999 111.057 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 30.4 ttpt -93.36 165.86 12.57 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.74 -1.573 . . . . 2.0 108.156 177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.684 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 61.5 pttt -63.75 148.37 49.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.394 -0.595 . . . . 3.1099999999999999 109.394 169.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -68.19 160.15 29.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.458 -0.571 . . . . 3.9199999999999999 109.458 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -66.77 112.57 9.94 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.579 -0.282 . . . . 3.8399999999999999 110.926 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.51 ' HB2' ' HE2' ' A' ' 52' ' ' MET . 74.1 Cg_endo -80.06 100.79 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.327 2.018 . . . . 1.5800000000000001 111.971 179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -85.01 105.28 15.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 4.25 109.744 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' MET . . . . . 0.51 ' HE2' ' HB2' ' A' ' 50' ' ' PRO . 23.1 mmt -102.44 107.38 18.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.721 -0.391 . . . . 5.54 110.166 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.348 1.459 . . . . 6.1299999999999999 108.626 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' B' ' 2' ' ' LYS . 21.2 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.415 -0.217 . . . . 5.9000000000000004 110.415 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.5 ' HD2' ' OE2' ' B' ' 21' ' ' GLU . 15.5 tptm 73.61 148.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.945 0.778 . . . . 1.8500000000000001 110.264 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -72.24 -165.64 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.571 -0.741 . . . . 0.88 111.732 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.522 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 9.2 m 69.59 63.94 0.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.61 -1.177 . . . . 1.1200000000000001 111.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 37.45 4.13 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.269 -0.878 . . . . 0.33000000000000002 112.196 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -106.2 135.47 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.053 0.454 . . . . 1.0700000000000001 109.898 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.464 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.3 p -87.74 126.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.923 0.392 . . . . 1.0900000000000001 111.066 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.564 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 2.1 mpt_? -123.3 154.08 39.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.282 -0.261 . . . . 2.3900000000000001 110.514 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.476 ' HE2' ' O ' ' A' ' 32' ' ' ASP . 2.0 tpmt? -89.51 159.99 16.95 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.639 -0.504 . . . . 2.04 109.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.47 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.0 t -82.85 -117.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.067 -0.345 . . . . 1.0700000000000001 110.067 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.47 ' H ' ' HB ' ' B' ' 10' ' ' VAL . 35.9 t0 -178.25 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.558 -0.534 . . . . 1.6599999999999999 109.558 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.747 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.7 pt-20 -161.18 -84.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.253 -0.885 . . . . 1.9099999999999999 110.381 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.534 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -68.52 -33.42 74.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.42 -0.809 . . . . 1.4299999999999999 111.459 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.74 -9.8 0.08 OUTLIER Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.654 -1.26 . . . . 0.31 113.393 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.627 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.0 mtt180 -54.65 104.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.183 0.492 . . . . 0.93999999999999995 111.967 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.64 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.7 p -100.3 141.02 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.341 -0.614 . . . . 1.6499999999999999 109.341 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.564 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 39.3 t -79.6 101.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.968 0.413 . . . . 1.1000000000000001 111.206 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.69 HD11 HD12 ' A' ' 43' ' ' ILE . 26.1 mm -66.64 136.67 94.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 1.3100000000000001 110.175 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.553 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.2 138.42 28.88 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.633 2.222 . . . . 0.34000000000000002 112.321 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -61.6 -30.6 48.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.004 -0.544 . . . . 1.3600000000000001 110.143 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.5 ' OE2' ' HD2' ' B' ' 2' ' ' LYS . 14.6 pt-20 -70.11 -28.07 65.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 1.3500000000000001 110.55 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.722 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 6.4 mt -80.02 -46.83 15.9 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.38 0.609 . . . . 1.1000000000000001 109.515 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.44 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 32.8 ptt85 -66.49 -33.0 74.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.622 -0.881 . . . . 1.9099999999999999 108.622 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 11.8 ttm180 -61.5 -38.61 87.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.684 -0.689 . . . . 3.1800000000000002 110.781 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 99.2 m -63.42 -35.94 82.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.39 0.614 . . . . 1.04 110.629 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.755 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 2.7 mt -88.71 -5.96 57.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.506 -0.77 . . . . 1.1100000000000001 109.364 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.62 28.64 65.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.028 -0.987 . . . . 0.34000000000000002 112.47 -174.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.692 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.0 pt -109.9 167.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.593 . . . . 1.25 111.504 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -173.51 151.62 1.98 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.782 -1.099 . . . . 1.05 109.468 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.575 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.1 pt-20 36.11 -86.76 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.415 1.635 . . . . 1.1200000000000001 115.415 171.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -79.86 5.05 14.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.156 0.799 . . . . 1.28 113.156 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -89.28 173.21 8.52 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.496 -0.482 . . . . 1.3700000000000001 110.486 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.5 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.81 154.38 38.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.335 0.588 . . . . 1.05 112.099 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.502 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.6 mp -122.25 153.74 38.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.946 -1.025 . . . . 1.8500000000000001 108.996 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.441 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 21.7 mt-10 -101.74 108.01 19.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.4 -0.593 . . . . 1.3999999999999999 109.4 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.522 ' N ' HD12 ' B' ' 36' ' ' ILE . 1.9 mp -95.08 122.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.641 0.734 . . . . 1.0900000000000001 111.546 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.512 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 14.5 m-85 -113.07 171.94 7.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.613 -1.255 . . . . 4.8300000000000001 107.613 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . 0.436 HG11 ' OG1' ' A' ' 4' ' ' THR . 10.5 p -128.18 142.96 42.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.161 -0.616 . . . . 1.05 110.68 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -134.0 91.04 2.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.126 -0.488 . . . . 1.1200000000000001 110.053 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.99 -91.28 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.62 -0.718 . . . . 1.6399999999999999 111.817 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.2 10.84 8.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.808 -0.633 . . . . 2.8100000000000001 110.281 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -114.57 154.16 28.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.125 -0.695 . . . . 1.71 109.125 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.864 ' HB ' HD13 ' A' ' 45' ' ' LEU . 46.5 mt -107.58 137.84 36.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.996 -0.372 . . . . 1.1299999999999999 109.996 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.539 HD11 HD12 ' A' ' 44' ' ' ILE . 17.5 mm -113.52 118.24 57.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.176 -0.675 . . . . 1.1000000000000001 109.176 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.504 ' N ' HD12 ' B' ' 45' ' ' LEU . 0.4 OUTLIER -123.99 107.82 11.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.546 0.689 . . . . 1.95 109.933 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 31.9 ttpt -96.62 163.13 13.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.731 -1.211 . . . . 1.73 107.731 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.755 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 24.4 pttm -71.11 150.24 45.67 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.855 -0.795 . . . . 2.8700000000000001 108.855 171.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.441 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 46.2 t80 -61.03 147.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.629 . . . . 3.6899999999999999 109.3 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.4 tppt? -66.79 110.7 5.35 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-O 120.758 0.314 . . . . 3.8100000000000001 110.572 -179.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -71.66 110.65 2.94 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.722 2.281 . . . . 1.5600000000000001 112.193 -176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.89 102.37 13.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.976 -0.556 . . . . 4.3600000000000003 109.703 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.73 108.57 19.92 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.624 -0.51 . . . . 5.6500000000000004 109.624 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 42.5 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.268 -0.872 . . . . 6.3399999999999999 109.26 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.518 0.199 . . . . 5.4100000000000001 110.71 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.889 ' HG3' ' H ' ' A' ' 3' ' ' SER . 14.3 ptmt -118.04 -81.33 0.62 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.093 -0.243 . . . . 2.3399999999999999 110.836 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.889 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 72.3 m -155.98 -163.42 1.48 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.92000000000000004 111.436 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.538 HG22 ' HD1' ' B' ' 37' ' ' TYR . 5.8 m 62.27 55.55 2.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.091 -0.959 . . . . 1.2 110.776 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.89 35.89 4.69 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.489 -0.778 . . . . 0.34000000000000002 112.159 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 10.2 tp -93.43 160.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.946 -1.131 . . . . 1.3300000000000001 107.946 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -124.67 126.65 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.792 -0.447 . . . . 1.1599999999999999 109.792 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' CZ ' ' HG3' ' A' ' 19' ' ' PRO . 9.7 mtt-85 -137.17 170.73 15.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.758 0.314 . . . . 2.6600000000000001 110.806 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.585 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.9 mmpt? -91.8 162.6 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 1.9299999999999999 111.273 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' B' ' 30' ' ' GLU . 1.4 t -85.08 -133.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 1.0600000000000001 108.051 168.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.92 -67.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.698 -0.482 . . . . 1.3200000000000001 109.698 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.611 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 3.0 pt-20 -140.9 -94.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 1.3899999999999999 111.515 169.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.579 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -66.1 -28.22 68.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.397 0.518 . . . . 1.22 112.397 -172.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.51 -5.56 0.05 OUTLIER Glycine 0 C--O 1.222 -0.616 0 C-N-CA 119.782 -1.199 . . . . 0.34000000000000002 114.158 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.589 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 31.9 mtt180 -58.56 104.94 0.25 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.073 0.936 . . . . 1.54 111.708 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.678 HG11 HD23 ' B' ' 45' ' ' LEU . 7.2 p -96.14 138.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.995 -0.743 . . . . 1.6899999999999999 108.995 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.545 HG21 ' HG3' ' B' ' 15' ' ' ARG . 25.5 t -79.0 100.62 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.47 -0.332 . . . . 1.1599999999999999 111.263 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.1 mm -67.67 128.71 93.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 1.3300000000000001 110.147 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.801 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 87.8 Cg_exo -47.72 141.92 15.07 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.256 2.637 . . . . 0.34999999999999998 113.17 173.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.419 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 10.5 tt -59.28 -34.67 54.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.19 -0.459 . . . . 1.6399999999999999 110.795 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.45 -27.93 64.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.384 0.611 . . . . 1.73 110.256 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.801 ' HG ' ' HB2' ' A' ' 19' ' ' PRO . 5.0 mt -80.45 -46.93 15.11 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.537 -0.756 . . . . 1.1100000000000001 109.141 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.52 ' HB2' HG13 ' A' ' 28' ' ' ILE . 13.3 ptt180 -65.37 -32.38 73.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.31 -0.996 . . . . 2.4100000000000001 108.31 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.49 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 2.3 tmt_? -65.05 -35.81 82.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.077 -0.965 . . . . 3.4100000000000001 110.272 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -64.73 -37.02 86.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.337 0.589 . . . . 1.1299999999999999 110.463 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.686 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -89.25 -14.11 36.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 1.1000000000000001 109.886 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.4 30.73 77.1 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.262 -0.881 . . . . 0.28000000000000003 112.387 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.52 HG13 ' HB2' ' A' ' 23' ' ' ARG . 14.0 pt -103.98 165.97 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.984 0.421 . . . . 1.24 111.229 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.45 146.87 0.49 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.929 -1.032 . . . . 1.03 109.773 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.416 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 2.9 pt-20 35.0 -89.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.447 1.647 . . . . 1.22 115.447 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -80.86 5.49 15.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.28 0.845 . . . . 1.51 113.28 -172.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.72 176.75 9.09 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.14 -0.624 . . . . 1.54 110.429 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.485 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -123.19 146.12 48.06 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.111 -0.95 . . . . 1.0600000000000001 112.213 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.5 mp -121.48 151.54 40.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.088 -0.96 . . . . 1.72 108.793 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 11.2 tt0 -108.31 106.45 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.994 -0.743 . . . . 1.28 108.994 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.72 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.1 126.59 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.811 -1.086 . . . . 1.1000000000000001 112.023 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.593 ' HD1' ' HA ' ' B' ' 4' ' ' THR . 8.0 t80 -119.14 159.87 23.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.074 -1.084 . . . . 4.8399999999999999 108.074 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.95 143.09 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 121.833 -0.542 . . . . 0.97999999999999998 110.731 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -134.67 82.32 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 1.1499999999999999 110.653 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 17.0 t70 55.8 -90.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.573 -1.194 . . . . 1.8300000000000001 112.641 178.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -88.86 -23.03 22.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.54 110.349 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.775 ' HE2' HD13 ' A' ' 44' ' ' ILE . 20.1 pttm -119.32 158.12 26.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.463 -0.79 . . . . 1.5700000000000001 112.236 -167.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.611 HD11 HD11 ' B' ' 26' ' ' LEU . 49.7 mt -110.36 139.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.265 -0.879 . . . . 1.1499999999999999 109.547 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.775 HD13 ' HE2' ' A' ' 42' ' ' LYS . 13.4 mm -118.26 120.41 64.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.013 -0.54 . . . . 1.05 109.593 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.72 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -130.46 123.94 30.9 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.44 -0.904 . . . . 1.9299999999999999 111.886 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' B' ' 41' ' ' GLU . 38.6 ttpt -115.59 170.23 8.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.011 -1.107 . . . . 2.0 108.011 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.463 ' HG3' ' CG2' ' A' ' 28' ' ' ILE . 44.5 tttm -63.81 146.05 54.65 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.496 -0.557 . . . . 3.1099999999999999 109.496 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.423 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 67.0 t80 -60.65 157.06 15.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.563 -0.29 . . . . 3.9199999999999999 110.764 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -66.85 112.57 10.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.605 . . . . 3.8399999999999999 111.24 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.77 -54.07 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.806 2.338 . . . . 1.5800000000000001 111.951 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -101.07 130.91 47.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.898 -0.592 . . . . 4.25 109.745 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.2 ptp -80.25 123.48 27.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.108 0.48 . . . . 5.54 110.438 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.688 -0.687 . . . . 6.1299999999999999 110.34 -177.155 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.54 ' HG2' HD11 ' B' ' 6' ' ' ILE . 55.2 mtt . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.539 0.209 . . . . 5.9000000000000004 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.984 ' HG3' ' H ' ' B' ' 3' ' ' SER . 0.0 OUTLIER -108.69 -83.42 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.511 -0.313 . . . . 1.8500000000000001 111.775 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.984 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 73.4 m -157.74 -167.32 2.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.802 0.441 . . . . 0.88 110.0 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.593 ' HA ' ' HD1' ' A' ' 37' ' ' TYR . 25.7 m 62.84 63.26 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.865 0.84 . . . . 1.1200000000000001 110.783 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.95 38.37 5.77 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.188 -0.915 . . . . 0.33000000000000002 111.95 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . 0.54 HD11 ' HG2' ' B' ' 1' ' ' MET . 11.1 tp -108.91 138.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 1.0700000000000001 110.547 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.485 ' CG2' ' HB3' ' A' ' 33' ' ' ALA . 7.8 p -94.64 134.21 32.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.109 0.481 . . . . 1.0900000000000001 112.028 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.443 ' HG2' HH11 ' B' ' 8' ' ' ARG . 0.6 OUTLIER -136.6 174.46 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 2.3900000000000001 110.178 171.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -98.27 160.29 14.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.211 -0.45 . . . . 2.04 110.363 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.416 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 0.6 OUTLIER -82.36 -133.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.686 -1.598 . . . . 1.0700000000000001 106.686 166.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.416 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 28.2 t70 -177.95 -51.47 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.301 0.572 . . . . 1.6599999999999999 110.883 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -125.32 -124.85 0.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.354 -0.839 . . . . 1.9099999999999999 111.408 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -70.45 -8.65 52.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 1.4299999999999999 112.377 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.41 -8.86 0.32 Allowed Glycine 0 C--O 1.219 -0.804 0 C-N-CA 119.749 -1.215 . . . . 0.31 112.535 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.611 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 39.4 mtt180 -58.96 100.24 0.06 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.918 0.39 . . . . 0.93999999999999995 111.595 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.589 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.9 p -94.33 137.85 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 1.6499999999999999 109.092 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.579 HG21 ' HG3' ' A' ' 15' ' ' ARG . 44.0 t -79.66 101.15 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.246 -0.434 . . . . 1.1000000000000001 111.535 -172.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.69 132.16 91.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 1.3100000000000001 110.512 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.585 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 91.0 Cg_exo -47.88 140.41 18.18 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.155 2.57 . . . . 0.34000000000000002 113.125 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.41 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 8.9 tt -57.91 -35.15 50.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.978 -0.555 . . . . 1.3600000000000001 110.73 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.05 -23.91 60.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.219 0.533 . . . . 1.3500000000000001 110.506 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.748 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 10.6 mt -82.68 -47.75 11.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.299 -0.63 . . . . 1.1000000000000001 109.299 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.41 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 4.4 ppt_? -65.81 -28.21 68.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.433 -0.951 . . . . 1.9099999999999999 108.433 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -62.48 -47.65 83.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.979 -1.009 . . . . 3.1800000000000002 111.027 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -57.17 -37.84 72.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.522 0.677 . . . . 1.04 110.874 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.7 mt -85.91 -19.77 30.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.415 -0.811 . . . . 1.1100000000000001 109.922 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.46 33.07 71.95 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.704 -0.68 . . . . 0.34000000000000002 112.249 -171.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.509 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.2 pt -110.91 166.38 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-O 120.685 0.279 . . . . 1.25 110.84 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.35 150.69 0.58 Allowed 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.29 0.994 . . . . 1.05 110.192 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.611 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.15 -89.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.549 1.685 . . . . 1.1200000000000001 115.549 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.418 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.5 mmpt? -82.43 4.98 22.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.978 0.733 . . . . 1.28 112.978 -172.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.63 171.15 15.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 1.3700000000000001 110.83 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.75 144.72 46.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.366 0.603 . . . . 1.05 111.882 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.45 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.4 mp -118.55 149.74 40.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.179 -0.919 . . . . 1.8500000000000001 108.917 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 7.5 tt0 -104.45 101.44 11.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.544 -0.753 . . . . 1.3999999999999999 108.99 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.533 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.0 mp -90.71 126.39 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.671 0.748 . . . . 1.0900000000000001 112.016 -175.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.538 ' HD1' HG22 ' A' ' 4' ' ' THR . 2.1 t80 -118.04 160.42 21.52 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.836 -1.172 . . . . 4.8300000000000001 107.836 171.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.92 140.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.53 -0.468 . . . . 1.05 110.301 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -136.88 86.84 2.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.123 0.487 . . . . 1.1200000000000001 110.592 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.17 -97.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.026 -0.988 . . . . 1.6399999999999999 112.402 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.419 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 36.1 mt-10 -102.88 -4.6 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 2.8100000000000001 110.417 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.467 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 26.0 pttm -124.03 159.09 30.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.361 0.6 . . . . 1.71 112.0 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.694 ' HB ' HD13 ' A' ' 45' ' ' LEU . 60.2 mt -111.31 138.98 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.254 -0.885 . . . . 1.1299999999999999 109.725 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.749 HD13 HD12 ' A' ' 44' ' ' ILE . 18.7 mm -115.05 121.43 67.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.621 -0.718 . . . . 1.1000000000000001 109.3 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.678 HD23 HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.05 111.46 14.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.077 0.942 . . . . 1.95 110.937 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.484 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 34.1 ttpt -104.75 169.75 8.27 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.826 -1.534 . . . . 1.73 107.806 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.418 ' N ' ' HG2' ' B' ' 46' ' ' LYS . 60.3 tttm -73.85 145.26 45.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.591 -0.522 . . . . 2.8700000000000001 109.591 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -60.77 146.96 44.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 3.6899999999999999 110.145 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.54 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.3 tppt? -66.61 112.71 10.17 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 115.828 -0.623 . . . . 3.8100000000000001 111.56 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.54 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 73.6 Cg_endo -76.71 -48.83 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.455 2.104 . . . . 1.5600000000000001 112.088 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -94.66 124.75 38.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.513 -0.551 . . . . 4.3600000000000003 109.513 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.4 ptp -80.86 111.18 17.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.522 0.677 . . . . 5.6500000000000004 110.942 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.269 -0.872 . . . . 6.3399999999999999 110.461 177.861 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' H1 ' HD12 ' A' ' 6' ' ' ILE . 65.9 mtt . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.884 0.374 . . . . 5.4100000000000001 110.079 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.937 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -93.61 -84.28 0.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 2.3399999999999999 110.582 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.937 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 75.1 m -143.27 -167.33 2.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.847 -0.798 . . . . 0.92000000000000004 108.847 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.637 HG23 ' HD1' ' B' ' 37' ' ' TYR . 15.2 m 66.85 69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 1.2 111.692 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.62 42.07 5.87 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.705 -0.759 . . . . 0.34000000000000002 111.638 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.41 HD12 ' H1 ' ' A' ' 1' ' ' MET . 9.6 tp -115.64 141.93 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 1.3300000000000001 110.514 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.3 p -88.35 129.59 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.042 -0.526 . . . . 1.1599999999999999 111.303 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -127.26 163.34 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.65 -0.25 . . . . 2.6600000000000001 110.378 174.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.546 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.9 mmpt? -89.54 162.09 15.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.501 -0.318 . . . . 1.9299999999999999 110.654 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.6 t -86.77 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.757 -0.831 . . . . 1.0600000000000001 108.757 172.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.552 ' HB2' ' HE ' ' B' ' 15' ' ' ARG . 25.4 t70 -159.6 -66.14 0.08 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.699 -0.852 . . . . 1.3200000000000001 108.699 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.842 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.7 pt-20 -153.47 -84.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.02 -0.991 . . . . 1.3899999999999999 110.254 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.565 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -75.98 -14.92 60.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.89 -1.05 . . . . 1.22 112.492 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.595 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 157.46 -11.2 0.25 Allowed Glycine 0 C--O 1.22 -0.778 0 C-N-CA 119.513 -1.327 . . . . 0.34000000000000002 114.546 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.727 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.7 ttt180 -66.13 99.66 0.54 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.54 1.17 . . . . 1.54 112.131 -177.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.739 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 20.8 m -95.97 141.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 1.6899999999999999 110.428 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.505 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.29 103.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.379 -0.373 . . . . 1.1599999999999999 110.777 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.669 HG22 HD11 ' B' ' 43' ' ' ILE . 21.0 mt -85.38 133.89 41.51 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 1.3300000000000001 110.335 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 43.9 Cg_exo -40.87 138.32 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.094 3.196 . . . . 0.34999999999999998 114.405 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -58.42 -31.41 42.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 1.6399999999999999 110.285 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.408 ' OE2' ' HB2' ' A' ' 2' ' ' LYS . 12.3 pt-20 -70.67 -26.76 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 1.73 110.238 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.639 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.2 mt -81.11 -47.34 13.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.995 -0.548 . . . . 1.1100000000000001 109.774 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.594 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 1.9 ptt180 -63.28 -35.78 81.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.051 -1.092 . . . . 2.4100000000000001 108.051 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.594 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 3.1 tmt_? -61.94 -37.31 84.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.731 -1.122 . . . . 3.4100000000000001 110.893 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.58 -34.8 78.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.344 0.592 . . . . 1.1299999999999999 110.549 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.809 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.6 mt -87.89 -9.05 54.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 1.1000000000000001 109.793 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.89 66.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.275 -0.875 . . . . 0.28000000000000003 112.269 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.575 HD13 HD11 ' A' ' 34' ' ' LEU . 2.4 pp -112.07 169.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 1.24 111.257 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 179.67 157.31 0.63 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.441 -0.8 . . . . 1.03 110.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.867 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 35.22 -90.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.378 1.621 . . . . 1.22 115.378 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.454 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -75.56 -4.5 40.29 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.882 0.697 . . . . 1.51 112.882 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.49 -178.44 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.508 -0.477 . . . . 1.54 111.409 -172.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.526 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -125.91 152.46 45.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.704 0.764 . . . . 1.0600000000000001 112.842 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.575 HD11 HD13 ' A' ' 28' ' ' ILE . 7.1 mp -127.94 156.89 41.92 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.477 -1.238 . . . . 1.72 107.855 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -105.83 107.6 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.117 -0.697 . . . . 1.28 109.117 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.502 HG13 HD23 ' A' ' 45' ' ' LEU . 1.8 mp -92.79 122.85 44.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.639 -0.71 . . . . 1.1000000000000001 111.217 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.722 ' HD1' HG21 ' B' ' 4' ' ' THR . 0.8 OUTLIER -124.44 159.94 29.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.207 -0.906 . . . . 4.8399999999999999 108.79 175.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.1 135.66 55.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.754 -0.379 . . . . 0.97999999999999998 110.524 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.04 96.07 3.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.977 -0.379 . . . . 1.1499999999999999 109.977 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 64.71 -97.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.13 -0.941 . . . . 1.8300000000000001 110.783 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.04 10.86 8.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.085 -0.961 . . . . 2.54 109.489 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -111.17 156.52 21.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.382 -0.826 . . . . 1.5700000000000001 109.586 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.953 ' HB ' HD11 ' B' ' 45' ' ' LEU . 38.0 mt -110.21 133.4 55.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.115 -0.493 . . . . 1.1499999999999999 109.838 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.786 HD11 HD12 ' B' ' 44' ' ' ILE . 15.8 mm -117.45 112.71 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.406 -0.59 . . . . 1.05 109.406 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.588 HD21 HG23 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -121.19 108.97 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.266 -0.573 . . . . 1.9299999999999999 109.505 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -107.05 141.18 38.69 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.012 -1.107 . . . . 2.0 108.012 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.809 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 20.9 ptmt -47.8 139.16 7.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.914 0.324 . . . . 3.1099999999999999 110.375 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.32 135.91 49.31 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.899 -0.778 . . . . 3.9199999999999999 108.899 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.78 111.95 9.88 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.539 -0.541 . . . . 3.8399999999999999 109.539 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.508 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 80.6 Cg_endo -72.85 128.52 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.513 2.142 . . . . 1.5800000000000001 111.486 -176.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -98.99 107.17 19.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.039 0.447 . . . . 4.25 110.154 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.8 ptp -113.89 138.53 50.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.596 . . . . 5.54 110.438 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.176 -0.916 . . . . 6.1299999999999999 109.474 -179.562 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.951 0.405 . . . . 5.9000000000000004 110.602 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.901 ' HG3' ' H ' ' B' ' 3' ' ' SER . 10.9 ptmt -71.54 -85.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.786 -0.643 . . . . 1.8500000000000001 111.765 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.901 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 66.2 m -138.31 -166.08 1.92 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.31 -0.626 . . . . 0.88 109.31 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.722 HG21 ' HD1' ' A' ' 37' ' ' TYR . 20.6 m 64.78 67.07 0.56 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.703 0.763 . . . . 1.1200000000000001 111.466 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.95 38.53 5.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.284 -0.871 . . . . 0.33000000000000002 111.975 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.16 139.03 28.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.493 -0.558 . . . . 1.0700000000000001 109.493 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.526 ' CG2' ' HB3' ' A' ' 33' ' ' ALA . 7.7 p -90.1 125.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 120.971 0.415 . . . . 1.0900000000000001 110.81 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.515 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 1.2 tpt180 -124.18 160.06 28.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 2.3900000000000001 110.345 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.522 ' HE2' ' HA ' ' B' ' 9' ' ' LYS . 10.2 mmpt? -87.26 163.12 17.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.415 -0.357 . . . . 2.04 110.65 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.2 t -86.42 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.049 -0.352 . . . . 1.0700000000000001 110.049 176.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.498 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 26.9 t70 173.11 -68.97 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.969 -0.752 . . . . 1.6599999999999999 108.969 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.867 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.8 pt-20 -166.56 -85.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.751 -1.113 . . . . 1.9099999999999999 109.872 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.691 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.318 -0.856 . . . . 1.4299999999999999 112.155 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 18' ' ' ILE . . . 164.35 -3.13 0.06 OUTLIER Glycine 0 C--O 1.224 -0.475 0 C-N-CA 119.617 -1.278 . . . . 0.31 113.442 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 1.7 ttt180 -65.67 97.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.101 0.451 . . . . 0.93999999999999995 111.764 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.727 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 18.5 m -94.12 144.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 1.6499999999999999 110.32 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.515 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 40.8 t -81.84 104.53 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.36 -0.382 . . . . 1.1000000000000001 110.873 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.705 HG22 HD12 ' A' ' 43' ' ' ILE . 2.3 mt -80.68 138.96 50.6 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.308 -0.256 . . . . 1.3100000000000001 110.308 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.614 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 59.1 Cg_exo -42.96 135.3 5.33 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.449 2.766 . . . . 0.34000000000000002 113.809 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.69 -32.22 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.471 -0.786 . . . . 1.3600000000000001 110.727 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.581 ' OE2' ' HE3' ' B' ' 2' ' ' LYS . 18.4 pt-20 -72.96 -23.46 60.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.132 0.492 . . . . 1.3500000000000001 110.499 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.706 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -81.9 -46.99 13.32 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.161 -0.472 . . . . 1.1000000000000001 109.769 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.587 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 6.9 ptt180 -63.41 -35.47 80.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.174 -1.047 . . . . 1.9099999999999999 108.174 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.587 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 51.2 ttt180 -56.98 -44.92 83.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.555 -1.202 . . . . 3.1800000000000002 110.821 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 89.7 m -59.29 -37.31 77.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 1.04 110.615 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.838 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 3.2 mt -86.74 -8.41 57.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 1.1100000000000001 109.759 -175.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 31.96 81.3 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.311 -0.859 . . . . 0.34000000000000002 112.133 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.791 HG12 ' HB2' ' B' ' 26' ' ' LEU . 10.9 pt -120.43 169.09 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 1.25 111.007 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.77 157.46 1.21 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.951 -1.022 . . . . 1.05 110.172 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pt-20 39.65 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.381 1.623 . . . . 1.1200000000000001 115.381 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -81.49 6.79 13.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.681 0.622 . . . . 1.28 112.681 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 57.8 m-20 -86.02 176.67 7.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.373 . . . . 1.3700000000000001 110.951 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.548 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -124.38 152.98 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.656 0.741 . . . . 1.05 112.936 -175.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.551 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.4 mp -124.53 157.09 36.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.69 -1.141 . . . . 1.8500000000000001 109.143 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.56 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 46.5 mt-10 -102.9 105.47 15.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.874 -0.603 . . . . 1.3999999999999999 109.392 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.734 HG13 ' HB3' ' B' ' 45' ' ' LEU . 1.9 mp -91.89 122.51 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.282 0.563 . . . . 1.0900000000000001 111.207 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.637 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.4 OUTLIER -124.38 161.04 26.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 4.8300000000000001 108.961 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.56 136.26 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.845 -0.342 . . . . 1.05 110.605 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -128.23 89.21 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.828 0.347 . . . . 1.1200000000000001 110.077 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 60.42 -90.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.334 -0.848 . . . . 1.6399999999999999 111.041 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.51 7.34 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.867 -0.606 . . . . 2.8100000000000001 110.427 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -104.31 158.23 16.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.648 -0.501 . . . . 1.71 109.648 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.669 HD11 HG22 ' A' ' 18' ' ' ILE . 28.5 mt -109.13 134.49 50.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.059 -0.719 . . . . 1.1299999999999999 109.059 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.786 HD12 HD11 ' A' ' 44' ' ' ILE . 15.6 mm -123.23 108.73 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.373 -0.603 . . . . 1.1000000000000001 109.373 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.953 HD11 ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -120.88 110.96 16.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.177 0.989 . . . . 1.95 111.03 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.45 ' HG2' ' N ' ' B' ' 47' ' ' LYS . 30.0 ttpt -90.71 161.33 15.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.747 -1.57 . . . . 1.73 107.843 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.838 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 45.9 pttt -64.19 137.99 58.22 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.849 -0.426 . . . . 2.8700000000000001 109.849 171.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.56 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 88.0 t80 -65.99 131.84 47.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.183 -0.673 . . . . 3.6899999999999999 109.183 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.517 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -67.93 111.17 6.96 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 3.8100000000000001 109.539 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.517 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 74.3 Cg_endo -72.88 131.92 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.745 2.297 . . . . 1.5600000000000001 111.816 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -92.85 115.9 28.54 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.65 -0.5 . . . . 4.3600000000000003 109.65 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 22.7 ptp -120.71 144.43 48.24 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.857 -0.61 . . . . 5.6500000000000004 110.238 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.248 0.976 0 N-CA-C 109.686 -0.487 . . . . 6.3399999999999999 109.686 179.115 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.733 0.302 . . . . 5.4100000000000001 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.551 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 2.1 tmtt? -80.42 148.38 30.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.53 0.681 . . . . 2.3399999999999999 112.205 -169.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.461 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 67.4 m -73.39 -162.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.55 -1.204 . . . . 0.92000000000000004 111.741 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 3.9 m 65.88 65.26 0.53 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.019 -0.991 . . . . 1.2 111.452 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.42 37.2 3.84 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 114.944 -1.026 . . . . 0.34000000000000002 111.932 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tp -107.29 138.89 31.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.969 -0.382 . . . . 1.3300000000000001 109.969 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.464 ' CG2' ' HB2' ' B' ' 33' ' ' ALA . 7.4 p -89.13 127.78 41.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.898 0.38 . . . . 1.1599999999999999 111.0 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -123.57 164.8 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 2.6600000000000001 110.492 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.418 ' HZ2' ' HB1' ' B' ' 33' ' ' ALA . 29.6 mmmt -98.95 158.62 15.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.447 -0.342 . . . . 1.9299999999999999 110.317 -178.473 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.4 t -82.58 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.988 -0.745 . . . . 1.0600000000000001 108.988 174.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.559 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 20.8 t70 -155.6 -66.01 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.957 -0.757 . . . . 1.3200000000000001 108.957 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.9 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.4 pt-20 -156.01 -82.82 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.698 -1.137 . . . . 1.3899999999999999 109.098 168.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.526 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -60.16 -38.13 82.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 1.22 111.62 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -15.19 0.08 OUTLIER Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.572 -1.299 . . . . 0.34000000000000002 114.552 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.96 104.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.251 1.025 . . . . 1.54 111.637 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.6 p -101.38 141.7 17.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 1.6899999999999999 109.692 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 ' HG3' ' B' ' 15' ' ' ARG . 45.1 t -78.84 108.65 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.262 -0.426 . . . . 1.1599999999999999 111.39 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.1 mm -74.26 132.94 78.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 1.3300000000000001 110.89 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.596 ' HD2' HD11 ' A' ' 22' ' ' LEU . 77.8 Cg_exo -46.93 140.83 12.8 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.403 2.735 . . . . 0.34999999999999998 113.298 173.392 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.937 HD12 ' HD2' ' A' ' 23' ' ' ARG . 4.2 tp -60.49 -32.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.606 -0.724 . . . . 1.6399999999999999 110.132 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.551 ' OE2' ' HA ' ' A' ' 2' ' ' LYS . 6.6 pt-20 -70.67 -26.29 63.37 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.128 0.489 . . . . 1.73 109.934 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.758 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 12.3 mt -82.1 -47.96 11.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.321 -0.622 . . . . 1.1100000000000001 109.321 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.937 ' HD2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -64.31 -32.12 73.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.606 -0.887 . . . . 2.4100000000000001 108.606 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -63.74 -42.7 97.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.314 -0.857 . . . . 3.4100000000000001 111.397 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.3 m -61.41 -35.28 77.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.383 0.611 . . . . 1.1299999999999999 110.75 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.758 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -91.09 -10.53 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.452 -0.795 . . . . 1.1000000000000001 109.446 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.2 34.7 81.12 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.449 -0.796 . . . . 0.28000000000000003 112.22 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.52 HG12 ' HB2' ' A' ' 26' ' ' LEU . 13.9 pt -106.86 163.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.372 0.606 . . . . 1.24 111.665 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.97 148.96 1.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.462 -1.245 . . . . 1.03 109.373 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.868 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 2.5 pt-20 33.07 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.62 1.711 . . . . 1.22 115.62 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -76.04 4.9 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.509 0.929 . . . . 1.51 113.509 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -85.78 171.47 11.54 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.578 -0.449 . . . . 1.54 110.112 -178.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.466 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -124.03 153.26 41.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.527 0.68 . . . . 1.0600000000000001 112.16 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.4 mp -123.09 153.38 40.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.813 -1.085 . . . . 1.72 108.22 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.6 106.16 16.38 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.717 -0.846 . . . . 1.28 108.717 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.801 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -89.8 124.42 42.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.292 -0.867 . . . . 1.1000000000000001 111.365 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.7 m-85 -115.06 172.8 6.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.471 -1.307 . . . . 4.8399999999999999 107.471 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.55 141.19 46.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 120.693 -0.403 . . . . 0.97999999999999998 110.173 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -129.32 76.84 1.75 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.491 . . . . 1.1499999999999999 110.19 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 54.03 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.254 -1.339 . . . . 1.8300000000000001 113.001 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -105.03 -13.43 15.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.978 -0.556 . . . . 2.54 110.777 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -115.25 158.73 21.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 1.5700000000000001 110.932 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HD12 ' B' ' 26' ' ' LEU . 59.0 mt -104.37 137.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.842 -0.799 . . . . 1.1499999999999999 108.842 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.565 HD11 HD12 ' B' ' 44' ' ' ILE . 15.9 mm -123.88 105.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.614 -0.513 . . . . 1.05 109.614 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.881 HD13 ' HB ' ' B' ' 43' ' ' ILE . 0.4 OUTLIER -119.62 118.71 31.69 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.316 -0.953 . . . . 1.9299999999999999 111.185 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 46' ' ' LYS . 35.2 ttpt -102.88 165.13 11.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.97 -1.468 . . . . 2.0 107.882 177.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 81.8 tttt -65.22 137.02 57.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.064 -0.717 . . . . 3.1099999999999999 109.064 171.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.32 154.36 20.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.371 -0.603 . . . . 3.9199999999999999 109.371 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -66.94 115.74 28.27 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 3.8399999999999999 110.652 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.66 -29.13 9.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.899 2.399 . . . . 1.5800000000000001 113.049 -169.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -69.43 134.72 49.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.267 0.556 . . . . 4.25 110.277 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -94.11 146.89 23.65 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.856 -0.611 . . . . 5.54 109.812 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.247 0.956 0 CA-C-N 116.185 -0.462 . . . . 6.1299999999999999 110.047 179.791 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.642 0.258 . . . . 5.9000000000000004 111.512 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.414 ' HE2' ' OE2' ' B' ' 21' ' ' GLU . 0.4 OUTLIER -81.84 142.89 32.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.485 0.66 . . . . 1.8500000000000001 111.764 -168.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 52.6 m -70.79 -162.53 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.488 -1.233 . . . . 0.88 112.002 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 3.9 m 69.33 59.37 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.703 -1.135 . . . . 1.1200000000000001 111.337 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.76 35.89 3.14 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.33000000000000002 112.282 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -109.52 136.92 43.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.975 0.417 . . . . 1.0700000000000001 110.761 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.3 p -88.94 125.37 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.982 0.42 . . . . 1.0900000000000001 111.688 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.94 165.93 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.509 -0.314 . . . . 2.3900000000000001 110.321 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -96.04 162.54 13.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.974 -0.38 . . . . 2.04 109.974 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 t -82.34 -108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.798 -0.361 . . . . 1.0700000000000001 110.293 177.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.487 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 7.0 t70 175.17 -77.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.107 -0.701 . . . . 1.6599999999999999 109.107 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.868 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -159.27 -71.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.045 -0.979 . . . . 1.9099999999999999 108.832 168.541 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.577 ' H ' HD21 ' B' ' 13' ' ' LEU . 2.4 pt? -77.74 -29.07 50.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.58 -1.191 . . . . 1.4299999999999999 111.271 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.46 -11.86 0.18 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 119.206 -1.473 . . . . 0.31 114.011 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.623 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.9 ttt180 -56.61 99.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.628 0.714 . . . . 0.93999999999999995 111.741 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.6 p -95.01 141.83 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.777 -0.453 . . . . 1.6499999999999999 109.777 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.38 109.44 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.406 . . . . 1.1000000000000001 111.071 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.491 HD11 HD12 ' A' ' 43' ' ' ILE . 30.8 mm -75.34 134.48 73.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.155 -0.475 . . . . 1.3100000000000001 110.701 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.635 ' HD2' HD13 ' B' ' 22' ' ' LEU . 92.9 Cg_exo -48.46 141.12 20.08 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.087 2.525 . . . . 0.34000000000000002 113.044 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.556 HD12 ' HD2' ' B' ' 23' ' ' ARG . 6.5 tp -59.93 -32.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.937 -0.574 . . . . 1.3600000000000001 110.222 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.414 ' OE2' ' HE2' ' B' ' 2' ' ' LYS . 8.9 pt-20 -73.47 -23.62 60.1 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.172 0.51 . . . . 1.3500000000000001 110.328 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.761 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.8 mt -81.36 -48.19 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.417 -0.586 . . . . 1.1000000000000001 109.417 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.556 ' HD2' HD12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -64.15 -33.48 75.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 1.9099999999999999 108.154 177.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.45 -47.11 85.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.191 -0.913 . . . . 3.1800000000000002 111.289 171.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -60.77 -35.14 75.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.358 0.599 . . . . 1.04 111.045 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.761 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 2.5 mt -90.36 -10.9 42.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 1.1100000000000001 109.785 -176.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 24.72 64.66 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.34000000000000002 112.298 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.54 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.3 pt -96.98 166.53 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-O 121.293 0.568 . . . . 1.25 111.048 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.87 152.69 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.548 -1.206 . . . . 1.05 109.111 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.9 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.5 pt-20 33.78 -90.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.778 1.77 . . . . 1.1200000000000001 115.778 169.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.48 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.0 mmpt? -83.98 7.19 19.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.01 0.744 . . . . 1.28 113.01 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -84.48 174.54 9.96 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.129 -0.357 . . . . 1.3700000000000001 110.57 178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.464 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -122.7 152.97 40.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.481 0.658 . . . . 1.05 112.453 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.451 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.5 mp -120.92 151.88 39.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.935 -1.03 . . . . 1.8500000000000001 108.979 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -104.18 102.35 12.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.652 -0.869 . . . . 1.3999999999999999 108.652 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.414 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.8 mp -90.07 124.88 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.391 0.615 . . . . 1.0900000000000001 111.68 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 7.3 m-85 -114.16 175.13 5.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.012 -1.107 . . . . 4.8300000000000001 108.012 171.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.25 143.11 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 110.008 -0.367 . . . . 1.05 110.008 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -132.94 77.13 1.72 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.827 0.346 . . . . 1.1200000000000001 110.628 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 t70 56.14 -75.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.565 -1.198 . . . . 1.6399999999999999 113.05 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -103.17 -25.44 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 2.8100000000000001 110.81 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.426 ' HE2' ' HB2' ' B' ' 42' ' ' LYS . 1.0 OUTLIER -111.62 160.06 17.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.857 -0.611 . . . . 1.71 111.127 -173.633 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.881 ' HB ' HD13 ' A' ' 45' ' ' LEU . 68.0 mt -105.58 138.16 32.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.459 -0.792 . . . . 1.1299999999999999 109.351 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.565 HD12 HD11 ' A' ' 44' ' ' ILE . 16.9 mm -114.64 112.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.491 -0.559 . . . . 1.1000000000000001 109.491 -175.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.5 HD13 ' N ' ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.92 108.97 15.43 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.938 -0.705 . . . . 1.95 110.247 -178.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.43 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 35.4 ttpt -96.23 164.96 12.44 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.087 -1.079 . . . . 1.73 108.087 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.528 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 82.9 tttt -70.48 139.06 51.6 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.769 -0.826 . . . . 2.8700000000000001 108.769 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.26 147.47 44.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.823 -0.806 . . . . 3.6899999999999999 108.823 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -67.5 114.84 21.45 Favored Pre-proline 0 CA--C 1.512 -0.508 0 CA-C-O 121.366 0.603 . . . . 3.8100000000000001 110.664 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.31 -27.95 9.1 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.936 2.424 . . . . 1.5600000000000001 113.288 -168.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -70.75 122.11 19.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.719 0.295 . . . . 4.3600000000000003 110.217 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' B' ' 52' ' ' MET . 1.1 pmm? -91.92 110.43 21.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.498 0.666 . . . . 5.6500000000000004 111.349 -177.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.468 -0.787 . . . . 6.3399999999999999 109.367 172.215 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 110.244 -0.28 . . . . 5.4100000000000001 110.244 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.463 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 31.8 tptt -105.36 154.51 20.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.962 0.41 . . . . 2.3399999999999999 110.732 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -85.73 -167.56 1.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.498 -0.774 . . . . 0.92000000000000004 111.539 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.637 HG23 ' HD1' ' B' ' 37' ' ' TYR . 49.2 m 72.15 72.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.999 -1.0 . . . . 1.2 112.574 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 40.02 7.13 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.405 -0.816 . . . . 0.34000000000000002 111.756 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 tp -111.47 139.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.052 0.453 . . . . 1.3300000000000001 110.1 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' CG2' ' HB3' ' B' ' 33' ' ' ALA . 10.9 p -94.04 132.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.306 -0.406 . . . . 1.1599999999999999 111.205 -174.021 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.401 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 3.2 mpt_? -134.14 164.85 26.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.251 -0.431 . . . . 2.6600000000000001 110.498 176.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.466 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 0.8 OUTLIER -83.69 161.12 21.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.923 -0.58 . . . . 1.9299999999999999 109.611 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.35 -102.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 110.022 -0.362 . . . . 1.0600000000000001 110.022 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 17.2 t0 174.48 -73.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.712 -0.847 . . . . 1.3200000000000001 108.712 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.855 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.3 pt-20 -164.78 -80.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.398 -1.274 . . . . 1.3899999999999999 109.43 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.705 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.7 pt? -65.81 -31.48 72.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.053 -0.976 . . . . 1.22 112.032 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.62 -19.81 0.38 Allowed Glycine 0 C--O 1.221 -0.719 0 C-N-CA 119.783 -1.198 . . . . 0.34000000000000002 113.816 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.634 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.3 ttt180 -49.49 105.8 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.386 0.593 . . . . 1.54 112.385 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -97.39 141.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.175 -0.466 . . . . 1.6899999999999999 109.941 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.19 110.92 14.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 1.1599999999999999 111.8 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.512 HD13 HG21 ' B' ' 43' ' ' ILE . 40.7 mm -80.95 134.49 52.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 1.3300000000000001 110.597 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.653 ' HD2' HD12 ' A' ' 22' ' ' LEU . 80.4 Cg_exo -49.99 141.11 30.33 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.275 2.65 . . . . 0.34999999999999998 113.533 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.59 -33.3 54.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.651 -0.704 . . . . 1.6399999999999999 110.689 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.89 -23.54 62.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.155 0.503 . . . . 1.73 109.747 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.689 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.7 mt -82.22 -49.51 10.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.838 -0.619 . . . . 1.1100000000000001 109.875 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -65.29 -31.31 72.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.73 -0.841 . . . . 2.4100000000000001 108.73 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -39.54 94.66 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.525 -0.761 . . . . 3.4100000000000001 110.895 173.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -62.59 -33.28 74.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 1.1299999999999999 110.254 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.829 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.9 mt -88.43 -11.25 46.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.422 -0.808 . . . . 1.1000000000000001 109.573 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.03 24.39 66.92 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.252 -0.886 . . . . 0.28000000000000003 112.401 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.8 HG12 ' HB2' ' A' ' 26' ' ' LEU . 18.5 pt -107.71 166.55 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 1.24 111.467 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.38 146.39 0.63 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.812 -1.085 . . . . 1.03 109.807 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.961 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 37.5 -85.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 115.33 1.604 . . . . 1.22 115.33 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HE3' ' HB2' ' A' ' 30' ' ' GLU . 11.0 mmpt? -71.51 -1.42 13.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.91 0.707 . . . . 1.51 112.91 -173.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -86.59 175.98 8.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.99 0.424 . . . . 1.54 111.428 -177.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.521 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -122.8 152.33 40.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.626 -0.715 . . . . 1.0600000000000001 112.59 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.8 mp -124.69 156.95 36.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.344 -1.354 . . . . 1.72 107.344 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.585 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 26.4 tt0 -108.03 107.96 18.87 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.204 -0.665 . . . . 1.28 109.204 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.611 HG13 HD11 ' A' ' 45' ' ' LEU . 2.0 mp -92.8 123.21 44.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.618 -0.719 . . . . 1.1000000000000001 111.282 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.65 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.05 162.56 25.75 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.201 -0.909 . . . . 4.8399999999999999 109.092 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.42 139.89 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.989 0.423 . . . . 0.97999999999999998 110.611 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.06 80.17 1.96 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.233 0.539 . . . . 1.1499999999999999 110.243 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.94 -77.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.353 -1.294 . . . . 1.8300000000000001 111.459 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.28 -31.47 6.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 2.54 110.639 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.694 ' HE2' HD11 ' A' ' 44' ' ' ILE . 25.2 pttm -96.8 156.34 16.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.196 -0.601 . . . . 1.5700000000000001 111.46 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.707 HD12 HD12 ' B' ' 26' ' ' LEU . 13.8 mt -107.06 137.67 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.462 -0.79 . . . . 1.1499999999999999 109.575 -176.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.694 HD11 ' HE2' ' A' ' 42' ' ' LYS . 15.1 mm -124.24 109.62 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 1.05 110.112 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.72 HD23 HD12 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -117.77 113.84 22.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.897 -0.721 . . . . 1.9299999999999999 109.51 176.64 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HG2' ' HB3' ' A' ' 35' ' ' GLU . 12.7 ptpt -91.98 162.57 14.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.647 -1.242 . . . . 2.0 107.647 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.829 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 51.4 pttt -65.97 148.01 52.46 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.82 -0.807 . . . . 3.1099999999999999 108.82 168.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.82 126.72 28.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.712 -1.218 . . . . 3.9199999999999999 107.712 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -66.93 119.61 65.33 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.674 -0.491 . . . . 3.8399999999999999 109.674 -171.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.5 107.02 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.726 2.284 . . . . 1.5800000000000001 112.36 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -109.34 96.94 6.63 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.564 -0.744 . . . . 4.25 109.55 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 ptm -104.21 145.7 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 5.54 110.082 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.564 -0.731 . . . . 6.1299999999999999 110.783 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.459 0.171 . . . . 5.9000000000000004 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -76.41 150.64 36.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.394 0.616 . . . . 1.8500000000000001 112.096 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m -81.4 -164.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.825 -1.079 . . . . 0.88 110.973 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.575 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.8 m 74.16 71.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.269 -0.878 . . . . 1.1200000000000001 111.98 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.73 39.13 7.22 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.199 -0.91 . . . . 0.33000000000000002 111.812 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.67 138.71 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.164 0.506 . . . . 1.0700000000000001 110.029 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.521 ' CG2' ' HB3' ' A' ' 33' ' ' ALA . 7.4 p -93.37 129.34 43.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.114 -0.494 . . . . 1.0900000000000001 111.244 -173.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.413 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 1.5 mpt_? -131.03 163.54 27.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 2.3900000000000001 110.574 176.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -82.67 161.22 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.364 -0.606 . . . . 2.04 109.364 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.99 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.806 -0.357 . . . . 1.0700000000000001 110.251 177.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.556 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 17.4 t70 175.42 -77.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.173 -0.677 . . . . 1.6599999999999999 109.173 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.961 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -160.57 -73.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.965 -1.016 . . . . 1.9099999999999999 108.626 172.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.407 ' H ' HD22 ' B' ' 13' ' ' LEU . 2.5 pt? -80.12 -23.1 41.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.394 -1.275 . . . . 1.4299999999999999 111.534 -174.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.9 -18.95 0.66 Allowed Glycine 0 C--O 1.221 -0.665 0 C-N-CA 119.557 -1.306 . . . . 0.31 113.553 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.63 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.4 ttt180 -50.12 105.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.312 0.486 . . . . 0.93999999999999995 112.312 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.634 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 11.5 p -97.94 142.98 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 1.6499999999999999 109.906 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.47 111.46 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.025 0.44 . . . . 1.1000000000000001 111.889 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.621 HD13 HD13 ' A' ' 43' ' ' ILE . 25.1 mm -78.34 132.51 65.93 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.642 -0.708 . . . . 1.3100000000000001 110.777 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.59 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 88.8 Cg_exo -48.73 140.27 22.95 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.233 2.622 . . . . 0.34000000000000002 113.291 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.11 -33.01 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 1.3600000000000001 110.961 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.83 -25.49 62.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.932 0.396 . . . . 1.3500000000000001 110.264 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.757 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -80.54 -48.79 12.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.808 -0.633 . . . . 1.1000000000000001 109.608 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -65.44 -33.22 75.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.381 -0.97 . . . . 1.9099999999999999 108.381 178.593 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.5 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 5.7 tmm_? -59.57 -42.4 92.36 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.261 -0.881 . . . . 3.1800000000000002 109.844 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 80.3 m -60.96 -38.15 84.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.677 0.751 . . . . 1.04 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.814 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 4.9 mt -85.72 -11.26 54.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.994 -1.003 . . . . 1.1100000000000001 109.789 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.86 86.71 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.294 -0.866 . . . . 0.34000000000000002 111.782 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.514 HG13 ' HB2' ' B' ' 26' ' ' LEU . 2.7 pp -122.15 167.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.917 0.389 . . . . 1.25 111.345 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.409 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -174.13 154.93 2.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.164 -0.926 . . . . 1.05 109.432 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.855 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.4 pt-20 36.2 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.419 1.637 . . . . 1.1200000000000001 115.419 170.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.463 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.8 mmpt? -79.45 6.91 9.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 1.28 112.822 -173.358 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.466 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -92.9 176.73 6.32 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 122.223 -0.298 . . . . 1.3700000000000001 110.94 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.471 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . . . -123.01 153.33 39.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.168 0.803 . . . . 1.05 113.168 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -124.71 155.94 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.377 -1.283 . . . . 1.8500000000000001 107.557 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -108.16 107.37 17.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 1.3999999999999999 109.768 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.718 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.3 124.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.259 -0.882 . . . . 1.0900000000000001 111.432 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.637 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.7 OUTLIER -127.0 164.49 21.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.195 -0.911 . . . . 4.8300000000000001 108.827 176.028 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.38 139.91 48.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.988 -0.285 . . . . 1.05 110.874 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.73 89.37 2.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.642 -0.423 . . . . 1.1200000000000001 110.333 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 t70 63.88 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.001 -1.0 . . . . 1.6399999999999999 111.396 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.14 4.77 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.274 -0.876 . . . . 2.8100000000000001 110.604 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -103.79 155.13 18.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.704 -0.48 . . . . 1.71 109.704 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.64 HD12 HD12 ' A' ' 26' ' ' LEU . 13.0 mt -109.6 134.13 52.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.454 -0.573 . . . . 1.1299999999999999 109.454 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.688 HD13 HD13 ' A' ' 44' ' ' ILE . 11.7 mm -125.65 106.13 15.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.322 -0.399 . . . . 1.1000000000000001 110.382 -172.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.72 HD12 HD23 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.08 116.04 24.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.758 -0.777 . . . . 1.95 110.067 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.42 163.47 13.4 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.087 -1.079 . . . . 1.73 108.087 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.814 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 62.1 pttt -63.18 151.32 40.62 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.179 -0.674 . . . . 2.8700000000000001 109.179 169.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -60.83 132.03 52.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.131 -1.062 . . . . 3.6899999999999999 108.131 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.436 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.3 tppt? -65.48 118.65 52.75 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 109.897 -0.409 . . . . 3.8100000000000001 109.897 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.436 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 22.8 Cg_endo -61.74 106.48 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.486 2.124 . . . . 1.5600000000000001 112.094 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -98.25 104.71 16.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.403 -0.817 . . . . 4.3600000000000003 109.044 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.8 ptm -115.33 117.5 30.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.211 -0.449 . . . . 5.6500000000000004 110.465 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.456 -0.783 . . . . 6.3399999999999999 110.215 177.366 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 121.337 0.589 . . . . 5.4100000000000001 110.68 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.424 ' HB2' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -119.29 -158.68 0.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.49 -0.777 . . . . 2.3399999999999999 110.209 -178.741 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.424 ' H ' ' HB2' ' A' ' 2' ' ' LYS . 51.8 m -66.2 -175.41 0.33 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.797 0.808 . . . . 0.92000000000000004 112.854 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.633 HG22 ' HD1' ' B' ' 37' ' ' TYR . 17.8 m 72.11 67.74 0.14 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.28 -1.327 . . . . 1.2 111.409 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.88 43.85 4.97 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.349 -0.841 . . . . 0.34000000000000002 111.438 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -108.15 137.63 38.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.587 -0.445 . . . . 1.3300000000000001 109.968 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.511 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 9.8 p -98.67 124.23 51.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.907 0.384 . . . . 1.1599999999999999 110.652 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 0.5 OUTLIER -128.7 163.84 24.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.497 -0.32 . . . . 2.6600000000000001 111.297 -178.39 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.86 162.98 23.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 1.9299999999999999 110.645 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HB ' ' H ' ' A' ' 11' ' ' ASP . 2.3 t -86.75 -109.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.272 -0.422 . . . . 1.0600000000000001 109.975 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.476 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 16.7 t0 179.11 -67.3 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.044 -0.725 . . . . 1.3200000000000001 109.044 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.608 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.1 pt-20 -168.15 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.92 -1.036 . . . . 1.3899999999999999 110.255 175.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.587 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.3 pt? -80.52 -0.64 38.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.555 -1.202 . . . . 1.22 112.326 -171.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 144.35 -22.75 2.05 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 119.744 -1.217 . . . . 0.34000000000000002 113.967 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.711 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.6 ttt180 -58.12 106.82 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.436 0.618 . . . . 1.54 112.466 -174.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.712 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.4 p -98.3 140.07 18.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.753 -0.462 . . . . 1.6899999999999999 109.753 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.585 HG22 ' HG3' ' B' ' 15' ' ' ARG . 40.7 t -79.8 101.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.8 0.333 . . . . 1.1599999999999999 110.867 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.638 HD12 HD13 ' B' ' 43' ' ' ILE . 10.4 mt -81.04 135.1 51.67 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 1.3300000000000001 110.264 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.471 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 54.4 Cg_exo -42.85 136.0 4.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.494 2.796 . . . . 0.34999999999999998 113.663 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.06 -29.3 41.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.612 -0.722 . . . . 1.6399999999999999 109.98 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -68.87 -27.38 65.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.047 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.712 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.3 mt -82.91 -47.01 12.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.01 -0.541 . . . . 1.1100000000000001 109.675 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -65.69 -30.65 71.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.604 -0.888 . . . . 2.4100000000000001 108.604 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -62.44 -42.18 99.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 3.4100000000000001 110.846 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.9 m -60.81 -35.64 77.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.244 0.545 . . . . 1.1299999999999999 111.039 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.808 HD13 HD12 ' B' ' 43' ' ' ILE . 1.3 mt -90.3 -9.71 46.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.818 -0.628 . . . . 1.1000000000000001 109.719 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.26 34.91 86.6 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.241 -0.89 . . . . 0.28000000000000003 112.099 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.548 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.6 pt -115.41 165.96 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.104 0.478 . . . . 1.24 111.096 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.1 154.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 1.03 109.593 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.579 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 4.6 pt-20 37.83 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.356 1.613 . . . . 1.22 115.356 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.579 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.8 mmpt? -76.15 -1.61 27.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.818 0.673 . . . . 1.51 112.818 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -85.87 174.05 9.56 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.672 -0.411 . . . . 1.54 110.307 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.462 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.18 153.38 40.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.746 0.784 . . . . 1.0600000000000001 113.061 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.653 HD21 ' HA ' ' A' ' 47' ' ' LYS . 18.5 mt -124.47 153.34 42.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.398 -1.274 . . . . 1.72 107.598 173.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -106.82 105.39 15.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.324 -0.621 . . . . 1.28 109.324 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.851 HG13 HD22 ' A' ' 45' ' ' LEU . 1.8 mp -90.37 123.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.473 -0.785 . . . . 1.1000000000000001 111.06 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.722 ' HD1' HG22 ' B' ' 4' ' ' THR . 0.2 OUTLIER -124.92 158.85 32.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.716 -0.846 . . . . 4.8399999999999999 108.716 175.545 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.42 HG13 ' OG1' ' B' ' 4' ' ' THR . 9.7 p -112.56 139.48 37.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.68 -0.408 . . . . 0.97999999999999998 110.795 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -135.48 82.15 1.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.381 -0.372 . . . . 1.1499999999999999 110.109 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.17 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.357 -0.838 . . . . 1.8300000000000001 111.511 -175.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -121.28 -15.35 8.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 2.54 110.038 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -85.21 144.45 28.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.642 . . . . 1.5700000000000001 110.344 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.881 HD12 HD12 ' B' ' 26' ' ' LEU . 18.4 mt -106.05 131.58 55.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.431 -0.804 . . . . 1.1499999999999999 108.929 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.654 HD13 HD11 ' B' ' 44' ' ' ILE . 17.9 mm -119.32 112.25 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.389 -0.369 . . . . 1.05 110.054 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.851 HD22 HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -117.03 108.74 16.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.483 -0.562 . . . . 1.9299999999999999 109.483 -178.039 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.405 ' HB2' ' HG2' ' B' ' 42' ' ' LYS . 31.9 ttpt -103.18 134.89 45.84 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.813 -0.81 . . . . 2.0 108.813 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.653 ' HA ' HD21 ' A' ' 34' ' ' LEU . 60.3 pttt -47.51 144.85 2.84 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 123.064 0.227 . . . . 3.1099999999999999 110.623 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -60.4 144.69 50.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 110.108 -0.33 . . . . 3.9199999999999999 110.108 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.791 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.88 114.69 24.64 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 109.575 -0.528 . . . . 3.8399999999999999 109.575 -179.042 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.791 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 58.0 Cg_endo -69.5 110.03 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.581 2.187 . . . . 1.5800000000000001 111.17 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.8 151.72 27.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.092 -0.504 . . . . 4.25 110.816 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 145.8 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.133 0.492 . . . . 5.54 110.983 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.389 -0.815 . . . . 6.1299999999999999 110.423 178.52 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.674 ' HG2' ' H ' ' B' ' 2' ' ' LYS . 12.9 ttt . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.474 -0.565 . . . . 5.9000000000000004 109.474 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.748 ' HD3' ' H ' ' B' ' 3' ' ' SER . 0.0 OUTLIER -89.36 -95.42 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.941 1.089 . . . . 1.8500000000000001 113.941 -170.092 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.748 ' H ' ' HD3' ' B' ' 2' ' ' LYS . 69.1 m -130.44 -174.29 3.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.88 111.162 -173.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.722 HG22 ' HD1' ' A' ' 37' ' ' TYR . 27.9 m 65.73 69.3 0.46 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.403 -0.817 . . . . 1.1200000000000001 111.005 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.75 41.54 4.38 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.021 -0.99 . . . . 0.33000000000000002 111.721 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tp -105.44 137.21 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.664 -0.495 . . . . 1.0700000000000001 109.664 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.462 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 12.5 p -96.99 128.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.967 0.413 . . . . 1.0900000000000001 110.356 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.404 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 0.9 OUTLIER -134.45 156.59 48.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.29 -0.414 . . . . 2.3900000000000001 110.638 -178.002 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.58 ' HE2' ' HA ' ' B' ' 9' ' ' LYS . 10.8 mmpt? -82.0 161.01 23.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 2.04 110.624 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.501 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 1.7 t -84.3 -118.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.029 0.443 . . . . 1.0700000000000001 110.146 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.51 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 17.3 t0 -171.91 -63.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.194 -0.669 . . . . 1.6599999999999999 109.194 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.722 ' HG3' ' H ' ' B' ' 13' ' ' LEU . 4.2 pt-20 -169.59 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.909 . . . . 1.9099999999999999 110.41 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.722 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -61.01 -29.64 69.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.405 -0.816 . . . . 1.4299999999999999 112.564 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.88 -9.78 0.31 Allowed Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.992 -1.099 . . . . 0.31 112.974 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.1 mtt180 -60.78 106.0 0.52 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.02 0.378 . . . . 0.93999999999999995 112.02 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.711 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 9.7 p -100.99 142.1 16.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.146 -0.479 . . . . 1.6499999999999999 109.734 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.65 108.98 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.601 -0.272 . . . . 1.1000000000000001 111.162 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.584 HG13 ' O ' ' A' ' 14' ' ' GLY . 3.4 mt -85.17 138.31 36.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.092 -0.336 . . . . 1.3100000000000001 110.092 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.645 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 62.2 Cg_exo -43.16 136.6 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.395 2.73 . . . . 0.34000000000000002 113.89 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -56.03 -33.42 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 1.3600000000000001 110.813 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.73 -22.75 59.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.394 -0.366 . . . . 1.3500000000000001 110.38 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.712 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -82.04 -47.17 12.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.33 -0.619 . . . . 1.1000000000000001 109.33 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -64.98 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.723 -0.843 . . . . 1.9099999999999999 108.723 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.7 -36.65 81.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.737 -1.119 . . . . 3.1800000000000002 110.635 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' THR . . . . . 0.403 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 76.7 m -63.45 -36.03 82.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.529 0.68 . . . . 1.04 110.526 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.881 HD12 HD12 ' A' ' 43' ' ' ILE . 2.1 mt -89.7 -10.61 45.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.338 -0.846 . . . . 1.1100000000000001 109.777 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.22 15.77 68.12 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.34000000000000002 112.698 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' B' ' 26' ' ' LEU . 15.5 pt -98.15 168.81 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.818 0.342 . . . . 1.25 111.247 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.44 146.66 0.28 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.309 -0.86 . . . . 1.05 109.835 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.608 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.3 pt-20 37.47 -89.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.299 1.592 . . . . 1.1200000000000001 115.299 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.474 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 10.8 mmpt? -75.23 4.91 6.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.515 0.561 . . . . 1.28 112.515 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -97.25 -177.99 4.02 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.086 -0.646 . . . . 1.3700000000000001 110.896 -175.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.511 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -126.47 153.61 44.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.235 1.198 . . . . 1.05 114.235 -171.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.71 HD22 ' HA ' ' B' ' 47' ' ' LYS . 19.5 mt -127.02 153.68 45.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.186 -1.37 . . . . 1.8500000000000001 108.024 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -106.41 104.76 14.53 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.204 -0.665 . . . . 1.3999999999999999 109.204 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.635 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.94 124.5 45.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.52 0.676 . . . . 1.0900000000000001 111.748 -175.168 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.633 ' HD1' HG22 ' A' ' 4' ' ' THR . 0.3 OUTLIER -126.46 162.95 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.079 -0.964 . . . . 4.8300000000000001 108.658 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.27 140.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.019 0.437 . . . . 1.05 111.338 -171.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.31 78.87 1.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.588 . . . . 1.1200000000000001 109.59 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.71 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.504 -1.225 . . . . 1.6399999999999999 111.216 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -128.71 -13.62 4.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 2.8100000000000001 110.391 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.405 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 24.0 mtpt -85.27 143.87 28.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.504 . . . . 1.71 109.748 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.808 HD12 HD13 ' A' ' 26' ' ' LEU . 26.5 mt -104.25 132.5 50.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.927 -0.768 . . . . 1.1299999999999999 108.927 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.654 HD11 HD13 ' A' ' 44' ' ' ILE . 15.5 mm -120.53 108.89 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.1 -0.333 . . . . 1.1000000000000001 110.1 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.635 ' HB3' HG13 ' B' ' 36' ' ' ILE . 0.1 OUTLIER -118.81 108.79 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.352 0.596 . . . . 1.95 110.629 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -90.34 156.06 18.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.776 -1.194 . . . . 1.73 107.776 173.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD22 ' B' ' 34' ' ' LEU . 24.1 pttm -63.53 159.67 18.15 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.023 -0.671 . . . . 2.8700000000000001 109.338 173.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -59.64 149.4 30.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.379 -0.373 . . . . 3.6899999999999999 110.026 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.714 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -68.93 116.08 37.89 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.988 -0.745 . . . . 3.8100000000000001 108.988 173.692 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.714 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 60.5 Cg_endo -71.01 109.74 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 1.5600000000000001 111.278 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.86 152.16 31.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.876 -0.602 . . . . 4.3600000000000003 110.528 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.36 149.19 50.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 5.6500000000000004 110.402 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.217 -0.897 . . . . 6.3399999999999999 110.957 -179.098 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.349 -0.241 . . . . 5.4100000000000001 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.43 ' HD3' ' N ' ' A' ' 3' ' ' SER . 6.1 tmtt? -139.24 156.88 46.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 2.3399999999999999 109.859 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . 0.43 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 44.0 m -72.79 -167.65 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.461 0.648 . . . . 0.92000000000000004 112.102 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.571 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.7 m 71.73 60.58 0.15 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.749 -1.114 . . . . 1.2 111.382 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.09 36.29 3.2 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.439 -0.8 . . . . 0.34000000000000002 112.131 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tp -105.15 134.92 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.905 0.383 . . . . 1.3300000000000001 110.128 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.552 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 13.1 p -93.41 129.51 43.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.112 0.482 . . . . 1.1599999999999999 111.36 -176.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.416 HH12 ' HA ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -129.81 165.82 21.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 2.6600000000000001 110.814 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.593 ' HD3' ' O ' ' B' ' 32' ' ' ASP . 7.5 tppt? -87.84 159.79 18.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.629 -0.714 . . . . 1.9299999999999999 109.825 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' B' ' 30' ' ' GLU . 2.0 t -82.05 -118.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.716 -0.846 . . . . 1.0600000000000001 108.716 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.553 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 20.3 t0 -174.79 -69.3 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.647 -0.501 . . . . 1.3200000000000001 109.647 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.879 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.2 OUTLIER -154.98 -78.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.393 -0.821 . . . . 1.3899999999999999 110.349 174.325 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.486 HD23 ' H ' ' A' ' 13' ' ' LEU . 2.6 pt? -81.85 0.02 41.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.827 -1.079 . . . . 1.22 112.511 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.81 -21.05 3.59 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 120.076 -1.059 . . . . 0.34000000000000002 113.143 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.673 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.1 mtt180 -53.49 106.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.066 0.433 . . . . 1.54 111.961 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.665 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 12.1 p -102.3 142.83 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.283 -0.417 . . . . 1.6899999999999999 110.063 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.496 HG21 ' HG3' ' B' ' 15' ' ' ARG . 51.9 t -76.87 102.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.415 . . . . 1.1599999999999999 111.939 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -70.67 132.36 87.26 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 1.3300000000000001 110.414 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.579 ' HD2' HD11 ' A' ' 22' ' ' LEU . 99.3 Cg_exo -47.76 141.92 15.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.019 2.479 . . . . 0.34999999999999998 113.016 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.35 -32.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.681 . . . . 1.6399999999999999 110.117 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.53 -24.45 61.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.02 0.438 . . . . 1.73 110.146 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.6 mt -83.12 -48.69 10.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.504 -0.554 . . . . 1.1100000000000001 109.504 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.495 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 22.6 ptt85 -64.5 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.408 -0.96 . . . . 2.4100000000000001 108.408 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.495 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 14.4 ttt180 -58.88 -43.62 90.94 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.14 -0.936 . . . . 3.4100000000000001 110.75 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -61.05 -32.76 72.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 1.1299999999999999 110.31 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.802 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 2.5 mt -92.98 -9.53 39.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.472 -0.785 . . . . 1.1000000000000001 110.003 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 28.01 69.61 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.28000000000000003 112.635 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.695 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.2 pt -107.0 167.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.117 0.484 . . . . 1.24 111.626 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.54 150.89 1.44 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.1 -0.955 . . . . 1.03 110.2 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.842 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.2 pt-20 35.12 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.723 1.749 . . . . 1.22 115.723 173.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.3 mmpt? -80.01 5.63 13.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.022 0.749 . . . . 1.51 113.022 -171.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.73 177.81 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.866 0.365 . . . . 1.54 111.422 -177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HB3' ' CG2' ' B' ' 7' ' ' VAL . . . -123.36 151.33 42.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.993 -0.549 . . . . 1.0600000000000001 112.151 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.536 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.7 mp -126.63 157.28 39.34 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.433 -0.951 . . . . 1.72 108.433 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -111.37 105.86 14.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.295 -0.632 . . . . 1.28 109.295 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.721 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -90.09 125.14 42.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.201 -0.909 . . . . 1.1000000000000001 111.484 -176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.51 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.9 m-85 -114.55 173.97 6.19 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.459 -1.311 . . . . 4.8399999999999999 107.459 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.85 142.2 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.563 -0.455 . . . . 0.97999999999999998 110.294 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.85 77.23 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.885 -0.326 . . . . 1.1499999999999999 110.435 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t70 57.79 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.619 1.199 . . . . 1.8300000000000001 112.655 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.432 ' OE2' ' HG3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -117.19 7.16 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.52 -0.309 . . . . 2.54 111.351 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.674 ' HG2' ' HB2' ' B' ' 46' ' ' LYS . 35.6 mtmm -127.04 162.87 25.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.138 0.494 . . . . 1.5700000000000001 111.41 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.649 HD12 HD12 ' B' ' 18' ' ' ILE . 54.0 mt -106.68 138.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.428 -0.805 . . . . 1.1499999999999999 109.294 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.602 HD12 HD12 ' B' ' 44' ' ' ILE . 16.8 mm -125.78 106.13 15.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 109.705 -0.48 . . . . 1.05 109.705 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.824 HD11 ' HB ' ' B' ' 43' ' ' ILE . 0.5 OUTLIER -123.04 128.09 49.68 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.293 -0.963 . . . . 1.9299999999999999 111.474 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' B' ' 42' ' ' LYS . 38.1 ttpt -121.96 145.94 47.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.999 -1.001 . . . . 2.0 108.328 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.802 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 60.2 pttt -48.41 143.04 5.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.114 0.259 . . . . 3.1099999999999999 110.847 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -60.44 140.4 57.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.865 -0.791 . . . . 3.9199999999999999 108.865 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.707 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.2 tppt? -65.88 121.06 73.9 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.206 -0.452 . . . . 3.8399999999999999 110.546 -174.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.707 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 37.7 Cg_endo -66.16 102.65 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.143 1.896 . . . . 1.5800000000000001 110.856 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -97.61 110.73 23.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 4.25 110.399 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 45.5 tpp -134.4 122.71 22.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.875 -0.602 . . . . 5.54 110.386 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.095 -0.955 . . . . 6.1299999999999999 112.318 179.626 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.239 -0.282 . . . . 5.9000000000000004 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.475 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.9 tmtt? -162.41 148.35 12.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.144 -0.687 . . . . 1.8500000000000001 109.144 174.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.451 ' N ' ' HD3' ' B' ' 2' ' ' LYS . 70.5 m -69.36 -166.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.665 0.745 . . . . 0.88 112.128 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.51 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 7.8 m 66.82 66.16 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.651 -1.159 . . . . 1.1200000000000001 111.302 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.64 34.45 4.97 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.606 -0.725 . . . . 0.33000000000000002 112.403 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 tp -102.39 134.12 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.967 0.413 . . . . 1.0700000000000001 110.342 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.2 p -94.66 127.03 46.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.129 0.49 . . . . 1.0900000000000001 111.614 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.54 166.96 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.141 -0.481 . . . . 2.3900000000000001 110.52 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.83 161.85 16.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 2.04 109.79 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.511 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 2.2 t -81.06 -109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.59 -0.522 . . . . 1.0700000000000001 109.59 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.5 ' HB2' ' NE ' ' A' ' 15' ' ' ARG . 24.5 t70 176.65 -79.0 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.453 -0.573 . . . . 1.6599999999999999 109.453 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.842 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.6 pt-20 -154.92 -81.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.521 -0.763 . . . . 1.9099999999999999 110.024 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.596 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -65.49 -29.9 70.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.34 -0.845 . . . . 1.4299999999999999 112.102 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.72 -9.81 0.32 Allowed Glycine 0 C--O 1.223 -0.587 0 C-N-CA 119.685 -1.245 . . . . 0.31 112.888 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.665 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 9.6 mtt180 -54.9 105.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.0 0.37 . . . . 0.93999999999999995 112.0 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.673 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 12.7 p -98.72 141.44 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 1.6499999999999999 110.132 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 15' ' ' ARG . 42.4 t -77.28 101.1 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 1.1000000000000001 111.74 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 43' ' ' ILE . 26.0 mm -67.17 135.51 93.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.876 -0.602 . . . . 1.3100000000000001 110.708 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.55 ' HD2' HD11 ' B' ' 22' ' ' LEU . 89.2 Cg_exo -49.85 137.64 35.02 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.846 2.364 . . . . 0.34000000000000002 112.62 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 tt -57.86 -33.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 1.3600000000000001 110.344 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.475 ' OE1' ' HA ' ' B' ' 2' ' ' LYS . 12.3 pt-20 -69.94 -27.34 64.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 1.3500000000000001 110.276 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.734 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.3 mt -82.03 -48.41 11.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 1.1000000000000001 109.457 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -68.29 -25.84 65.34 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.225 -1.028 . . . . 1.9099999999999999 108.225 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.91 -37.48 75.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.619 -0.719 . . . . 3.1800000000000002 110.742 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 98.2 m -61.35 -35.59 77.87 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.419 0.628 . . . . 1.04 110.503 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.734 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -89.27 -11.11 44.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.395 -0.82 . . . . 1.1100000000000001 109.864 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.18 22.59 69.16 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.551 -0.75 . . . . 0.34000000000000002 112.872 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.4 pt -101.95 167.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.173 0.511 . . . . 1.25 111.579 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.25 150.77 1.54 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.871 -1.059 . . . . 1.05 110.262 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.879 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.0 -89.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.725 1.75 . . . . 1.1200000000000001 115.725 172.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . 0.419 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.7 mmpt? -79.58 7.98 7.29 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.225 0.824 . . . . 1.28 113.225 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.593 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 71.6 m-20 -88.96 176.6 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.036 0.38 . . . . 1.3700000000000001 111.06 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.457 ' HB3' ' CG2' ' A' ' 7' ' ' VAL . . . -121.43 150.91 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.536 0.684 . . . . 1.05 112.632 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.8 mp -123.02 156.21 35.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.964 -1.016 . . . . 1.8500000000000001 109.256 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . 0.509 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 43.7 mt-10 -108.77 105.42 14.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.805 -0.634 . . . . 1.3999999999999999 109.385 175.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.02 124.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.301 -0.863 . . . . 1.0900000000000001 111.351 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.571 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 17.0 m-85 -113.57 174.78 5.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.517 -1.29 . . . . 4.8300000000000001 107.517 172.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.45 142.96 42.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.598 -0.441 . . . . 1.05 110.158 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.58 78.12 1.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 1.1200000000000001 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 60.02 -75.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.627 -1.169 . . . . 1.6399999999999999 112.618 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -107.43 -25.58 11.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.957 0.408 . . . . 2.8100000000000001 111.033 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 24.8 pttm -116.3 162.45 17.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.167 0.508 . . . . 1.71 111.919 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.824 ' HB ' HD11 ' A' ' 45' ' ' LEU . 59.9 mt -106.04 139.03 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.39 -0.823 . . . . 1.1299999999999999 110.169 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -118.11 109.66 27.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 116.081 -0.509 . . . . 1.1000000000000001 109.754 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.496 HD13 ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.39 116.88 28.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.433 -0.507 . . . . 1.95 110.146 -176.335 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.674 ' HB2' ' HG2' ' A' ' 42' ' ' LYS . 38.5 ttpt -116.88 139.8 50.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.702 -0.851 . . . . 1.73 108.702 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.674 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 63.2 pttt -47.69 147.59 1.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.202 0.314 . . . . 2.8700000000000001 110.939 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . 0.509 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 78.6 t80 -59.79 139.7 57.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.112 -0.699 . . . . 3.6899999999999999 109.112 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.514 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.0 tppt? -65.46 121.05 72.91 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.32 -0.4 . . . . 3.8100000000000001 110.462 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.514 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 39.9 Cg_endo -66.56 98.83 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.349 2.033 . . . . 1.5600000000000001 110.961 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -89.62 108.39 19.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.493 -0.776 . . . . 4.3600000000000003 110.569 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 46.6 tpp -115.78 151.43 35.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.623 -0.717 . . . . 5.6500000000000004 109.239 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.339 -0.838 . . . . 6.3399999999999999 111.448 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.41 ' HE2' HD12 ' A' ' 6' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.108 0.04 . . . . 5.4100000000000001 111.108 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.491 ' HG2' ' OE2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -150.13 162.42 40.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 121.076 -0.25 . . . . 2.3399999999999999 110.424 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -80.83 -166.56 1.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.592 0.71 . . . . 0.92000000000000004 112.32 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.668 HG23 ' HD1' ' B' ' 37' ' ' TYR . 25.1 m 72.0 71.6 0.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.573 -1.194 . . . . 1.2 111.313 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.42 38.99 6.09 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.332 -0.849 . . . . 0.34000000000000002 111.879 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.41 HD12 ' HE2' ' A' ' 1' ' ' MET . 9.1 tp -105.51 136.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.706 -0.479 . . . . 1.3300000000000001 109.706 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 ' CG2' ' HB2' ' B' ' 33' ' ' ALA . 11.2 p -95.84 127.3 48.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.902 0.382 . . . . 1.1599999999999999 110.938 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -125.96 161.13 28.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.344 -0.389 . . . . 2.6600000000000001 110.671 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.45 161.09 23.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.218 -0.66 . . . . 1.9299999999999999 109.218 175.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.427 ' HB ' ' H ' ' A' ' 11' ' ' ASP . 3.0 t -80.21 -108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.564 -0.532 . . . . 1.0600000000000001 109.564 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' H ' ' HB ' ' A' ' 10' ' ' VAL . 26.9 t70 175.26 -67.29 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.02 -0.733 . . . . 1.3200000000000001 109.02 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.823 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.4 pt-20 -158.47 -86.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.939 -1.028 . . . . 1.3899999999999999 109.986 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.606 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -77.24 -27.73 53.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 1.22 112.112 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.49 -0.33 0.06 OUTLIER Glycine 0 C--O 1.225 -0.464 0 C-N-CA 119.483 -1.342 . . . . 0.34000000000000002 114.461 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.695 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.9 ttt180 -66.81 99.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.495 1.148 . . . . 1.54 111.578 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.687 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 19.0 m -96.46 144.58 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 1.6899999999999999 110.386 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.572 HG21 ' HG3' ' B' ' 15' ' ' ARG . 41.4 t -82.0 107.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.302 -0.408 . . . . 1.1599999999999999 111.178 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.554 HG13 ' O ' ' B' ' 14' ' ' GLY . 3.6 mt -79.9 139.24 53.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 110.186 -0.302 . . . . 1.3300000000000001 110.186 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.541 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 70.8 Cg_exo -46.33 140.03 11.82 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.422 2.748 . . . . 0.34999999999999998 113.839 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.468 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 6.7 tp -58.19 -32.84 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 1.6399999999999999 110.443 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.491 ' OE2' ' HG2' ' A' ' 2' ' ' LYS . 20.5 pt-20 -72.81 -23.03 60.73 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.406 -0.361 . . . . 1.73 110.419 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.698 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.3 mt -83.37 -46.48 12.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.297 0.57 . . . . 1.1100000000000001 109.858 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.503 HH11 ' HB1' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -64.13 -31.37 72.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 2.4100000000000001 108.011 176.572 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -38.48 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.966 -1.016 . . . . 3.4100000000000001 111.605 173.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -60.66 -36.54 78.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.542 0.687 . . . . 1.1299999999999999 110.473 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.891 HD13 HD11 ' B' ' 43' ' ' ILE . 1.9 mt -89.28 -9.22 51.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.464 -0.789 . . . . 1.1000000000000001 109.713 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.13 29.37 70.91 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.257 -0.883 . . . . 0.28000000000000003 112.118 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.634 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.3 pt -110.12 167.29 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.189 0.518 . . . . 1.24 111.124 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.503 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -179.68 154.87 0.62 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.727 -1.124 . . . . 1.03 109.22 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.626 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.1 pt-20 37.82 -89.46 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.904 1.446 . . . . 1.22 114.904 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.432 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.1 5.11 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.493 0.553 . . . . 1.51 112.493 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.412 ' HB2' ' H ' ' A' ' 29' ' ' ALA . 2.7 m-20 -87.67 172.73 9.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.81 0.338 . . . . 1.54 110.419 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -117.37 149.04 41.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.353 0.597 . . . . 1.0600000000000001 111.692 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.837 HD13 ' HA ' ' A' ' 47' ' ' LYS . 14.1 tp -126.21 149.33 49.12 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.984 -1.117 . . . . 1.72 107.984 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -107.03 106.03 16.35 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.209 0.528 . . . . 1.28 110.049 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 1.015 HG13 HD22 ' A' ' 45' ' ' LEU . 1.7 mp -94.14 125.73 46.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 1.1000000000000001 111.312 -173.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.726 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -126.97 160.97 29.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.453 -0.794 . . . . 4.8399999999999999 109.555 175.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.83 138.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.84 0.352 . . . . 0.97999999999999998 110.794 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.59 81.69 2.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.788 -0.449 . . . . 1.1499999999999999 109.788 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 2.5 t70 58.55 -82.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.704 -1.135 . . . . 1.8300000000000001 111.454 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.412 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 24.3 mt-10 -114.08 -19.62 11.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 2.54 111.018 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -92.73 159.03 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 1.5700000000000001 110.242 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.829 HD11 HD13 ' B' ' 26' ' ' LEU . 26.7 mt -110.28 133.54 55.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.843 -0.617 . . . . 1.1499999999999999 109.367 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.726 ' HB ' ' HD1' ' A' ' 37' ' ' TYR . 17.9 mm -121.21 115.44 46.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.829 -0.434 . . . . 1.05 109.829 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 1.077 HD11 HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.03 118.91 35.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.546 -0.538 . . . . 1.9299999999999999 109.546 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.453 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 30.7 ttpt -112.35 148.65 33.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.117 -1.438 . . . . 2.0 107.117 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.837 ' HA ' HD13 ' A' ' 34' ' ' LEU . 84.5 tttt -56.69 149.66 17.44 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.491 -0.559 . . . . 3.1099999999999999 109.491 174.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 33' ' ' ALA . 17.3 p90 -59.16 146.12 40.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.38 -0.97 . . . . 3.9199999999999999 108.38 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.927 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.53 115.19 27.53 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.309 -0.557 . . . . 3.8399999999999999 109.754 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.927 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 32.2 Cg_endo -62.48 117.04 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.644 2.229 . . . . 1.5800000000000001 112.292 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.93 99.32 12.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.228 -0.896 . . . . 4.25 109.831 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.3 tpt -127.55 124.32 37.91 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.461 -0.791 . . . . 5.54 109.733 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.94 -0.573 . . . . 6.1299999999999999 110.893 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.469 0.176 . . . . 5.9000000000000004 110.773 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' B' ' 3' ' ' SER . 0.1 OUTLIER -160.27 162.14 33.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.908 -0.404 . . . . 1.8500000000000001 109.908 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.455 ' N ' ' HD3' ' B' ' 2' ' ' LYS . 46.8 m -79.47 -167.26 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.4 0.68 . . . . 0.88 112.497 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.649 HG22 ' HD2' ' A' ' 37' ' ' TYR . 25.0 m 71.94 70.58 0.16 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.638 -1.164 . . . . 1.1200000000000001 111.79 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.39 39.18 6.05 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.33000000000000002 111.796 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.41 137.23 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.374 -0.602 . . . . 1.0700000000000001 109.374 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.477 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 10.0 p -95.61 127.99 47.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 120.958 0.408 . . . . 1.0900000000000001 110.41 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.66 159.93 30.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.155 -0.475 . . . . 2.3900000000000001 110.316 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -81.42 157.55 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.926 -0.768 . . . . 2.04 108.926 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 t -76.73 -104.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.577 -0.527 . . . . 1.0700000000000001 109.577 175.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.412 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 23.5 t0 170.2 -71.04 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.879 -0.786 . . . . 1.6599999999999999 108.879 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.626 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.1 pt-20 -154.45 -83.51 0.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 1.9099999999999999 110.173 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.559 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.5 pt? -84.13 -22.33 31.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.38 -0.827 . . . . 1.4299999999999999 112.434 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . 0.554 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 159.42 -4.74 0.11 Allowed Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.477 -1.344 . . . . 0.31 113.871 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.687 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 2.1 ttt180 -66.77 96.98 0.43 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.926 0.863 . . . . 0.93999999999999995 111.513 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.695 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 24.7 m -94.42 144.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.012 -0.54 . . . . 1.6499999999999999 110.43 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.472 HG21 ' HG3' ' A' ' 15' ' ' ARG . 46.4 t -81.75 107.75 14.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.342 -0.39 . . . . 1.1000000000000001 111.073 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.464 HD13 HD12 ' A' ' 43' ' ' ILE . 8.6 mt -82.14 138.16 45.83 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.485 -0.325 . . . . 1.3100000000000001 110.611 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.477 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 70.6 Cg_exo -44.67 140.44 6.48 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.61 2.873 . . . . 0.34000000000000002 113.969 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.421 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 5.3 tp -57.68 -34.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.105 -0.952 . . . . 1.3600000000000001 110.611 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . 0.453 ' OE2' ' HG2' ' B' ' 2' ' ' LYS . 7.8 pt-20 -71.11 -24.29 62.26 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 109.962 -0.384 . . . . 1.3500000000000001 109.962 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.721 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.0 mt -83.51 -46.35 12.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.004 -0.544 . . . . 1.1000000000000001 109.708 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' B' ' 28' ' ' ILE . 2.9 ppt_? -64.73 -31.57 72.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.866 -1.161 . . . . 1.9099999999999999 107.866 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 31.3 ttt180 -59.29 -46.73 87.76 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 114.81 -1.086 . . . . 3.1800000000000002 111.164 170.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.1 m -58.49 -35.33 72.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.313 0.578 . . . . 1.04 111.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.829 HD13 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -90.22 -10.33 44.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.488 -0.778 . . . . 1.1100000000000001 109.917 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.22 63.66 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.531 -0.758 . . . . 0.34000000000000002 112.768 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.655 HG12 ' HB2' ' B' ' 26' ' ' LEU . 13.3 pt -101.49 167.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.408 . . . . 1.25 111.126 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . 0.422 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -178.03 152.71 0.75 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.102 -0.953 . . . . 1.05 109.548 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.823 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.8 pt-20 34.36 -90.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.126 1.528 . . . . 1.1200000000000001 115.126 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -75.89 5.07 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.985 0.735 . . . . 1.28 112.985 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.422 ' HB2' ' H ' ' B' ' 29' ' ' ALA . 16.0 m-20 -91.76 176.41 6.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.891 -0.506 . . . . 1.3700000000000001 111.335 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.471 ' HB2' ' CG2' ' A' ' 7' ' ' VAL . . . -116.65 150.68 37.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.639 -0.709 . . . . 1.05 112.167 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.839 HD11 ' HA ' ' B' ' 47' ' ' LYS . 14.0 tp -128.36 150.67 50.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.219 -1.03 . . . . 1.8500000000000001 108.219 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -106.35 107.25 18.16 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.607 -0.516 . . . . 1.3999999999999999 109.607 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 1.054 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -94.53 124.1 46.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.992 -0.549 . . . . 1.0900000000000001 111.291 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.815 ' HD2' ' HB ' ' B' ' 44' ' ' ILE . 0.3 OUTLIER -123.58 159.61 28.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.639 -0.71 . . . . 4.8300000000000001 109.513 175.196 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.89 136.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.954 0.407 . . . . 1.05 110.622 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.47 79.9 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 1.1200000000000001 109.557 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 57.02 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.858 -1.064 . . . . 1.6399999999999999 111.507 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.63 -3.33 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.964 -0.562 . . . . 2.8100000000000001 111.104 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -102.82 158.76 16.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.58 -0.526 . . . . 1.71 109.58 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.891 HD11 HD13 ' A' ' 26' ' ' LEU . 22.7 mt -111.8 133.51 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.431 -0.581 . . . . 1.1299999999999999 109.431 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.815 ' HB ' ' HD2' ' B' ' 37' ' ' TYR . 18.3 mm -123.99 116.1 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.765 -0.458 . . . . 1.1000000000000001 109.765 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 1.077 HD11 HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.71 117.57 30.65 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.565 -0.454 . . . . 1.95 109.942 -177.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . 0.667 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 18.8 ttpt -111.25 142.03 44.0 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.224 -1.028 . . . . 1.73 108.224 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.839 ' HA ' HD11 ' B' ' 34' ' ' LEU . 79.3 tttt -49.97 141.95 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.227 -0.286 . . . . 2.8700000000000001 110.227 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -59.87 148.74 33.73 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.614 -0.513 . . . . 3.6899999999999999 109.614 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.6 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -67.12 113.14 12.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.377 -0.601 . . . . 3.8100000000000001 109.377 -174.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . 0.6 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 39.9 Cg_endo -66.19 113.97 2.84 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.817 2.345 . . . . 1.5600000000000001 111.768 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.49 106.1 13.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 4.3600000000000003 109.445 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.8 tpt -137.63 116.14 12.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.571 -0.741 . . . . 5.6500000000000004 109.893 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.634 -0.698 . . . . 6.3399999999999999 110.993 -178.681 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.908 0.385 . . . . 5.4100000000000001 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.61 -152.36 0.39 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.235 -0.439 . . . . 2.3399999999999999 110.069 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -68.47 -170.44 0.2 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.456 0.646 . . . . 0.92000000000000004 111.065 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.645 HG23 ' HD1' ' B' ' 37' ' ' TYR . 11.5 m 70.79 68.22 0.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.903 -1.044 . . . . 1.2 111.683 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.89 37.66 5.99 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.31 -0.859 . . . . 0.34000000000000002 111.894 174.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tp -104.14 135.76 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.767 -0.457 . . . . 1.3300000000000001 109.767 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.616 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.8 p -90.67 124.79 43.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.996 0.427 . . . . 1.1599999999999999 110.797 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.69 159.58 27.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.277 -0.419 . . . . 2.6600000000000001 110.525 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.565 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 1.1 tpmt? -83.58 158.32 21.98 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.89 -0.781 . . . . 1.9299999999999999 108.89 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.4 t -78.61 -105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 120.615 -0.434 . . . . 1.0600000000000001 110.055 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.444 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 14.4 t70 175.32 -78.03 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.448 -0.575 . . . . 1.3200000000000001 109.448 -173.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.869 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER -161.59 -77.71 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 1.3899999999999999 109.679 172.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.423 ' H ' HD22 ' A' ' 13' ' ' LEU . 2.7 pt? -72.66 -18.37 61.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.036 -0.984 . . . . 1.22 112.358 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.86 -21.32 1.0 Allowed Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.018 -1.087 . . . . 0.34000000000000002 113.76 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.689 ' HD3' ' HB2' ' B' ' 11' ' ' ASP . 6.8 ttm180 -51.92 104.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.381 0.591 . . . . 1.54 112.433 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.677 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 14.9 p -97.11 143.22 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.951 -0.389 . . . . 1.6899999999999999 109.951 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.412 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.2 t -77.14 105.9 6.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 1.1599999999999999 111.597 -175.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.455 HD11 HG22 ' B' ' 43' ' ' ILE . 35.8 mm -77.42 134.82 65.93 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 1.3300000000000001 110.218 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.623 ' HD2' HD11 ' A' ' 22' ' ' LEU . 87.3 Cg_exo -48.81 140.45 23.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.122 2.548 . . . . 0.34999999999999998 113.199 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.4 tt -60.76 -33.3 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 1.6399999999999999 110.339 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.04 -24.41 63.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.166 0.508 . . . . 1.73 109.725 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.767 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mt -82.05 -49.81 9.79 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.792 -0.64 . . . . 1.1100000000000001 109.415 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -64.88 -34.6 78.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.624 -0.88 . . . . 2.4100000000000001 108.624 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -44.36 85.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.241 -0.89 . . . . 3.4100000000000001 111.129 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.2 m -63.14 -33.15 74.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.309 0.576 . . . . 1.1299999999999999 110.956 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.82 HD12 HD13 ' B' ' 43' ' ' ILE . 3.1 mt -88.09 -12.91 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.918 -0.583 . . . . 1.1000000000000001 110.036 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.56 76.71 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.28000000000000003 112.17 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.3 pt -108.13 167.34 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.993 0.425 . . . . 1.24 111.26 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.55 152.67 0.66 Allowed 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 1.03 109.674 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.805 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.3 pt-20 37.65 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.566 1.691 . . . . 1.22 115.566 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.461 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.17 7.02 12.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.704 0.631 . . . . 1.51 112.704 -172.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -87.27 177.89 7.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 1.54 111.433 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.547 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -121.57 146.89 46.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.226 0.824 . . . . 1.0600000000000001 113.226 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.499 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.0 mp -124.16 156.48 36.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 1.72 108.455 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.69 107.61 18.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.583 -0.525 . . . . 1.28 109.583 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.965 HG13 HD13 ' A' ' 45' ' ' LEU . 1.8 mp -90.3 120.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.599 0.714 . . . . 1.1000000000000001 110.698 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.798 ' HD1' HG22 ' B' ' 4' ' ' THR . 1.0 OUTLIER -123.14 158.13 31.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.094 -0.957 . . . . 4.8399999999999999 109.012 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.73 137.72 45.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.97999999999999998 110.779 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 83.04 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 1.1499999999999999 110.857 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.413 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 4.4 t70 63.53 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.793 -1.094 . . . . 1.8300000000000001 111.817 178.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.413 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 0.8 OUTLIER -128.33 9.62 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.006 -0.543 . . . . 2.54 111.255 -178.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -118.84 158.64 25.25 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.322 -0.399 . . . . 1.5700000000000001 109.978 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.744 HD13 HD12 ' B' ' 26' ' ' LEU . 15.9 mt -110.06 138.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.263 -0.426 . . . . 1.1499999999999999 109.89 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.762 HD12 HD13 ' B' ' 44' ' ' ILE . 11.4 mm -122.79 115.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.443 -0.344 . . . . 1.05 110.268 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.965 HD13 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -114.36 117.08 30.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.876 -0.73 . . . . 1.9299999999999999 109.092 176.124 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -107.62 126.8 53.02 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.028 -0.73 . . . . 2.0 109.028 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.625 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 59.3 pttt -44.71 139.48 2.92 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.255 0.347 . . . . 3.1099999999999999 111.148 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.88 138.2 58.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.71 -0.848 . . . . 3.9199999999999999 108.71 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 13.5 tppt? -67.74 110.61 5.72 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 123.198 0.311 . . . . 3.8399999999999999 110.348 -176.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.88 -40.12 17.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.586 2.191 . . . . 1.5800000000000001 112.406 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.414 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 45.6 t30 -94.86 144.09 25.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.85 -0.796 . . . . 4.25 108.85 174.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.5 ptm -79.98 147.42 31.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.976 0.417 . . . . 5.54 110.231 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.003 -0.999 . . . . 6.1299999999999999 108.74 179.085 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 111.505 0.187 . . . . 5.9000000000000004 111.505 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' LYS . . . . . 0.794 ' HG3' ' H ' ' B' ' 3' ' ' SER . 13.6 ptmt -124.76 -84.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 121.398 -0.121 . . . . 1.8500000000000001 111.131 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' SER . . . . . 0.794 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 75.2 m -128.85 -173.25 2.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.88 108.858 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' THR . . . . . 0.798 HG22 ' HD1' ' A' ' 37' ' ' TYR . 35.4 m 64.68 70.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.594 0.711 . . . . 1.1200000000000001 111.317 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.08 38.15 5.49 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.773 -0.727 . . . . 0.33000000000000002 112.255 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tp -104.6 133.81 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.628 -0.508 . . . . 1.0700000000000001 109.628 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' VAL . . . . . 0.547 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 11.0 p -92.0 117.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.529 0.68 . . . . 1.0900000000000001 111.486 -172.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ARG . . . . . 0.447 ' HG2' ' HB ' ' B' ' 17' ' ' VAL . 1.0 OUTLIER -109.73 159.61 17.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 2.3900000000000001 110.209 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LYS . . . . . 0.571 ' HZ1' ' HB2' ' B' ' 9' ' ' LYS . 0.0 OUTLIER -86.64 155.93 20.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.233 -1.025 . . . . 2.04 108.233 171.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.2 t -78.24 -111.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.497 -0.557 . . . . 1.0700000000000001 109.497 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ASP . . . . . 0.689 ' HB2' ' HD3' ' A' ' 15' ' ' ARG . 26.4 t0 179.88 -68.94 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.4 -0.592 . . . . 1.6599999999999999 109.4 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' GLU . . . . . 0.805 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.3 pt-20 -160.38 -83.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.819 . . . . 1.9099999999999999 110.563 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' LEU . . . . . 0.544 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -74.45 -16.13 60.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.031 -0.986 . . . . 1.4299999999999999 112.198 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.22 -16.79 1.16 Allowed Glycine 0 C--O 1.221 -0.66 0 C-N-CA 119.911 -1.137 . . . . 0.31 113.05 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ARG . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.9 mtt180 -52.48 111.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.788 0.294 . . . . 0.93999999999999995 111.75 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' VAL . . . . . 0.654 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.5 p -105.14 142.09 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.721 -0.474 . . . . 1.6499999999999999 109.721 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' VAL . . . . . 0.447 ' HB ' ' HG2' ' B' ' 8' ' ' ARG . 48.6 t -77.65 108.53 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 1.1000000000000001 112.019 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.559 HD11 HD11 ' A' ' 43' ' ' ILE . 19.9 mm -76.28 135.65 69.35 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.942 -0.572 . . . . 1.3100000000000001 110.422 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' PRO . . . . . 0.683 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.06 139.89 25.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.987 2.458 . . . . 0.34000000000000002 113.215 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.526 HG13 ' HE ' ' B' ' 23' ' ' ARG . 12.3 tt -59.87 -33.6 53.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.587 -0.733 . . . . 1.3600000000000001 110.707 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.55 -22.98 59.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.105 0.478 . . . . 1.3500000000000001 110.251 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.2 mt -80.38 -48.47 12.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.957 -0.757 . . . . 1.1000000000000001 108.957 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ARG . . . . . 0.526 ' HE ' HG13 ' B' ' 20' ' ' ILE . 15.0 ptt180 -65.58 -33.71 76.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.936 -0.765 . . . . 1.9099999999999999 108.936 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ARG . . . . . 0.454 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 33.9 ttp180 -64.78 -37.83 88.93 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.409 -0.814 . . . . 3.1800000000000002 110.495 175.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 95.7 m -63.83 -34.34 77.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 1.04 110.422 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -88.72 -10.36 48.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.48 0.657 . . . . 1.1100000000000001 109.572 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.27 77.06 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 114.889 -1.051 . . . . 0.34000000000000002 112.282 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.0 pt -111.67 166.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.932 0.396 . . . . 1.25 111.196 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.85 148.67 0.54 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.224 -0.898 . . . . 1.05 110.182 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' GLU . . . . . 0.869 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.0 pt-20 35.85 -87.23 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.293 1.59 . . . . 1.1200000000000001 115.293 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -75.04 5.11 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.075 0.769 . . . . 1.28 113.075 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ASP . . . . . 0.565 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 3.2 m-20 -86.67 173.74 9.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 1.3700000000000001 111.636 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' ALA . . . . . 0.616 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -118.28 144.86 45.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.621 -0.718 . . . . 1.05 112.401 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' LEU . . . . . 0.808 HD22 ' HA ' ' B' ' 47' ' ' LYS . 15.9 mt -124.77 152.27 44.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.846 -1.168 . . . . 1.8500000000000001 107.846 174.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 19.3 tt0 -106.78 104.84 14.62 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.167 -0.679 . . . . 1.3999999999999999 109.167 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ILE . . . . . 0.923 HG13 HD12 ' B' ' 45' ' ' LEU . 1.9 mp -90.26 121.39 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.346 0.593 . . . . 1.0900000000000001 110.971 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' TYR . . . . . 0.645 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -127.21 158.64 36.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.358 -0.837 . . . . 4.8300000000000001 109.498 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.0 p -110.94 138.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.626 -0.429 . . . . 1.05 111.221 -173.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.47 77.94 1.78 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.1200000000000001 110.336 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 t70 58.56 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.504 -1.225 . . . . 1.6399999999999999 112.384 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLU . . . . . 0.426 ' H ' ' HG3' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -115.58 -10.74 11.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 2.8100000000000001 110.924 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -109.84 157.6 19.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 1.71 110.667 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.82 HD13 HD12 ' A' ' 26' ' ' LEU . 12.1 mt -109.84 137.5 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.016 -0.538 . . . . 1.1299999999999999 109.83 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ILE . . . . . 0.762 HD13 HD12 ' A' ' 44' ' ' ILE . 10.1 mm -123.61 115.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.457 -0.338 . . . . 1.1000000000000001 110.214 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' LEU . . . . . 0.923 HD12 HG13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -112.9 111.94 23.05 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.95 108.886 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.31 128.65 47.37 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.084 -0.71 . . . . 1.73 109.084 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LYS . . . . . 0.808 ' HA ' HD22 ' B' ' 34' ' ' LEU . 55.0 pttt -44.86 138.92 3.29 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.281 0.363 . . . . 2.8700000000000001 111.407 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.53 138.48 58.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.853 -0.795 . . . . 3.6899999999999999 108.853 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' B' ' 49' ' ' LYS . 12.8 tppt? -67.68 113.99 17.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.145 -0.317 . . . . 3.8100000000000001 110.145 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.99 -40.28 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.594 2.196 . . . . 1.5600000000000001 112.177 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ASN . . . . . 0.415 ' O ' ' HG3' ' B' ' 49' ' ' LYS . 48.1 t30 -108.23 135.3 49.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.253 -0.647 . . . . 4.3600000000000003 109.253 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.6 ptm -81.23 115.87 20.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 5.6500000000000004 111.214 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.556 -0.747 . . . . 6.3399999999999999 110.459 -178.511 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.818 -0.808 . . . . 0.48 108.818 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.655 HG23 ' HD1' ' B' ' 37' ' ' TYR . 59.4 m 63.32 75.41 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.813 0.815 . . . . 0.48 111.311 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.61 35.97 12.82 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.271 -0.877 . . . . 0.32 111.339 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 134.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.745 -0.465 . . . . 0.49 109.745 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -86.99 125.66 40.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 120.988 0.423 . . . . 0.37 111.384 -173.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.44 155.86 36.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 1.96 110.863 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -82.34 162.57 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.881 -0.414 . . . . 1.16 109.881 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.531 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.5 t -85.05 -108.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.772 -0.371 . . . . 0.44 110.231 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.583 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t70 177.26 -74.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.98 -0.748 . . . . 1.32 108.98 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.921 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.9 OUTLIER -161.57 -80.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.942 -1.026 . . . . 1.39 109.686 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.535 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -68.4 -32.78 73.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.6 111.302 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.78 -16.31 0.11 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.879 -1.153 . . . . 0.34 113.947 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.36 103.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.584 0.692 . . . . 1.26 111.867 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.714 HG11 HD13 ' B' ' 45' ' ' LEU . 13.4 p -96.55 140.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.866 -0.42 . . . . 1.04 109.866 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.4 t -77.76 101.75 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.323 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.7 129.06 88.89 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.818 -0.628 . . . . 0.62 110.229 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.683 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 57.2 Cg_exo -45.5 139.09 10.08 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.387 2.725 . . . . 0.31 113.407 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 8.6 tt -57.03 -33.26 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.86 110.827 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -73.2 -24.86 60.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.098 0.475 . . . . 1.73 110.472 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 10.5 mt -81.49 -48.09 12.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.402 -0.592 . . . . 0.44 109.402 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HE ' ' HA ' ' A' ' 20' ' ' ILE . 12.2 ptt180 -64.7 -33.81 76.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.083 -0.71 . . . . 1.92 109.083 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.76 -40.38 94.96 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.281 -0.872 . . . . 2.94 110.677 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.6 m -61.12 -38.36 86.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.205 0.526 . . . . 0.34 110.634 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.739 HD11 HD11 ' B' ' 43' ' ' ILE . 2.2 mt -87.14 -10.67 52.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.26 109.704 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.98 25.83 71.02 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.377 -0.829 . . . . 0.28 112.466 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.683 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.5 pt -106.71 167.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.43 111.606 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -177.32 152.84 0.88 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.883 -1.053 . . . . 0.26 109.549 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.0 pt-20 32.4 -89.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.779 1.77 . . . . 1.22 115.779 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.7 mmpt? -77.27 -0.43 25.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.746 0.647 . . . . 0.85 112.746 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -81.94 174.67 11.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.007 0.432 . . . . 1.54 110.535 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.93 152.59 42.28 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.405 0.621 . . . . 0.23 112.499 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.3 mp -120.04 152.51 37.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.91 -1.041 . . . . 1.15 109.204 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.53 100.14 10.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.611 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -91.13 123.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.347 0.594 . . . . 0.29 111.352 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.665 ' HD1' HG23 ' B' ' 4' ' ' THR . 3.4 t80 -126.24 163.4 23.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.317 -0.856 . . . . 4.3 108.721 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.91 139.25 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.706 -0.398 . . . . 0.26 110.686 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 81.26 2.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.345 -0.388 . . . . 1.15 110.335 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 55.26 -80.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.637 -1.165 . . . . 1.83 112.843 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 3.68 19.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.08 0.4 . . . . 2.54 112.08 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -143.38 170.79 15.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.87 112.611 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HD11 ' B' ' 26' ' ' LEU . 31.5 mt -106.58 139.06 29.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.973 -1.012 . . . . 0.34 110.257 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.655 HD12 HD12 ' B' ' 44' ' ' ILE . 22.4 mm -121.64 107.07 19.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 0.2 109.458 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.6 118.55 28.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.912 0.863 . . . . 1.3 111.362 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 32.9 ttpt -102.64 165.43 11.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.197 -1.365 . . . . 1.41 107.932 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 57.5 pttt -66.43 147.91 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.524 -0.917 . . . . 2.68 108.524 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 t80 . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 120.173 -0.611 . . . . 3.55 109.402 178.474 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.615 0.722 . . . . 0.46 112.255 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.665 HG23 ' HD1' ' A' ' 37' ' ' TYR . 60.9 m 78.79 72.61 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.283 -1.326 . . . . 0.41 111.345 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.92 36.53 10.12 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.983 -1.008 . . . . 0.32 111.28 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tp -107.3 137.6 37.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.102 0.477 . . . . 0.52 109.931 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 6.6 p -88.17 129.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 116.278 -0.419 . . . . 0.37 111.163 -173.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 2.5 mpt_? -126.43 155.91 41.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.729 -0.214 . . . . 1.74 111.074 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.4 mmpt? -81.28 162.38 23.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.847 -0.427 . . . . 1.23 109.847 176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.5 t -86.16 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.117 0.484 . . . . 0.39 110.513 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' B' ' 10' ' ' VAL . 6.6 t70 172.91 -76.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.794 -0.817 . . . . 1.66 108.794 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.2 pt-20 -166.65 -76.8 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.693 -1.14 . . . . 1.91 108.754 170.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.655 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.3 pp -76.8 -6.16 51.16 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.435 -1.711 . . . . 0.72 112.644 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.35 -16.02 3.89 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.317 -1.421 . . . . 0.31 113.692 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.4 ttt180 -56.17 99.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.334 0.567 . . . . 0.75 111.6 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.0 p -93.83 139.89 17.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.159 -0.473 . . . . 1.04 109.955 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.448 HG22 ' HG3' ' A' ' 15' ' ' ARG . 25.6 t -79.99 100.52 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.903 0.383 . . . . 0.25 111.63 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 43' ' ' ILE . 36.8 mm -68.74 131.94 91.02 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.55 110.79 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' B' ' 22' ' ' LEU . 93.5 Cg_exo -48.23 139.03 22.23 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.269 2.646 . . . . 0.28 113.279 173.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.03 -32.17 43.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 0.82 110.851 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -72.43 -25.05 61.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.499 . . . . 1.35 110.037 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -81.81 -48.41 11.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 0.33 109.537 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -30.34 71.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.847 -0.797 . . . . 1.48 108.847 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.04 -39.34 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.264 -0.88 . . . . 2.77 111.217 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.71 -38.09 83.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.391 0.615 . . . . 0.31 110.417 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -87.44 -10.71 51.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.24 109.742 -174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 30.52 75.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.217 -0.901 . . . . 0.34 112.647 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.9 pt -110.75 166.91 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.094 0.474 . . . . 0.47 111.141 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.41 150.71 1.47 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.978 -1.01 . . . . 0.22 110.391 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.921 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.6 pt-20 34.65 -87.3 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.43 1.641 . . . . 1.12 115.43 171.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.41 -11.88 61.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.485 0.55 . . . . 0.65 112.485 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.9 m-20 -78.75 177.13 8.91 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.165 0.507 . . . . 1.37 111.443 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -125.18 155.47 39.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.675 0.75 . . . . 0.22 112.577 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.8 mp -121.99 154.85 36.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.63 -1.168 . . . . 1.23 108.8 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 40.6 mt-10 -102.48 104.3 14.73 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.169 -0.678 . . . . 1.4 109.169 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.989 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -89.83 123.29 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.857 -0.61 . . . . 0.29 110.953 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.655 ' HD1' HG23 ' A' ' 4' ' ' THR . 3.8 t80 -124.3 158.82 31.67 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.115 -0.698 . . . . 4.28 109.115 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.29 137.18 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.811 -0.356 . . . . 0.28 110.495 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' B' ' 42' ' ' LYS . 37.0 t70 -128.76 82.46 2.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 1.12 111.108 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 61.19 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.949 -1.023 . . . . 1.64 112.322 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.44 9.46 15.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.579 -0.737 . . . . 2.81 111.042 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.657 ' HD2' HD11 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -138.41 169.16 18.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.139 -0.482 . . . . 0.98 111.206 -177.833 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -115.26 139.47 41.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.42 110.625 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.657 HD11 ' HD2' ' B' ' 42' ' ' LYS . 19.6 mm -117.71 116.0 50.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.527 -0.545 . . . . 0.25 109.527 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.989 HD22 HG13 ' B' ' 36' ' ' ILE . 1.0 OUTLIER -115.89 110.41 18.97 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.287 -0.565 . . . . 1.29 109.806 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -95.83 162.06 13.75 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.0 -1.111 . . . . 1.22 108.0 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 56.5 pttt -66.82 148.27 52.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.813 -0.81 . . . . 2.5 108.813 169.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.843 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 76.3 t80 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.673 -0.862 . . . . 3.39 108.673 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.35 0.595 . . . . 0.48 111.066 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.0 m 68.86 56.18 0.43 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.18 -0.918 . . . . 0.48 110.931 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.58 34.32 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.462 -0.79 . . . . 0.32 112.362 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 tp -105.19 136.68 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 120.928 0.394 . . . . 0.49 110.086 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.528 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.2 p -90.67 128.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.946 0.403 . . . . 0.37 110.691 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpt_? -125.96 157.12 38.59 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.171 -0.33 . . . . 1.96 110.497 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.35 158.39 15.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.123 -0.325 . . . . 1.16 110.123 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.3 t -82.93 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.44 109.031 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.4 ' H ' HG12 ' A' ' 10' ' ' VAL . 14.7 t0 -153.96 -62.5 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.443 -0.577 . . . . 1.32 109.443 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.3 pt-20 -157.2 -85.34 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.131 -0.94 . . . . 1.39 109.775 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -74.18 -15.47 61.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.768 -1.105 . . . . 0.6 111.759 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.68 -20.74 0.8 Allowed Glycine 0 C--O 1.222 -0.647 0 C-N-CA 119.853 -1.165 . . . . 0.34 114.063 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 4.3 ttt180 -52.9 106.41 0.16 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.104 0.952 . . . . 1.26 111.976 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -101.84 141.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.82 . . . . 1.04 109.433 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.55 100.08 3.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 0.25 111.452 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.07 133.43 89.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.62 110.582 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 76.7 Cg_exo -46.61 140.67 11.99 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.297 2.664 . . . . 0.31 113.243 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.21 -30.09 48.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.129 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.142 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.757 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 9.3 mt -82.74 -47.99 11.35 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.883 -0.599 . . . . 0.44 109.657 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -33.94 76.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.432 -0.951 . . . . 1.92 108.432 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -61.37 -42.94 99.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.121 -0.945 . . . . 2.94 111.653 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -33.75 74.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.132 0.491 . . . . 0.34 110.829 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.6 mt -89.55 -9.1 51.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 0.26 109.744 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.7 76.96 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.419 -0.81 . . . . 0.28 112.52 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 26' ' ' LEU . 21.8 pt -113.55 166.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.985 0.422 . . . . 0.43 111.403 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.4 152.01 3.19 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.11 -0.95 . . . . 0.26 109.863 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 4.3 pt-20 31.05 -89.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.901 1.815 . . . . 1.22 115.901 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.9 mmpt? -78.76 6.73 8.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.468 0.914 . . . . 0.85 113.468 -171.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.508 ' O ' HG23 ' B' ' 10' ' ' VAL . 10.9 m-20 -87.39 175.16 8.12 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.071 -0.393 . . . . 1.54 110.494 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.59 154.05 41.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.653 0.739 . . . . 0.23 112.72 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.6 mp -122.94 154.97 37.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.461 -1.245 . . . . 1.15 108.28 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -106.35 104.22 13.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.269 -0.641 . . . . 1.28 109.269 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.55 122.98 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.341 0.591 . . . . 0.29 111.561 -174.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 2.2 m-85 -113.1 171.89 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.821 -1.177 . . . . 4.3 107.821 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.0 p -124.59 142.9 39.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.519 -0.472 . . . . 0.26 110.651 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -133.48 90.96 2.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.285 -0.416 . . . . 1.15 110.115 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 56.88 -96.45 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.606 -0.725 . . . . 1.83 111.393 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -116.02 11.81 15.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.412 -0.813 . . . . 2.54 110.229 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -113.99 156.39 24.16 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.304 -0.407 . . . . 0.87 110.03 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.697 HD13 HD12 ' B' ' 18' ' ' ILE . 46.4 mt -108.36 138.36 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.221 -0.659 . . . . 0.34 109.221 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' B' ' 44' ' ' ILE . 17.4 mm -124.55 107.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.421 -0.585 . . . . 0.2 109.421 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.33 110.99 16.79 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.225 1.012 . . . . 1.3 111.057 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 30.4 ttpt -93.36 165.86 12.57 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.74 -1.573 . . . . 1.41 108.156 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 61.5 pttt -63.75 148.37 49.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.394 -0.595 . . . . 2.68 109.394 169.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.325 -0.499 0 N-CA-C 109.458 -0.571 . . . . 3.55 109.458 176.468 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.562 0.696 . . . . 0.46 111.732 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 9.2 m 69.59 63.94 0.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.61 -1.177 . . . . 0.41 111.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 37.45 4.13 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.269 -0.878 . . . . 0.32 112.196 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -106.2 135.47 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.053 0.454 . . . . 0.52 109.898 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.498 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.3 p -87.74 126.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.923 0.392 . . . . 0.37 111.066 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 2.1 mpt_? -123.3 154.08 39.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.282 -0.261 . . . . 1.74 110.514 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 32' ' ' ASP . 2.0 tpmt? -89.51 159.99 16.95 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.639 -0.504 . . . . 1.23 109.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.0 t -82.85 -117.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.067 -0.345 . . . . 0.39 110.067 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.479 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 35.9 t0 -178.25 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.558 -0.534 . . . . 1.66 109.558 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.7 pt-20 -161.18 -84.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.253 -0.885 . . . . 1.91 110.381 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.515 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -68.52 -33.42 74.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.42 -0.809 . . . . 0.72 111.459 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.74 -9.8 0.08 OUTLIER Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.654 -1.26 . . . . 0.31 113.393 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.0 mtt180 -54.65 104.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.183 0.492 . . . . 0.75 111.967 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.7 p -100.3 141.02 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.341 -0.614 . . . . 1.04 109.341 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 39.3 t -79.6 101.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.968 0.413 . . . . 0.25 111.206 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.697 HD12 HD13 ' A' ' 43' ' ' ILE . 26.1 mm -66.64 136.67 94.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.55 110.175 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.588 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.2 138.42 28.88 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.633 2.222 . . . . 0.28 112.321 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -61.6 -30.6 48.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.004 -0.544 . . . . 0.82 110.143 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.11 -28.07 65.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 1.35 110.55 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 6.4 mt -80.02 -46.83 15.9 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.38 0.609 . . . . 0.33 109.515 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 32.8 ptt85 -66.49 -33.0 74.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.622 -0.881 . . . . 1.48 108.622 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.446 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 11.8 ttm180 -61.5 -38.61 87.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.684 -0.689 . . . . 2.77 110.781 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 99.2 m -63.42 -35.94 82.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.39 0.614 . . . . 0.31 110.629 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 2.7 mt -88.71 -5.96 57.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.506 -0.77 . . . . 0.24 109.364 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.62 28.64 65.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.028 -0.987 . . . . 0.34 112.47 -174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.697 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.0 pt -109.9 167.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.593 . . . . 0.47 111.504 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -173.51 151.62 1.98 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.782 -1.099 . . . . 0.22 109.468 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.1 pt-20 36.11 -86.76 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.415 1.635 . . . . 1.12 115.415 171.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -79.86 5.05 14.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.156 0.799 . . . . 0.65 113.156 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.8 m-20 -89.28 173.21 8.52 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.496 -0.482 . . . . 1.37 110.486 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.81 154.38 38.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.335 0.588 . . . . 0.22 112.099 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.6 mp -122.25 153.74 38.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.946 -1.025 . . . . 1.23 108.996 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 21.7 mt-10 -101.74 108.01 19.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.4 -0.593 . . . . 1.4 109.4 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.451 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.9 mp -95.08 122.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.641 0.734 . . . . 0.29 111.546 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 14.5 m-85 -113.07 171.94 7.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.613 -1.255 . . . . 4.28 107.613 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 4' ' ' THR . 10.5 p -128.18 142.96 42.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.161 -0.616 . . . . 0.28 110.68 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -134.0 91.04 2.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.126 -0.488 . . . . 1.12 110.053 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.99 -91.28 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.62 -0.718 . . . . 1.64 111.817 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.2 10.84 8.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.808 -0.633 . . . . 2.81 110.281 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -114.57 154.16 28.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.125 -0.695 . . . . 0.98 109.125 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 45' ' ' LEU . 46.5 mt -107.58 137.84 36.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.996 -0.372 . . . . 0.42 109.996 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 44' ' ' ILE . 17.5 mm -113.52 118.24 57.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.176 -0.675 . . . . 0.25 109.176 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.4 OUTLIER -123.99 107.82 11.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.546 0.689 . . . . 1.29 109.933 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 31.9 ttpt -96.62 163.13 13.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.731 -1.211 . . . . 1.22 107.731 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 24.4 pttm -71.11 150.24 45.67 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.855 -0.795 . . . . 2.5 108.855 171.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.456 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 46.2 t80 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.629 . . . . 3.39 109.3 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 22' ' ' LEU . 72.3 m . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.48 111.436 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.609 ' H ' ' HA ' ' B' ' 37' ' ' TYR . 5.8 m 62.27 55.55 2.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.091 -0.959 . . . . 0.48 110.776 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.89 35.89 4.69 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.489 -0.778 . . . . 0.32 112.159 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 10.2 tp -93.43 160.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.946 -1.131 . . . . 0.49 107.946 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -124.67 126.65 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.792 -0.447 . . . . 0.37 109.792 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 19' ' ' PRO . 9.7 mtt-85 -137.17 170.73 15.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.758 0.314 . . . . 1.96 110.806 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.9 mmpt? -91.8 162.6 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 1.16 111.273 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG22 HD11 ' B' ' 34' ' ' LEU . 1.4 t -85.08 -133.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 168.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.92 -67.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.698 -0.482 . . . . 1.32 109.698 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 3.0 pt-20 -140.9 -94.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 1.39 111.515 169.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -66.1 -28.22 68.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.397 0.518 . . . . 0.6 112.397 -172.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.51 -5.56 0.05 OUTLIER Glycine 0 C--O 1.222 -0.616 0 C-N-CA 119.782 -1.199 . . . . 0.34 114.158 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.602 ' HG3' HG22 ' B' ' 17' ' ' VAL . 31.9 mtt180 -58.56 104.94 0.25 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.073 0.936 . . . . 1.26 111.708 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 45' ' ' LEU . 7.2 p -96.14 138.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.995 -0.743 . . . . 1.04 108.995 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 15' ' ' ARG . 25.5 t -79.0 100.62 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.263 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.1 mm -67.67 128.71 93.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.62 110.147 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.821 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 87.8 Cg_exo -47.72 141.92 15.07 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.256 2.637 . . . . 0.31 113.17 173.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 10.5 tt -59.28 -34.67 54.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.19 -0.459 . . . . 0.86 110.795 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.45 -27.93 64.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.384 0.611 . . . . 1.73 110.256 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.821 ' HG ' ' HB2' ' A' ' 19' ' ' PRO . 5.0 mt -80.45 -46.93 15.11 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.537 -0.756 . . . . 0.44 109.141 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' ILE . 13.3 ptt180 -65.37 -32.38 73.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.31 -0.996 . . . . 1.92 108.31 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.493 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 2.3 tmt_? -65.05 -35.81 82.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.077 -0.965 . . . . 2.94 110.272 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -64.73 -37.02 86.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.34 110.463 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -89.25 -14.11 36.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.26 109.886 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.4 30.73 77.1 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.262 -0.881 . . . . 0.28 112.387 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 23' ' ' ARG . 14.0 pt -103.98 165.97 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.43 111.229 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.45 146.87 0.49 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.929 -1.032 . . . . 0.26 109.773 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 2.9 pt-20 35.0 -89.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.447 1.647 . . . . 1.22 115.447 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -80.86 5.49 15.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.28 0.845 . . . . 0.85 113.28 -172.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.72 176.75 9.09 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.14 -0.624 . . . . 1.54 110.429 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.19 146.12 48.06 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.111 -0.95 . . . . 0.23 112.213 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.5 mp -121.48 151.54 40.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.088 -0.96 . . . . 1.15 108.793 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 11.2 tt0 -108.31 106.45 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.994 -0.743 . . . . 1.28 108.994 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.1 126.59 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.811 -1.086 . . . . 0.29 112.023 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.618 ' HA ' ' H ' ' B' ' 4' ' ' THR . 8.0 t80 -119.14 159.87 23.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.074 -1.084 . . . . 4.3 108.074 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.95 143.09 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 121.833 -0.542 . . . . 0.26 110.731 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -134.67 82.32 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 1.15 110.653 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 17.0 t70 55.8 -90.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.573 -1.194 . . . . 1.83 112.641 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 10.7 mt-10 -88.86 -23.03 22.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.54 110.349 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.805 ' HE2' HD11 ' A' ' 44' ' ' ILE . 20.1 pttm -119.32 158.12 26.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.463 -0.79 . . . . 0.87 112.236 -167.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.692 HD11 HD11 ' B' ' 26' ' ' LEU . 49.7 mt -110.36 139.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.265 -0.879 . . . . 0.34 109.547 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.805 HD11 ' HE2' ' A' ' 42' ' ' LYS . 13.4 mm -118.26 120.41 64.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.013 -0.54 . . . . 0.2 109.593 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.712 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -130.46 123.94 30.9 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.44 -0.904 . . . . 1.3 111.886 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 41' ' ' GLU . 38.6 ttpt -115.59 170.23 8.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.011 -1.107 . . . . 1.41 108.011 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 28' ' ' ILE . 44.5 tttm -63.81 146.05 54.65 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.496 -0.557 . . . . 2.68 109.496 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 67.0 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.563 -0.29 . . . . 3.55 110.764 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.0 -0.37 . . . . 0.46 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.618 ' H ' ' HA ' ' A' ' 37' ' ' TYR . 25.7 m 62.84 63.26 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.865 0.84 . . . . 0.41 110.783 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.95 38.37 5.77 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.188 -0.915 . . . . 0.32 111.95 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 tp -108.91 138.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.52 110.547 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.504 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.8 p -94.64 134.21 32.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.109 0.481 . . . . 0.37 112.028 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 8' ' ' ARG . 0.6 OUTLIER -136.6 174.46 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 1.74 110.178 171.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -98.27 160.29 14.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.211 -0.45 . . . . 1.23 110.363 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -82.36 -133.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.686 -1.598 . . . . 0.39 106.686 166.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 28.2 t70 -177.95 -51.47 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.301 0.572 . . . . 1.66 110.883 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -125.32 -124.85 0.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.354 -0.839 . . . . 1.91 111.408 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -70.45 -8.65 52.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.72 112.377 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.41 -8.86 0.32 Allowed Glycine 0 C--O 1.219 -0.804 0 C-N-CA 119.749 -1.215 . . . . 0.31 112.535 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 39.4 mtt180 -58.96 100.24 0.06 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.918 0.39 . . . . 0.75 111.595 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.9 p -94.33 137.85 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 1.04 109.092 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 15' ' ' ARG . 44.0 t -79.66 101.15 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.246 -0.434 . . . . 0.25 111.535 -172.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.69 132.16 91.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.55 110.512 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.614 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 91.0 Cg_exo -47.88 140.41 18.18 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.155 2.57 . . . . 0.28 113.125 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 8.9 tt -57.91 -35.15 50.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.978 -0.555 . . . . 0.82 110.73 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.05 -23.91 60.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.219 0.533 . . . . 1.35 110.506 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 10.6 mt -82.68 -47.75 11.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 4.4 ppt_? -65.81 -28.21 68.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.433 -0.951 . . . . 1.48 108.433 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -62.48 -47.65 83.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.979 -1.009 . . . . 2.77 111.027 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -57.17 -37.84 72.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.522 0.677 . . . . 0.31 110.874 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.7 mt -85.91 -19.77 30.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.415 -0.811 . . . . 0.24 109.922 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.46 33.07 71.95 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.704 -0.68 . . . . 0.34 112.249 -171.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.2 pt -110.91 166.38 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-O 120.685 0.279 . . . . 0.47 110.84 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.35 150.69 0.58 Allowed 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.29 0.994 . . . . 0.22 110.192 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.15 -89.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.549 1.685 . . . . 1.12 115.549 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.5 mmpt? -82.43 4.98 22.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.978 0.733 . . . . 0.65 112.978 -172.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.63 171.15 15.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 1.37 110.83 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.75 144.72 46.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.366 0.603 . . . . 0.22 111.882 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.479 HD11 HG22 ' A' ' 10' ' ' VAL . 6.4 mp -118.55 149.74 40.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.179 -0.919 . . . . 1.23 108.917 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 7.5 tt0 -104.45 101.44 11.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.544 -0.753 . . . . 1.4 108.99 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.0 mp -90.71 126.39 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.671 0.748 . . . . 0.29 112.016 -175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.609 ' HA ' ' H ' ' A' ' 4' ' ' THR . 2.1 t80 -118.04 160.42 21.52 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.836 -1.172 . . . . 4.28 107.836 171.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.92 140.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.53 -0.468 . . . . 0.28 110.301 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -136.88 86.84 2.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.123 0.487 . . . . 1.12 110.592 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.17 -97.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.026 -0.988 . . . . 1.64 112.402 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 36.1 mt-10 -102.88 -4.6 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 2.81 110.417 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.472 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 26.0 pttm -124.03 159.09 30.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.361 0.6 . . . . 0.98 112.0 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 45' ' ' LEU . 60.2 mt -111.31 138.98 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.254 -0.885 . . . . 0.42 109.725 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 44' ' ' ILE . 18.7 mm -115.05 121.43 67.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.3 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.05 111.46 14.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.077 0.942 . . . . 1.29 110.937 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 34.1 ttpt -104.75 169.75 8.27 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.826 -1.534 . . . . 1.22 107.806 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' B' ' 46' ' ' LYS . 60.3 tttm -73.85 145.26 45.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.591 -0.522 . . . . 2.5 109.591 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 3.39 110.145 178.919 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 108.847 -0.798 . . . . 0.48 108.847 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.623 HG23 ' HD1' ' B' ' 37' ' ' TYR . 15.2 m 66.85 69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.48 111.692 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.62 42.07 5.87 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.705 -0.759 . . . . 0.32 111.638 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tp -115.64 141.93 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.49 110.514 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.3 p -88.35 129.59 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.042 -0.526 . . . . 0.37 111.303 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' HD13 ' B' ' 36' ' ' ILE . 3.2 mpt_? -127.26 163.34 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.65 -0.25 . . . . 1.96 110.378 174.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.9 mmpt? -89.54 162.09 15.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.501 -0.318 . . . . 1.16 110.654 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.6 t -86.77 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.757 -0.831 . . . . 0.44 108.757 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HB2' ' HE ' ' B' ' 15' ' ' ARG . 25.4 t70 -159.6 -66.14 0.08 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.699 -0.852 . . . . 1.32 108.699 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.7 pt-20 -153.47 -84.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.02 -0.991 . . . . 1.39 110.254 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.552 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -75.98 -14.92 60.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.89 -1.05 . . . . 0.6 112.492 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 157.46 -11.2 0.25 Allowed Glycine 0 C--O 1.22 -0.778 0 C-N-CA 119.513 -1.327 . . . . 0.34 114.546 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.7 ttt180 -66.13 99.66 0.54 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.54 1.17 . . . . 1.26 112.131 -177.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 20.8 m -95.97 141.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 1.04 110.428 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.29 103.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.379 -0.373 . . . . 0.25 110.777 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.693 HG21 HD13 ' B' ' 43' ' ' ILE . 21.0 mt -85.38 133.89 41.51 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.335 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 43.9 Cg_exo -40.87 138.32 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.094 3.196 . . . . 0.31 114.405 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -58.42 -31.41 42.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.86 110.285 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.67 -26.76 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 1.73 110.238 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.2 mt -81.11 -47.34 13.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.995 -0.548 . . . . 0.44 109.774 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 1.9 ptt180 -63.28 -35.78 81.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.051 -1.092 . . . . 1.92 108.051 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 3.1 tmt_? -61.94 -37.31 84.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.731 -1.122 . . . . 2.94 110.893 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.58 -34.8 78.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.344 0.592 . . . . 0.34 110.549 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.6 mt -87.89 -9.05 54.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 0.26 109.793 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.89 66.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.275 -0.875 . . . . 0.28 112.269 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.602 HD13 HD11 ' A' ' 34' ' ' LEU . 2.4 pp -112.07 169.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.43 111.257 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 179.67 157.31 0.63 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.441 -0.8 . . . . 0.26 110.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 35.22 -90.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.378 1.621 . . . . 1.22 115.378 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -75.56 -4.5 40.29 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.882 0.697 . . . . 0.85 112.882 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.457 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.2 OUTLIER -85.49 -178.44 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.508 -0.477 . . . . 1.54 111.409 -172.066 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -125.91 152.46 45.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.704 0.764 . . . . 0.23 112.842 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.602 HD11 HD13 ' A' ' 28' ' ' ILE . 7.1 mp -127.94 156.89 41.92 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.477 -1.238 . . . . 1.15 107.855 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -105.83 107.6 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.117 -0.697 . . . . 1.28 109.117 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 45' ' ' LEU . 1.8 mp -92.79 122.85 44.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.639 -0.71 . . . . 0.29 111.217 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.691 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.8 OUTLIER -124.44 159.94 29.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.207 -0.906 . . . . 4.3 108.79 175.675 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.1 135.66 55.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.754 -0.379 . . . . 0.26 110.524 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.04 96.07 3.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.977 -0.379 . . . . 1.15 109.977 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 64.71 -97.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.13 -0.941 . . . . 1.83 110.783 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.04 10.86 8.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.085 -0.961 . . . . 2.54 109.489 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -111.17 156.52 21.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.382 -0.826 . . . . 0.87 109.586 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.963 ' HB ' HD12 ' B' ' 45' ' ' LEU . 38.0 mt -110.21 133.4 55.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.115 -0.493 . . . . 0.34 109.838 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 44' ' ' ILE . 15.8 mm -117.45 112.71 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.406 -0.59 . . . . 0.2 109.406 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 HG21 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -121.19 108.97 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.266 -0.573 . . . . 1.3 109.505 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -107.05 141.18 38.69 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.012 -1.107 . . . . 1.41 108.012 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 20.9 ptmt -47.8 139.16 7.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.914 0.324 . . . . 2.68 110.375 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.899 -0.778 . . . . 3.55 108.899 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.31 -0.626 . . . . 0.46 109.31 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.691 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.6 m 64.78 67.07 0.56 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.703 0.763 . . . . 0.41 111.466 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.95 38.53 5.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.284 -0.871 . . . . 0.32 111.975 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.16 139.03 28.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.493 -0.558 . . . . 0.52 109.493 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.7 p -90.1 125.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 120.971 0.415 . . . . 0.37 110.81 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 1.2 tpt180 -124.18 160.06 28.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 1.74 110.345 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.2 mmpt? -87.26 163.12 17.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.415 -0.357 . . . . 1.23 110.65 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.2 t -86.42 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.049 -0.352 . . . . 0.39 110.049 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.531 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 26.9 t70 173.11 -68.97 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.969 -0.752 . . . . 1.66 108.969 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.8 pt-20 -166.56 -85.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.751 -1.113 . . . . 1.91 109.872 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.675 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.318 -0.856 . . . . 0.72 112.155 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 18' ' ' ILE . . . 164.35 -3.13 0.06 OUTLIER Glycine 0 C--O 1.224 -0.475 0 C-N-CA 119.617 -1.278 . . . . 0.31 113.442 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 1.7 ttt180 -65.67 97.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.101 0.451 . . . . 0.75 111.764 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 18.5 m -94.12 144.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 1.04 110.32 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 40.8 t -81.84 104.53 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.36 -0.382 . . . . 0.25 110.873 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.726 HG21 HD13 ' A' ' 43' ' ' ILE . 2.3 mt -80.68 138.96 50.6 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.308 -0.256 . . . . 0.55 110.308 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.647 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 59.1 Cg_exo -42.96 135.3 5.33 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.449 2.766 . . . . 0.28 113.809 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.69 -32.22 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.471 -0.786 . . . . 0.82 110.727 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.96 -23.46 60.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.132 0.492 . . . . 1.35 110.499 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -81.9 -46.99 13.32 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.161 -0.472 . . . . 0.33 109.769 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 6.9 ptt180 -63.41 -35.47 80.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.174 -1.047 . . . . 1.48 108.174 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.59 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 51.2 ttt180 -56.98 -44.92 83.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.555 -1.202 . . . . 2.77 110.821 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 89.7 m -59.29 -37.31 77.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.615 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.858 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 3.2 mt -86.74 -8.41 57.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 0.24 109.759 -175.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 31.96 81.3 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.311 -0.859 . . . . 0.34 112.133 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.801 HG12 ' HB2' ' B' ' 26' ' ' LEU . 10.9 pt -120.43 169.09 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.47 111.007 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.77 157.46 1.21 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.951 -1.022 . . . . 0.22 110.172 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.858 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pt-20 39.65 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.381 1.623 . . . . 1.12 115.381 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -81.49 6.79 13.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.681 0.622 . . . . 0.65 112.681 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.8 m-20 -86.02 176.67 7.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.373 . . . . 1.37 110.951 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -124.38 152.98 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.656 0.741 . . . . 0.22 112.936 -175.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.4 mp -124.53 157.09 36.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.69 -1.141 . . . . 1.23 109.143 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 46.5 mt-10 -102.9 105.47 15.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.874 -0.603 . . . . 1.4 109.392 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' B' ' 45' ' ' LEU . 1.9 mp -91.89 122.51 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.282 0.563 . . . . 0.29 111.207 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.623 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.4 OUTLIER -124.38 161.04 26.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 4.28 108.961 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.56 136.26 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.845 -0.342 . . . . 0.28 110.605 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -128.23 89.21 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.828 0.347 . . . . 1.12 110.077 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 60.42 -90.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.334 -0.848 . . . . 1.64 111.041 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.51 7.34 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.867 -0.606 . . . . 2.81 110.427 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -104.31 158.23 16.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.648 -0.501 . . . . 0.98 109.648 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.693 HD13 HG21 ' A' ' 18' ' ' ILE . 28.5 mt -109.13 134.49 50.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.059 -0.719 . . . . 0.42 109.059 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -123.23 108.73 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.373 -0.603 . . . . 0.25 109.373 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -120.88 110.96 16.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.177 0.989 . . . . 1.29 111.03 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 30.0 ttpt -90.71 161.33 15.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.747 -1.57 . . . . 1.22 107.843 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 45.9 pttt -64.19 137.99 58.22 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.849 -0.426 . . . . 2.5 109.849 171.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.574 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 88.0 t80 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.183 -0.673 . . . . 3.39 109.183 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.454 0.645 . . . . 0.48 111.741 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 3.9 m 65.88 65.26 0.53 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.019 -0.991 . . . . 0.48 111.452 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.42 37.2 3.84 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 114.944 -1.026 . . . . 0.32 111.932 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tp -107.29 138.89 31.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.969 -0.382 . . . . 0.49 109.969 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.4 p -89.13 127.78 41.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.898 0.38 . . . . 0.37 111.0 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -123.57 164.8 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 1.96 110.492 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -98.95 158.62 15.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.447 -0.342 . . . . 1.16 110.317 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.4 t -82.58 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.988 -0.745 . . . . 0.44 108.988 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.538 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 20.8 t70 -155.6 -66.01 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.957 -0.757 . . . . 1.32 108.957 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.919 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.4 pt-20 -156.01 -82.82 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.698 -1.137 . . . . 1.39 109.098 168.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -60.16 -38.13 82.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.6 111.62 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -15.19 0.08 OUTLIER Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.572 -1.299 . . . . 0.34 114.552 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.96 104.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.251 1.025 . . . . 1.26 111.637 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.6 p -101.38 141.7 17.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 1.04 109.692 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' B' ' 15' ' ' ARG . 45.1 t -78.84 108.65 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.39 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.1 mm -74.26 132.94 78.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 0.62 110.89 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 22' ' ' LEU . 77.8 Cg_exo -46.93 140.83 12.8 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.403 2.735 . . . . 0.31 113.298 173.392 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.961 HD12 ' HD2' ' A' ' 23' ' ' ARG . 4.2 tp -60.49 -32.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.606 -0.724 . . . . 0.86 110.132 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.67 -26.29 63.37 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.128 0.489 . . . . 1.73 109.934 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 12.3 mt -82.1 -47.96 11.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.321 -0.622 . . . . 0.44 109.321 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.961 ' HD2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -64.31 -32.12 73.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.606 -0.887 . . . . 1.92 108.606 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -63.74 -42.7 97.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.314 -0.857 . . . . 2.94 111.397 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.3 m -61.41 -35.28 77.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.383 0.611 . . . . 0.34 110.75 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -91.09 -10.53 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.452 -0.795 . . . . 0.26 109.446 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.2 34.7 81.12 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.449 -0.796 . . . . 0.28 112.22 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 26' ' ' LEU . 13.9 pt -106.86 163.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.372 0.606 . . . . 0.43 111.665 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.97 148.96 1.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.462 -1.245 . . . . 0.26 109.373 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.9 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 2.5 pt-20 33.07 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.62 1.711 . . . . 1.22 115.62 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -76.04 4.9 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.509 0.929 . . . . 0.85 113.509 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' O ' HG23 ' B' ' 10' ' ' VAL . 22.2 m-20 -85.78 171.47 11.54 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.578 -0.449 . . . . 1.54 110.112 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.03 153.26 41.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.527 0.68 . . . . 0.23 112.16 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.4 mp -123.09 153.38 40.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.813 -1.085 . . . . 1.15 108.22 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.6 106.16 16.38 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.717 -0.846 . . . . 1.28 108.717 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.803 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -89.8 124.42 42.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.292 -0.867 . . . . 0.29 111.365 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.7 m-85 -115.06 172.8 6.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.471 -1.307 . . . . 4.3 107.471 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.55 141.19 46.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 120.693 -0.403 . . . . 0.26 110.173 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -129.32 76.84 1.75 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.491 . . . . 1.15 110.19 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 54.03 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.254 -1.339 . . . . 1.83 113.001 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -105.03 -13.43 15.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.978 -0.556 . . . . 2.54 110.777 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -115.25 158.73 21.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.932 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.72 HD11 HD11 ' B' ' 26' ' ' LEU . 59.0 mt -104.37 137.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.842 -0.799 . . . . 0.34 108.842 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' B' ' 44' ' ' ILE . 15.9 mm -123.88 105.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.614 -0.513 . . . . 0.2 109.614 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.876 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.4 OUTLIER -119.62 118.71 31.69 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.316 -0.953 . . . . 1.3 111.185 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.88 165.13 11.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.97 -1.468 . . . . 1.41 107.882 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 81.8 tttt -65.22 137.02 57.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.064 -0.717 . . . . 2.68 109.064 171.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 t80 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 109.371 -0.603 . . . . 3.55 109.371 176.789 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.457 0.646 . . . . 0.46 112.002 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 3.9 m 69.33 59.37 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.703 -1.135 . . . . 0.41 111.337 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.76 35.89 3.14 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.32 112.282 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -109.52 136.92 43.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.975 0.417 . . . . 0.52 110.761 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.3 p -88.94 125.37 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.982 0.42 . . . . 0.37 111.688 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.94 165.93 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.509 -0.314 . . . . 1.74 110.321 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -96.04 162.54 13.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.974 -0.38 . . . . 1.23 109.974 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.7 t -82.34 -108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.798 -0.361 . . . . 0.39 110.293 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.56 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 7.0 t70 175.17 -77.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.107 -0.701 . . . . 1.66 109.107 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.9 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -159.27 -71.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.045 -0.979 . . . . 1.91 108.832 168.541 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.669 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.4 pt? -77.74 -29.07 50.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.58 -1.191 . . . . 0.72 111.271 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.46 -11.86 0.18 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 119.206 -1.473 . . . . 0.31 114.011 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.9 ttt180 -56.61 99.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.628 0.714 . . . . 0.75 111.741 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.6 p -95.01 141.83 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.777 -0.453 . . . . 1.04 109.777 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.38 109.44 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.406 . . . . 0.25 111.071 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.5 HD12 HD13 ' A' ' 43' ' ' ILE . 30.8 mm -75.34 134.48 73.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.155 -0.475 . . . . 0.55 110.701 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.64 ' HD2' HD12 ' B' ' 22' ' ' LEU . 92.9 Cg_exo -48.46 141.12 20.08 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.087 2.525 . . . . 0.28 113.044 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.566 HD12 ' HD2' ' B' ' 23' ' ' ARG . 6.5 tp -59.93 -32.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.937 -0.574 . . . . 0.82 110.222 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.47 -23.62 60.1 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.172 0.51 . . . . 1.35 110.328 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.8 mt -81.36 -48.19 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.417 -0.586 . . . . 0.33 109.417 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.566 ' HD2' HD12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -64.15 -33.48 75.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 1.48 108.154 177.94 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.45 -47.11 85.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.191 -0.913 . . . . 2.77 111.289 171.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -60.77 -35.14 75.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.358 0.599 . . . . 0.31 111.045 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 2.5 mt -90.36 -10.9 42.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 0.24 109.785 -176.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 24.72 64.66 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.34 112.298 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.3 pt -96.98 166.53 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-O 121.293 0.568 . . . . 0.47 111.048 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.87 152.69 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.548 -1.206 . . . . 0.22 109.111 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.919 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.5 pt-20 33.78 -90.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.778 1.77 . . . . 1.12 115.778 169.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.465 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.0 mmpt? -83.98 7.19 19.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.01 0.744 . . . . 0.65 113.01 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.4 m-20 -84.48 174.54 9.96 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.129 -0.357 . . . . 1.37 110.57 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.7 152.97 40.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.481 0.658 . . . . 0.22 112.453 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.5 mp -120.92 151.88 39.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.935 -1.03 . . . . 1.23 108.979 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -104.18 102.35 12.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.652 -0.869 . . . . 1.4 108.652 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.8 mp -90.07 124.88 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.391 0.615 . . . . 0.29 111.68 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 7.3 m-85 -114.16 175.13 5.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.012 -1.107 . . . . 4.28 108.012 171.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.25 143.11 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 110.008 -0.367 . . . . 0.28 110.008 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -132.94 77.13 1.72 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.827 0.346 . . . . 1.12 110.628 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 t70 56.14 -75.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.565 -1.198 . . . . 1.64 113.05 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -103.17 -25.44 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 2.81 110.81 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' B' ' 42' ' ' LYS . 1.0 OUTLIER -111.62 160.06 17.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.857 -0.611 . . . . 0.98 111.127 -173.633 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.876 ' HB ' HD12 ' A' ' 45' ' ' LEU . 68.0 mt -105.58 138.16 32.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.459 -0.792 . . . . 0.42 109.351 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' A' ' 44' ' ' ILE . 16.9 mm -114.64 112.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.491 -0.559 . . . . 0.25 109.491 -175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.499 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.92 108.97 15.43 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.938 -0.705 . . . . 1.29 110.247 -178.027 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 35.4 ttpt -96.23 164.96 12.44 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 82.9 tttt -70.48 139.06 51.6 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.769 -0.826 . . . . 2.5 108.769 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 56.0 t80 . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 108.823 -0.806 . . . . 3.39 108.823 175.507 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.203 0.525 . . . . 0.48 111.539 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HD1' ' B' ' 37' ' ' TYR . 49.2 m 72.15 72.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.999 -1.0 . . . . 0.48 112.574 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 40.02 7.13 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.405 -0.816 . . . . 0.32 111.756 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 tp -111.47 139.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.052 0.453 . . . . 0.49 110.1 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 10.9 p -94.04 132.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.306 -0.406 . . . . 0.37 111.205 -174.021 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.14 164.85 26.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.251 -0.431 . . . . 1.96 110.498 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 0.8 OUTLIER -83.69 161.12 21.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.923 -0.58 . . . . 1.16 109.611 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.8 t -79.35 -102.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 110.022 -0.362 . . . . 0.44 110.022 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.515 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 17.2 t0 174.48 -73.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.875 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.3 pt-20 -164.78 -80.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.398 -1.274 . . . . 1.39 109.43 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.69 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.7 pt? -65.81 -31.48 72.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.053 -0.976 . . . . 0.6 112.032 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.62 -19.81 0.38 Allowed Glycine 0 C--O 1.221 -0.719 0 C-N-CA 119.783 -1.198 . . . . 0.34 113.816 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.3 ttt180 -49.49 105.8 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.386 0.593 . . . . 1.26 112.385 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -97.39 141.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.175 -0.466 . . . . 1.04 109.941 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.19 110.92 14.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.25 111.8 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.542 HD12 HG21 ' B' ' 43' ' ' ILE . 40.7 mm -80.95 134.49 52.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.62 110.597 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 22' ' ' LEU . 80.4 Cg_exo -49.99 141.11 30.33 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.275 2.65 . . . . 0.31 113.533 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.59 -33.3 54.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.651 -0.704 . . . . 0.86 110.689 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.89 -23.54 62.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.155 0.503 . . . . 1.73 109.747 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.7 mt -82.22 -49.51 10.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.44 109.875 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -65.29 -31.31 72.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.73 -0.841 . . . . 1.92 108.73 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -39.54 94.66 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.525 -0.761 . . . . 2.94 110.895 173.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -62.59 -33.28 74.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.34 110.254 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.9 mt -88.43 -11.25 46.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.422 -0.808 . . . . 0.26 109.573 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.03 24.39 66.92 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.252 -0.886 . . . . 0.28 112.401 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.82 HG12 ' HB2' ' A' ' 26' ' ' LEU . 18.5 pt -107.71 166.55 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.43 111.467 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.38 146.39 0.63 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.812 -1.085 . . . . 0.26 109.807 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.993 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 37.5 -85.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 115.33 1.604 . . . . 1.22 115.33 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 30' ' ' GLU . 11.0 mmpt? -71.51 -1.42 13.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.91 0.707 . . . . 0.85 112.91 -173.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' HG23 ' B' ' 10' ' ' VAL . 9.2 m-20 -86.59 175.98 8.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.99 0.424 . . . . 1.54 111.428 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -122.8 152.33 40.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.626 -0.715 . . . . 0.23 112.59 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.8 mp -124.69 156.95 36.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.344 -1.354 . . . . 1.15 107.344 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 26.4 tt0 -108.03 107.96 18.87 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.204 -0.665 . . . . 1.28 109.204 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 45' ' ' LEU . 2.0 mp -92.8 123.21 44.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.618 -0.719 . . . . 0.29 111.282 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.659 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.05 162.56 25.75 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.201 -0.909 . . . . 4.3 109.092 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.42 139.89 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.989 0.423 . . . . 0.26 110.611 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.06 80.17 1.96 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.233 0.539 . . . . 1.15 110.243 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.94 -77.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.353 -1.294 . . . . 1.83 111.459 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.28 -31.47 6.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 2.54 110.639 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.729 ' HE2' HD11 ' A' ' 44' ' ' ILE . 25.2 pttm -96.8 156.34 16.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.196 -0.601 . . . . 0.87 111.46 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HD11 ' B' ' 26' ' ' LEU . 13.8 mt -107.06 137.67 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.462 -0.79 . . . . 0.34 109.575 -176.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' B' ' 44' ' ' ILE . 15.1 mm -124.24 109.62 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.2 110.112 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -117.77 113.84 22.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.897 -0.721 . . . . 1.3 109.51 176.64 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 35' ' ' GLU . 12.7 ptpt -91.98 162.57 14.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.647 -1.242 . . . . 1.41 107.647 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 51.4 pttt -65.97 148.01 52.46 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.82 -0.807 . . . . 2.68 108.82 168.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 107.712 -1.218 . . . . 3.55 107.712 173.239 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 121.137 0.494 . . . . 0.46 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.538 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.8 m 74.16 71.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.269 -0.878 . . . . 0.41 111.98 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.73 39.13 7.22 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.199 -0.91 . . . . 0.32 111.812 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.67 138.71 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.164 0.506 . . . . 0.52 110.029 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.546 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.4 p -93.37 129.34 43.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.114 -0.494 . . . . 0.37 111.244 -173.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 1.5 mpt_? -131.03 163.54 27.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 1.74 110.574 176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -82.67 161.22 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.364 -0.606 . . . . 1.23 109.364 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.8 t -78.99 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.806 -0.357 . . . . 0.39 110.251 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.664 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 17.4 t70 175.42 -77.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.173 -0.677 . . . . 1.66 109.173 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.993 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -160.57 -73.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.965 -1.016 . . . . 1.91 108.626 172.559 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.472 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.5 pt? -80.12 -23.1 41.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.394 -1.275 . . . . 0.72 111.534 -174.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.9 -18.95 0.66 Allowed Glycine 0 C--O 1.221 -0.665 0 C-N-CA 119.557 -1.306 . . . . 0.31 113.553 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.4 ttt180 -50.12 105.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.312 0.486 . . . . 0.75 112.312 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 11.5 p -97.94 142.98 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 1.04 109.906 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.47 111.46 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.025 0.44 . . . . 0.25 111.889 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.646 HD12 HD13 ' A' ' 43' ' ' ILE . 25.1 mm -78.34 132.51 65.93 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.642 -0.708 . . . . 0.55 110.777 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.617 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 88.8 Cg_exo -48.73 140.27 22.95 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.233 2.622 . . . . 0.28 113.291 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.11 -33.01 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.82 110.961 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.83 -25.49 62.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.932 0.396 . . . . 1.35 110.264 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -80.54 -48.79 12.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.808 -0.633 . . . . 0.33 109.608 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -65.44 -33.22 75.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.381 -0.97 . . . . 1.48 108.381 178.593 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.503 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 5.7 tmm_? -59.57 -42.4 92.36 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.261 -0.881 . . . . 2.77 109.844 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 80.3 m -60.96 -38.15 84.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.677 0.751 . . . . 0.31 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.843 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 4.9 mt -85.72 -11.26 54.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.994 -1.003 . . . . 0.24 109.789 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.86 86.71 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.294 -0.866 . . . . 0.34 111.782 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.549 HG13 ' HB2' ' B' ' 26' ' ' LEU . 2.7 pp -122.15 167.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.47 111.345 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -174.13 154.93 2.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.164 -0.926 . . . . 0.22 109.432 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.4 pt-20 36.2 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.419 1.637 . . . . 1.12 115.419 170.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.447 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.8 mmpt? -79.45 6.91 9.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 0.65 112.822 -173.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.9 176.73 6.32 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 122.223 -0.298 . . . . 1.37 110.94 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -123.01 153.33 39.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.168 0.803 . . . . 0.22 113.168 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -124.71 155.94 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.377 -1.283 . . . . 1.23 107.557 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -108.16 107.37 17.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 1.4 109.768 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.3 124.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.259 -0.882 . . . . 0.29 111.432 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.595 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.7 OUTLIER -127.0 164.49 21.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.195 -0.911 . . . . 4.28 108.827 176.028 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.38 139.91 48.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.988 -0.285 . . . . 0.28 110.874 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.73 89.37 2.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.642 -0.423 . . . . 1.12 110.333 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 t70 63.88 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.001 -1.0 . . . . 1.64 111.396 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.14 4.77 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.274 -0.876 . . . . 2.81 110.604 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -103.79 155.13 18.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 26' ' ' LEU . 13.0 mt -109.6 134.13 52.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.454 -0.573 . . . . 0.42 109.454 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 44' ' ' ILE . 11.7 mm -125.65 106.13 15.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.322 -0.399 . . . . 0.25 110.382 -172.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.08 116.04 24.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.758 -0.777 . . . . 1.29 110.067 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.42 163.47 13.4 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 62.1 pttt -63.18 151.32 40.62 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.179 -0.674 . . . . 2.5 109.179 169.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 t80 . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 108.131 -1.062 . . . . 3.39 108.131 172.504 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.797 0.808 . . . . 0.48 112.854 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.594 HG23 ' HD1' ' B' ' 37' ' ' TYR . 17.8 m 72.11 67.74 0.14 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.28 -1.327 . . . . 0.48 111.409 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.88 43.85 4.97 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.349 -0.841 . . . . 0.32 111.438 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -108.15 137.63 38.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.587 -0.445 . . . . 0.49 109.968 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.544 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 9.8 p -98.67 124.23 51.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.907 0.384 . . . . 0.37 110.652 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 0.5 OUTLIER -128.7 163.84 24.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.497 -0.32 . . . . 1.96 111.297 -178.39 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.86 162.98 23.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 1.16 110.645 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.3 t -86.75 -109.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.272 -0.422 . . . . 0.44 109.975 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 16.7 t0 179.11 -67.3 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.044 -0.725 . . . . 1.32 109.044 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.1 pt-20 -168.15 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.92 -1.036 . . . . 1.39 110.255 175.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.3 pt? -80.52 -0.64 38.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.555 -1.202 . . . . 0.6 112.326 -171.53 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 144.35 -22.75 2.05 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 119.744 -1.217 . . . . 0.34 113.967 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.6 ttt180 -58.12 106.82 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.436 0.618 . . . . 1.26 112.466 -174.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.4 p -98.3 140.07 18.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.753 -0.462 . . . . 1.04 109.753 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' HG3' ' B' ' 15' ' ' ARG . 40.7 t -79.8 101.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.8 0.333 . . . . 0.25 110.867 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.682 HD13 HD13 ' B' ' 43' ' ' ILE . 10.4 mt -81.04 135.1 51.67 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.62 110.264 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 54.4 Cg_exo -42.85 136.0 4.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.494 2.796 . . . . 0.31 113.663 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.06 -29.3 41.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.612 -0.722 . . . . 0.86 109.98 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -68.87 -27.38 65.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.047 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.721 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.3 mt -82.91 -47.01 12.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.44 109.675 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -65.69 -30.65 71.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.604 -0.888 . . . . 1.92 108.604 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -62.44 -42.18 99.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 2.94 110.846 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.9 m -60.81 -35.64 77.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.244 0.545 . . . . 0.34 111.039 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.852 HD11 HD11 ' B' ' 43' ' ' ILE . 1.3 mt -90.3 -9.71 46.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.818 -0.628 . . . . 0.26 109.719 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.26 34.91 86.6 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.241 -0.89 . . . . 0.28 112.099 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.563 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.6 pt -115.41 165.96 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.104 0.478 . . . . 0.43 111.096 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.1 154.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 0.26 109.593 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 4.6 pt-20 37.83 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.356 1.613 . . . . 1.22 115.356 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.56 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.8 mmpt? -76.15 -1.61 27.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.818 0.673 . . . . 0.85 112.818 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' HG23 ' B' ' 10' ' ' VAL . 37.2 m-20 -85.87 174.05 9.56 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.672 -0.411 . . . . 1.54 110.307 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.18 153.38 40.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.746 0.784 . . . . 0.23 113.061 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 47' ' ' LYS . 18.5 mt -124.47 153.34 42.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.398 -1.274 . . . . 1.15 107.598 173.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -106.82 105.39 15.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.324 -0.621 . . . . 1.28 109.324 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.89 HG13 HD22 ' A' ' 45' ' ' LEU . 1.8 mp -90.37 123.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.473 -0.785 . . . . 0.29 111.06 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.2 OUTLIER -124.92 158.85 32.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.716 -0.846 . . . . 4.3 108.716 175.545 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.7 p -112.56 139.48 37.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.68 -0.408 . . . . 0.26 110.795 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -135.48 82.15 1.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.381 -0.372 . . . . 1.15 110.109 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.17 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.357 -0.838 . . . . 1.83 111.511 -175.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -121.28 -15.35 8.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 2.54 110.038 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -85.21 144.45 28.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.642 . . . . 0.87 110.344 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.932 HD11 HD11 ' B' ' 26' ' ' LEU . 18.4 mt -106.05 131.58 55.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.431 -0.804 . . . . 0.34 108.929 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 44' ' ' ILE . 17.9 mm -119.32 112.25 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.389 -0.369 . . . . 0.2 110.054 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -117.03 108.74 16.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.483 -0.562 . . . . 1.3 109.483 -178.039 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HB2' ' HG2' ' B' ' 42' ' ' LYS . 31.9 ttpt -103.18 134.89 45.84 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.813 -0.81 . . . . 1.41 108.813 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HA ' HD23 ' A' ' 34' ' ' LEU . 60.3 pttt -47.51 144.85 2.84 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 123.064 0.227 . . . . 2.68 110.623 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 110.108 -0.33 . . . . 3.55 110.108 -177.795 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.46 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.71 HG23 ' HD1' ' A' ' 37' ' ' TYR . 27.9 m 65.73 69.3 0.46 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.403 -0.817 . . . . 0.41 111.005 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.75 41.54 4.38 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.021 -0.99 . . . . 0.32 111.721 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tp -105.44 137.21 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.664 -0.495 . . . . 0.52 109.664 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.503 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 12.5 p -96.99 128.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.967 0.413 . . . . 0.37 110.356 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.45 156.59 48.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.29 -0.414 . . . . 1.74 110.638 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.8 mmpt? -82.0 161.01 23.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 1.23 110.624 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 1.7 t -84.3 -118.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.029 0.443 . . . . 0.39 110.146 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 17.3 t0 -171.91 -63.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.194 -0.669 . . . . 1.66 109.194 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.735 ' HG3' ' H ' ' B' ' 13' ' ' LEU . 4.2 pt-20 -169.59 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.909 . . . . 1.91 110.41 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.735 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -61.01 -29.64 69.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.405 -0.816 . . . . 0.72 112.564 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.88 -9.78 0.31 Allowed Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.992 -1.099 . . . . 0.31 112.974 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.1 mtt180 -60.78 106.0 0.52 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.02 0.378 . . . . 0.75 112.02 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 9.7 p -100.99 142.1 16.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.146 -0.479 . . . . 1.04 109.734 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.65 108.98 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.601 -0.272 . . . . 0.25 111.162 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 43' ' ' ILE . 3.4 mt -85.17 138.31 36.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.092 -0.336 . . . . 0.55 110.092 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.677 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 62.2 Cg_exo -43.16 136.6 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.395 2.73 . . . . 0.28 113.89 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -56.03 -33.42 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.82 110.813 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.73 -22.75 59.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.394 -0.366 . . . . 1.35 110.38 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -82.04 -47.17 12.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.33 -0.619 . . . . 0.33 109.33 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -64.98 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.723 -0.843 . . . . 1.48 108.723 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.7 -36.65 81.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.737 -1.119 . . . . 2.77 110.635 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 25' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 76.7 m -63.45 -36.03 82.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.529 0.68 . . . . 0.31 110.526 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.932 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -89.7 -10.61 45.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.338 -0.846 . . . . 0.24 109.777 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.22 15.77 68.12 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.34 112.698 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' B' ' 26' ' ' LEU . 15.5 pt -98.15 168.81 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.818 0.342 . . . . 0.47 111.247 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.44 146.66 0.28 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.309 -0.86 . . . . 0.22 109.835 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.3 pt-20 37.47 -89.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.299 1.592 . . . . 1.12 115.299 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HB2' ' B' ' 30' ' ' GLU . 10.8 mmpt? -75.23 4.91 6.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.515 0.561 . . . . 0.65 112.515 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -97.25 -177.99 4.02 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.086 -0.646 . . . . 1.37 110.896 -175.298 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -126.47 153.61 44.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.235 1.198 . . . . 0.22 114.235 -171.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' B' ' 47' ' ' LYS . 19.5 mt -127.02 153.68 45.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.186 -1.37 . . . . 1.23 108.024 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -106.41 104.76 14.53 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.204 -0.665 . . . . 1.4 109.204 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.631 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.94 124.5 45.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.52 0.676 . . . . 0.29 111.748 -175.168 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -126.46 162.95 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.079 -0.964 . . . . 4.28 108.658 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.27 140.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.019 0.437 . . . . 0.28 111.338 -171.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.31 78.87 1.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.588 . . . . 1.12 109.59 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.71 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.504 -1.225 . . . . 1.64 111.216 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -128.71 -13.62 4.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 2.81 110.391 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 24.0 mtpt -85.27 143.87 28.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.504 . . . . 0.98 109.748 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 26' ' ' LEU . 26.5 mt -104.25 132.5 50.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.927 -0.768 . . . . 0.42 108.927 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 44' ' ' ILE . 15.5 mm -120.53 108.89 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.1 -0.333 . . . . 0.25 110.1 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.631 ' HB3' HG13 ' B' ' 36' ' ' ILE . 0.1 OUTLIER -118.81 108.79 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.352 0.596 . . . . 1.29 110.629 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 28.7 ttpt -90.34 156.06 18.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.776 -1.194 . . . . 1.22 107.776 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' B' ' 34' ' ' LEU . 24.1 pttm -63.53 159.67 18.15 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.023 -0.671 . . . . 2.5 109.338 173.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.379 -0.373 . . . . 3.39 110.026 178.211 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.461 0.648 . . . . 0.48 112.102 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.7 m 71.73 60.58 0.15 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.749 -1.114 . . . . 0.48 111.382 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.09 36.29 3.2 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.439 -0.8 . . . . 0.32 112.131 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tp -105.15 134.92 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.905 0.383 . . . . 0.49 110.128 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 13.1 p -93.41 129.51 43.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.112 0.482 . . . . 0.37 111.36 -176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -129.81 165.82 21.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.96 110.814 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' B' ' 32' ' ' ASP . 7.5 tppt? -87.84 159.79 18.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.629 -0.714 . . . . 1.16 109.825 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.0 t -82.05 -118.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.716 -0.846 . . . . 0.44 108.716 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 20.3 t0 -174.79 -69.3 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.647 -0.501 . . . . 1.32 109.647 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.897 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.2 OUTLIER -154.98 -78.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.393 -0.821 . . . . 1.39 110.349 174.325 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.6 pt? -81.85 0.02 41.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.827 -1.079 . . . . 0.6 112.511 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.81 -21.05 3.59 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 120.076 -1.059 . . . . 0.34 113.143 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.1 mtt180 -53.49 106.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.066 0.433 . . . . 1.26 111.961 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 12.1 p -102.3 142.83 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.283 -0.417 . . . . 1.04 110.063 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' B' ' 15' ' ' ARG . 51.9 t -76.87 102.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.415 . . . . 0.25 111.939 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -70.67 132.36 87.26 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.62 110.414 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 99.3 Cg_exo -47.76 141.92 15.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.019 2.479 . . . . 0.31 113.016 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.35 -32.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.681 . . . . 0.86 110.117 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.53 -24.45 61.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.02 0.438 . . . . 1.73 110.146 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.6 mt -83.12 -48.69 10.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.504 -0.554 . . . . 0.44 109.504 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 22.6 ptt85 -64.5 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.408 -0.96 . . . . 1.92 108.408 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.5 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 14.4 ttt180 -58.88 -43.62 90.94 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.14 -0.936 . . . . 2.94 110.75 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -61.05 -32.76 72.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.34 110.31 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 2.5 mt -92.98 -9.53 39.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.003 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 28.01 69.61 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.28 112.635 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.713 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.2 pt -107.0 167.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.117 0.484 . . . . 0.43 111.626 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.54 150.89 1.44 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.1 -0.955 . . . . 0.26 110.2 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.856 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.2 pt-20 35.12 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.723 1.749 . . . . 1.22 115.723 173.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -80.01 5.63 13.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.022 0.749 . . . . 0.85 113.022 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.7 OUTLIER -81.73 177.81 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.866 0.365 . . . . 1.54 111.422 -177.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.36 151.33 42.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.993 -0.549 . . . . 0.23 112.151 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.7 mp -126.63 157.28 39.34 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.433 -0.951 . . . . 1.15 108.433 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -111.37 105.86 14.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.295 -0.632 . . . . 1.28 109.295 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.717 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -90.09 125.14 42.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.201 -0.909 . . . . 0.29 111.484 -176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.9 m-85 -114.55 173.97 6.19 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.459 -1.311 . . . . 4.3 107.459 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.85 142.2 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.563 -0.455 . . . . 0.26 110.294 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.85 77.23 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.885 -0.326 . . . . 1.15 110.435 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t70 57.79 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.619 1.199 . . . . 1.83 112.655 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' OE2' ' HG3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -117.19 7.16 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.52 -0.309 . . . . 2.54 111.351 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' B' ' 46' ' ' LYS . 35.6 mtmm -127.04 162.87 25.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.138 0.494 . . . . 0.87 111.41 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.653 HD13 HD12 ' B' ' 18' ' ' ILE . 54.0 mt -106.68 138.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.428 -0.805 . . . . 0.34 109.294 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' B' ' 44' ' ' ILE . 16.8 mm -125.78 106.13 15.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 109.705 -0.48 . . . . 0.2 109.705 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.5 OUTLIER -123.04 128.09 49.68 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.293 -0.963 . . . . 1.3 111.474 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' B' ' 42' ' ' LYS . 38.1 ttpt -121.96 145.94 47.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.999 -1.001 . . . . 1.41 108.328 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 60.2 pttt -48.41 143.04 5.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.114 0.259 . . . . 2.68 110.847 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.3 t80 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.865 -0.791 . . . . 3.55 108.865 177.503 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.665 0.745 . . . . 0.46 112.128 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 7.8 m 66.82 66.16 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.651 -1.159 . . . . 0.41 111.302 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.64 34.45 4.97 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.606 -0.725 . . . . 0.32 112.403 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 tp -102.39 134.12 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.967 0.413 . . . . 0.52 110.342 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.2 p -94.66 127.03 46.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.129 0.49 . . . . 0.37 111.614 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.54 166.96 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.141 -0.481 . . . . 1.74 110.52 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.83 161.85 16.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 1.23 109.79 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 2.2 t -81.06 -109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.498 ' HB2' ' NE ' ' A' ' 15' ' ' ARG . 24.5 t70 176.65 -79.0 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.453 -0.573 . . . . 1.66 109.453 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.6 pt-20 -154.92 -81.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.521 -0.763 . . . . 1.91 110.024 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.603 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -65.49 -29.9 70.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.34 -0.845 . . . . 0.72 112.102 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.72 -9.81 0.32 Allowed Glycine 0 C--O 1.223 -0.587 0 C-N-CA 119.685 -1.245 . . . . 0.31 112.888 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 9.6 mtt180 -54.9 105.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.0 0.37 . . . . 0.75 112.0 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 12.7 p -98.72 141.44 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 1.04 110.132 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 15' ' ' ARG . 42.4 t -77.28 101.1 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.25 111.74 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 43' ' ' ILE . 26.0 mm -67.17 135.51 93.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.876 -0.602 . . . . 0.55 110.708 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' B' ' 22' ' ' LEU . 89.2 Cg_exo -49.85 137.64 35.02 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.846 2.364 . . . . 0.28 112.62 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 tt -57.86 -33.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.82 110.344 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.94 -27.34 64.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 1.35 110.276 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.3 mt -82.03 -48.41 11.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.33 109.457 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -68.29 -25.84 65.34 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.225 -1.028 . . . . 1.48 108.225 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.91 -37.48 75.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.619 -0.719 . . . . 2.77 110.742 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 98.2 m -61.35 -35.59 77.87 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.419 0.628 . . . . 0.31 110.503 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -89.27 -11.11 44.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.395 -0.82 . . . . 0.24 109.864 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.18 22.59 69.16 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.551 -0.75 . . . . 0.34 112.872 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.4 pt -101.95 167.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.173 0.511 . . . . 0.47 111.579 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.25 150.77 1.54 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.22 110.262 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.897 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.0 -89.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.725 1.75 . . . . 1.12 115.725 172.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.7 mmpt? -79.58 7.98 7.29 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.225 0.824 . . . . 0.65 113.225 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 71.6 m-20 -88.96 176.6 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.036 0.38 . . . . 1.37 111.06 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -121.43 150.91 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.536 0.684 . . . . 0.22 112.632 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.8 mp -123.02 156.21 35.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.964 -1.016 . . . . 1.23 109.256 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 43.7 mt-10 -108.77 105.42 14.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.805 -0.634 . . . . 1.4 109.385 175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.02 124.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.301 -0.863 . . . . 0.29 111.351 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 17.0 m-85 -113.57 174.78 5.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.517 -1.29 . . . . 4.28 107.517 172.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.45 142.96 42.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.598 -0.441 . . . . 0.28 110.158 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.58 78.12 1.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 1.12 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 60.02 -75.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.627 -1.169 . . . . 1.64 112.618 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -107.43 -25.58 11.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.957 0.408 . . . . 2.81 111.033 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 24.8 pttm -116.3 162.45 17.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.167 0.508 . . . . 0.98 111.919 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.858 ' HB ' HD12 ' A' ' 45' ' ' LEU . 59.9 mt -106.04 139.03 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.39 -0.823 . . . . 0.42 110.169 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -118.11 109.66 27.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 116.081 -0.509 . . . . 0.25 109.754 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.501 HD11 ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.39 116.88 28.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.433 -0.507 . . . . 1.29 110.146 -176.335 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.665 ' HB2' ' HG2' ' A' ' 42' ' ' LYS . 38.5 ttpt -116.88 139.8 50.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.702 -0.851 . . . . 1.22 108.702 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 63.2 pttt -47.69 147.59 1.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.202 0.314 . . . . 2.5 110.939 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' TYR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 78.6 t80 . . . . . 0 C--N 1.324 -0.504 0 N-CA-C 109.112 -0.699 . . . . 3.39 109.112 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.592 0.71 . . . . 0.48 112.32 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.654 HG23 ' HD1' ' B' ' 37' ' ' TYR . 25.1 m 72.0 71.6 0.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.573 -1.194 . . . . 0.48 111.313 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.42 38.99 6.09 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.332 -0.849 . . . . 0.32 111.879 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.51 136.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.706 -0.479 . . . . 0.49 109.706 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 11.2 p -95.84 127.3 48.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.902 0.382 . . . . 0.37 110.938 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -125.96 161.13 28.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.344 -0.389 . . . . 1.96 110.671 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -81.45 161.09 23.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.218 -0.66 . . . . 1.16 109.218 175.766 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.0 t -80.21 -108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.564 -0.532 . . . . 0.44 109.564 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 26.9 t70 175.26 -67.29 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.02 -0.733 . . . . 1.32 109.02 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.4 pt-20 -158.47 -86.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.939 -1.028 . . . . 1.39 109.986 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.604 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -77.24 -27.73 53.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.6 112.112 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.49 -0.33 0.06 OUTLIER Glycine 0 C--O 1.225 -0.464 0 C-N-CA 119.483 -1.342 . . . . 0.34 114.461 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.9 ttt180 -66.81 99.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.495 1.148 . . . . 1.26 111.578 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 19.0 m -96.46 144.58 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 1.04 110.386 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' B' ' 15' ' ' ARG . 41.4 t -82.0 107.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.302 -0.408 . . . . 0.25 111.178 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' O ' ' B' ' 14' ' ' GLY . 3.6 mt -79.9 139.24 53.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 110.186 -0.302 . . . . 0.62 110.186 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 70.8 Cg_exo -46.33 140.03 11.82 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.422 2.748 . . . . 0.31 113.839 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 6.7 tp -58.19 -32.84 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.86 110.443 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -72.81 -23.03 60.73 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.406 -0.361 . . . . 1.73 110.419 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.705 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.3 mt -83.37 -46.48 12.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.297 0.57 . . . . 0.44 109.858 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -64.13 -31.37 72.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 1.92 108.011 176.572 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -38.48 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.966 -1.016 . . . . 2.94 111.605 173.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -60.66 -36.54 78.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.542 0.687 . . . . 0.34 110.473 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.942 HD11 HD11 ' B' ' 43' ' ' ILE . 1.9 mt -89.28 -9.22 51.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.464 -0.789 . . . . 0.26 109.713 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.13 29.37 70.91 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.257 -0.883 . . . . 0.28 112.118 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.3 pt -110.12 167.29 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.189 0.518 . . . . 0.43 111.124 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -179.68 154.87 0.62 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.727 -1.124 . . . . 0.26 109.22 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.1 pt-20 37.82 -89.46 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.904 1.446 . . . . 1.22 114.904 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.1 5.11 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.493 0.553 . . . . 0.85 112.493 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.537 ' O ' HG23 ' B' ' 10' ' ' VAL . 2.7 m-20 -87.67 172.73 9.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.81 0.338 . . . . 1.54 110.419 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -117.37 149.04 41.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.353 0.597 . . . . 0.23 111.692 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 47' ' ' LYS . 14.1 tp -126.21 149.33 49.12 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.984 -1.117 . . . . 1.15 107.984 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -107.03 106.03 16.35 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.209 0.528 . . . . 1.28 110.049 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 1.017 HG13 HD22 ' A' ' 45' ' ' LEU . 1.7 mp -94.14 125.73 46.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.29 111.312 -173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.737 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -126.97 160.97 29.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.453 -0.794 . . . . 4.3 109.555 175.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.83 138.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.84 0.352 . . . . 0.26 110.794 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.59 81.69 2.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.788 -0.449 . . . . 1.15 109.788 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 2.5 t70 58.55 -82.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.704 -1.135 . . . . 1.83 111.454 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 24.3 mt-10 -114.08 -19.62 11.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 2.54 111.018 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -92.73 159.03 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.87 110.242 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.868 HD11 HD11 ' B' ' 26' ' ' LEU . 26.7 mt -110.28 133.54 55.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.843 -0.617 . . . . 0.34 109.367 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.737 ' HB ' ' HD1' ' A' ' 37' ' ' TYR . 17.9 mm -121.21 115.44 46.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.829 -0.434 . . . . 0.2 109.829 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.03 118.91 35.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.546 -0.538 . . . . 1.3 109.546 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 30.7 ttpt -112.35 148.65 33.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.117 -1.438 . . . . 1.41 107.117 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.837 ' HA ' HD12 ' A' ' 34' ' ' LEU . 84.5 tttt -56.69 149.66 17.44 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.491 -0.559 . . . . 2.68 109.491 174.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 33' ' ' ALA . 17.3 p90 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.38 -0.97 . . . . 3.55 108.38 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.488 0.661 . . . . 0.46 112.497 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 37' ' ' TYR . 25.0 m 71.94 70.58 0.16 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.638 -1.164 . . . . 0.41 111.79 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.39 39.18 6.05 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.32 111.796 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.41 137.23 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.374 -0.602 . . . . 0.52 109.374 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.527 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 10.0 p -95.61 127.99 47.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 120.958 0.408 . . . . 0.37 110.41 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.66 159.93 30.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.155 -0.475 . . . . 1.74 110.316 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -81.42 157.55 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.926 -0.768 . . . . 1.23 108.926 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 32' ' ' ASP . 3.1 t -76.73 -104.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.577 -0.527 . . . . 0.39 109.577 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.414 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 23.5 t0 170.2 -71.04 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.879 -0.786 . . . . 1.66 108.879 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.1 pt-20 -154.45 -83.51 0.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 1.91 110.173 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.5 pt? -84.13 -22.33 31.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.38 -0.827 . . . . 0.72 112.434 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 159.42 -4.74 0.11 Allowed Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.477 -1.344 . . . . 0.31 113.871 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 2.1 ttt180 -66.77 96.98 0.43 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.926 0.863 . . . . 0.75 111.513 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 24.7 m -94.42 144.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.012 -0.54 . . . . 1.04 110.43 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 15' ' ' ARG . 46.4 t -81.75 107.75 14.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.342 -0.39 . . . . 0.25 111.073 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.534 HD13 HD13 ' A' ' 43' ' ' ILE . 8.6 mt -82.14 138.16 45.83 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.485 -0.325 . . . . 0.55 110.611 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.51 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 70.6 Cg_exo -44.67 140.44 6.48 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.61 2.873 . . . . 0.28 113.969 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 5.3 tp -57.68 -34.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.105 -0.952 . . . . 0.82 110.611 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 7.8 pt-20 -71.11 -24.29 62.26 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 109.962 -0.384 . . . . 1.35 109.962 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.0 mt -83.51 -46.35 12.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.33 109.708 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' B' ' 28' ' ' ILE . 2.9 ppt_? -64.73 -31.57 72.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.866 -1.161 . . . . 1.48 107.866 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 31.3 ttt180 -59.29 -46.73 87.76 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 114.81 -1.086 . . . . 2.77 111.164 170.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.1 m -58.49 -35.33 72.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.313 0.578 . . . . 0.31 111.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -90.22 -10.33 44.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.488 -0.778 . . . . 0.24 109.917 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.22 63.66 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.531 -0.758 . . . . 0.34 112.768 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.678 HG12 ' HB2' ' B' ' 26' ' ' LEU . 13.3 pt -101.49 167.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.408 . . . . 0.47 111.126 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ALA . . . . . 0.45 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -178.03 152.71 0.75 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.102 -0.953 . . . . 0.22 109.548 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.8 pt-20 34.36 -90.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.126 1.528 . . . . 1.12 115.126 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -75.89 5.07 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.985 0.735 . . . . 0.65 112.985 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.0 m-20 -91.76 176.41 6.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.891 -0.506 . . . . 1.37 111.335 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -116.65 150.68 37.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.639 -0.709 . . . . 0.22 112.167 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 47' ' ' LYS . 14.0 tp -128.36 150.67 50.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.219 -1.03 . . . . 1.23 108.219 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -106.35 107.25 18.16 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.607 -0.516 . . . . 1.4 109.607 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 1.033 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -94.53 124.1 46.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.992 -0.549 . . . . 0.29 111.291 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.825 ' HD2' ' HB ' ' B' ' 44' ' ' ILE . 0.3 OUTLIER -123.58 159.61 28.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.639 -0.71 . . . . 4.28 109.513 175.196 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.89 136.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.954 0.407 . . . . 0.28 110.622 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.47 79.9 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 1.12 109.557 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 57.02 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.858 -1.064 . . . . 1.64 111.507 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.63 -3.33 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.964 -0.562 . . . . 2.81 111.104 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -102.82 158.76 16.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.58 -0.526 . . . . 0.98 109.58 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 26' ' ' LEU . 22.7 mt -111.8 133.51 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.431 -0.581 . . . . 0.42 109.431 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HD2' ' B' ' 37' ' ' TYR . 18.3 mm -123.99 116.1 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.765 -0.458 . . . . 0.25 109.765 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.71 117.57 30.65 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.565 -0.454 . . . . 1.29 109.942 -177.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 18.8 ttpt -111.25 142.03 44.0 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.224 -1.028 . . . . 1.22 108.224 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' B' ' 34' ' ' LEU . 79.3 tttt -49.97 141.95 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.227 -0.286 . . . . 2.5 110.227 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 11.8 p90 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 109.614 -0.513 . . . . 3.39 109.614 -177.482 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.456 0.646 . . . . 0.48 111.065 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' HD1' ' B' ' 37' ' ' TYR . 11.5 m 70.79 68.22 0.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.903 -1.044 . . . . 0.48 111.683 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' B' ' 35' ' ' GLU . . . 91.89 37.66 5.99 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.31 -0.859 . . . . 0.32 111.894 174.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tp -104.14 135.76 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.767 -0.457 . . . . 0.49 109.767 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.615 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.8 p -90.67 124.79 43.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.996 0.427 . . . . 0.37 110.797 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.69 159.58 27.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.277 -0.419 . . . . 1.96 110.525 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 1.1 tpmt? -83.58 158.32 21.98 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.89 -0.781 . . . . 1.16 108.89 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.4 t -78.61 -105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.055 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.578 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 14.4 t70 175.32 -78.03 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.448 -0.575 . . . . 1.32 109.448 -173.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER -161.59 -77.71 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 1.39 109.679 172.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.7 pt? -72.66 -18.37 61.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.036 -0.984 . . . . 0.6 112.358 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.86 -21.32 1.0 Allowed Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.018 -1.087 . . . . 0.34 113.76 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.705 ' HD3' ' HB2' ' B' ' 11' ' ' ASP . 6.8 ttm180 -51.92 104.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.381 0.591 . . . . 1.26 112.433 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 14.9 p -97.11 143.22 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.951 -0.389 . . . . 1.04 109.951 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.2 t -77.14 105.9 6.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.25 111.597 -175.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.477 HD12 HG21 ' B' ' 43' ' ' ILE . 35.8 mm -77.42 134.82 65.93 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.62 110.218 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' HD12 ' A' ' 22' ' ' LEU . 87.3 Cg_exo -48.81 140.45 23.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.122 2.548 . . . . 0.31 113.199 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.4 tt -60.76 -33.3 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.86 110.339 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.04 -24.41 63.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.166 0.508 . . . . 1.73 109.725 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.78 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mt -82.05 -49.81 9.79 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.792 -0.64 . . . . 0.44 109.415 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -64.88 -34.6 78.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.624 -0.88 . . . . 1.92 108.624 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -44.36 85.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.241 -0.89 . . . . 2.94 111.129 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.2 m -63.14 -33.15 74.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.309 0.576 . . . . 0.34 110.956 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.845 HD11 HD11 ' B' ' 43' ' ' ILE . 3.1 mt -88.09 -12.91 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.918 -0.583 . . . . 0.26 110.036 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.56 76.71 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.28 112.17 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.692 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.3 pt -108.13 167.34 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.43 111.26 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.55 152.67 0.66 Allowed 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 0.26 109.674 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.826 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.3 pt-20 37.65 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.566 1.691 . . . . 1.22 115.566 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.17 7.02 12.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.704 0.631 . . . . 0.85 112.704 -172.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' B' ' 10' ' ' VAL . 28.6 m-20 -87.27 177.89 7.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 1.54 111.433 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -121.57 146.89 46.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.226 0.824 . . . . 0.23 113.226 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.0 mp -124.16 156.48 36.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 1.15 108.455 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.69 107.61 18.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.583 -0.525 . . . . 1.28 109.583 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.981 HG13 HD12 ' A' ' 45' ' ' LEU . 1.8 mp -90.3 120.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.599 0.714 . . . . 0.29 110.698 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.742 ' HD1' HG23 ' B' ' 4' ' ' THR . 1.0 OUTLIER -123.14 158.13 31.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.094 -0.957 . . . . 4.3 109.012 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.73 137.72 45.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.26 110.779 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 83.04 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 1.15 110.857 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 t70 63.53 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.793 -1.094 . . . . 1.83 111.817 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.33 9.62 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.006 -0.543 . . . . 2.54 111.255 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -118.84 158.64 25.25 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.322 -0.399 . . . . 0.87 109.978 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 26' ' ' LEU . 15.9 mt -110.06 138.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.263 -0.426 . . . . 0.34 109.89 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 44' ' ' ILE . 11.4 mm -122.79 115.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.443 -0.344 . . . . 0.2 110.268 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -114.36 117.08 30.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.876 -0.73 . . . . 1.3 109.092 176.124 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -107.62 126.8 53.02 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.028 -0.73 . . . . 1.41 109.028 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 59.3 pttt -44.71 139.48 2.92 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.255 0.347 . . . . 2.68 111.148 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 108.71 -0.848 . . . . 3.55 108.71 173.147 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.46 108.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 4' ' ' THR . . . . . 0.742 HG23 ' HD1' ' A' ' 37' ' ' TYR . 35.4 m 64.68 70.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.594 0.711 . . . . 0.41 111.317 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.08 38.15 5.49 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.773 -0.727 . . . . 0.32 112.255 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tp -104.6 133.81 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.628 -0.508 . . . . 0.52 109.628 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 11.0 p -92.0 117.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.529 0.68 . . . . 0.37 111.486 -172.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -109.73 159.61 17.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 1.74 110.209 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 155.93 20.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.233 -1.025 . . . . 1.23 108.233 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 34' ' ' LEU . 2.2 t -78.24 -111.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.497 -0.557 . . . . 0.39 109.497 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ASP . . . . . 0.705 ' HB2' ' HD3' ' A' ' 15' ' ' ARG . 26.4 t0 179.88 -68.94 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.4 -0.592 . . . . 1.66 109.4 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' GLU . . . . . 0.826 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.3 pt-20 -160.38 -83.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.819 . . . . 1.91 110.563 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' LEU . . . . . 0.545 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -74.45 -16.13 60.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.031 -0.986 . . . . 0.72 112.198 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.22 -16.79 1.16 Allowed Glycine 0 C--O 1.221 -0.66 0 C-N-CA 119.911 -1.137 . . . . 0.31 113.05 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.9 mtt180 -52.48 111.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.788 0.294 . . . . 0.75 111.75 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.5 p -105.14 142.09 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.721 -0.474 . . . . 1.04 109.721 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' VAL . . . . . 0.479 ' HB ' ' HG2' ' B' ' 8' ' ' ARG . 48.6 t -77.65 108.53 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 0.25 112.019 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.561 HD12 HD13 ' A' ' 43' ' ' ILE . 19.9 mm -76.28 135.65 69.35 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.942 -0.572 . . . . 0.55 110.422 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' PRO . . . . . 0.714 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.06 139.89 25.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.987 2.458 . . . . 0.28 113.215 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.579 HG13 ' HE ' ' B' ' 23' ' ' ARG . 12.3 tt -59.87 -33.6 53.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.587 -0.733 . . . . 0.82 110.707 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.55 -22.98 59.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.105 0.478 . . . . 1.35 110.251 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.2 mt -80.38 -48.47 12.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.957 -0.757 . . . . 0.33 108.957 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ARG . . . . . 0.579 ' HE ' HG13 ' B' ' 20' ' ' ILE . 15.0 ptt180 -65.58 -33.71 76.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.936 -0.765 . . . . 1.48 108.936 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ARG . . . . . 0.457 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 33.9 ttp180 -64.78 -37.83 88.93 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.409 -0.814 . . . . 2.77 110.495 175.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 95.7 m -63.83 -34.34 77.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.31 110.422 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 43' ' ' ILE . 3.1 mt -88.72 -10.36 48.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.48 0.657 . . . . 0.24 109.572 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.27 77.06 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 114.889 -1.051 . . . . 0.34 112.282 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ILE . . . . . 0.641 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.0 pt -111.67 166.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.932 0.396 . . . . 0.47 111.196 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.85 148.67 0.54 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.224 -0.898 . . . . 0.22 110.182 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.0 pt-20 35.85 -87.23 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.293 1.59 . . . . 1.12 115.293 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -75.04 5.11 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.075 0.769 . . . . 0.65 113.075 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ASP . . . . . 0.579 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 3.2 m-20 -86.67 173.74 9.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 1.37 111.636 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -118.28 144.86 45.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.621 -0.718 . . . . 0.22 112.401 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' LEU . . . . . 0.831 HD23 ' HA ' ' B' ' 47' ' ' LYS . 15.9 mt -124.77 152.27 44.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.846 -1.168 . . . . 1.23 107.846 174.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 19.3 tt0 -106.78 104.84 14.62 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.167 -0.679 . . . . 1.4 109.167 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ILE . . . . . 0.951 HG13 HD12 ' B' ' 45' ' ' LEU . 1.9 mp -90.26 121.39 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.346 0.593 . . . . 0.29 110.971 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' TYR . . . . . 0.601 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -127.21 158.64 36.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.358 -0.837 . . . . 4.28 109.498 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.0 p -110.94 138.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.626 -0.429 . . . . 0.28 111.221 -173.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.47 77.94 1.78 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.12 110.336 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 t70 58.56 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.504 -1.225 . . . . 1.64 112.384 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -115.58 -10.74 11.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 2.81 110.924 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -109.84 157.6 19.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.98 110.667 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 26' ' ' LEU . 12.1 mt -109.84 137.5 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.016 -0.538 . . . . 0.42 109.83 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 44' ' ' ILE . 10.1 mm -123.61 115.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.457 -0.338 . . . . 0.25 110.214 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 45' ' ' LEU . . . . . 0.951 HD12 HG13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -112.9 111.94 23.05 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.29 108.886 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.31 128.65 47.37 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.084 -0.71 . . . . 1.22 109.084 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LYS . . . . . 0.831 ' HA ' HD23 ' B' ' 34' ' ' LEU . 55.0 pttt -44.86 138.92 3.29 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.281 0.363 . . . . 2.5 111.407 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 108.853 -0.795 . . . . 3.39 108.853 173.723 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.648 -0.501 . . . . 4.93 109.648 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.877 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -131.26 -85.6 0.5 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.994 -0.282 . . . . 1.67 111.585 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.877 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 75.7 m -147.51 -170.9 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.818 -0.808 . . . . 0.48 108.818 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.655 HG23 ' HD1' ' B' ' 37' ' ' TYR . 59.4 m 63.32 75.41 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.813 0.815 . . . . 0.48 111.311 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.61 35.97 12.82 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.271 -0.877 . . . . 0.32 111.339 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 134.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.745 -0.465 . . . . 0.49 109.745 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -86.99 125.66 40.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 120.988 0.423 . . . . 0.37 111.384 -173.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.44 155.86 36.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 1.96 110.863 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -82.34 162.57 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.881 -0.414 . . . . 1.16 109.881 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.531 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.5 t -85.05 -108.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.772 -0.371 . . . . 0.44 110.231 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.583 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t70 177.26 -74.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.98 -0.748 . . . . 1.32 108.98 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.921 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.9 OUTLIER -161.57 -80.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.942 -1.026 . . . . 1.39 109.686 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.535 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -68.4 -32.78 73.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.6 111.302 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.78 -16.31 0.11 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.879 -1.153 . . . . 0.34 113.947 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.36 103.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.584 0.692 . . . . 1.26 111.867 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.714 HG11 HD13 ' B' ' 45' ' ' LEU . 13.4 p -96.55 140.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.866 -0.42 . . . . 1.04 109.866 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.4 t -77.76 101.75 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.323 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.7 129.06 88.89 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.818 -0.628 . . . . 0.62 110.229 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.683 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 57.2 Cg_exo -45.5 139.09 10.08 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.387 2.725 . . . . 0.31 113.407 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 8.6 tt -57.03 -33.26 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.86 110.827 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -73.2 -24.86 60.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.098 0.475 . . . . 1.73 110.472 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 10.5 mt -81.49 -48.09 12.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.402 -0.592 . . . . 0.44 109.402 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HE ' ' HA ' ' A' ' 20' ' ' ILE . 12.2 ptt180 -64.7 -33.81 76.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.083 -0.71 . . . . 1.92 109.083 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.76 -40.38 94.96 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.281 -0.872 . . . . 2.94 110.677 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.6 m -61.12 -38.36 86.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.205 0.526 . . . . 0.34 110.634 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.739 HD11 HD11 ' B' ' 43' ' ' ILE . 2.2 mt -87.14 -10.67 52.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.26 109.704 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.98 25.83 71.02 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.377 -0.829 . . . . 0.28 112.466 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.683 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.5 pt -106.71 167.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.43 111.606 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -177.32 152.84 0.88 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.883 -1.053 . . . . 0.26 109.549 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.0 pt-20 32.4 -89.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.779 1.77 . . . . 1.22 115.779 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.7 mmpt? -77.27 -0.43 25.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.746 0.647 . . . . 0.85 112.746 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -81.94 174.67 11.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.007 0.432 . . . . 1.54 110.535 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.93 152.59 42.28 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.405 0.621 . . . . 0.23 112.499 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.3 mp -120.04 152.51 37.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.91 -1.041 . . . . 1.15 109.204 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.53 100.14 10.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.611 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -91.13 123.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.347 0.594 . . . . 0.29 111.352 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.665 ' HD1' HG23 ' B' ' 4' ' ' THR . 3.4 t80 -126.24 163.4 23.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.317 -0.856 . . . . 4.3 108.721 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.91 139.25 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.706 -0.398 . . . . 0.26 110.686 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 81.26 2.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.345 -0.388 . . . . 1.15 110.335 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 55.26 -80.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.637 -1.165 . . . . 1.83 112.843 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 3.68 19.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.08 0.4 . . . . 2.54 112.08 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -143.38 170.79 15.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.87 112.611 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HD11 ' B' ' 26' ' ' LEU . 31.5 mt -106.58 139.06 29.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.973 -1.012 . . . . 0.34 110.257 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.655 HD12 HD12 ' B' ' 44' ' ' ILE . 22.4 mm -121.64 107.07 19.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 0.2 109.458 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.6 118.55 28.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.912 0.863 . . . . 1.3 111.362 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 32.9 ttpt -102.64 165.43 11.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.197 -1.365 . . . . 1.41 107.932 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 57.5 pttt -66.43 147.91 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.524 -0.917 . . . . 2.68 108.524 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.2 137.57 57.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.173 -0.611 . . . . 3.55 109.402 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.52 111.28 7.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.576 -0.527 . . . . 3.38 109.576 -178.473 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 92.0 Cg_endo -74.33 119.13 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.505 2.137 . . . . 1.58 112.211 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 47.7 t30 -86.71 77.69 9.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.46 0.648 . . . . 3.85 109.33 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.442 ' HG2' ' HB2' ' A' ' 50' ' ' PRO . 79.0 mmm -117.03 122.65 44.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.409 -0.814 . . . . 5.0 109.705 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 119.21 -0.424 . . . . 6.13 110.133 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.803 0.335 . . . . 5.41 111.461 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' B' ' 2' ' ' LYS . 15.1 ptmt -103.04 -163.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.027 -0.731 . . . . 1.29 109.027 171.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -67.31 -177.67 0.73 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.615 0.722 . . . . 0.46 112.255 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.665 HG23 ' HD1' ' A' ' 37' ' ' TYR . 60.9 m 78.79 72.61 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.283 -1.326 . . . . 0.41 111.345 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.92 36.53 10.12 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.983 -1.008 . . . . 0.32 111.28 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tp -107.3 137.6 37.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.102 0.477 . . . . 0.52 109.931 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 6.6 p -88.17 129.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 116.278 -0.419 . . . . 0.37 111.163 -173.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 2.5 mpt_? -126.43 155.91 41.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.729 -0.214 . . . . 1.74 111.074 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.4 mmpt? -81.28 162.38 23.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.847 -0.427 . . . . 1.23 109.847 176.052 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.5 t -86.16 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.117 0.484 . . . . 0.39 110.513 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' B' ' 10' ' ' VAL . 6.6 t70 172.91 -76.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.794 -0.817 . . . . 1.66 108.794 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.2 pt-20 -166.65 -76.8 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.693 -1.14 . . . . 1.91 108.754 170.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.655 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.3 pp -76.8 -6.16 51.16 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.435 -1.711 . . . . 0.72 112.644 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.35 -16.02 3.89 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.317 -1.421 . . . . 0.31 113.692 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.4 ttt180 -56.17 99.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.334 0.567 . . . . 0.75 111.6 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.0 p -93.83 139.89 17.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.159 -0.473 . . . . 1.04 109.955 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.448 HG22 ' HG3' ' A' ' 15' ' ' ARG . 25.6 t -79.99 100.52 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.903 0.383 . . . . 0.25 111.63 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 43' ' ' ILE . 36.8 mm -68.74 131.94 91.02 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.55 110.79 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' B' ' 22' ' ' LEU . 93.5 Cg_exo -48.23 139.03 22.23 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.269 2.646 . . . . 0.28 113.279 173.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.03 -32.17 43.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 0.82 110.851 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' B' ' 2' ' ' LYS . 18.1 pt-20 -72.43 -25.05 61.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.499 . . . . 1.35 110.037 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -81.81 -48.41 11.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 0.33 109.537 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -30.34 71.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.847 -0.797 . . . . 1.48 108.847 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.04 -39.34 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.264 -0.88 . . . . 2.77 111.217 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.71 -38.09 83.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.391 0.615 . . . . 0.31 110.417 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -87.44 -10.71 51.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.24 109.742 -174.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 30.52 75.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.217 -0.901 . . . . 0.34 112.647 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.9 pt -110.75 166.91 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.094 0.474 . . . . 0.47 111.141 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.41 150.71 1.47 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.978 -1.01 . . . . 0.22 110.391 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.921 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.6 pt-20 34.65 -87.3 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.43 1.641 . . . . 1.12 115.43 171.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.41 -11.88 61.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.485 0.55 . . . . 0.65 112.485 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.9 m-20 -78.75 177.13 8.91 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.165 0.507 . . . . 1.37 111.443 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -125.18 155.47 39.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.675 0.75 . . . . 0.22 112.577 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.8 mp -121.99 154.85 36.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.63 -1.168 . . . . 1.23 108.8 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 40.6 mt-10 -102.48 104.3 14.73 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.169 -0.678 . . . . 1.4 109.169 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.989 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -89.83 123.29 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.857 -0.61 . . . . 0.29 110.953 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.655 ' HD1' HG23 ' A' ' 4' ' ' THR . 3.8 t80 -124.3 158.82 31.67 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.115 -0.698 . . . . 4.28 109.115 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.29 137.18 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.811 -0.356 . . . . 0.28 110.495 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' B' ' 42' ' ' LYS . 37.0 t70 -128.76 82.46 2.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 1.12 111.108 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 61.19 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.949 -1.023 . . . . 1.64 112.322 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.44 9.46 15.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.579 -0.737 . . . . 2.81 111.042 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.657 ' HD2' HD11 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -138.41 169.16 18.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.139 -0.482 . . . . 0.98 111.206 -177.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -115.26 139.47 41.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.42 110.625 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.657 HD11 ' HD2' ' B' ' 42' ' ' LYS . 19.6 mm -117.71 116.0 50.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.527 -0.545 . . . . 0.25 109.527 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.989 HD22 HG13 ' B' ' 36' ' ' ILE . 1.0 OUTLIER -115.89 110.41 18.97 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.287 -0.565 . . . . 1.29 109.806 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -95.83 162.06 13.75 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.0 -1.111 . . . . 1.22 108.0 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 56.5 pttt -66.82 148.27 52.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.813 -0.81 . . . . 2.5 108.813 169.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.843 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 76.3 t80 -65.82 125.69 26.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.673 -0.862 . . . . 3.39 108.673 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.844 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -68.4 112.5 11.21 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.722 -0.473 . . . . 3.18 109.722 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.844 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 76.6 Cg_endo -73.35 124.41 9.41 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.695 2.263 . . . . 1.56 112.375 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -89.87 76.95 7.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 3.92 109.474 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -123.1 113.83 19.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.874 -0.603 . . . . 5.19 110.458 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.247 0.927 0 CA-C-N 116.057 -0.52 . . . . 6.34 110.233 -179.838 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 23.4 mmt . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.054 -0.35 . . . . 4.93 110.054 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 1' ' ' MET . 11.2 tptm 69.9 144.6 0.05 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.866 0.729 . . . . 1.67 110.879 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m -72.54 -163.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.506 -0.77 . . . . 0.48 111.066 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.0 m 68.86 56.18 0.43 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.18 -0.918 . . . . 0.48 110.931 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.58 34.32 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.462 -0.79 . . . . 0.32 112.362 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 tp -105.19 136.68 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 120.928 0.394 . . . . 0.49 110.086 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.528 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.2 p -90.67 128.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.946 0.403 . . . . 0.37 110.691 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpt_? -125.96 157.12 38.59 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.171 -0.33 . . . . 1.96 110.497 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.35 158.39 15.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.123 -0.325 . . . . 1.16 110.123 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.3 t -82.93 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.44 109.031 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.4 ' H ' HG12 ' A' ' 10' ' ' VAL . 14.7 t0 -153.96 -62.5 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.443 -0.577 . . . . 1.32 109.443 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.3 pt-20 -157.2 -85.34 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.131 -0.94 . . . . 1.39 109.775 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -74.18 -15.47 61.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.768 -1.105 . . . . 0.6 111.759 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.68 -20.74 0.8 Allowed Glycine 0 C--O 1.222 -0.647 0 C-N-CA 119.853 -1.165 . . . . 0.34 114.063 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 4.3 ttt180 -52.9 106.41 0.16 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.104 0.952 . . . . 1.26 111.976 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -101.84 141.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.82 . . . . 1.04 109.433 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.55 100.08 3.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 0.25 111.452 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.07 133.43 89.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.62 110.582 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 76.7 Cg_exo -46.61 140.67 11.99 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.297 2.664 . . . . 0.31 113.243 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.21 -30.09 48.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.129 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 2' ' ' LYS . 11.8 pt-20 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.142 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.757 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 9.3 mt -82.74 -47.99 11.35 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.883 -0.599 . . . . 0.44 109.657 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -33.94 76.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.432 -0.951 . . . . 1.92 108.432 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -61.37 -42.94 99.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.121 -0.945 . . . . 2.94 111.653 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -33.75 74.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.132 0.491 . . . . 0.34 110.829 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.6 mt -89.55 -9.1 51.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 0.26 109.744 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.7 76.96 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.419 -0.81 . . . . 0.28 112.52 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 26' ' ' LEU . 21.8 pt -113.55 166.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.985 0.422 . . . . 0.43 111.403 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.4 152.01 3.19 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.11 -0.95 . . . . 0.26 109.863 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 4.3 pt-20 31.05 -89.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.901 1.815 . . . . 1.22 115.901 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.9 mmpt? -78.76 6.73 8.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.468 0.914 . . . . 0.85 113.468 -171.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.508 ' O ' HG23 ' B' ' 10' ' ' VAL . 10.9 m-20 -87.39 175.16 8.12 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.071 -0.393 . . . . 1.54 110.494 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.59 154.05 41.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.653 0.739 . . . . 0.23 112.72 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.6 mp -122.94 154.97 37.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.461 -1.245 . . . . 1.15 108.28 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -106.35 104.22 13.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.269 -0.641 . . . . 1.28 109.269 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.55 122.98 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.341 0.591 . . . . 0.29 111.561 -174.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 2.2 m-85 -113.1 171.89 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.821 -1.177 . . . . 4.3 107.821 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.0 p -124.59 142.9 39.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.519 -0.472 . . . . 0.26 110.651 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -133.48 90.96 2.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.285 -0.416 . . . . 1.15 110.115 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 56.88 -96.45 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.606 -0.725 . . . . 1.83 111.393 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -116.02 11.81 15.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.412 -0.813 . . . . 2.54 110.229 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -113.99 156.39 24.16 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.304 -0.407 . . . . 0.87 110.03 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.697 HD13 HD12 ' B' ' 18' ' ' ILE . 46.4 mt -108.36 138.36 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.221 -0.659 . . . . 0.34 109.221 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' B' ' 44' ' ' ILE . 17.4 mm -124.55 107.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.421 -0.585 . . . . 0.2 109.421 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.33 110.99 16.79 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.225 1.012 . . . . 1.3 111.057 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 30.4 ttpt -93.36 165.86 12.57 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.74 -1.573 . . . . 1.41 108.156 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 61.5 pttt -63.75 148.37 49.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.394 -0.595 . . . . 2.68 109.394 169.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -68.19 160.15 29.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.458 -0.571 . . . . 3.55 109.458 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -66.77 112.57 9.94 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.579 -0.282 . . . . 3.38 110.926 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.06 100.79 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.327 2.018 . . . . 1.58 111.971 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -85.01 105.28 15.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 3.85 109.744 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' MET . . . . . 0.425 ' O ' HG23 ' A' ' 53' ' ' THR . 23.1 mmt -102.44 107.38 18.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.721 -0.391 . . . . 5.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.348 1.459 . . . . 6.13 108.626 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' B' ' 2' ' ' LYS . 21.2 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.415 -0.217 . . . . 5.41 110.415 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.502 ' HD2' ' OE2' ' B' ' 21' ' ' GLU . 15.5 tptm 73.61 148.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.945 0.778 . . . . 1.29 110.264 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -72.24 -165.64 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.571 -0.741 . . . . 0.46 111.732 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 9.2 m 69.59 63.94 0.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.61 -1.177 . . . . 0.41 111.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 37.45 4.13 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.269 -0.878 . . . . 0.32 112.196 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -106.2 135.47 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.053 0.454 . . . . 0.52 109.898 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.498 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.3 p -87.74 126.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.923 0.392 . . . . 0.37 111.066 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 2.1 mpt_? -123.3 154.08 39.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.282 -0.261 . . . . 1.74 110.514 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 32' ' ' ASP . 2.0 tpmt? -89.51 159.99 16.95 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.639 -0.504 . . . . 1.23 109.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.0 t -82.85 -117.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.067 -0.345 . . . . 0.39 110.067 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.479 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 35.9 t0 -178.25 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.558 -0.534 . . . . 1.66 109.558 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.7 pt-20 -161.18 -84.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.253 -0.885 . . . . 1.91 110.381 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.515 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -68.52 -33.42 74.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.42 -0.809 . . . . 0.72 111.459 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.74 -9.8 0.08 OUTLIER Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.654 -1.26 . . . . 0.31 113.393 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.0 mtt180 -54.65 104.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.183 0.492 . . . . 0.75 111.967 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.7 p -100.3 141.02 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.341 -0.614 . . . . 1.04 109.341 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 39.3 t -79.6 101.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.968 0.413 . . . . 0.25 111.206 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.697 HD12 HD13 ' A' ' 43' ' ' ILE . 26.1 mm -66.64 136.67 94.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.55 110.175 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.588 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.2 138.42 28.88 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.633 2.222 . . . . 0.28 112.321 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -61.6 -30.6 48.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.004 -0.544 . . . . 0.82 110.143 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' B' ' 2' ' ' LYS . 14.6 pt-20 -70.11 -28.07 65.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 1.35 110.55 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 6.4 mt -80.02 -46.83 15.9 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.38 0.609 . . . . 0.33 109.515 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 32.8 ptt85 -66.49 -33.0 74.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.622 -0.881 . . . . 1.48 108.622 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.446 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 11.8 ttm180 -61.5 -38.61 87.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.684 -0.689 . . . . 2.77 110.781 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 99.2 m -63.42 -35.94 82.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.39 0.614 . . . . 0.31 110.629 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 2.7 mt -88.71 -5.96 57.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.506 -0.77 . . . . 0.24 109.364 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.62 28.64 65.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.028 -0.987 . . . . 0.34 112.47 -174.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.697 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.0 pt -109.9 167.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.593 . . . . 0.47 111.504 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -173.51 151.62 1.98 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.782 -1.099 . . . . 0.22 109.468 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.1 pt-20 36.11 -86.76 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.415 1.635 . . . . 1.12 115.415 171.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -79.86 5.05 14.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.156 0.799 . . . . 0.65 113.156 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.8 m-20 -89.28 173.21 8.52 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.496 -0.482 . . . . 1.37 110.486 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.81 154.38 38.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.335 0.588 . . . . 0.22 112.099 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.6 mp -122.25 153.74 38.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.946 -1.025 . . . . 1.23 108.996 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 21.7 mt-10 -101.74 108.01 19.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.4 -0.593 . . . . 1.4 109.4 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.451 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.9 mp -95.08 122.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.641 0.734 . . . . 0.29 111.546 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 14.5 m-85 -113.07 171.94 7.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.613 -1.255 . . . . 4.28 107.613 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 4' ' ' THR . 10.5 p -128.18 142.96 42.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.161 -0.616 . . . . 0.28 110.68 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -134.0 91.04 2.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.126 -0.488 . . . . 1.12 110.053 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.99 -91.28 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.62 -0.718 . . . . 1.64 111.817 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.2 10.84 8.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.808 -0.633 . . . . 2.81 110.281 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -114.57 154.16 28.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.125 -0.695 . . . . 0.98 109.125 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 45' ' ' LEU . 46.5 mt -107.58 137.84 36.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.996 -0.372 . . . . 0.42 109.996 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 44' ' ' ILE . 17.5 mm -113.52 118.24 57.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.176 -0.675 . . . . 0.25 109.176 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.4 OUTLIER -123.99 107.82 11.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.546 0.689 . . . . 1.29 109.933 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 31.9 ttpt -96.62 163.13 13.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.731 -1.211 . . . . 1.22 107.731 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 24.4 pttm -71.11 150.24 45.67 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.855 -0.795 . . . . 2.5 108.855 171.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.456 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 46.2 t80 -61.03 147.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.629 . . . . 3.39 109.3 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.426 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.4 tppt? -66.79 110.7 5.35 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-O 120.758 0.314 . . . . 3.18 110.572 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.426 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 56.8 Cg_endo -71.66 110.65 2.94 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.722 2.281 . . . . 1.56 112.193 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.89 102.37 13.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.976 -0.556 . . . . 3.92 109.703 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.73 108.57 19.92 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.624 -0.51 . . . . 5.19 109.624 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 42.5 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.268 -0.872 . . . . 6.34 109.26 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.518 0.199 . . . . 4.93 110.71 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.873 ' HG3' ' H ' ' A' ' 3' ' ' SER . 14.3 ptmt -118.04 -81.33 0.62 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.093 -0.243 . . . . 1.67 110.836 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.873 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 72.3 m -155.98 -163.42 1.48 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.48 111.436 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.609 ' H ' ' HA ' ' B' ' 37' ' ' TYR . 5.8 m 62.27 55.55 2.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.091 -0.959 . . . . 0.48 110.776 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.89 35.89 4.69 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.489 -0.778 . . . . 0.32 112.159 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 10.2 tp -93.43 160.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.946 -1.131 . . . . 0.49 107.946 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -124.67 126.65 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.792 -0.447 . . . . 0.37 109.792 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 19' ' ' PRO . 9.7 mtt-85 -137.17 170.73 15.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.758 0.314 . . . . 1.96 110.806 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.9 mmpt? -91.8 162.6 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 1.16 111.273 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG22 HD11 ' B' ' 34' ' ' LEU . 1.4 t -85.08 -133.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 168.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.92 -67.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.698 -0.482 . . . . 1.32 109.698 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 3.0 pt-20 -140.9 -94.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 1.39 111.515 169.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -66.1 -28.22 68.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.397 0.518 . . . . 0.6 112.397 -172.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.51 -5.56 0.05 OUTLIER Glycine 0 C--O 1.222 -0.616 0 C-N-CA 119.782 -1.199 . . . . 0.34 114.158 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.602 ' HG3' HG22 ' B' ' 17' ' ' VAL . 31.9 mtt180 -58.56 104.94 0.25 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.073 0.936 . . . . 1.26 111.708 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 45' ' ' LEU . 7.2 p -96.14 138.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.995 -0.743 . . . . 1.04 108.995 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 15' ' ' ARG . 25.5 t -79.0 100.62 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.263 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.1 mm -67.67 128.71 93.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.62 110.147 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.821 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 87.8 Cg_exo -47.72 141.92 15.07 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.256 2.637 . . . . 0.31 113.17 173.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 10.5 tt -59.28 -34.67 54.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.19 -0.459 . . . . 0.86 110.795 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.45 -27.93 64.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.384 0.611 . . . . 1.73 110.256 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.821 ' HG ' ' HB2' ' A' ' 19' ' ' PRO . 5.0 mt -80.45 -46.93 15.11 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.537 -0.756 . . . . 0.44 109.141 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' ILE . 13.3 ptt180 -65.37 -32.38 73.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.31 -0.996 . . . . 1.92 108.31 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.493 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 2.3 tmt_? -65.05 -35.81 82.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.077 -0.965 . . . . 2.94 110.272 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -64.73 -37.02 86.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.34 110.463 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -89.25 -14.11 36.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.26 109.886 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.4 30.73 77.1 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.262 -0.881 . . . . 0.28 112.387 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 23' ' ' ARG . 14.0 pt -103.98 165.97 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.43 111.229 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.45 146.87 0.49 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.929 -1.032 . . . . 0.26 109.773 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 2.9 pt-20 35.0 -89.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.447 1.647 . . . . 1.22 115.447 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -80.86 5.49 15.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.28 0.845 . . . . 0.85 113.28 -172.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.72 176.75 9.09 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.14 -0.624 . . . . 1.54 110.429 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.19 146.12 48.06 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.111 -0.95 . . . . 0.23 112.213 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.5 mp -121.48 151.54 40.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.088 -0.96 . . . . 1.15 108.793 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 11.2 tt0 -108.31 106.45 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.994 -0.743 . . . . 1.28 108.994 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.1 126.59 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.811 -1.086 . . . . 0.29 112.023 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.618 ' HA ' ' H ' ' B' ' 4' ' ' THR . 8.0 t80 -119.14 159.87 23.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.074 -1.084 . . . . 4.3 108.074 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.95 143.09 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 121.833 -0.542 . . . . 0.26 110.731 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -134.67 82.32 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 1.15 110.653 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 17.0 t70 55.8 -90.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.573 -1.194 . . . . 1.83 112.641 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 10.7 mt-10 -88.86 -23.03 22.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.54 110.349 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.805 ' HE2' HD11 ' A' ' 44' ' ' ILE . 20.1 pttm -119.32 158.12 26.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.463 -0.79 . . . . 0.87 112.236 -167.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.692 HD11 HD11 ' B' ' 26' ' ' LEU . 49.7 mt -110.36 139.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.265 -0.879 . . . . 0.34 109.547 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.805 HD11 ' HE2' ' A' ' 42' ' ' LYS . 13.4 mm -118.26 120.41 64.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.013 -0.54 . . . . 0.2 109.593 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.712 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -130.46 123.94 30.9 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.44 -0.904 . . . . 1.3 111.886 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 41' ' ' GLU . 38.6 ttpt -115.59 170.23 8.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.011 -1.107 . . . . 1.41 108.011 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 28' ' ' ILE . 44.5 tttm -63.81 146.05 54.65 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.496 -0.557 . . . . 2.68 109.496 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 67.0 t80 -60.65 157.06 15.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.563 -0.29 . . . . 3.55 110.764 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -66.85 112.57 10.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.605 . . . . 3.38 111.24 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.77 -54.07 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.806 2.338 . . . . 1.58 111.951 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -101.07 130.91 47.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.898 -0.592 . . . . 3.85 109.745 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.2 ptp -80.25 123.48 27.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.108 0.48 . . . . 5.0 110.438 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.688 -0.687 . . . . 6.13 110.34 -177.155 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.522 ' HG2' HD11 ' B' ' 6' ' ' ILE . 55.2 mtt . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.539 0.209 . . . . 5.41 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.956 ' HG3' ' H ' ' B' ' 3' ' ' SER . 0.0 OUTLIER -108.69 -83.42 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.511 -0.313 . . . . 1.29 111.775 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.956 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 73.4 m -157.74 -167.32 2.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.802 0.441 . . . . 0.46 110.0 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.618 ' H ' ' HA ' ' A' ' 37' ' ' TYR . 25.7 m 62.84 63.26 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.865 0.84 . . . . 0.41 110.783 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.95 38.37 5.77 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.188 -0.915 . . . . 0.32 111.95 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' ILE . . . . . 0.522 HD11 ' HG2' ' B' ' 1' ' ' MET . 11.1 tp -108.91 138.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.52 110.547 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.504 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.8 p -94.64 134.21 32.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.109 0.481 . . . . 0.37 112.028 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 8' ' ' ARG . 0.6 OUTLIER -136.6 174.46 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 1.74 110.178 171.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -98.27 160.29 14.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.211 -0.45 . . . . 1.23 110.363 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -82.36 -133.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.686 -1.598 . . . . 0.39 106.686 166.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 28.2 t70 -177.95 -51.47 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.301 0.572 . . . . 1.66 110.883 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -125.32 -124.85 0.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.354 -0.839 . . . . 1.91 111.408 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -70.45 -8.65 52.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.72 112.377 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.41 -8.86 0.32 Allowed Glycine 0 C--O 1.219 -0.804 0 C-N-CA 119.749 -1.215 . . . . 0.31 112.535 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 39.4 mtt180 -58.96 100.24 0.06 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.918 0.39 . . . . 0.75 111.595 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.9 p -94.33 137.85 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 1.04 109.092 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 15' ' ' ARG . 44.0 t -79.66 101.15 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.246 -0.434 . . . . 0.25 111.535 -172.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.69 132.16 91.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.55 110.512 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.614 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 91.0 Cg_exo -47.88 140.41 18.18 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.155 2.57 . . . . 0.28 113.125 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 8.9 tt -57.91 -35.15 50.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.978 -0.555 . . . . 0.82 110.73 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.05 -23.91 60.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.219 0.533 . . . . 1.35 110.506 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 10.6 mt -82.68 -47.75 11.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 4.4 ppt_? -65.81 -28.21 68.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.433 -0.951 . . . . 1.48 108.433 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -62.48 -47.65 83.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.979 -1.009 . . . . 2.77 111.027 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -57.17 -37.84 72.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.522 0.677 . . . . 0.31 110.874 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.7 mt -85.91 -19.77 30.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.415 -0.811 . . . . 0.24 109.922 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.46 33.07 71.95 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.704 -0.68 . . . . 0.34 112.249 -171.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.2 pt -110.91 166.38 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-O 120.685 0.279 . . . . 0.47 110.84 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.35 150.69 0.58 Allowed 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.29 0.994 . . . . 0.22 110.192 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.15 -89.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.549 1.685 . . . . 1.12 115.549 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.5 mmpt? -82.43 4.98 22.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.978 0.733 . . . . 0.65 112.978 -172.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.63 171.15 15.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 1.37 110.83 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.75 144.72 46.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.366 0.603 . . . . 0.22 111.882 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.479 HD11 HG22 ' A' ' 10' ' ' VAL . 6.4 mp -118.55 149.74 40.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.179 -0.919 . . . . 1.23 108.917 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 7.5 tt0 -104.45 101.44 11.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.544 -0.753 . . . . 1.4 108.99 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.0 mp -90.71 126.39 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.671 0.748 . . . . 0.29 112.016 -175.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.609 ' HA ' ' H ' ' A' ' 4' ' ' THR . 2.1 t80 -118.04 160.42 21.52 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.836 -1.172 . . . . 4.28 107.836 171.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.92 140.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.53 -0.468 . . . . 0.28 110.301 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -136.88 86.84 2.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.123 0.487 . . . . 1.12 110.592 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.17 -97.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.026 -0.988 . . . . 1.64 112.402 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 36.1 mt-10 -102.88 -4.6 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 2.81 110.417 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.472 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 26.0 pttm -124.03 159.09 30.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.361 0.6 . . . . 0.98 112.0 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 45' ' ' LEU . 60.2 mt -111.31 138.98 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.254 -0.885 . . . . 0.42 109.725 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 44' ' ' ILE . 18.7 mm -115.05 121.43 67.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.3 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.05 111.46 14.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.077 0.942 . . . . 1.29 110.937 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 34.1 ttpt -104.75 169.75 8.27 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.826 -1.534 . . . . 1.22 107.806 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' B' ' 46' ' ' LYS . 60.3 tttm -73.85 145.26 45.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.591 -0.522 . . . . 2.5 109.591 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -60.77 146.96 44.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 3.39 110.145 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.565 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.3 tppt? -66.61 112.71 10.17 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 115.828 -0.623 . . . . 3.18 111.56 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.565 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 73.6 Cg_endo -76.71 -48.83 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.455 2.104 . . . . 1.56 112.088 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -94.66 124.75 38.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.513 -0.551 . . . . 3.92 109.513 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.4 ptp -80.86 111.18 17.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.522 0.677 . . . . 5.19 110.942 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.269 -0.872 . . . . 6.34 110.461 177.861 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.884 0.374 . . . . 4.93 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.916 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -93.61 -84.28 0.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 1.67 110.582 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.916 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 75.1 m -143.27 -167.33 2.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.847 -0.798 . . . . 0.48 108.847 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.623 HG23 ' HD1' ' B' ' 37' ' ' TYR . 15.2 m 66.85 69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.48 111.692 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.62 42.07 5.87 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.705 -0.759 . . . . 0.32 111.638 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tp -115.64 141.93 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.49 110.514 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.3 p -88.35 129.59 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.042 -0.526 . . . . 0.37 111.303 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' HD13 ' B' ' 36' ' ' ILE . 3.2 mpt_? -127.26 163.34 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.65 -0.25 . . . . 1.96 110.378 174.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.9 mmpt? -89.54 162.09 15.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.501 -0.318 . . . . 1.16 110.654 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.6 t -86.77 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.757 -0.831 . . . . 0.44 108.757 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HB2' ' HE ' ' B' ' 15' ' ' ARG . 25.4 t70 -159.6 -66.14 0.08 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.699 -0.852 . . . . 1.32 108.699 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.7 pt-20 -153.47 -84.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.02 -0.991 . . . . 1.39 110.254 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.552 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -75.98 -14.92 60.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.89 -1.05 . . . . 0.6 112.492 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 157.46 -11.2 0.25 Allowed Glycine 0 C--O 1.22 -0.778 0 C-N-CA 119.513 -1.327 . . . . 0.34 114.546 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.7 ttt180 -66.13 99.66 0.54 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.54 1.17 . . . . 1.26 112.131 -177.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 20.8 m -95.97 141.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 1.04 110.428 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.29 103.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.379 -0.373 . . . . 0.25 110.777 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.693 HG21 HD13 ' B' ' 43' ' ' ILE . 21.0 mt -85.38 133.89 41.51 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.335 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 43.9 Cg_exo -40.87 138.32 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.094 3.196 . . . . 0.31 114.405 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -58.42 -31.41 42.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.86 110.285 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' OE2' ' HB2' ' A' ' 2' ' ' LYS . 12.3 pt-20 -70.67 -26.76 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 1.73 110.238 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.2 mt -81.11 -47.34 13.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.995 -0.548 . . . . 0.44 109.774 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 1.9 ptt180 -63.28 -35.78 81.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.051 -1.092 . . . . 1.92 108.051 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 3.1 tmt_? -61.94 -37.31 84.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.731 -1.122 . . . . 2.94 110.893 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.58 -34.8 78.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.344 0.592 . . . . 0.34 110.549 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.6 mt -87.89 -9.05 54.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 0.26 109.793 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.89 66.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.275 -0.875 . . . . 0.28 112.269 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.602 HD13 HD11 ' A' ' 34' ' ' LEU . 2.4 pp -112.07 169.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.43 111.257 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 179.67 157.31 0.63 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.441 -0.8 . . . . 0.26 110.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 35.22 -90.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.378 1.621 . . . . 1.22 115.378 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -75.56 -4.5 40.29 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.882 0.697 . . . . 0.85 112.882 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.457 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.2 OUTLIER -85.49 -178.44 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.508 -0.477 . . . . 1.54 111.409 -172.066 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -125.91 152.46 45.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.704 0.764 . . . . 0.23 112.842 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.602 HD11 HD13 ' A' ' 28' ' ' ILE . 7.1 mp -127.94 156.89 41.92 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.477 -1.238 . . . . 1.15 107.855 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -105.83 107.6 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.117 -0.697 . . . . 1.28 109.117 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 45' ' ' LEU . 1.8 mp -92.79 122.85 44.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.639 -0.71 . . . . 0.29 111.217 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.691 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.8 OUTLIER -124.44 159.94 29.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.207 -0.906 . . . . 4.3 108.79 175.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.1 135.66 55.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.754 -0.379 . . . . 0.26 110.524 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.04 96.07 3.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.977 -0.379 . . . . 1.15 109.977 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 64.71 -97.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.13 -0.941 . . . . 1.83 110.783 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.04 10.86 8.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.085 -0.961 . . . . 2.54 109.489 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -111.17 156.52 21.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.382 -0.826 . . . . 0.87 109.586 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.963 ' HB ' HD12 ' B' ' 45' ' ' LEU . 38.0 mt -110.21 133.4 55.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.115 -0.493 . . . . 0.34 109.838 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 44' ' ' ILE . 15.8 mm -117.45 112.71 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.406 -0.59 . . . . 0.2 109.406 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 HG21 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -121.19 108.97 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.266 -0.573 . . . . 1.3 109.505 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -107.05 141.18 38.69 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.012 -1.107 . . . . 1.41 108.012 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 20.9 ptmt -47.8 139.16 7.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.914 0.324 . . . . 2.68 110.375 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.32 135.91 49.31 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.899 -0.778 . . . . 3.55 108.899 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.506 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.78 111.95 9.88 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.539 -0.541 . . . . 3.38 109.539 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 80.6 Cg_endo -72.85 128.52 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.513 2.142 . . . . 1.58 111.486 -176.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -98.99 107.17 19.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.039 0.447 . . . . 3.85 110.154 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.8 ptp -113.89 138.53 50.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.596 . . . . 5.0 110.438 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.176 -0.916 . . . . 6.13 109.474 -179.562 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.951 0.405 . . . . 5.41 110.602 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.899 ' HG3' ' H ' ' B' ' 3' ' ' SER . 10.9 ptmt -71.54 -85.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.786 -0.643 . . . . 1.29 111.765 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.899 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 66.2 m -138.31 -166.08 1.92 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.31 -0.626 . . . . 0.46 109.31 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.691 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.6 m 64.78 67.07 0.56 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.703 0.763 . . . . 0.41 111.466 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.95 38.53 5.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.284 -0.871 . . . . 0.32 111.975 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.16 139.03 28.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.493 -0.558 . . . . 0.52 109.493 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.7 p -90.1 125.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 120.971 0.415 . . . . 0.37 110.81 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 1.2 tpt180 -124.18 160.06 28.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 1.74 110.345 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.2 mmpt? -87.26 163.12 17.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.415 -0.357 . . . . 1.23 110.65 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.2 t -86.42 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.049 -0.352 . . . . 0.39 110.049 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.531 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 26.9 t70 173.11 -68.97 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.969 -0.752 . . . . 1.66 108.969 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.8 pt-20 -166.56 -85.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.751 -1.113 . . . . 1.91 109.872 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.675 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.318 -0.856 . . . . 0.72 112.155 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 18' ' ' ILE . . . 164.35 -3.13 0.06 OUTLIER Glycine 0 C--O 1.224 -0.475 0 C-N-CA 119.617 -1.278 . . . . 0.31 113.442 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 1.7 ttt180 -65.67 97.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.101 0.451 . . . . 0.75 111.764 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 18.5 m -94.12 144.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 1.04 110.32 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 40.8 t -81.84 104.53 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.36 -0.382 . . . . 0.25 110.873 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.726 HG21 HD13 ' A' ' 43' ' ' ILE . 2.3 mt -80.68 138.96 50.6 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.308 -0.256 . . . . 0.55 110.308 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.647 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 59.1 Cg_exo -42.96 135.3 5.33 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.449 2.766 . . . . 0.28 113.809 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.69 -32.22 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.471 -0.786 . . . . 0.82 110.727 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.591 ' OE2' ' HE3' ' B' ' 2' ' ' LYS . 18.4 pt-20 -72.96 -23.46 60.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.132 0.492 . . . . 1.35 110.499 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -81.9 -46.99 13.32 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.161 -0.472 . . . . 0.33 109.769 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 6.9 ptt180 -63.41 -35.47 80.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.174 -1.047 . . . . 1.48 108.174 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.59 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 51.2 ttt180 -56.98 -44.92 83.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.555 -1.202 . . . . 2.77 110.821 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 89.7 m -59.29 -37.31 77.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.615 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.858 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 3.2 mt -86.74 -8.41 57.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 0.24 109.759 -175.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 31.96 81.3 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.311 -0.859 . . . . 0.34 112.133 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.801 HG12 ' HB2' ' B' ' 26' ' ' LEU . 10.9 pt -120.43 169.09 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.47 111.007 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.77 157.46 1.21 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.951 -1.022 . . . . 0.22 110.172 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.858 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pt-20 39.65 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.381 1.623 . . . . 1.12 115.381 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -81.49 6.79 13.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.681 0.622 . . . . 0.65 112.681 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.8 m-20 -86.02 176.67 7.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.373 . . . . 1.37 110.951 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -124.38 152.98 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.656 0.741 . . . . 0.22 112.936 -175.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.4 mp -124.53 157.09 36.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.69 -1.141 . . . . 1.23 109.143 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 46.5 mt-10 -102.9 105.47 15.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.874 -0.603 . . . . 1.4 109.392 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' B' ' 45' ' ' LEU . 1.9 mp -91.89 122.51 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.282 0.563 . . . . 0.29 111.207 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.623 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.4 OUTLIER -124.38 161.04 26.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 4.28 108.961 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.56 136.26 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.845 -0.342 . . . . 0.28 110.605 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -128.23 89.21 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.828 0.347 . . . . 1.12 110.077 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 60.42 -90.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.334 -0.848 . . . . 1.64 111.041 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.51 7.34 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.867 -0.606 . . . . 2.81 110.427 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -104.31 158.23 16.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.648 -0.501 . . . . 0.98 109.648 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.693 HD13 HG21 ' A' ' 18' ' ' ILE . 28.5 mt -109.13 134.49 50.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.059 -0.719 . . . . 0.42 109.059 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -123.23 108.73 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.373 -0.603 . . . . 0.25 109.373 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -120.88 110.96 16.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.177 0.989 . . . . 1.29 111.03 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 30.0 ttpt -90.71 161.33 15.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.747 -1.57 . . . . 1.22 107.843 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 45.9 pttt -64.19 137.99 58.22 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.849 -0.426 . . . . 2.5 109.849 171.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.574 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 88.0 t80 -65.99 131.84 47.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.183 -0.673 . . . . 3.39 109.183 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.51 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -67.93 111.17 6.96 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 3.18 109.539 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.51 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 74.3 Cg_endo -72.88 131.92 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.745 2.297 . . . . 1.56 111.816 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -92.85 115.9 28.54 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.65 -0.5 . . . . 3.92 109.65 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 22.7 ptp -120.71 144.43 48.24 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.857 -0.61 . . . . 5.19 110.238 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.248 0.976 0 N-CA-C 109.686 -0.487 . . . . 6.34 109.686 179.115 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.733 0.302 . . . . 4.93 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.585 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 2.1 tmtt? -80.42 148.38 30.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.53 0.681 . . . . 1.67 112.205 -169.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.447 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 67.4 m -73.39 -162.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.55 -1.204 . . . . 0.48 111.741 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 3.9 m 65.88 65.26 0.53 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.019 -0.991 . . . . 0.48 111.452 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.42 37.2 3.84 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 114.944 -1.026 . . . . 0.32 111.932 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tp -107.29 138.89 31.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.969 -0.382 . . . . 0.49 109.969 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.4 p -89.13 127.78 41.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.898 0.38 . . . . 0.37 111.0 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -123.57 164.8 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 1.96 110.492 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -98.95 158.62 15.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.447 -0.342 . . . . 1.16 110.317 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.4 t -82.58 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.988 -0.745 . . . . 0.44 108.988 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.538 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 20.8 t70 -155.6 -66.01 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.957 -0.757 . . . . 1.32 108.957 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.919 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.4 pt-20 -156.01 -82.82 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.698 -1.137 . . . . 1.39 109.098 168.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -60.16 -38.13 82.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.6 111.62 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -15.19 0.08 OUTLIER Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.572 -1.299 . . . . 0.34 114.552 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.96 104.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.251 1.025 . . . . 1.26 111.637 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.6 p -101.38 141.7 17.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 1.04 109.692 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' B' ' 15' ' ' ARG . 45.1 t -78.84 108.65 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.39 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.1 mm -74.26 132.94 78.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 0.62 110.89 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 22' ' ' LEU . 77.8 Cg_exo -46.93 140.83 12.8 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.403 2.735 . . . . 0.31 113.298 173.392 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.961 HD12 ' HD2' ' A' ' 23' ' ' ARG . 4.2 tp -60.49 -32.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.606 -0.724 . . . . 0.86 110.132 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 2' ' ' LYS . 6.6 pt-20 -70.67 -26.29 63.37 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.128 0.489 . . . . 1.73 109.934 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 12.3 mt -82.1 -47.96 11.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.321 -0.622 . . . . 0.44 109.321 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.961 ' HD2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -64.31 -32.12 73.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.606 -0.887 . . . . 1.92 108.606 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -63.74 -42.7 97.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.314 -0.857 . . . . 2.94 111.397 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.3 m -61.41 -35.28 77.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.383 0.611 . . . . 0.34 110.75 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -91.09 -10.53 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.452 -0.795 . . . . 0.26 109.446 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.2 34.7 81.12 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.449 -0.796 . . . . 0.28 112.22 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 26' ' ' LEU . 13.9 pt -106.86 163.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.372 0.606 . . . . 0.43 111.665 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.97 148.96 1.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.462 -1.245 . . . . 0.26 109.373 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.9 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 2.5 pt-20 33.07 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.62 1.711 . . . . 1.22 115.62 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -76.04 4.9 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.509 0.929 . . . . 0.85 113.509 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' O ' HG23 ' B' ' 10' ' ' VAL . 22.2 m-20 -85.78 171.47 11.54 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.578 -0.449 . . . . 1.54 110.112 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.03 153.26 41.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.527 0.68 . . . . 0.23 112.16 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.4 mp -123.09 153.38 40.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.813 -1.085 . . . . 1.15 108.22 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.6 106.16 16.38 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.717 -0.846 . . . . 1.28 108.717 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.803 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -89.8 124.42 42.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.292 -0.867 . . . . 0.29 111.365 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.7 m-85 -115.06 172.8 6.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.471 -1.307 . . . . 4.3 107.471 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.55 141.19 46.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 120.693 -0.403 . . . . 0.26 110.173 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -129.32 76.84 1.75 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.491 . . . . 1.15 110.19 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 54.03 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.254 -1.339 . . . . 1.83 113.001 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -105.03 -13.43 15.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.978 -0.556 . . . . 2.54 110.777 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -115.25 158.73 21.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.932 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.72 HD11 HD11 ' B' ' 26' ' ' LEU . 59.0 mt -104.37 137.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.842 -0.799 . . . . 0.34 108.842 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' B' ' 44' ' ' ILE . 15.9 mm -123.88 105.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.614 -0.513 . . . . 0.2 109.614 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.876 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.4 OUTLIER -119.62 118.71 31.69 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.316 -0.953 . . . . 1.3 111.185 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.88 165.13 11.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.97 -1.468 . . . . 1.41 107.882 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 81.8 tttt -65.22 137.02 57.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.064 -0.717 . . . . 2.68 109.064 171.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.32 154.36 20.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.371 -0.603 . . . . 3.55 109.371 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -66.94 115.74 28.27 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 3.38 110.652 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.66 -29.13 9.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.899 2.399 . . . . 1.58 113.049 -169.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -69.43 134.72 49.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.267 0.556 . . . . 3.85 110.277 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -94.11 146.89 23.65 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.856 -0.611 . . . . 5.0 109.812 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.247 0.956 0 CA-C-N 116.185 -0.462 . . . . 6.13 110.047 179.791 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.642 0.258 . . . . 5.41 111.512 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.429 ' HE2' ' OE2' ' B' ' 21' ' ' GLU . 0.4 OUTLIER -81.84 142.89 32.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.485 0.66 . . . . 1.29 111.764 -168.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 52.6 m -70.79 -162.53 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.488 -1.233 . . . . 0.46 112.002 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 3.9 m 69.33 59.37 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.703 -1.135 . . . . 0.41 111.337 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.76 35.89 3.14 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.32 112.282 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -109.52 136.92 43.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.975 0.417 . . . . 0.52 110.761 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.3 p -88.94 125.37 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.982 0.42 . . . . 0.37 111.688 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.94 165.93 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.509 -0.314 . . . . 1.74 110.321 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -96.04 162.54 13.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.974 -0.38 . . . . 1.23 109.974 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.7 t -82.34 -108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.798 -0.361 . . . . 0.39 110.293 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.56 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 7.0 t70 175.17 -77.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.107 -0.701 . . . . 1.66 109.107 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.9 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -159.27 -71.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.045 -0.979 . . . . 1.91 108.832 168.541 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.669 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.4 pt? -77.74 -29.07 50.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.58 -1.191 . . . . 0.72 111.271 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.46 -11.86 0.18 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 119.206 -1.473 . . . . 0.31 114.011 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.9 ttt180 -56.61 99.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.628 0.714 . . . . 0.75 111.741 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.6 p -95.01 141.83 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.777 -0.453 . . . . 1.04 109.777 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.38 109.44 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.406 . . . . 0.25 111.071 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.5 HD12 HD13 ' A' ' 43' ' ' ILE . 30.8 mm -75.34 134.48 73.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.155 -0.475 . . . . 0.55 110.701 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.64 ' HD2' HD12 ' B' ' 22' ' ' LEU . 92.9 Cg_exo -48.46 141.12 20.08 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.087 2.525 . . . . 0.28 113.044 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.566 HD12 ' HD2' ' B' ' 23' ' ' ARG . 6.5 tp -59.93 -32.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.937 -0.574 . . . . 0.82 110.222 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.429 ' OE2' ' HE2' ' B' ' 2' ' ' LYS . 8.9 pt-20 -73.47 -23.62 60.1 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.172 0.51 . . . . 1.35 110.328 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.8 mt -81.36 -48.19 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.417 -0.586 . . . . 0.33 109.417 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.566 ' HD2' HD12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -64.15 -33.48 75.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 1.48 108.154 177.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.45 -47.11 85.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.191 -0.913 . . . . 2.77 111.289 171.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -60.77 -35.14 75.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.358 0.599 . . . . 0.31 111.045 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 2.5 mt -90.36 -10.9 42.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 0.24 109.785 -176.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 24.72 64.66 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.34 112.298 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.3 pt -96.98 166.53 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-O 121.293 0.568 . . . . 0.47 111.048 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.87 152.69 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.548 -1.206 . . . . 0.22 109.111 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.919 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.5 pt-20 33.78 -90.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.778 1.77 . . . . 1.12 115.778 169.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.465 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.0 mmpt? -83.98 7.19 19.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.01 0.744 . . . . 0.65 113.01 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.4 m-20 -84.48 174.54 9.96 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.129 -0.357 . . . . 1.37 110.57 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.7 152.97 40.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.481 0.658 . . . . 0.22 112.453 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.5 mp -120.92 151.88 39.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.935 -1.03 . . . . 1.23 108.979 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -104.18 102.35 12.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.652 -0.869 . . . . 1.4 108.652 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.8 mp -90.07 124.88 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.391 0.615 . . . . 0.29 111.68 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 7.3 m-85 -114.16 175.13 5.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.012 -1.107 . . . . 4.28 108.012 171.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.25 143.11 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 110.008 -0.367 . . . . 0.28 110.008 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -132.94 77.13 1.72 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.827 0.346 . . . . 1.12 110.628 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 t70 56.14 -75.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.565 -1.198 . . . . 1.64 113.05 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -103.17 -25.44 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 2.81 110.81 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' B' ' 42' ' ' LYS . 1.0 OUTLIER -111.62 160.06 17.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.857 -0.611 . . . . 0.98 111.127 -173.633 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.876 ' HB ' HD12 ' A' ' 45' ' ' LEU . 68.0 mt -105.58 138.16 32.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.459 -0.792 . . . . 0.42 109.351 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' A' ' 44' ' ' ILE . 16.9 mm -114.64 112.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.491 -0.559 . . . . 0.25 109.491 -175.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.499 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.92 108.97 15.43 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.938 -0.705 . . . . 1.29 110.247 -178.027 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 35.4 ttpt -96.23 164.96 12.44 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 82.9 tttt -70.48 139.06 51.6 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.769 -0.826 . . . . 2.5 108.769 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.26 147.47 44.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.823 -0.806 . . . . 3.39 108.823 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -67.5 114.84 21.45 Favored Pre-proline 0 CA--C 1.512 -0.508 0 CA-C-O 121.366 0.603 . . . . 3.18 110.664 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.31 -27.95 9.1 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.936 2.424 . . . . 1.56 113.288 -168.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -70.75 122.11 19.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.719 0.295 . . . . 3.92 110.217 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -91.92 110.43 21.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.498 0.666 . . . . 5.19 111.349 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.468 -0.787 . . . . 6.34 109.367 172.215 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 110.244 -0.28 . . . . 4.93 110.244 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 31.8 tptt -105.36 154.51 20.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.962 0.41 . . . . 1.67 110.732 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -85.73 -167.56 1.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.498 -0.774 . . . . 0.48 111.539 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HD1' ' B' ' 37' ' ' TYR . 49.2 m 72.15 72.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.999 -1.0 . . . . 0.48 112.574 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 40.02 7.13 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.405 -0.816 . . . . 0.32 111.756 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 tp -111.47 139.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.052 0.453 . . . . 0.49 110.1 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 10.9 p -94.04 132.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.306 -0.406 . . . . 0.37 111.205 -174.021 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.14 164.85 26.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.251 -0.431 . . . . 1.96 110.498 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 0.8 OUTLIER -83.69 161.12 21.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.923 -0.58 . . . . 1.16 109.611 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.8 t -79.35 -102.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 110.022 -0.362 . . . . 0.44 110.022 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 17.2 t0 174.48 -73.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.875 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.3 pt-20 -164.78 -80.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.398 -1.274 . . . . 1.39 109.43 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.69 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.7 pt? -65.81 -31.48 72.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.053 -0.976 . . . . 0.6 112.032 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.62 -19.81 0.38 Allowed Glycine 0 C--O 1.221 -0.719 0 C-N-CA 119.783 -1.198 . . . . 0.34 113.816 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.3 ttt180 -49.49 105.8 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.386 0.593 . . . . 1.26 112.385 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -97.39 141.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.175 -0.466 . . . . 1.04 109.941 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.19 110.92 14.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.25 111.8 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.542 HD12 HG21 ' B' ' 43' ' ' ILE . 40.7 mm -80.95 134.49 52.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.62 110.597 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 22' ' ' LEU . 80.4 Cg_exo -49.99 141.11 30.33 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.275 2.65 . . . . 0.31 113.533 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.59 -33.3 54.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.651 -0.704 . . . . 0.86 110.689 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.89 -23.54 62.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.155 0.503 . . . . 1.73 109.747 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.7 mt -82.22 -49.51 10.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.44 109.875 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -65.29 -31.31 72.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.73 -0.841 . . . . 1.92 108.73 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -39.54 94.66 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.525 -0.761 . . . . 2.94 110.895 173.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -62.59 -33.28 74.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.34 110.254 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.9 mt -88.43 -11.25 46.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.422 -0.808 . . . . 0.26 109.573 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.03 24.39 66.92 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.252 -0.886 . . . . 0.28 112.401 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.82 HG12 ' HB2' ' A' ' 26' ' ' LEU . 18.5 pt -107.71 166.55 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.43 111.467 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.38 146.39 0.63 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.812 -1.085 . . . . 0.26 109.807 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.993 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 37.5 -85.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 115.33 1.604 . . . . 1.22 115.33 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 30' ' ' GLU . 11.0 mmpt? -71.51 -1.42 13.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.91 0.707 . . . . 0.85 112.91 -173.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' HG23 ' B' ' 10' ' ' VAL . 9.2 m-20 -86.59 175.98 8.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.99 0.424 . . . . 1.54 111.428 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -122.8 152.33 40.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.626 -0.715 . . . . 0.23 112.59 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.8 mp -124.69 156.95 36.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.344 -1.354 . . . . 1.15 107.344 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 26.4 tt0 -108.03 107.96 18.87 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.204 -0.665 . . . . 1.28 109.204 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 45' ' ' LEU . 2.0 mp -92.8 123.21 44.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.618 -0.719 . . . . 0.29 111.282 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.659 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.05 162.56 25.75 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.201 -0.909 . . . . 4.3 109.092 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.42 139.89 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.989 0.423 . . . . 0.26 110.611 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.06 80.17 1.96 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.233 0.539 . . . . 1.15 110.243 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.94 -77.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.353 -1.294 . . . . 1.83 111.459 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.28 -31.47 6.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 2.54 110.639 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.729 ' HE2' HD11 ' A' ' 44' ' ' ILE . 25.2 pttm -96.8 156.34 16.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.196 -0.601 . . . . 0.87 111.46 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HD11 ' B' ' 26' ' ' LEU . 13.8 mt -107.06 137.67 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.462 -0.79 . . . . 0.34 109.575 -176.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' B' ' 44' ' ' ILE . 15.1 mm -124.24 109.62 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.2 110.112 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -117.77 113.84 22.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.897 -0.721 . . . . 1.3 109.51 176.64 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 35' ' ' GLU . 12.7 ptpt -91.98 162.57 14.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.647 -1.242 . . . . 1.41 107.647 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 51.4 pttt -65.97 148.01 52.46 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.82 -0.807 . . . . 2.68 108.82 168.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.82 126.72 28.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.712 -1.218 . . . . 3.55 107.712 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -66.93 119.61 65.33 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.674 -0.491 . . . . 3.38 109.674 -171.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.5 107.02 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.726 2.284 . . . . 1.58 112.36 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -109.34 96.94 6.63 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.564 -0.744 . . . . 3.85 109.55 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 ptm -104.21 145.7 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 5.0 110.082 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.564 -0.731 . . . . 6.13 110.783 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.459 0.171 . . . . 5.41 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -76.41 150.64 36.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.394 0.616 . . . . 1.29 112.096 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m -81.4 -164.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.825 -1.079 . . . . 0.46 110.973 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.538 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.8 m 74.16 71.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.269 -0.878 . . . . 0.41 111.98 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.73 39.13 7.22 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.199 -0.91 . . . . 0.32 111.812 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.67 138.71 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.164 0.506 . . . . 0.52 110.029 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.546 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.4 p -93.37 129.34 43.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.114 -0.494 . . . . 0.37 111.244 -173.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 1.5 mpt_? -131.03 163.54 27.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 1.74 110.574 176.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -82.67 161.22 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.364 -0.606 . . . . 1.23 109.364 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.8 t -78.99 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.806 -0.357 . . . . 0.39 110.251 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.664 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 17.4 t70 175.42 -77.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.173 -0.677 . . . . 1.66 109.173 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.993 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -160.57 -73.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.965 -1.016 . . . . 1.91 108.626 172.559 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.472 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.5 pt? -80.12 -23.1 41.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.394 -1.275 . . . . 0.72 111.534 -174.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.9 -18.95 0.66 Allowed Glycine 0 C--O 1.221 -0.665 0 C-N-CA 119.557 -1.306 . . . . 0.31 113.553 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.4 ttt180 -50.12 105.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.312 0.486 . . . . 0.75 112.312 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 11.5 p -97.94 142.98 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 1.04 109.906 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.47 111.46 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.025 0.44 . . . . 0.25 111.889 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.646 HD12 HD13 ' A' ' 43' ' ' ILE . 25.1 mm -78.34 132.51 65.93 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.642 -0.708 . . . . 0.55 110.777 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.617 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 88.8 Cg_exo -48.73 140.27 22.95 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.233 2.622 . . . . 0.28 113.291 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.11 -33.01 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.82 110.961 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.83 -25.49 62.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.932 0.396 . . . . 1.35 110.264 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -80.54 -48.79 12.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.808 -0.633 . . . . 0.33 109.608 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -65.44 -33.22 75.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.381 -0.97 . . . . 1.48 108.381 178.593 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.503 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 5.7 tmm_? -59.57 -42.4 92.36 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.261 -0.881 . . . . 2.77 109.844 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 80.3 m -60.96 -38.15 84.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.677 0.751 . . . . 0.31 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.843 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 4.9 mt -85.72 -11.26 54.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.994 -1.003 . . . . 0.24 109.789 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.86 86.71 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.294 -0.866 . . . . 0.34 111.782 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.549 HG13 ' HB2' ' B' ' 26' ' ' LEU . 2.7 pp -122.15 167.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.47 111.345 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -174.13 154.93 2.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.164 -0.926 . . . . 0.22 109.432 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.4 pt-20 36.2 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.419 1.637 . . . . 1.12 115.419 170.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.447 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.8 mmpt? -79.45 6.91 9.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 0.65 112.822 -173.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.9 176.73 6.32 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 122.223 -0.298 . . . . 1.37 110.94 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -123.01 153.33 39.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.168 0.803 . . . . 0.22 113.168 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -124.71 155.94 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.377 -1.283 . . . . 1.23 107.557 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -108.16 107.37 17.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 1.4 109.768 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.3 124.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.259 -0.882 . . . . 0.29 111.432 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.595 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.7 OUTLIER -127.0 164.49 21.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.195 -0.911 . . . . 4.28 108.827 176.028 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.38 139.91 48.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.988 -0.285 . . . . 0.28 110.874 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.73 89.37 2.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.642 -0.423 . . . . 1.12 110.333 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 t70 63.88 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.001 -1.0 . . . . 1.64 111.396 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.14 4.77 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.274 -0.876 . . . . 2.81 110.604 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -103.79 155.13 18.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 26' ' ' LEU . 13.0 mt -109.6 134.13 52.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.454 -0.573 . . . . 0.42 109.454 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 44' ' ' ILE . 11.7 mm -125.65 106.13 15.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.322 -0.399 . . . . 0.25 110.382 -172.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.08 116.04 24.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.758 -0.777 . . . . 1.29 110.067 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.42 163.47 13.4 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 62.1 pttt -63.18 151.32 40.62 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.179 -0.674 . . . . 2.5 109.179 169.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -60.83 132.03 52.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.131 -1.062 . . . . 3.39 108.131 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.472 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.3 tppt? -65.48 118.65 52.75 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 109.897 -0.409 . . . . 3.18 109.897 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 22.8 Cg_endo -61.74 106.48 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.486 2.124 . . . . 1.56 112.094 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -98.25 104.71 16.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.403 -0.817 . . . . 3.92 109.044 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.8 ptm -115.33 117.5 30.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.211 -0.449 . . . . 5.19 110.465 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.456 -0.783 . . . . 6.34 110.215 177.366 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 121.337 0.589 . . . . 4.93 110.68 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.29 -158.68 0.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.49 -0.777 . . . . 1.67 110.209 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.8 m -66.2 -175.41 0.33 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.797 0.808 . . . . 0.48 112.854 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.594 HG23 ' HD1' ' B' ' 37' ' ' TYR . 17.8 m 72.11 67.74 0.14 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.28 -1.327 . . . . 0.48 111.409 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.88 43.85 4.97 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.349 -0.841 . . . . 0.32 111.438 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -108.15 137.63 38.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.587 -0.445 . . . . 0.49 109.968 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.544 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 9.8 p -98.67 124.23 51.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.907 0.384 . . . . 0.37 110.652 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 0.5 OUTLIER -128.7 163.84 24.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.497 -0.32 . . . . 1.96 111.297 -178.39 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.86 162.98 23.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 1.16 110.645 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.3 t -86.75 -109.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.272 -0.422 . . . . 0.44 109.975 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 16.7 t0 179.11 -67.3 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.044 -0.725 . . . . 1.32 109.044 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.1 pt-20 -168.15 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.92 -1.036 . . . . 1.39 110.255 175.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.3 pt? -80.52 -0.64 38.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.555 -1.202 . . . . 0.6 112.326 -171.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 144.35 -22.75 2.05 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 119.744 -1.217 . . . . 0.34 113.967 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.6 ttt180 -58.12 106.82 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.436 0.618 . . . . 1.26 112.466 -174.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.4 p -98.3 140.07 18.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.753 -0.462 . . . . 1.04 109.753 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' HG3' ' B' ' 15' ' ' ARG . 40.7 t -79.8 101.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.8 0.333 . . . . 0.25 110.867 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.682 HD13 HD13 ' B' ' 43' ' ' ILE . 10.4 mt -81.04 135.1 51.67 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.62 110.264 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 54.4 Cg_exo -42.85 136.0 4.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.494 2.796 . . . . 0.31 113.663 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.06 -29.3 41.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.612 -0.722 . . . . 0.86 109.98 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -68.87 -27.38 65.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.047 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.721 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.3 mt -82.91 -47.01 12.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.44 109.675 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -65.69 -30.65 71.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.604 -0.888 . . . . 1.92 108.604 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -62.44 -42.18 99.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 2.94 110.846 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.9 m -60.81 -35.64 77.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.244 0.545 . . . . 0.34 111.039 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.852 HD11 HD11 ' B' ' 43' ' ' ILE . 1.3 mt -90.3 -9.71 46.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.818 -0.628 . . . . 0.26 109.719 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.26 34.91 86.6 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.241 -0.89 . . . . 0.28 112.099 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.563 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.6 pt -115.41 165.96 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.104 0.478 . . . . 0.43 111.096 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.1 154.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 0.26 109.593 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 4.6 pt-20 37.83 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.356 1.613 . . . . 1.22 115.356 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.56 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.8 mmpt? -76.15 -1.61 27.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.818 0.673 . . . . 0.85 112.818 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' HG23 ' B' ' 10' ' ' VAL . 37.2 m-20 -85.87 174.05 9.56 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.672 -0.411 . . . . 1.54 110.307 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.18 153.38 40.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.746 0.784 . . . . 0.23 113.061 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 47' ' ' LYS . 18.5 mt -124.47 153.34 42.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.398 -1.274 . . . . 1.15 107.598 173.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -106.82 105.39 15.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.324 -0.621 . . . . 1.28 109.324 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.89 HG13 HD22 ' A' ' 45' ' ' LEU . 1.8 mp -90.37 123.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.473 -0.785 . . . . 0.29 111.06 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.2 OUTLIER -124.92 158.85 32.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.716 -0.846 . . . . 4.3 108.716 175.545 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.7 p -112.56 139.48 37.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.68 -0.408 . . . . 0.26 110.795 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -135.48 82.15 1.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.381 -0.372 . . . . 1.15 110.109 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.17 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.357 -0.838 . . . . 1.83 111.511 -175.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -121.28 -15.35 8.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 2.54 110.038 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -85.21 144.45 28.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.642 . . . . 0.87 110.344 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.932 HD11 HD11 ' B' ' 26' ' ' LEU . 18.4 mt -106.05 131.58 55.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.431 -0.804 . . . . 0.34 108.929 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 44' ' ' ILE . 17.9 mm -119.32 112.25 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.389 -0.369 . . . . 0.2 110.054 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -117.03 108.74 16.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.483 -0.562 . . . . 1.3 109.483 -178.039 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HB2' ' HG2' ' B' ' 42' ' ' LYS . 31.9 ttpt -103.18 134.89 45.84 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.813 -0.81 . . . . 1.41 108.813 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HA ' HD23 ' A' ' 34' ' ' LEU . 60.3 pttt -47.51 144.85 2.84 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 123.064 0.227 . . . . 2.68 110.623 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -60.4 144.69 50.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 110.108 -0.33 . . . . 3.55 110.108 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.788 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.88 114.69 24.64 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 109.575 -0.528 . . . . 3.38 109.575 -179.042 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.788 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 58.0 Cg_endo -69.5 110.03 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.581 2.187 . . . . 1.58 111.17 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 18.5 p-10 -81.8 151.72 27.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.092 -0.504 . . . . 3.85 110.816 -178.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 145.8 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.133 0.492 . . . . 5.0 110.983 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.389 -0.815 . . . . 6.13 110.423 178.52 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.682 ' HG2' ' H ' ' B' ' 2' ' ' LYS . 12.9 ttt . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.474 -0.565 . . . . 5.41 109.474 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.757 ' HD3' ' H ' ' B' ' 3' ' ' SER . 0.0 OUTLIER -89.36 -95.42 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.941 1.089 . . . . 1.29 113.941 -170.092 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.757 ' H ' ' HD3' ' B' ' 2' ' ' LYS . 69.1 m -130.44 -174.29 3.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.46 111.162 -173.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.71 HG23 ' HD1' ' A' ' 37' ' ' TYR . 27.9 m 65.73 69.3 0.46 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.403 -0.817 . . . . 0.41 111.005 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.75 41.54 4.38 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.021 -0.99 . . . . 0.32 111.721 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tp -105.44 137.21 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.664 -0.495 . . . . 0.52 109.664 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.503 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 12.5 p -96.99 128.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.967 0.413 . . . . 0.37 110.356 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.45 156.59 48.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.29 -0.414 . . . . 1.74 110.638 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.8 mmpt? -82.0 161.01 23.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 1.23 110.624 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 1.7 t -84.3 -118.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.029 0.443 . . . . 0.39 110.146 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 17.3 t0 -171.91 -63.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.194 -0.669 . . . . 1.66 109.194 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.735 ' HG3' ' H ' ' B' ' 13' ' ' LEU . 4.2 pt-20 -169.59 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.909 . . . . 1.91 110.41 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.735 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -61.01 -29.64 69.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.405 -0.816 . . . . 0.72 112.564 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.88 -9.78 0.31 Allowed Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.992 -1.099 . . . . 0.31 112.974 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.1 mtt180 -60.78 106.0 0.52 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.02 0.378 . . . . 0.75 112.02 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 9.7 p -100.99 142.1 16.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.146 -0.479 . . . . 1.04 109.734 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.65 108.98 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.601 -0.272 . . . . 0.25 111.162 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 43' ' ' ILE . 3.4 mt -85.17 138.31 36.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.092 -0.336 . . . . 0.55 110.092 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.677 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 62.2 Cg_exo -43.16 136.6 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.395 2.73 . . . . 0.28 113.89 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -56.03 -33.42 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.82 110.813 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.73 -22.75 59.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.394 -0.366 . . . . 1.35 110.38 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -82.04 -47.17 12.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.33 -0.619 . . . . 0.33 109.33 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -64.98 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.723 -0.843 . . . . 1.48 108.723 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.7 -36.65 81.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.737 -1.119 . . . . 2.77 110.635 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 25' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 76.7 m -63.45 -36.03 82.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.529 0.68 . . . . 0.31 110.526 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.932 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -89.7 -10.61 45.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.338 -0.846 . . . . 0.24 109.777 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.22 15.77 68.12 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.34 112.698 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' B' ' 26' ' ' LEU . 15.5 pt -98.15 168.81 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.818 0.342 . . . . 0.47 111.247 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.44 146.66 0.28 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.309 -0.86 . . . . 0.22 109.835 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.3 pt-20 37.47 -89.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.299 1.592 . . . . 1.12 115.299 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HB2' ' B' ' 30' ' ' GLU . 10.8 mmpt? -75.23 4.91 6.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.515 0.561 . . . . 0.65 112.515 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -97.25 -177.99 4.02 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.086 -0.646 . . . . 1.37 110.896 -175.298 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -126.47 153.61 44.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.235 1.198 . . . . 0.22 114.235 -171.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' B' ' 47' ' ' LYS . 19.5 mt -127.02 153.68 45.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.186 -1.37 . . . . 1.23 108.024 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -106.41 104.76 14.53 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.204 -0.665 . . . . 1.4 109.204 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.631 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.94 124.5 45.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.52 0.676 . . . . 0.29 111.748 -175.168 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -126.46 162.95 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.079 -0.964 . . . . 4.28 108.658 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.27 140.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.019 0.437 . . . . 0.28 111.338 -171.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.31 78.87 1.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.588 . . . . 1.12 109.59 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.71 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.504 -1.225 . . . . 1.64 111.216 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -128.71 -13.62 4.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 2.81 110.391 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 24.0 mtpt -85.27 143.87 28.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.504 . . . . 0.98 109.748 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 26' ' ' LEU . 26.5 mt -104.25 132.5 50.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.927 -0.768 . . . . 0.42 108.927 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 44' ' ' ILE . 15.5 mm -120.53 108.89 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.1 -0.333 . . . . 0.25 110.1 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.631 ' HB3' HG13 ' B' ' 36' ' ' ILE . 0.1 OUTLIER -118.81 108.79 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.352 0.596 . . . . 1.29 110.629 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 28.7 ttpt -90.34 156.06 18.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.776 -1.194 . . . . 1.22 107.776 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' B' ' 34' ' ' LEU . 24.1 pttm -63.53 159.67 18.15 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.023 -0.671 . . . . 2.5 109.338 173.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -59.64 149.4 30.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.379 -0.373 . . . . 3.39 110.026 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.723 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -68.93 116.08 37.89 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.988 -0.745 . . . . 3.18 108.988 173.692 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.723 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 60.5 Cg_endo -71.01 109.74 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 1.56 111.278 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.86 152.16 31.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.876 -0.602 . . . . 3.92 110.528 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.36 149.19 50.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 5.19 110.402 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.217 -0.897 . . . . 6.34 110.957 -179.098 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.349 -0.241 . . . . 4.93 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 3' ' ' SER . 6.1 tmtt? -139.24 156.88 46.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 1.67 109.859 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 44.0 m -72.79 -167.65 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.461 0.648 . . . . 0.48 112.102 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.7 m 71.73 60.58 0.15 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.749 -1.114 . . . . 0.48 111.382 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.09 36.29 3.2 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.439 -0.8 . . . . 0.32 112.131 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tp -105.15 134.92 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.905 0.383 . . . . 0.49 110.128 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 13.1 p -93.41 129.51 43.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.112 0.482 . . . . 0.37 111.36 -176.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -129.81 165.82 21.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.96 110.814 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' B' ' 32' ' ' ASP . 7.5 tppt? -87.84 159.79 18.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.629 -0.714 . . . . 1.16 109.825 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.0 t -82.05 -118.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.716 -0.846 . . . . 0.44 108.716 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 20.3 t0 -174.79 -69.3 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.647 -0.501 . . . . 1.32 109.647 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.897 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.2 OUTLIER -154.98 -78.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.393 -0.821 . . . . 1.39 110.349 174.325 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.6 pt? -81.85 0.02 41.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.827 -1.079 . . . . 0.6 112.511 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.81 -21.05 3.59 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 120.076 -1.059 . . . . 0.34 113.143 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.1 mtt180 -53.49 106.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.066 0.433 . . . . 1.26 111.961 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 12.1 p -102.3 142.83 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.283 -0.417 . . . . 1.04 110.063 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' B' ' 15' ' ' ARG . 51.9 t -76.87 102.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.415 . . . . 0.25 111.939 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -70.67 132.36 87.26 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.62 110.414 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 99.3 Cg_exo -47.76 141.92 15.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.019 2.479 . . . . 0.31 113.016 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.35 -32.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.681 . . . . 0.86 110.117 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.53 -24.45 61.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.02 0.438 . . . . 1.73 110.146 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.6 mt -83.12 -48.69 10.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.504 -0.554 . . . . 0.44 109.504 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 22.6 ptt85 -64.5 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.408 -0.96 . . . . 1.92 108.408 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.5 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 14.4 ttt180 -58.88 -43.62 90.94 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.14 -0.936 . . . . 2.94 110.75 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -61.05 -32.76 72.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.34 110.31 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 2.5 mt -92.98 -9.53 39.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.003 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 28.01 69.61 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.28 112.635 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.713 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.2 pt -107.0 167.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.117 0.484 . . . . 0.43 111.626 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.54 150.89 1.44 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.1 -0.955 . . . . 0.26 110.2 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.856 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.2 pt-20 35.12 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.723 1.749 . . . . 1.22 115.723 173.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -80.01 5.63 13.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.022 0.749 . . . . 0.85 113.022 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.7 OUTLIER -81.73 177.81 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.866 0.365 . . . . 1.54 111.422 -177.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.36 151.33 42.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.993 -0.549 . . . . 0.23 112.151 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.7 mp -126.63 157.28 39.34 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.433 -0.951 . . . . 1.15 108.433 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -111.37 105.86 14.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.295 -0.632 . . . . 1.28 109.295 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.717 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -90.09 125.14 42.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.201 -0.909 . . . . 0.29 111.484 -176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.9 m-85 -114.55 173.97 6.19 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.459 -1.311 . . . . 4.3 107.459 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.85 142.2 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.563 -0.455 . . . . 0.26 110.294 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.85 77.23 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.885 -0.326 . . . . 1.15 110.435 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t70 57.79 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.619 1.199 . . . . 1.83 112.655 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' OE2' ' HG3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -117.19 7.16 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.52 -0.309 . . . . 2.54 111.351 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' B' ' 46' ' ' LYS . 35.6 mtmm -127.04 162.87 25.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.138 0.494 . . . . 0.87 111.41 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.653 HD13 HD12 ' B' ' 18' ' ' ILE . 54.0 mt -106.68 138.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.428 -0.805 . . . . 0.34 109.294 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' B' ' 44' ' ' ILE . 16.8 mm -125.78 106.13 15.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 109.705 -0.48 . . . . 0.2 109.705 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.5 OUTLIER -123.04 128.09 49.68 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.293 -0.963 . . . . 1.3 111.474 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' B' ' 42' ' ' LYS . 38.1 ttpt -121.96 145.94 47.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.999 -1.001 . . . . 1.41 108.328 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 60.2 pttt -48.41 143.04 5.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.114 0.259 . . . . 2.68 110.847 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -60.44 140.4 57.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.865 -0.791 . . . . 3.55 108.865 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.729 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.2 tppt? -65.88 121.06 73.9 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.206 -0.452 . . . . 3.38 110.546 -174.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 37.7 Cg_endo -66.16 102.65 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.143 1.896 . . . . 1.58 110.856 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -97.61 110.73 23.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 3.85 110.399 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 45.5 tpp -134.4 122.71 22.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.875 -0.602 . . . . 5.0 110.386 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.095 -0.955 . . . . 6.13 112.318 179.626 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.239 -0.282 . . . . 5.41 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.49 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.9 tmtt? -162.41 148.35 12.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.144 -0.687 . . . . 1.29 109.144 174.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.431 ' N ' ' HD3' ' B' ' 2' ' ' LYS . 70.5 m -69.36 -166.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.665 0.745 . . . . 0.46 112.128 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 7.8 m 66.82 66.16 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.651 -1.159 . . . . 0.41 111.302 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.64 34.45 4.97 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.606 -0.725 . . . . 0.32 112.403 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 tp -102.39 134.12 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.967 0.413 . . . . 0.52 110.342 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.2 p -94.66 127.03 46.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.129 0.49 . . . . 0.37 111.614 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.54 166.96 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.141 -0.481 . . . . 1.74 110.52 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.83 161.85 16.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 1.23 109.79 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 2.2 t -81.06 -109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.498 ' HB2' ' NE ' ' A' ' 15' ' ' ARG . 24.5 t70 176.65 -79.0 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.453 -0.573 . . . . 1.66 109.453 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.6 pt-20 -154.92 -81.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.521 -0.763 . . . . 1.91 110.024 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.603 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -65.49 -29.9 70.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.34 -0.845 . . . . 0.72 112.102 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.72 -9.81 0.32 Allowed Glycine 0 C--O 1.223 -0.587 0 C-N-CA 119.685 -1.245 . . . . 0.31 112.888 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 9.6 mtt180 -54.9 105.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.0 0.37 . . . . 0.75 112.0 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 12.7 p -98.72 141.44 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 1.04 110.132 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 15' ' ' ARG . 42.4 t -77.28 101.1 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.25 111.74 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 43' ' ' ILE . 26.0 mm -67.17 135.51 93.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.876 -0.602 . . . . 0.55 110.708 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' B' ' 22' ' ' LEU . 89.2 Cg_exo -49.85 137.64 35.02 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.846 2.364 . . . . 0.28 112.62 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 tt -57.86 -33.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.82 110.344 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' B' ' 2' ' ' LYS . 12.3 pt-20 -69.94 -27.34 64.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 1.35 110.276 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.3 mt -82.03 -48.41 11.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.33 109.457 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -68.29 -25.84 65.34 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.225 -1.028 . . . . 1.48 108.225 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.91 -37.48 75.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.619 -0.719 . . . . 2.77 110.742 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 98.2 m -61.35 -35.59 77.87 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.419 0.628 . . . . 0.31 110.503 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -89.27 -11.11 44.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.395 -0.82 . . . . 0.24 109.864 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.18 22.59 69.16 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.551 -0.75 . . . . 0.34 112.872 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.4 pt -101.95 167.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.173 0.511 . . . . 0.47 111.579 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.25 150.77 1.54 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.22 110.262 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.897 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.0 -89.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.725 1.75 . . . . 1.12 115.725 172.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.7 mmpt? -79.58 7.98 7.29 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.225 0.824 . . . . 0.65 113.225 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 71.6 m-20 -88.96 176.6 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.036 0.38 . . . . 1.37 111.06 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -121.43 150.91 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.536 0.684 . . . . 0.22 112.632 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.8 mp -123.02 156.21 35.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.964 -1.016 . . . . 1.23 109.256 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 43.7 mt-10 -108.77 105.42 14.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.805 -0.634 . . . . 1.4 109.385 175.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.02 124.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.301 -0.863 . . . . 0.29 111.351 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 17.0 m-85 -113.57 174.78 5.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.517 -1.29 . . . . 4.28 107.517 172.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.45 142.96 42.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.598 -0.441 . . . . 0.28 110.158 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.58 78.12 1.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 1.12 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 60.02 -75.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.627 -1.169 . . . . 1.64 112.618 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -107.43 -25.58 11.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.957 0.408 . . . . 2.81 111.033 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 24.8 pttm -116.3 162.45 17.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.167 0.508 . . . . 0.98 111.919 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.858 ' HB ' HD12 ' A' ' 45' ' ' LEU . 59.9 mt -106.04 139.03 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.39 -0.823 . . . . 0.42 110.169 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -118.11 109.66 27.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 116.081 -0.509 . . . . 0.25 109.754 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.501 HD11 ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.39 116.88 28.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.433 -0.507 . . . . 1.29 110.146 -176.335 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.665 ' HB2' ' HG2' ' A' ' 42' ' ' LYS . 38.5 ttpt -116.88 139.8 50.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.702 -0.851 . . . . 1.22 108.702 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 63.2 pttt -47.69 147.59 1.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.202 0.314 . . . . 2.5 110.939 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' TYR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 78.6 t80 -59.79 139.7 57.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.112 -0.699 . . . . 3.39 109.112 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.54 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.0 tppt? -65.46 121.05 72.91 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.32 -0.4 . . . . 3.18 110.462 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.54 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 39.9 Cg_endo -66.56 98.83 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.349 2.033 . . . . 1.56 110.961 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -89.62 108.39 19.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.493 -0.776 . . . . 3.92 110.569 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 46.6 tpp -115.78 151.43 35.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.623 -0.717 . . . . 5.19 109.239 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.339 -0.838 . . . . 6.34 111.448 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.108 0.04 . . . . 4.93 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HG2' ' OE2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -150.13 162.42 40.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 121.076 -0.25 . . . . 1.67 110.424 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -80.83 -166.56 1.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.592 0.71 . . . . 0.48 112.32 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.654 HG23 ' HD1' ' B' ' 37' ' ' TYR . 25.1 m 72.0 71.6 0.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.573 -1.194 . . . . 0.48 111.313 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.42 38.99 6.09 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.332 -0.849 . . . . 0.32 111.879 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.51 136.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.706 -0.479 . . . . 0.49 109.706 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 11.2 p -95.84 127.3 48.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.902 0.382 . . . . 0.37 110.938 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -125.96 161.13 28.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.344 -0.389 . . . . 1.96 110.671 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -81.45 161.09 23.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.218 -0.66 . . . . 1.16 109.218 175.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.0 t -80.21 -108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.564 -0.532 . . . . 0.44 109.564 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 26.9 t70 175.26 -67.29 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.02 -0.733 . . . . 1.32 109.02 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.4 pt-20 -158.47 -86.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.939 -1.028 . . . . 1.39 109.986 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.604 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -77.24 -27.73 53.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.6 112.112 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.49 -0.33 0.06 OUTLIER Glycine 0 C--O 1.225 -0.464 0 C-N-CA 119.483 -1.342 . . . . 0.34 114.461 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.9 ttt180 -66.81 99.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.495 1.148 . . . . 1.26 111.578 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 19.0 m -96.46 144.58 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 1.04 110.386 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' B' ' 15' ' ' ARG . 41.4 t -82.0 107.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.302 -0.408 . . . . 0.25 111.178 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' O ' ' B' ' 14' ' ' GLY . 3.6 mt -79.9 139.24 53.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 110.186 -0.302 . . . . 0.62 110.186 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 70.8 Cg_exo -46.33 140.03 11.82 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.422 2.748 . . . . 0.31 113.839 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 6.7 tp -58.19 -32.84 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.86 110.443 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' OE2' ' HG2' ' A' ' 2' ' ' LYS . 20.5 pt-20 -72.81 -23.03 60.73 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.406 -0.361 . . . . 1.73 110.419 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.705 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.3 mt -83.37 -46.48 12.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.297 0.57 . . . . 0.44 109.858 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -64.13 -31.37 72.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 1.92 108.011 176.572 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -38.48 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.966 -1.016 . . . . 2.94 111.605 173.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -60.66 -36.54 78.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.542 0.687 . . . . 0.34 110.473 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.942 HD11 HD11 ' B' ' 43' ' ' ILE . 1.9 mt -89.28 -9.22 51.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.464 -0.789 . . . . 0.26 109.713 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.13 29.37 70.91 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.257 -0.883 . . . . 0.28 112.118 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.3 pt -110.12 167.29 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.189 0.518 . . . . 0.43 111.124 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -179.68 154.87 0.62 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.727 -1.124 . . . . 0.26 109.22 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.1 pt-20 37.82 -89.46 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.904 1.446 . . . . 1.22 114.904 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.1 5.11 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.493 0.553 . . . . 0.85 112.493 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.537 ' O ' HG23 ' B' ' 10' ' ' VAL . 2.7 m-20 -87.67 172.73 9.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.81 0.338 . . . . 1.54 110.419 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -117.37 149.04 41.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.353 0.597 . . . . 0.23 111.692 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 47' ' ' LYS . 14.1 tp -126.21 149.33 49.12 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.984 -1.117 . . . . 1.15 107.984 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -107.03 106.03 16.35 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.209 0.528 . . . . 1.28 110.049 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 1.017 HG13 HD22 ' A' ' 45' ' ' LEU . 1.7 mp -94.14 125.73 46.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.29 111.312 -173.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.737 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -126.97 160.97 29.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.453 -0.794 . . . . 4.3 109.555 175.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.83 138.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.84 0.352 . . . . 0.26 110.794 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.59 81.69 2.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.788 -0.449 . . . . 1.15 109.788 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 2.5 t70 58.55 -82.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.704 -1.135 . . . . 1.83 111.454 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 24.3 mt-10 -114.08 -19.62 11.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 2.54 111.018 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -92.73 159.03 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.87 110.242 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.868 HD11 HD11 ' B' ' 26' ' ' LEU . 26.7 mt -110.28 133.54 55.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.843 -0.617 . . . . 0.34 109.367 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.737 ' HB ' ' HD1' ' A' ' 37' ' ' TYR . 17.9 mm -121.21 115.44 46.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.829 -0.434 . . . . 0.2 109.829 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.03 118.91 35.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.546 -0.538 . . . . 1.3 109.546 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 30.7 ttpt -112.35 148.65 33.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.117 -1.438 . . . . 1.41 107.117 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.837 ' HA ' HD12 ' A' ' 34' ' ' LEU . 84.5 tttt -56.69 149.66 17.44 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.491 -0.559 . . . . 2.68 109.491 174.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 33' ' ' ALA . 17.3 p90 -59.16 146.12 40.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.38 -0.97 . . . . 3.55 108.38 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.926 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.53 115.19 27.53 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.309 -0.557 . . . . 3.38 109.754 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.926 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 32.2 Cg_endo -62.48 117.04 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.644 2.229 . . . . 1.58 112.292 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.93 99.32 12.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.228 -0.896 . . . . 3.85 109.831 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.3 tpt -127.55 124.32 37.91 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.461 -0.791 . . . . 5.0 109.733 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.94 -0.573 . . . . 6.13 110.893 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.469 0.176 . . . . 5.41 110.773 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.451 ' HG2' ' OE2' ' B' ' 21' ' ' GLU . 0.1 OUTLIER -160.27 162.14 33.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.908 -0.404 . . . . 1.29 109.908 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.439 ' N ' ' HD3' ' B' ' 2' ' ' LYS . 46.8 m -79.47 -167.26 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.4 0.68 . . . . 0.46 112.497 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 37' ' ' TYR . 25.0 m 71.94 70.58 0.16 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.638 -1.164 . . . . 0.41 111.79 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.39 39.18 6.05 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.32 111.796 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.41 137.23 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.374 -0.602 . . . . 0.52 109.374 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.527 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 10.0 p -95.61 127.99 47.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 120.958 0.408 . . . . 0.37 110.41 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.66 159.93 30.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.155 -0.475 . . . . 1.74 110.316 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -81.42 157.55 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.926 -0.768 . . . . 1.23 108.926 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 32' ' ' ASP . 3.1 t -76.73 -104.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.577 -0.527 . . . . 0.39 109.577 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.414 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 23.5 t0 170.2 -71.04 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.879 -0.786 . . . . 1.66 108.879 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.1 pt-20 -154.45 -83.51 0.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 1.91 110.173 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.5 pt? -84.13 -22.33 31.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.38 -0.827 . . . . 0.72 112.434 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 159.42 -4.74 0.11 Allowed Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.477 -1.344 . . . . 0.31 113.871 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 2.1 ttt180 -66.77 96.98 0.43 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.926 0.863 . . . . 0.75 111.513 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 24.7 m -94.42 144.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.012 -0.54 . . . . 1.04 110.43 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 15' ' ' ARG . 46.4 t -81.75 107.75 14.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.342 -0.39 . . . . 0.25 111.073 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.534 HD13 HD13 ' A' ' 43' ' ' ILE . 8.6 mt -82.14 138.16 45.83 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.485 -0.325 . . . . 0.55 110.611 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.51 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 70.6 Cg_exo -44.67 140.44 6.48 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.61 2.873 . . . . 0.28 113.969 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 5.3 tp -57.68 -34.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.105 -0.952 . . . . 0.82 110.611 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' B' ' 2' ' ' LYS . 7.8 pt-20 -71.11 -24.29 62.26 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 109.962 -0.384 . . . . 1.35 109.962 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.0 mt -83.51 -46.35 12.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.33 109.708 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' B' ' 28' ' ' ILE . 2.9 ppt_? -64.73 -31.57 72.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.866 -1.161 . . . . 1.48 107.866 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 31.3 ttt180 -59.29 -46.73 87.76 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 114.81 -1.086 . . . . 2.77 111.164 170.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.1 m -58.49 -35.33 72.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.313 0.578 . . . . 0.31 111.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -90.22 -10.33 44.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.488 -0.778 . . . . 0.24 109.917 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.22 63.66 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.531 -0.758 . . . . 0.34 112.768 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.678 HG12 ' HB2' ' B' ' 26' ' ' LEU . 13.3 pt -101.49 167.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.408 . . . . 0.47 111.126 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ALA . . . . . 0.45 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -178.03 152.71 0.75 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.102 -0.953 . . . . 0.22 109.548 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.8 pt-20 34.36 -90.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.126 1.528 . . . . 1.12 115.126 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -75.89 5.07 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.985 0.735 . . . . 0.65 112.985 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.0 m-20 -91.76 176.41 6.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.891 -0.506 . . . . 1.37 111.335 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -116.65 150.68 37.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.639 -0.709 . . . . 0.22 112.167 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 47' ' ' LYS . 14.0 tp -128.36 150.67 50.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.219 -1.03 . . . . 1.23 108.219 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -106.35 107.25 18.16 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.607 -0.516 . . . . 1.4 109.607 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 1.033 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -94.53 124.1 46.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.992 -0.549 . . . . 0.29 111.291 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.825 ' HD2' ' HB ' ' B' ' 44' ' ' ILE . 0.3 OUTLIER -123.58 159.61 28.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.639 -0.71 . . . . 4.28 109.513 175.196 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.89 136.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.954 0.407 . . . . 0.28 110.622 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.47 79.9 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 1.12 109.557 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 57.02 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.858 -1.064 . . . . 1.64 111.507 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.63 -3.33 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.964 -0.562 . . . . 2.81 111.104 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -102.82 158.76 16.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.58 -0.526 . . . . 0.98 109.58 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 26' ' ' LEU . 22.7 mt -111.8 133.51 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.431 -0.581 . . . . 0.42 109.431 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HD2' ' B' ' 37' ' ' TYR . 18.3 mm -123.99 116.1 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.765 -0.458 . . . . 0.25 109.765 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.71 117.57 30.65 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.565 -0.454 . . . . 1.29 109.942 -177.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 18.8 ttpt -111.25 142.03 44.0 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.224 -1.028 . . . . 1.22 108.224 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' B' ' 34' ' ' LEU . 79.3 tttt -49.97 141.95 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.227 -0.286 . . . . 2.5 110.227 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -59.87 148.74 33.73 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.614 -0.513 . . . . 3.39 109.614 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.596 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -67.12 113.14 12.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.377 -0.601 . . . . 3.18 109.377 -174.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 50' ' ' PRO . . . . . 0.596 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 39.9 Cg_endo -66.19 113.97 2.84 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.817 2.345 . . . . 1.56 111.768 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.49 106.1 13.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 3.92 109.445 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.8 tpt -137.63 116.14 12.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.571 -0.741 . . . . 5.19 109.893 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.634 -0.698 . . . . 6.34 110.993 -178.681 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.908 0.385 . . . . 4.93 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.61 -152.36 0.39 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.235 -0.439 . . . . 1.67 110.069 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -68.47 -170.44 0.2 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.456 0.646 . . . . 0.48 111.065 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' HD1' ' B' ' 37' ' ' TYR . 11.5 m 70.79 68.22 0.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.903 -1.044 . . . . 0.48 111.683 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' B' ' 35' ' ' GLU . . . 91.89 37.66 5.99 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.31 -0.859 . . . . 0.32 111.894 174.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tp -104.14 135.76 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.767 -0.457 . . . . 0.49 109.767 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.615 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.8 p -90.67 124.79 43.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.996 0.427 . . . . 0.37 110.797 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.69 159.58 27.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.277 -0.419 . . . . 1.96 110.525 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 1.1 tpmt? -83.58 158.32 21.98 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.89 -0.781 . . . . 1.16 108.89 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.4 t -78.61 -105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.055 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.578 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 14.4 t70 175.32 -78.03 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.448 -0.575 . . . . 1.32 109.448 -173.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER -161.59 -77.71 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 1.39 109.679 172.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.7 pt? -72.66 -18.37 61.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.036 -0.984 . . . . 0.6 112.358 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.86 -21.32 1.0 Allowed Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.018 -1.087 . . . . 0.34 113.76 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.705 ' HD3' ' HB2' ' B' ' 11' ' ' ASP . 6.8 ttm180 -51.92 104.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.381 0.591 . . . . 1.26 112.433 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 14.9 p -97.11 143.22 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.951 -0.389 . . . . 1.04 109.951 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.2 t -77.14 105.9 6.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.25 111.597 -175.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.477 HD12 HG21 ' B' ' 43' ' ' ILE . 35.8 mm -77.42 134.82 65.93 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.62 110.218 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' HD12 ' A' ' 22' ' ' LEU . 87.3 Cg_exo -48.81 140.45 23.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.122 2.548 . . . . 0.31 113.199 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.4 tt -60.76 -33.3 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.86 110.339 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.04 -24.41 63.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.166 0.508 . . . . 1.73 109.725 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.78 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mt -82.05 -49.81 9.79 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.792 -0.64 . . . . 0.44 109.415 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -64.88 -34.6 78.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.624 -0.88 . . . . 1.92 108.624 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -44.36 85.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.241 -0.89 . . . . 2.94 111.129 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.2 m -63.14 -33.15 74.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.309 0.576 . . . . 0.34 110.956 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.845 HD11 HD11 ' B' ' 43' ' ' ILE . 3.1 mt -88.09 -12.91 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.918 -0.583 . . . . 0.26 110.036 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.56 76.71 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.28 112.17 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.692 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.3 pt -108.13 167.34 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.43 111.26 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.55 152.67 0.66 Allowed 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 0.26 109.674 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.826 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.3 pt-20 37.65 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.566 1.691 . . . . 1.22 115.566 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.17 7.02 12.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.704 0.631 . . . . 0.85 112.704 -172.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' B' ' 10' ' ' VAL . 28.6 m-20 -87.27 177.89 7.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 1.54 111.433 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -121.57 146.89 46.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.226 0.824 . . . . 0.23 113.226 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.0 mp -124.16 156.48 36.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 1.15 108.455 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.69 107.61 18.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.583 -0.525 . . . . 1.28 109.583 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.981 HG13 HD12 ' A' ' 45' ' ' LEU . 1.8 mp -90.3 120.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.599 0.714 . . . . 0.29 110.698 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.742 ' HD1' HG23 ' B' ' 4' ' ' THR . 1.0 OUTLIER -123.14 158.13 31.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.094 -0.957 . . . . 4.3 109.012 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.73 137.72 45.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.26 110.779 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 83.04 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 1.15 110.857 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 t70 63.53 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.793 -1.094 . . . . 1.83 111.817 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.33 9.62 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.006 -0.543 . . . . 2.54 111.255 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -118.84 158.64 25.25 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.322 -0.399 . . . . 0.87 109.978 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 26' ' ' LEU . 15.9 mt -110.06 138.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.263 -0.426 . . . . 0.34 109.89 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 44' ' ' ILE . 11.4 mm -122.79 115.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.443 -0.344 . . . . 0.2 110.268 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -114.36 117.08 30.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.876 -0.73 . . . . 1.3 109.092 176.124 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -107.62 126.8 53.02 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.028 -0.73 . . . . 1.41 109.028 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 59.3 pttt -44.71 139.48 2.92 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.255 0.347 . . . . 2.68 111.148 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.88 138.2 58.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.71 -0.848 . . . . 3.55 108.71 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 13.5 tppt? -67.74 110.61 5.72 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 123.198 0.311 . . . . 3.38 110.348 -176.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.88 -40.12 17.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.586 2.191 . . . . 1.58 112.406 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 45.6 t30 -94.86 144.09 25.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.85 -0.796 . . . . 3.85 108.85 174.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.5 ptm -79.98 147.42 31.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.976 0.417 . . . . 5.0 110.231 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.003 -0.999 . . . . 6.13 108.74 179.085 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 111.505 0.187 . . . . 5.41 111.505 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' LYS . . . . . 0.771 ' HG3' ' H ' ' B' ' 3' ' ' SER . 13.6 ptmt -124.76 -84.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 121.398 -0.121 . . . . 1.29 111.131 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' SER . . . . . 0.771 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 75.2 m -128.85 -173.25 2.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.46 108.858 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' THR . . . . . 0.742 HG23 ' HD1' ' A' ' 37' ' ' TYR . 35.4 m 64.68 70.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.594 0.711 . . . . 0.41 111.317 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.08 38.15 5.49 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.773 -0.727 . . . . 0.32 112.255 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tp -104.6 133.81 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.628 -0.508 . . . . 0.52 109.628 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 11.0 p -92.0 117.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.529 0.68 . . . . 0.37 111.486 -172.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -109.73 159.61 17.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 1.74 110.209 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 155.93 20.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.233 -1.025 . . . . 1.23 108.233 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 34' ' ' LEU . 2.2 t -78.24 -111.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.497 -0.557 . . . . 0.39 109.497 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ASP . . . . . 0.705 ' HB2' ' HD3' ' A' ' 15' ' ' ARG . 26.4 t0 179.88 -68.94 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.4 -0.592 . . . . 1.66 109.4 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' GLU . . . . . 0.826 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.3 pt-20 -160.38 -83.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.819 . . . . 1.91 110.563 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' LEU . . . . . 0.545 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -74.45 -16.13 60.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.031 -0.986 . . . . 0.72 112.198 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.22 -16.79 1.16 Allowed Glycine 0 C--O 1.221 -0.66 0 C-N-CA 119.911 -1.137 . . . . 0.31 113.05 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.9 mtt180 -52.48 111.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.788 0.294 . . . . 0.75 111.75 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.5 p -105.14 142.09 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.721 -0.474 . . . . 1.04 109.721 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' VAL . . . . . 0.479 ' HB ' ' HG2' ' B' ' 8' ' ' ARG . 48.6 t -77.65 108.53 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 0.25 112.019 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.561 HD12 HD13 ' A' ' 43' ' ' ILE . 19.9 mm -76.28 135.65 69.35 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.942 -0.572 . . . . 0.55 110.422 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' PRO . . . . . 0.714 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.06 139.89 25.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.987 2.458 . . . . 0.28 113.215 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.579 HG13 ' HE ' ' B' ' 23' ' ' ARG . 12.3 tt -59.87 -33.6 53.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.587 -0.733 . . . . 0.82 110.707 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.55 -22.98 59.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.105 0.478 . . . . 1.35 110.251 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.2 mt -80.38 -48.47 12.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.957 -0.757 . . . . 0.33 108.957 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ARG . . . . . 0.579 ' HE ' HG13 ' B' ' 20' ' ' ILE . 15.0 ptt180 -65.58 -33.71 76.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.936 -0.765 . . . . 1.48 108.936 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ARG . . . . . 0.457 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 33.9 ttp180 -64.78 -37.83 88.93 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.409 -0.814 . . . . 2.77 110.495 175.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 95.7 m -63.83 -34.34 77.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.31 110.422 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 43' ' ' ILE . 3.1 mt -88.72 -10.36 48.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.48 0.657 . . . . 0.24 109.572 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.27 77.06 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 114.889 -1.051 . . . . 0.34 112.282 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ILE . . . . . 0.641 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.0 pt -111.67 166.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.932 0.396 . . . . 0.47 111.196 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.85 148.67 0.54 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.224 -0.898 . . . . 0.22 110.182 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.0 pt-20 35.85 -87.23 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.293 1.59 . . . . 1.12 115.293 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -75.04 5.11 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.075 0.769 . . . . 0.65 113.075 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ASP . . . . . 0.579 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 3.2 m-20 -86.67 173.74 9.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 1.37 111.636 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -118.28 144.86 45.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.621 -0.718 . . . . 0.22 112.401 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' LEU . . . . . 0.831 HD23 ' HA ' ' B' ' 47' ' ' LYS . 15.9 mt -124.77 152.27 44.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.846 -1.168 . . . . 1.23 107.846 174.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 19.3 tt0 -106.78 104.84 14.62 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.167 -0.679 . . . . 1.4 109.167 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ILE . . . . . 0.951 HG13 HD12 ' B' ' 45' ' ' LEU . 1.9 mp -90.26 121.39 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.346 0.593 . . . . 0.29 110.971 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' TYR . . . . . 0.601 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -127.21 158.64 36.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.358 -0.837 . . . . 4.28 109.498 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.0 p -110.94 138.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.626 -0.429 . . . . 0.28 111.221 -173.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.47 77.94 1.78 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.12 110.336 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 t70 58.56 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.504 -1.225 . . . . 1.64 112.384 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -115.58 -10.74 11.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 2.81 110.924 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -109.84 157.6 19.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.98 110.667 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 26' ' ' LEU . 12.1 mt -109.84 137.5 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.016 -0.538 . . . . 0.42 109.83 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 44' ' ' ILE . 10.1 mm -123.61 115.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.457 -0.338 . . . . 0.25 110.214 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 45' ' ' LEU . . . . . 0.951 HD12 HG13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -112.9 111.94 23.05 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.29 108.886 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.31 128.65 47.37 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.084 -0.71 . . . . 1.22 109.084 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LYS . . . . . 0.831 ' HA ' HD23 ' B' ' 34' ' ' LEU . 55.0 pttt -44.86 138.92 3.29 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.281 0.363 . . . . 2.5 111.407 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.53 138.48 58.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.853 -0.795 . . . . 3.39 108.853 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' B' ' 49' ' ' LYS . 12.8 tppt? -67.68 113.99 17.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.145 -0.317 . . . . 3.18 110.145 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.99 -40.28 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.594 2.196 . . . . 1.56 112.177 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' B' ' 49' ' ' LYS . 48.1 t30 -108.23 135.3 49.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.253 -0.647 . . . . 3.92 109.253 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.6 ptm -81.23 115.87 20.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 5.19 111.214 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.556 -0.747 . . . . 6.34 110.459 -178.511 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.7 m . . . . . 0 N--CA 1.455 -0.185 0 N-CA-C 108.818 -0.808 . . . . 0.48 108.818 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.655 HG23 ' HD1' ' B' ' 37' ' ' TYR . 59.4 m 63.32 75.41 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.813 0.815 . . . . 0.48 111.311 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.61 35.97 12.82 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.271 -0.877 . . . . 0.32 111.339 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 134.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.745 -0.465 . . . . 0.49 109.745 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -86.99 125.66 40.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 120.988 0.423 . . . . 0.37 111.384 -173.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.44 155.86 36.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 1.96 110.863 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -82.34 162.57 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.881 -0.414 . . . . 1.16 109.881 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.531 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.5 t -85.05 -108.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.772 -0.371 . . . . 0.44 110.231 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.583 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t70 177.26 -74.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.98 -0.748 . . . . 1.32 108.98 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.921 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.9 OUTLIER -161.57 -80.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.942 -1.026 . . . . 1.39 109.686 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.535 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -68.4 -32.78 73.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.6 111.302 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.78 -16.31 0.11 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.879 -1.153 . . . . 0.34 113.947 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.36 103.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.584 0.692 . . . . 1.26 111.867 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.714 HG11 HD13 ' B' ' 45' ' ' LEU . 13.4 p -96.55 140.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.866 -0.42 . . . . 1.04 109.866 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.4 t -77.76 101.75 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.323 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.7 129.06 88.89 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.818 -0.628 . . . . 0.62 110.229 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.683 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 57.2 Cg_exo -45.5 139.09 10.08 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.387 2.725 . . . . 0.31 113.407 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 8.6 tt -57.03 -33.26 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.86 110.827 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -73.2 -24.86 60.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.098 0.475 . . . . 1.73 110.472 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 10.5 mt -81.49 -48.09 12.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.402 -0.592 . . . . 0.44 109.402 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HE ' ' HA ' ' A' ' 20' ' ' ILE . 12.2 ptt180 -64.7 -33.81 76.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.083 -0.71 . . . . 1.92 109.083 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.76 -40.38 94.96 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.281 -0.872 . . . . 2.94 110.677 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.6 m -61.12 -38.36 86.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.205 0.526 . . . . 0.34 110.634 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.739 HD11 HD11 ' B' ' 43' ' ' ILE . 2.2 mt -87.14 -10.67 52.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.26 109.704 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.98 25.83 71.02 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.377 -0.829 . . . . 0.28 112.466 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.683 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.5 pt -106.71 167.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.43 111.606 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -177.32 152.84 0.88 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.883 -1.053 . . . . 0.26 109.549 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.0 pt-20 32.4 -89.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.779 1.77 . . . . 1.22 115.779 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.7 mmpt? -77.27 -0.43 25.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.746 0.647 . . . . 0.85 112.746 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.51 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -81.94 174.67 11.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.007 0.432 . . . . 1.54 110.535 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.93 152.59 42.28 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.405 0.621 . . . . 0.23 112.499 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.3 mp -120.04 152.51 37.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.91 -1.041 . . . . 1.15 109.204 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.53 100.14 10.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.611 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -91.13 123.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.347 0.594 . . . . 0.29 111.352 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.665 ' HD1' HG23 ' B' ' 4' ' ' THR . 3.4 t80 -126.24 163.4 23.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.317 -0.856 . . . . 4.3 108.721 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.91 139.25 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.706 -0.398 . . . . 0.26 110.686 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 81.26 2.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.345 -0.388 . . . . 1.15 110.335 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 55.26 -80.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.637 -1.165 . . . . 1.83 112.843 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 3.68 19.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.08 0.4 . . . . 2.54 112.08 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -143.38 170.79 15.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.87 112.611 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HD11 ' B' ' 26' ' ' LEU . 31.5 mt -106.58 139.06 29.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.973 -1.012 . . . . 0.34 110.257 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.655 HD12 HD12 ' B' ' 44' ' ' ILE . 22.4 mm -121.64 107.07 19.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 0.2 109.458 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.6 118.55 28.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.912 0.863 . . . . 1.3 111.362 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 32.9 ttpt -102.64 165.43 11.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.197 -1.365 . . . . 1.41 107.932 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 57.5 pttt -66.43 147.91 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.524 -0.917 . . . . 2.68 108.524 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 t80 . . . . . 0 N--CA 1.449 -0.523 0 C-N-CA 120.173 -0.611 . . . . 3.55 109.402 178.474 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.447 -0.598 0 CA-C-O 121.615 0.722 . . . . 0.46 112.255 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.665 HG23 ' HD1' ' A' ' 37' ' ' TYR . 60.9 m 78.79 72.61 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.283 -1.326 . . . . 0.41 111.345 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.92 36.53 10.12 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.983 -1.008 . . . . 0.32 111.28 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tp -107.3 137.6 37.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.102 0.477 . . . . 0.52 109.931 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 6.6 p -88.17 129.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 116.278 -0.419 . . . . 0.37 111.163 -173.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 2.5 mpt_? -126.43 155.91 41.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.729 -0.214 . . . . 1.74 111.074 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.4 mmpt? -81.28 162.38 23.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.847 -0.427 . . . . 1.23 109.847 176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.5 t -86.16 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.117 0.484 . . . . 0.39 110.513 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' B' ' 10' ' ' VAL . 6.6 t70 172.91 -76.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.794 -0.817 . . . . 1.66 108.794 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.2 pt-20 -166.65 -76.8 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.693 -1.14 . . . . 1.91 108.754 170.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.655 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.3 pp -76.8 -6.16 51.16 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.435 -1.711 . . . . 0.72 112.644 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.35 -16.02 3.89 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.317 -1.421 . . . . 0.31 113.692 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.4 ttt180 -56.17 99.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.334 0.567 . . . . 0.75 111.6 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.0 p -93.83 139.89 17.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.159 -0.473 . . . . 1.04 109.955 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.448 HG22 ' HG3' ' A' ' 15' ' ' ARG . 25.6 t -79.99 100.52 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.903 0.383 . . . . 0.25 111.63 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 43' ' ' ILE . 36.8 mm -68.74 131.94 91.02 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.55 110.79 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' B' ' 22' ' ' LEU . 93.5 Cg_exo -48.23 139.03 22.23 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.269 2.646 . . . . 0.28 113.279 173.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.03 -32.17 43.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 0.82 110.851 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -72.43 -25.05 61.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.499 . . . . 1.35 110.037 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -81.81 -48.41 11.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 0.33 109.537 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -30.34 71.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.847 -0.797 . . . . 1.48 108.847 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.04 -39.34 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.264 -0.88 . . . . 2.77 111.217 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.71 -38.09 83.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.391 0.615 . . . . 0.31 110.417 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -87.44 -10.71 51.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.24 109.742 -174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 30.52 75.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.217 -0.901 . . . . 0.34 112.647 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.9 pt -110.75 166.91 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.094 0.474 . . . . 0.47 111.141 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.41 150.71 1.47 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.978 -1.01 . . . . 0.22 110.391 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.921 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.6 pt-20 34.65 -87.3 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.43 1.641 . . . . 1.12 115.43 171.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.41 -11.88 61.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.485 0.55 . . . . 0.65 112.485 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.9 m-20 -78.75 177.13 8.91 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.165 0.507 . . . . 1.37 111.443 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -125.18 155.47 39.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.675 0.75 . . . . 0.22 112.577 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.8 mp -121.99 154.85 36.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.63 -1.168 . . . . 1.23 108.8 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 40.6 mt-10 -102.48 104.3 14.73 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.169 -0.678 . . . . 1.4 109.169 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.989 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -89.83 123.29 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.857 -0.61 . . . . 0.29 110.953 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.655 ' HD1' HG23 ' A' ' 4' ' ' THR . 3.8 t80 -124.3 158.82 31.67 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.115 -0.698 . . . . 4.28 109.115 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.29 137.18 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.811 -0.356 . . . . 0.28 110.495 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' B' ' 42' ' ' LYS . 37.0 t70 -128.76 82.46 2.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 1.12 111.108 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 61.19 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.949 -1.023 . . . . 1.64 112.322 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.44 9.46 15.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.579 -0.737 . . . . 2.81 111.042 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.657 ' HD2' HD11 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -138.41 169.16 18.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.139 -0.482 . . . . 0.98 111.206 -177.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -115.26 139.47 41.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.42 110.625 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.657 HD11 ' HD2' ' B' ' 42' ' ' LYS . 19.6 mm -117.71 116.0 50.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.527 -0.545 . . . . 0.25 109.527 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.989 HD22 HG13 ' B' ' 36' ' ' ILE . 1.0 OUTLIER -115.89 110.41 18.97 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.287 -0.565 . . . . 1.29 109.806 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -95.83 162.06 13.75 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.0 -1.111 . . . . 1.22 108.0 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 56.5 pttt -66.82 148.27 52.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.813 -0.81 . . . . 2.5 108.813 169.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.843 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 76.3 t80 . . . . . 0 N--CA 1.446 -0.66 0 N-CA-C 108.673 -0.862 . . . . 3.39 108.673 173.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m . . . . . 0 N--CA 1.445 -0.724 0 CA-C-O 121.35 0.595 . . . . 0.48 111.066 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.0 m 68.86 56.18 0.43 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.18 -0.918 . . . . 0.48 110.931 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.58 34.32 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.462 -0.79 . . . . 0.32 112.362 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 tp -105.19 136.68 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 120.928 0.394 . . . . 0.49 110.086 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.528 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.2 p -90.67 128.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.946 0.403 . . . . 0.37 110.691 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpt_? -125.96 157.12 38.59 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.171 -0.33 . . . . 1.96 110.497 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.35 158.39 15.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.123 -0.325 . . . . 1.16 110.123 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.3 t -82.93 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.44 109.031 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.4 ' H ' HG12 ' A' ' 10' ' ' VAL . 14.7 t0 -153.96 -62.5 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.443 -0.577 . . . . 1.32 109.443 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.3 pt-20 -157.2 -85.34 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.131 -0.94 . . . . 1.39 109.775 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -74.18 -15.47 61.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.768 -1.105 . . . . 0.6 111.759 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.68 -20.74 0.8 Allowed Glycine 0 C--O 1.222 -0.647 0 C-N-CA 119.853 -1.165 . . . . 0.34 114.063 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 4.3 ttt180 -52.9 106.41 0.16 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.104 0.952 . . . . 1.26 111.976 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -101.84 141.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.82 . . . . 1.04 109.433 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.55 100.08 3.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 0.25 111.452 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.07 133.43 89.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.62 110.582 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 76.7 Cg_exo -46.61 140.67 11.99 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.297 2.664 . . . . 0.31 113.243 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.21 -30.09 48.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.129 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.142 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.757 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 9.3 mt -82.74 -47.99 11.35 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.883 -0.599 . . . . 0.44 109.657 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -33.94 76.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.432 -0.951 . . . . 1.92 108.432 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -61.37 -42.94 99.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.121 -0.945 . . . . 2.94 111.653 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -33.75 74.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.132 0.491 . . . . 0.34 110.829 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.6 mt -89.55 -9.1 51.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 0.26 109.744 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.7 76.96 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.419 -0.81 . . . . 0.28 112.52 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 26' ' ' LEU . 21.8 pt -113.55 166.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.985 0.422 . . . . 0.43 111.403 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.4 152.01 3.19 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.11 -0.95 . . . . 0.26 109.863 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 4.3 pt-20 31.05 -89.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.901 1.815 . . . . 1.22 115.901 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.9 mmpt? -78.76 6.73 8.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.468 0.914 . . . . 0.85 113.468 -171.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.508 ' O ' HG23 ' B' ' 10' ' ' VAL . 10.9 m-20 -87.39 175.16 8.12 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.071 -0.393 . . . . 1.54 110.494 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.59 154.05 41.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.653 0.739 . . . . 0.23 112.72 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.6 mp -122.94 154.97 37.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.461 -1.245 . . . . 1.15 108.28 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -106.35 104.22 13.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.269 -0.641 . . . . 1.28 109.269 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.55 122.98 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.341 0.591 . . . . 0.29 111.561 -174.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 2.2 m-85 -113.1 171.89 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.821 -1.177 . . . . 4.3 107.821 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.0 p -124.59 142.9 39.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.519 -0.472 . . . . 0.26 110.651 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -133.48 90.96 2.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.285 -0.416 . . . . 1.15 110.115 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 56.88 -96.45 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.606 -0.725 . . . . 1.83 111.393 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -116.02 11.81 15.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.412 -0.813 . . . . 2.54 110.229 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -113.99 156.39 24.16 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.304 -0.407 . . . . 0.87 110.03 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.697 HD13 HD12 ' B' ' 18' ' ' ILE . 46.4 mt -108.36 138.36 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.221 -0.659 . . . . 0.34 109.221 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' B' ' 44' ' ' ILE . 17.4 mm -124.55 107.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.421 -0.585 . . . . 0.2 109.421 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.33 110.99 16.79 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.225 1.012 . . . . 1.3 111.057 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 30.4 ttpt -93.36 165.86 12.57 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.74 -1.573 . . . . 1.41 108.156 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 61.5 pttt -63.75 148.37 49.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.394 -0.595 . . . . 2.68 109.394 169.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.1 t80 . . . . . 0 C--N 1.325 -0.499 0 N-CA-C 109.458 -0.571 . . . . 3.55 109.458 176.468 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.448 -0.548 0 CA-C-O 121.562 0.696 . . . . 0.46 111.732 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 9.2 m 69.59 63.94 0.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.61 -1.177 . . . . 0.41 111.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 37.45 4.13 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.269 -0.878 . . . . 0.32 112.196 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -106.2 135.47 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.053 0.454 . . . . 0.52 109.898 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.498 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.3 p -87.74 126.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.923 0.392 . . . . 0.37 111.066 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 2.1 mpt_? -123.3 154.08 39.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.282 -0.261 . . . . 1.74 110.514 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 32' ' ' ASP . 2.0 tpmt? -89.51 159.99 16.95 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.639 -0.504 . . . . 1.23 109.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.0 t -82.85 -117.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.067 -0.345 . . . . 0.39 110.067 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.479 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 35.9 t0 -178.25 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.558 -0.534 . . . . 1.66 109.558 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.7 pt-20 -161.18 -84.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.253 -0.885 . . . . 1.91 110.381 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.515 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -68.52 -33.42 74.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.42 -0.809 . . . . 0.72 111.459 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.74 -9.8 0.08 OUTLIER Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.654 -1.26 . . . . 0.31 113.393 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.0 mtt180 -54.65 104.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.183 0.492 . . . . 0.75 111.967 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.7 p -100.3 141.02 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.341 -0.614 . . . . 1.04 109.341 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 39.3 t -79.6 101.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.968 0.413 . . . . 0.25 111.206 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.697 HD12 HD13 ' A' ' 43' ' ' ILE . 26.1 mm -66.64 136.67 94.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.55 110.175 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.588 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.2 138.42 28.88 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.633 2.222 . . . . 0.28 112.321 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -61.6 -30.6 48.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.004 -0.544 . . . . 0.82 110.143 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -70.11 -28.07 65.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 1.35 110.55 177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 6.4 mt -80.02 -46.83 15.9 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.38 0.609 . . . . 0.33 109.515 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 32.8 ptt85 -66.49 -33.0 74.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.622 -0.881 . . . . 1.48 108.622 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.446 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 11.8 ttm180 -61.5 -38.61 87.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.684 -0.689 . . . . 2.77 110.781 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 99.2 m -63.42 -35.94 82.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.39 0.614 . . . . 0.31 110.629 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 2.7 mt -88.71 -5.96 57.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.506 -0.77 . . . . 0.24 109.364 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.62 28.64 65.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.028 -0.987 . . . . 0.34 112.47 -174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.697 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.0 pt -109.9 167.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.593 . . . . 0.47 111.504 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -173.51 151.62 1.98 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.782 -1.099 . . . . 0.22 109.468 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.1 pt-20 36.11 -86.76 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.415 1.635 . . . . 1.12 115.415 171.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -79.86 5.05 14.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.156 0.799 . . . . 0.65 113.156 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.8 m-20 -89.28 173.21 8.52 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.496 -0.482 . . . . 1.37 110.486 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.81 154.38 38.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.335 0.588 . . . . 0.22 112.099 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.6 mp -122.25 153.74 38.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.946 -1.025 . . . . 1.23 108.996 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 21.7 mt-10 -101.74 108.01 19.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.4 -0.593 . . . . 1.4 109.4 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.451 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.9 mp -95.08 122.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.641 0.734 . . . . 0.29 111.546 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 14.5 m-85 -113.07 171.94 7.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.613 -1.255 . . . . 4.28 107.613 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 4' ' ' THR . 10.5 p -128.18 142.96 42.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.161 -0.616 . . . . 0.28 110.68 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -134.0 91.04 2.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.126 -0.488 . . . . 1.12 110.053 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.99 -91.28 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.62 -0.718 . . . . 1.64 111.817 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.2 10.84 8.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.808 -0.633 . . . . 2.81 110.281 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -114.57 154.16 28.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.125 -0.695 . . . . 0.98 109.125 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 45' ' ' LEU . 46.5 mt -107.58 137.84 36.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.996 -0.372 . . . . 0.42 109.996 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 44' ' ' ILE . 17.5 mm -113.52 118.24 57.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.176 -0.675 . . . . 0.25 109.176 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.4 OUTLIER -123.99 107.82 11.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.546 0.689 . . . . 1.29 109.933 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 31.9 ttpt -96.62 163.13 13.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.731 -1.211 . . . . 1.22 107.731 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 24.4 pttm -71.11 150.24 45.67 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.855 -0.795 . . . . 2.5 108.855 171.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.456 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 46.2 t80 . . . . . 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.629 . . . . 3.39 109.3 176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.456 ' OG ' HD11 ' A' ' 22' ' ' LEU . 72.3 m . . . . . 0 N--CA 1.453 -0.305 0 CA-C-O 120.901 0.382 . . . . 0.48 111.436 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.609 ' H ' ' HA ' ' B' ' 37' ' ' TYR . 5.8 m 62.27 55.55 2.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.091 -0.959 . . . . 0.48 110.776 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.89 35.89 4.69 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.489 -0.778 . . . . 0.32 112.159 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 10.2 tp -93.43 160.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.946 -1.131 . . . . 0.49 107.946 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -124.67 126.65 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.792 -0.447 . . . . 0.37 109.792 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 19' ' ' PRO . 9.7 mtt-85 -137.17 170.73 15.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.758 0.314 . . . . 1.96 110.806 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.9 mmpt? -91.8 162.6 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 1.16 111.273 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.479 HG22 HD11 ' B' ' 34' ' ' LEU . 1.4 t -85.08 -133.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 168.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.92 -67.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.698 -0.482 . . . . 1.32 109.698 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 3.0 pt-20 -140.9 -94.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 1.39 111.515 169.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -66.1 -28.22 68.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.397 0.518 . . . . 0.6 112.397 -172.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.51 -5.56 0.05 OUTLIER Glycine 0 C--O 1.222 -0.616 0 C-N-CA 119.782 -1.199 . . . . 0.34 114.158 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.602 ' HG3' HG22 ' B' ' 17' ' ' VAL . 31.9 mtt180 -58.56 104.94 0.25 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.073 0.936 . . . . 1.26 111.708 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 45' ' ' LEU . 7.2 p -96.14 138.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.995 -0.743 . . . . 1.04 108.995 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 15' ' ' ARG . 25.5 t -79.0 100.62 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.263 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.1 mm -67.67 128.71 93.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.62 110.147 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.821 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 87.8 Cg_exo -47.72 141.92 15.07 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.256 2.637 . . . . 0.31 113.17 173.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 10.5 tt -59.28 -34.67 54.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.19 -0.459 . . . . 0.86 110.795 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.45 -27.93 64.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.384 0.611 . . . . 1.73 110.256 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.821 ' HG ' ' HB2' ' A' ' 19' ' ' PRO . 5.0 mt -80.45 -46.93 15.11 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.537 -0.756 . . . . 0.44 109.141 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' ILE . 13.3 ptt180 -65.37 -32.38 73.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.31 -0.996 . . . . 1.92 108.31 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.493 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 2.3 tmt_? -65.05 -35.81 82.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.077 -0.965 . . . . 2.94 110.272 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -64.73 -37.02 86.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.34 110.463 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -89.25 -14.11 36.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.26 109.886 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.4 30.73 77.1 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.262 -0.881 . . . . 0.28 112.387 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 23' ' ' ARG . 14.0 pt -103.98 165.97 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.43 111.229 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.45 146.87 0.49 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.929 -1.032 . . . . 0.26 109.773 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 2.9 pt-20 35.0 -89.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.447 1.647 . . . . 1.22 115.447 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -80.86 5.49 15.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.28 0.845 . . . . 0.85 113.28 -172.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.72 176.75 9.09 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.14 -0.624 . . . . 1.54 110.429 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.19 146.12 48.06 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.111 -0.95 . . . . 0.23 112.213 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.5 mp -121.48 151.54 40.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.088 -0.96 . . . . 1.15 108.793 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 11.2 tt0 -108.31 106.45 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.994 -0.743 . . . . 1.28 108.994 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.1 126.59 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.811 -1.086 . . . . 0.29 112.023 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.618 ' HA ' ' H ' ' B' ' 4' ' ' THR . 8.0 t80 -119.14 159.87 23.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.074 -1.084 . . . . 4.3 108.074 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.95 143.09 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 121.833 -0.542 . . . . 0.26 110.731 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -134.67 82.32 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 1.15 110.653 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 17.0 t70 55.8 -90.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.573 -1.194 . . . . 1.83 112.641 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.41 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 10.7 mt-10 -88.86 -23.03 22.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.54 110.349 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.805 ' HE2' HD11 ' A' ' 44' ' ' ILE . 20.1 pttm -119.32 158.12 26.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.463 -0.79 . . . . 0.87 112.236 -167.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.692 HD11 HD11 ' B' ' 26' ' ' LEU . 49.7 mt -110.36 139.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.265 -0.879 . . . . 0.34 109.547 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.805 HD11 ' HE2' ' A' ' 42' ' ' LYS . 13.4 mm -118.26 120.41 64.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.013 -0.54 . . . . 0.2 109.593 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.712 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -130.46 123.94 30.9 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.44 -0.904 . . . . 1.3 111.886 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 41' ' ' GLU . 38.6 ttpt -115.59 170.23 8.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.011 -1.107 . . . . 1.41 108.011 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 28' ' ' ILE . 44.5 tttm -63.81 146.05 54.65 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.496 -0.557 . . . . 2.68 109.496 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 67.0 t80 . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 116.563 -0.29 . . . . 3.55 110.764 178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 73.4 m . . . . . 0 N--CA 1.451 -0.404 0 N-CA-C 110.0 -0.37 . . . . 0.46 110.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.618 ' H ' ' HA ' ' A' ' 37' ' ' TYR . 25.7 m 62.84 63.26 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.865 0.84 . . . . 0.41 110.783 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.95 38.37 5.77 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.188 -0.915 . . . . 0.32 111.95 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 11.1 tp -108.91 138.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.52 110.547 179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.504 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.8 p -94.64 134.21 32.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.109 0.481 . . . . 0.37 112.028 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 8' ' ' ARG . 0.6 OUTLIER -136.6 174.46 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 1.74 110.178 171.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -98.27 160.29 14.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.211 -0.45 . . . . 1.23 110.363 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -82.36 -133.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.686 -1.598 . . . . 0.39 106.686 166.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 28.2 t70 -177.95 -51.47 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.301 0.572 . . . . 1.66 110.883 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -125.32 -124.85 0.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.354 -0.839 . . . . 1.91 111.408 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -70.45 -8.65 52.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.72 112.377 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.41 -8.86 0.32 Allowed Glycine 0 C--O 1.219 -0.804 0 C-N-CA 119.749 -1.215 . . . . 0.31 112.535 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 39.4 mtt180 -58.96 100.24 0.06 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.918 0.39 . . . . 0.75 111.595 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.9 p -94.33 137.85 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 1.04 109.092 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 15' ' ' ARG . 44.0 t -79.66 101.15 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.246 -0.434 . . . . 0.25 111.535 -172.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.69 132.16 91.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.55 110.512 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.614 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 91.0 Cg_exo -47.88 140.41 18.18 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.155 2.57 . . . . 0.28 113.125 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 8.9 tt -57.91 -35.15 50.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.978 -0.555 . . . . 0.82 110.73 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.05 -23.91 60.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.219 0.533 . . . . 1.35 110.506 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 10.6 mt -82.68 -47.75 11.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 4.4 ppt_? -65.81 -28.21 68.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.433 -0.951 . . . . 1.48 108.433 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -62.48 -47.65 83.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.979 -1.009 . . . . 2.77 111.027 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -57.17 -37.84 72.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.522 0.677 . . . . 0.31 110.874 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.7 mt -85.91 -19.77 30.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.415 -0.811 . . . . 0.24 109.922 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.46 33.07 71.95 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.704 -0.68 . . . . 0.34 112.249 -171.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.2 pt -110.91 166.38 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-O 120.685 0.279 . . . . 0.47 110.84 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.35 150.69 0.58 Allowed 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.29 0.994 . . . . 0.22 110.192 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.15 -89.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.549 1.685 . . . . 1.12 115.549 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.5 mmpt? -82.43 4.98 22.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.978 0.733 . . . . 0.65 112.978 -172.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.63 171.15 15.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 1.37 110.83 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.75 144.72 46.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.366 0.603 . . . . 0.22 111.882 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.479 HD11 HG22 ' A' ' 10' ' ' VAL . 6.4 mp -118.55 149.74 40.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.179 -0.919 . . . . 1.23 108.917 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 7.5 tt0 -104.45 101.44 11.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.544 -0.753 . . . . 1.4 108.99 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.0 mp -90.71 126.39 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.671 0.748 . . . . 0.29 112.016 -175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.609 ' HA ' ' H ' ' A' ' 4' ' ' THR . 2.1 t80 -118.04 160.42 21.52 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.836 -1.172 . . . . 4.28 107.836 171.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.92 140.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.53 -0.468 . . . . 0.28 110.301 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -136.88 86.84 2.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.123 0.487 . . . . 1.12 110.592 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.17 -97.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.026 -0.988 . . . . 1.64 112.402 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 36.1 mt-10 -102.88 -4.6 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 2.81 110.417 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.472 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 26.0 pttm -124.03 159.09 30.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.361 0.6 . . . . 0.98 112.0 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 45' ' ' LEU . 60.2 mt -111.31 138.98 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.254 -0.885 . . . . 0.42 109.725 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 44' ' ' ILE . 18.7 mm -115.05 121.43 67.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.3 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.05 111.46 14.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.077 0.942 . . . . 1.29 110.937 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 34.1 ttpt -104.75 169.75 8.27 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.826 -1.534 . . . . 1.22 107.806 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' B' ' 46' ' ' LYS . 60.3 tttm -73.85 145.26 45.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.591 -0.522 . . . . 2.5 109.591 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 54.3 t80 . . . . . 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 3.39 110.145 178.919 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 75.1 m . . . . . 0 N--CA 1.445 -0.688 0 N-CA-C 108.847 -0.798 . . . . 0.48 108.847 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.623 HG23 ' HD1' ' B' ' 37' ' ' TYR . 15.2 m 66.85 69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.48 111.692 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.62 42.07 5.87 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.705 -0.759 . . . . 0.32 111.638 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tp -115.64 141.93 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.49 110.514 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.3 p -88.35 129.59 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.042 -0.526 . . . . 0.37 111.303 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' HD13 ' B' ' 36' ' ' ILE . 3.2 mpt_? -127.26 163.34 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.65 -0.25 . . . . 1.96 110.378 174.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.9 mmpt? -89.54 162.09 15.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.501 -0.318 . . . . 1.16 110.654 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.6 t -86.77 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.757 -0.831 . . . . 0.44 108.757 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HB2' ' HE ' ' B' ' 15' ' ' ARG . 25.4 t70 -159.6 -66.14 0.08 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.699 -0.852 . . . . 1.32 108.699 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.7 pt-20 -153.47 -84.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.02 -0.991 . . . . 1.39 110.254 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.552 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -75.98 -14.92 60.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.89 -1.05 . . . . 0.6 112.492 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 157.46 -11.2 0.25 Allowed Glycine 0 C--O 1.22 -0.778 0 C-N-CA 119.513 -1.327 . . . . 0.34 114.546 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.7 ttt180 -66.13 99.66 0.54 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.54 1.17 . . . . 1.26 112.131 -177.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 20.8 m -95.97 141.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 1.04 110.428 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.29 103.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.379 -0.373 . . . . 0.25 110.777 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.693 HG21 HD13 ' B' ' 43' ' ' ILE . 21.0 mt -85.38 133.89 41.51 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.335 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 43.9 Cg_exo -40.87 138.32 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.094 3.196 . . . . 0.31 114.405 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -58.42 -31.41 42.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.86 110.285 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -70.67 -26.76 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 1.73 110.238 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.2 mt -81.11 -47.34 13.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.995 -0.548 . . . . 0.44 109.774 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 1.9 ptt180 -63.28 -35.78 81.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.051 -1.092 . . . . 1.92 108.051 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 3.1 tmt_? -61.94 -37.31 84.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.731 -1.122 . . . . 2.94 110.893 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.58 -34.8 78.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.344 0.592 . . . . 0.34 110.549 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.6 mt -87.89 -9.05 54.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 0.26 109.793 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.89 66.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.275 -0.875 . . . . 0.28 112.269 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.602 HD13 HD11 ' A' ' 34' ' ' LEU . 2.4 pp -112.07 169.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.43 111.257 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 179.67 157.31 0.63 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.441 -0.8 . . . . 0.26 110.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 35.22 -90.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.378 1.621 . . . . 1.22 115.378 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -75.56 -4.5 40.29 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.882 0.697 . . . . 0.85 112.882 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.457 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.2 OUTLIER -85.49 -178.44 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.508 -0.477 . . . . 1.54 111.409 -172.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -125.91 152.46 45.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.704 0.764 . . . . 0.23 112.842 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.602 HD11 HD13 ' A' ' 28' ' ' ILE . 7.1 mp -127.94 156.89 41.92 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.477 -1.238 . . . . 1.15 107.855 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -105.83 107.6 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.117 -0.697 . . . . 1.28 109.117 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 45' ' ' LEU . 1.8 mp -92.79 122.85 44.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.639 -0.71 . . . . 0.29 111.217 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.691 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.8 OUTLIER -124.44 159.94 29.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.207 -0.906 . . . . 4.3 108.79 175.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.1 135.66 55.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.754 -0.379 . . . . 0.26 110.524 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.04 96.07 3.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.977 -0.379 . . . . 1.15 109.977 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 64.71 -97.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.13 -0.941 . . . . 1.83 110.783 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.04 10.86 8.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.085 -0.961 . . . . 2.54 109.489 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -111.17 156.52 21.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.382 -0.826 . . . . 0.87 109.586 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.963 ' HB ' HD12 ' B' ' 45' ' ' LEU . 38.0 mt -110.21 133.4 55.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.115 -0.493 . . . . 0.34 109.838 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 44' ' ' ILE . 15.8 mm -117.45 112.71 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.406 -0.59 . . . . 0.2 109.406 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 HG21 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -121.19 108.97 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.266 -0.573 . . . . 1.3 109.505 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -107.05 141.18 38.69 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.012 -1.107 . . . . 1.41 108.012 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 20.9 ptmt -47.8 139.16 7.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.914 0.324 . . . . 2.68 110.375 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.8 t80 . . . . . 0 N--CA 1.439 -0.984 0 N-CA-C 108.899 -0.778 . . . . 3.55 108.899 177.699 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.31 -0.626 . . . . 0.46 109.31 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.691 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.6 m 64.78 67.07 0.56 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.703 0.763 . . . . 0.41 111.466 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.95 38.53 5.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.284 -0.871 . . . . 0.32 111.975 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.16 139.03 28.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.493 -0.558 . . . . 0.52 109.493 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.7 p -90.1 125.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 120.971 0.415 . . . . 0.37 110.81 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 1.2 tpt180 -124.18 160.06 28.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 1.74 110.345 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.2 mmpt? -87.26 163.12 17.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.415 -0.357 . . . . 1.23 110.65 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.2 t -86.42 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.049 -0.352 . . . . 0.39 110.049 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.531 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 26.9 t70 173.11 -68.97 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.969 -0.752 . . . . 1.66 108.969 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.8 pt-20 -166.56 -85.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.751 -1.113 . . . . 1.91 109.872 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.675 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.318 -0.856 . . . . 0.72 112.155 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 18' ' ' ILE . . . 164.35 -3.13 0.06 OUTLIER Glycine 0 C--O 1.224 -0.475 0 C-N-CA 119.617 -1.278 . . . . 0.31 113.442 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 1.7 ttt180 -65.67 97.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.101 0.451 . . . . 0.75 111.764 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 18.5 m -94.12 144.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 1.04 110.32 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 40.8 t -81.84 104.53 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.36 -0.382 . . . . 0.25 110.873 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.726 HG21 HD13 ' A' ' 43' ' ' ILE . 2.3 mt -80.68 138.96 50.6 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.308 -0.256 . . . . 0.55 110.308 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.647 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 59.1 Cg_exo -42.96 135.3 5.33 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.449 2.766 . . . . 0.28 113.809 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.69 -32.22 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.471 -0.786 . . . . 0.82 110.727 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 18.4 pt-20 -72.96 -23.46 60.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.132 0.492 . . . . 1.35 110.499 -179.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -81.9 -46.99 13.32 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.161 -0.472 . . . . 0.33 109.769 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 6.9 ptt180 -63.41 -35.47 80.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.174 -1.047 . . . . 1.48 108.174 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.59 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 51.2 ttt180 -56.98 -44.92 83.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.555 -1.202 . . . . 2.77 110.821 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 89.7 m -59.29 -37.31 77.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.615 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.858 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 3.2 mt -86.74 -8.41 57.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 0.24 109.759 -175.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 31.96 81.3 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.311 -0.859 . . . . 0.34 112.133 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.801 HG12 ' HB2' ' B' ' 26' ' ' LEU . 10.9 pt -120.43 169.09 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.47 111.007 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.77 157.46 1.21 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.951 -1.022 . . . . 0.22 110.172 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.858 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pt-20 39.65 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.381 1.623 . . . . 1.12 115.381 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -81.49 6.79 13.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.681 0.622 . . . . 0.65 112.681 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.8 m-20 -86.02 176.67 7.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.373 . . . . 1.37 110.951 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -124.38 152.98 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.656 0.741 . . . . 0.22 112.936 -175.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.4 mp -124.53 157.09 36.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.69 -1.141 . . . . 1.23 109.143 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 46.5 mt-10 -102.9 105.47 15.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.874 -0.603 . . . . 1.4 109.392 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' B' ' 45' ' ' LEU . 1.9 mp -91.89 122.51 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.282 0.563 . . . . 0.29 111.207 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.623 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.4 OUTLIER -124.38 161.04 26.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 4.28 108.961 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.56 136.26 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.845 -0.342 . . . . 0.28 110.605 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -128.23 89.21 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.828 0.347 . . . . 1.12 110.077 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 60.42 -90.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.334 -0.848 . . . . 1.64 111.041 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.51 7.34 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.867 -0.606 . . . . 2.81 110.427 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -104.31 158.23 16.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.648 -0.501 . . . . 0.98 109.648 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.693 HD13 HG21 ' A' ' 18' ' ' ILE . 28.5 mt -109.13 134.49 50.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.059 -0.719 . . . . 0.42 109.059 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -123.23 108.73 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.373 -0.603 . . . . 0.25 109.373 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -120.88 110.96 16.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.177 0.989 . . . . 1.29 111.03 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 30.0 ttpt -90.71 161.33 15.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.747 -1.57 . . . . 1.22 107.843 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 45.9 pttt -64.19 137.99 58.22 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.849 -0.426 . . . . 2.5 109.849 171.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.574 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 88.0 t80 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.183 -0.673 . . . . 3.39 109.183 175.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.4 m . . . . . 0 N--CA 1.452 -0.337 0 CA-C-O 121.454 0.645 . . . . 0.48 111.741 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 3.9 m 65.88 65.26 0.53 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.019 -0.991 . . . . 0.48 111.452 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.42 37.2 3.84 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 114.944 -1.026 . . . . 0.32 111.932 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tp -107.29 138.89 31.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.969 -0.382 . . . . 0.49 109.969 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.4 p -89.13 127.78 41.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.898 0.38 . . . . 0.37 111.0 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -123.57 164.8 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 1.96 110.492 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -98.95 158.62 15.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.447 -0.342 . . . . 1.16 110.317 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.4 t -82.58 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.988 -0.745 . . . . 0.44 108.988 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.538 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 20.8 t70 -155.6 -66.01 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.957 -0.757 . . . . 1.32 108.957 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.919 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.4 pt-20 -156.01 -82.82 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.698 -1.137 . . . . 1.39 109.098 168.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -60.16 -38.13 82.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.6 111.62 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -15.19 0.08 OUTLIER Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.572 -1.299 . . . . 0.34 114.552 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.96 104.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.251 1.025 . . . . 1.26 111.637 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.6 p -101.38 141.7 17.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 1.04 109.692 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' B' ' 15' ' ' ARG . 45.1 t -78.84 108.65 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.39 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.1 mm -74.26 132.94 78.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 0.62 110.89 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 22' ' ' LEU . 77.8 Cg_exo -46.93 140.83 12.8 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.403 2.735 . . . . 0.31 113.298 173.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.961 HD12 ' HD2' ' A' ' 23' ' ' ARG . 4.2 tp -60.49 -32.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.606 -0.724 . . . . 0.86 110.132 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -70.67 -26.29 63.37 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.128 0.489 . . . . 1.73 109.934 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 12.3 mt -82.1 -47.96 11.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.321 -0.622 . . . . 0.44 109.321 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.961 ' HD2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -64.31 -32.12 73.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.606 -0.887 . . . . 1.92 108.606 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -63.74 -42.7 97.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.314 -0.857 . . . . 2.94 111.397 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.3 m -61.41 -35.28 77.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.383 0.611 . . . . 0.34 110.75 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -91.09 -10.53 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.452 -0.795 . . . . 0.26 109.446 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.2 34.7 81.12 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.449 -0.796 . . . . 0.28 112.22 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 26' ' ' LEU . 13.9 pt -106.86 163.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.372 0.606 . . . . 0.43 111.665 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.97 148.96 1.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.462 -1.245 . . . . 0.26 109.373 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.9 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 2.5 pt-20 33.07 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.62 1.711 . . . . 1.22 115.62 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -76.04 4.9 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.509 0.929 . . . . 0.85 113.509 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.518 ' O ' HG23 ' B' ' 10' ' ' VAL . 22.2 m-20 -85.78 171.47 11.54 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.578 -0.449 . . . . 1.54 110.112 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.03 153.26 41.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.527 0.68 . . . . 0.23 112.16 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.4 mp -123.09 153.38 40.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.813 -1.085 . . . . 1.15 108.22 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.6 106.16 16.38 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.717 -0.846 . . . . 1.28 108.717 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.803 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -89.8 124.42 42.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.292 -0.867 . . . . 0.29 111.365 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.7 m-85 -115.06 172.8 6.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.471 -1.307 . . . . 4.3 107.471 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.55 141.19 46.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 120.693 -0.403 . . . . 0.26 110.173 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -129.32 76.84 1.75 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.491 . . . . 1.15 110.19 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 54.03 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.254 -1.339 . . . . 1.83 113.001 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -105.03 -13.43 15.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.978 -0.556 . . . . 2.54 110.777 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -115.25 158.73 21.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.932 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.72 HD11 HD11 ' B' ' 26' ' ' LEU . 59.0 mt -104.37 137.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.842 -0.799 . . . . 0.34 108.842 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' B' ' 44' ' ' ILE . 15.9 mm -123.88 105.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.614 -0.513 . . . . 0.2 109.614 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.876 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.4 OUTLIER -119.62 118.71 31.69 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.316 -0.953 . . . . 1.3 111.185 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.88 165.13 11.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.97 -1.468 . . . . 1.41 107.882 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 81.8 tttt -65.22 137.02 57.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.064 -0.717 . . . . 2.68 109.064 171.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 t80 . . . . . 0 C--N 1.327 -0.4 0 N-CA-C 109.371 -0.603 . . . . 3.55 109.371 176.789 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 52.6 m . . . . . 0 N--CA 1.45 -0.427 0 CA-C-O 121.457 0.646 . . . . 0.46 112.002 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 3.9 m 69.33 59.37 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.703 -1.135 . . . . 0.41 111.337 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.76 35.89 3.14 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.32 112.282 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -109.52 136.92 43.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.975 0.417 . . . . 0.52 110.761 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.3 p -88.94 125.37 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.982 0.42 . . . . 0.37 111.688 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.94 165.93 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.509 -0.314 . . . . 1.74 110.321 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -96.04 162.54 13.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.974 -0.38 . . . . 1.23 109.974 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.7 t -82.34 -108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.798 -0.361 . . . . 0.39 110.293 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.56 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 7.0 t70 175.17 -77.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.107 -0.701 . . . . 1.66 109.107 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.9 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -159.27 -71.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.045 -0.979 . . . . 1.91 108.832 168.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.669 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.4 pt? -77.74 -29.07 50.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.58 -1.191 . . . . 0.72 111.271 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.46 -11.86 0.18 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 119.206 -1.473 . . . . 0.31 114.011 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.9 ttt180 -56.61 99.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.628 0.714 . . . . 0.75 111.741 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.6 p -95.01 141.83 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.777 -0.453 . . . . 1.04 109.777 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.38 109.44 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.406 . . . . 0.25 111.071 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.5 HD12 HD13 ' A' ' 43' ' ' ILE . 30.8 mm -75.34 134.48 73.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.155 -0.475 . . . . 0.55 110.701 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.64 ' HD2' HD12 ' B' ' 22' ' ' LEU . 92.9 Cg_exo -48.46 141.12 20.08 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.087 2.525 . . . . 0.28 113.044 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.566 HD12 ' HD2' ' B' ' 23' ' ' ARG . 6.5 tp -59.93 -32.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.937 -0.574 . . . . 0.82 110.222 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.47 -23.62 60.1 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.172 0.51 . . . . 1.35 110.328 -179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.8 mt -81.36 -48.19 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.417 -0.586 . . . . 0.33 109.417 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.566 ' HD2' HD12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -64.15 -33.48 75.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 1.48 108.154 177.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.45 -47.11 85.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.191 -0.913 . . . . 2.77 111.289 171.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -60.77 -35.14 75.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.358 0.599 . . . . 0.31 111.045 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 2.5 mt -90.36 -10.9 42.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 0.24 109.785 -176.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 24.72 64.66 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.34 112.298 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.3 pt -96.98 166.53 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-O 121.293 0.568 . . . . 0.47 111.048 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.87 152.69 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.548 -1.206 . . . . 0.22 109.111 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.919 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.5 pt-20 33.78 -90.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.778 1.77 . . . . 1.12 115.778 169.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.465 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.0 mmpt? -83.98 7.19 19.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.01 0.744 . . . . 0.65 113.01 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.4 m-20 -84.48 174.54 9.96 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.129 -0.357 . . . . 1.37 110.57 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.7 152.97 40.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.481 0.658 . . . . 0.22 112.453 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.5 mp -120.92 151.88 39.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.935 -1.03 . . . . 1.23 108.979 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -104.18 102.35 12.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.652 -0.869 . . . . 1.4 108.652 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.8 mp -90.07 124.88 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.391 0.615 . . . . 0.29 111.68 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 7.3 m-85 -114.16 175.13 5.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.012 -1.107 . . . . 4.28 108.012 171.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.25 143.11 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 110.008 -0.367 . . . . 0.28 110.008 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -132.94 77.13 1.72 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.827 0.346 . . . . 1.12 110.628 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 t70 56.14 -75.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.565 -1.198 . . . . 1.64 113.05 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -103.17 -25.44 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 2.81 110.81 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' B' ' 42' ' ' LYS . 1.0 OUTLIER -111.62 160.06 17.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.857 -0.611 . . . . 0.98 111.127 -173.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.876 ' HB ' HD12 ' A' ' 45' ' ' LEU . 68.0 mt -105.58 138.16 32.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.459 -0.792 . . . . 0.42 109.351 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' A' ' 44' ' ' ILE . 16.9 mm -114.64 112.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.491 -0.559 . . . . 0.25 109.491 -175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.499 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.92 108.97 15.43 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.938 -0.705 . . . . 1.29 110.247 -178.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 35.4 ttpt -96.23 164.96 12.44 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 82.9 tttt -70.48 139.06 51.6 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.769 -0.826 . . . . 2.5 108.769 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 56.0 t80 . . . . . 0 N--CA 1.451 -0.402 0 N-CA-C 108.823 -0.806 . . . . 3.39 108.823 175.507 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 121.203 0.525 . . . . 0.48 111.539 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HD1' ' B' ' 37' ' ' TYR . 49.2 m 72.15 72.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.999 -1.0 . . . . 0.48 112.574 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 40.02 7.13 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.405 -0.816 . . . . 0.32 111.756 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 tp -111.47 139.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.052 0.453 . . . . 0.49 110.1 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 10.9 p -94.04 132.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.306 -0.406 . . . . 0.37 111.205 -174.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.14 164.85 26.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.251 -0.431 . . . . 1.96 110.498 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 0.8 OUTLIER -83.69 161.12 21.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.923 -0.58 . . . . 1.16 109.611 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.8 t -79.35 -102.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 110.022 -0.362 . . . . 0.44 110.022 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.515 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 17.2 t0 174.48 -73.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.875 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.3 pt-20 -164.78 -80.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.398 -1.274 . . . . 1.39 109.43 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.69 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.7 pt? -65.81 -31.48 72.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.053 -0.976 . . . . 0.6 112.032 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.62 -19.81 0.38 Allowed Glycine 0 C--O 1.221 -0.719 0 C-N-CA 119.783 -1.198 . . . . 0.34 113.816 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.3 ttt180 -49.49 105.8 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.386 0.593 . . . . 1.26 112.385 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -97.39 141.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.175 -0.466 . . . . 1.04 109.941 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.19 110.92 14.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.25 111.8 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.542 HD12 HG21 ' B' ' 43' ' ' ILE . 40.7 mm -80.95 134.49 52.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.62 110.597 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 22' ' ' LEU . 80.4 Cg_exo -49.99 141.11 30.33 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.275 2.65 . . . . 0.31 113.533 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.59 -33.3 54.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.651 -0.704 . . . . 0.86 110.689 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.89 -23.54 62.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.155 0.503 . . . . 1.73 109.747 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.7 mt -82.22 -49.51 10.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.44 109.875 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -65.29 -31.31 72.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.73 -0.841 . . . . 1.92 108.73 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -39.54 94.66 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.525 -0.761 . . . . 2.94 110.895 173.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -62.59 -33.28 74.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.34 110.254 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.9 mt -88.43 -11.25 46.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.422 -0.808 . . . . 0.26 109.573 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.03 24.39 66.92 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.252 -0.886 . . . . 0.28 112.401 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.82 HG12 ' HB2' ' A' ' 26' ' ' LEU . 18.5 pt -107.71 166.55 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.43 111.467 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.38 146.39 0.63 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.812 -1.085 . . . . 0.26 109.807 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.993 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 37.5 -85.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 115.33 1.604 . . . . 1.22 115.33 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 30' ' ' GLU . 11.0 mmpt? -71.51 -1.42 13.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.91 0.707 . . . . 0.85 112.91 -173.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' HG23 ' B' ' 10' ' ' VAL . 9.2 m-20 -86.59 175.98 8.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.99 0.424 . . . . 1.54 111.428 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -122.8 152.33 40.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.626 -0.715 . . . . 0.23 112.59 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.8 mp -124.69 156.95 36.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.344 -1.354 . . . . 1.15 107.344 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 26.4 tt0 -108.03 107.96 18.87 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.204 -0.665 . . . . 1.28 109.204 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 45' ' ' LEU . 2.0 mp -92.8 123.21 44.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.618 -0.719 . . . . 0.29 111.282 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.659 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.05 162.56 25.75 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.201 -0.909 . . . . 4.3 109.092 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.42 139.89 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.989 0.423 . . . . 0.26 110.611 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.06 80.17 1.96 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.233 0.539 . . . . 1.15 110.243 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.94 -77.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.353 -1.294 . . . . 1.83 111.459 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.28 -31.47 6.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 2.54 110.639 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.729 ' HE2' HD11 ' A' ' 44' ' ' ILE . 25.2 pttm -96.8 156.34 16.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.196 -0.601 . . . . 0.87 111.46 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HD11 ' B' ' 26' ' ' LEU . 13.8 mt -107.06 137.67 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.462 -0.79 . . . . 0.34 109.575 -176.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' B' ' 44' ' ' ILE . 15.1 mm -124.24 109.62 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.2 110.112 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -117.77 113.84 22.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.897 -0.721 . . . . 1.3 109.51 176.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 35' ' ' GLU . 12.7 ptpt -91.98 162.57 14.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.647 -1.242 . . . . 1.41 107.647 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 51.4 pttt -65.97 148.01 52.46 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.82 -0.807 . . . . 2.68 108.82 168.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 . . . . . 0 N--CA 1.444 -0.771 0 N-CA-C 107.712 -1.218 . . . . 3.55 107.712 173.239 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m . . . . . 0 N--CA 1.447 -0.583 0 CA-C-O 121.137 0.494 . . . . 0.46 110.973 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.538 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.8 m 74.16 71.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.269 -0.878 . . . . 0.41 111.98 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.73 39.13 7.22 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.199 -0.91 . . . . 0.32 111.812 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.67 138.71 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.164 0.506 . . . . 0.52 110.029 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.546 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.4 p -93.37 129.34 43.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.114 -0.494 . . . . 0.37 111.244 -173.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 1.5 mpt_? -131.03 163.54 27.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 1.74 110.574 176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -82.67 161.22 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.364 -0.606 . . . . 1.23 109.364 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.8 t -78.99 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.806 -0.357 . . . . 0.39 110.251 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.664 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 17.4 t70 175.42 -77.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.173 -0.677 . . . . 1.66 109.173 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.993 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -160.57 -73.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.965 -1.016 . . . . 1.91 108.626 172.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.472 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.5 pt? -80.12 -23.1 41.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.394 -1.275 . . . . 0.72 111.534 -174.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.9 -18.95 0.66 Allowed Glycine 0 C--O 1.221 -0.665 0 C-N-CA 119.557 -1.306 . . . . 0.31 113.553 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.4 ttt180 -50.12 105.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.312 0.486 . . . . 0.75 112.312 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 11.5 p -97.94 142.98 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 1.04 109.906 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.47 111.46 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.025 0.44 . . . . 0.25 111.889 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.646 HD12 HD13 ' A' ' 43' ' ' ILE . 25.1 mm -78.34 132.51 65.93 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.642 -0.708 . . . . 0.55 110.777 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.617 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 88.8 Cg_exo -48.73 140.27 22.95 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.233 2.622 . . . . 0.28 113.291 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.11 -33.01 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.82 110.961 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.83 -25.49 62.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.932 0.396 . . . . 1.35 110.264 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -80.54 -48.79 12.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.808 -0.633 . . . . 0.33 109.608 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -65.44 -33.22 75.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.381 -0.97 . . . . 1.48 108.381 178.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.503 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 5.7 tmm_? -59.57 -42.4 92.36 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.261 -0.881 . . . . 2.77 109.844 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 80.3 m -60.96 -38.15 84.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.677 0.751 . . . . 0.31 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.843 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 4.9 mt -85.72 -11.26 54.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.994 -1.003 . . . . 0.24 109.789 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.86 86.71 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.294 -0.866 . . . . 0.34 111.782 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.549 HG13 ' HB2' ' B' ' 26' ' ' LEU . 2.7 pp -122.15 167.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.47 111.345 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -174.13 154.93 2.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.164 -0.926 . . . . 0.22 109.432 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.4 pt-20 36.2 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.419 1.637 . . . . 1.12 115.419 170.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.447 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.8 mmpt? -79.45 6.91 9.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 0.65 112.822 -173.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.9 176.73 6.32 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 122.223 -0.298 . . . . 1.37 110.94 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -123.01 153.33 39.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.168 0.803 . . . . 0.22 113.168 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -124.71 155.94 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.377 -1.283 . . . . 1.23 107.557 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -108.16 107.37 17.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 1.4 109.768 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.3 124.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.259 -0.882 . . . . 0.29 111.432 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.595 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.7 OUTLIER -127.0 164.49 21.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.195 -0.911 . . . . 4.28 108.827 176.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.38 139.91 48.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.988 -0.285 . . . . 0.28 110.874 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.73 89.37 2.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.642 -0.423 . . . . 1.12 110.333 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 t70 63.88 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.001 -1.0 . . . . 1.64 111.396 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.14 4.77 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.274 -0.876 . . . . 2.81 110.604 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -103.79 155.13 18.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 26' ' ' LEU . 13.0 mt -109.6 134.13 52.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.454 -0.573 . . . . 0.42 109.454 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 44' ' ' ILE . 11.7 mm -125.65 106.13 15.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.322 -0.399 . . . . 0.25 110.382 -172.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.08 116.04 24.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.758 -0.777 . . . . 1.29 110.067 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.42 163.47 13.4 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 62.1 pttt -63.18 151.32 40.62 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.179 -0.674 . . . . 2.5 109.179 169.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 t80 . . . . . 0 C--N 1.317 -0.805 0 N-CA-C 108.131 -1.062 . . . . 3.39 108.131 172.504 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.8 m . . . . . 0 N--CA 1.448 -0.567 0 CA-C-O 121.797 0.808 . . . . 0.48 112.854 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.594 HG23 ' HD1' ' B' ' 37' ' ' TYR . 17.8 m 72.11 67.74 0.14 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.28 -1.327 . . . . 0.48 111.409 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.88 43.85 4.97 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.349 -0.841 . . . . 0.32 111.438 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -108.15 137.63 38.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.587 -0.445 . . . . 0.49 109.968 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.544 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 9.8 p -98.67 124.23 51.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.907 0.384 . . . . 0.37 110.652 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 0.5 OUTLIER -128.7 163.84 24.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.497 -0.32 . . . . 1.96 111.297 -178.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.86 162.98 23.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 1.16 110.645 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.3 t -86.75 -109.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.272 -0.422 . . . . 0.44 109.975 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.492 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 16.7 t0 179.11 -67.3 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.044 -0.725 . . . . 1.32 109.044 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.1 pt-20 -168.15 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.92 -1.036 . . . . 1.39 110.255 175.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.3 pt? -80.52 -0.64 38.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.555 -1.202 . . . . 0.6 112.326 -171.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 144.35 -22.75 2.05 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 119.744 -1.217 . . . . 0.34 113.967 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.6 ttt180 -58.12 106.82 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.436 0.618 . . . . 1.26 112.466 -174.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.4 p -98.3 140.07 18.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.753 -0.462 . . . . 1.04 109.753 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' HG3' ' B' ' 15' ' ' ARG . 40.7 t -79.8 101.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.8 0.333 . . . . 0.25 110.867 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.682 HD13 HD13 ' B' ' 43' ' ' ILE . 10.4 mt -81.04 135.1 51.67 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.62 110.264 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 54.4 Cg_exo -42.85 136.0 4.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.494 2.796 . . . . 0.31 113.663 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.06 -29.3 41.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.612 -0.722 . . . . 0.86 109.98 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -68.87 -27.38 65.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.047 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.721 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.3 mt -82.91 -47.01 12.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.44 109.675 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -65.69 -30.65 71.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.604 -0.888 . . . . 1.92 108.604 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -62.44 -42.18 99.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 2.94 110.846 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.9 m -60.81 -35.64 77.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.244 0.545 . . . . 0.34 111.039 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.852 HD11 HD11 ' B' ' 43' ' ' ILE . 1.3 mt -90.3 -9.71 46.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.818 -0.628 . . . . 0.26 109.719 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.26 34.91 86.6 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.241 -0.89 . . . . 0.28 112.099 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.563 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.6 pt -115.41 165.96 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.104 0.478 . . . . 0.43 111.096 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.1 154.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 0.26 109.593 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 4.6 pt-20 37.83 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.356 1.613 . . . . 1.22 115.356 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.56 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.8 mmpt? -76.15 -1.61 27.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.818 0.673 . . . . 0.85 112.818 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' HG23 ' B' ' 10' ' ' VAL . 37.2 m-20 -85.87 174.05 9.56 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.672 -0.411 . . . . 1.54 110.307 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.18 153.38 40.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.746 0.784 . . . . 0.23 113.061 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 47' ' ' LYS . 18.5 mt -124.47 153.34 42.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.398 -1.274 . . . . 1.15 107.598 173.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -106.82 105.39 15.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.324 -0.621 . . . . 1.28 109.324 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.89 HG13 HD22 ' A' ' 45' ' ' LEU . 1.8 mp -90.37 123.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.473 -0.785 . . . . 0.29 111.06 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.2 OUTLIER -124.92 158.85 32.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.716 -0.846 . . . . 4.3 108.716 175.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.7 p -112.56 139.48 37.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.68 -0.408 . . . . 0.26 110.795 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -135.48 82.15 1.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.381 -0.372 . . . . 1.15 110.109 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.17 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.357 -0.838 . . . . 1.83 111.511 -175.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -121.28 -15.35 8.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 2.54 110.038 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -85.21 144.45 28.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.642 . . . . 0.87 110.344 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.932 HD11 HD11 ' B' ' 26' ' ' LEU . 18.4 mt -106.05 131.58 55.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.431 -0.804 . . . . 0.34 108.929 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 44' ' ' ILE . 17.9 mm -119.32 112.25 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.389 -0.369 . . . . 0.2 110.054 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -117.03 108.74 16.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.483 -0.562 . . . . 1.3 109.483 -178.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HB2' ' HG2' ' B' ' 42' ' ' LYS . 31.9 ttpt -103.18 134.89 45.84 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.813 -0.81 . . . . 1.41 108.813 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HA ' HD23 ' A' ' 34' ' ' LEU . 60.3 pttt -47.51 144.85 2.84 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 123.064 0.227 . . . . 2.68 110.623 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 . . . . . 0 N--CA 1.448 -0.57 0 N-CA-C 110.108 -0.33 . . . . 3.55 110.108 -177.795 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 69.1 m . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.659 0.266 . . . . 0.46 111.162 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.71 HG23 ' HD1' ' A' ' 37' ' ' TYR . 27.9 m 65.73 69.3 0.46 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.403 -0.817 . . . . 0.41 111.005 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.75 41.54 4.38 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.021 -0.99 . . . . 0.32 111.721 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tp -105.44 137.21 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.664 -0.495 . . . . 0.52 109.664 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.503 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 12.5 p -96.99 128.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.967 0.413 . . . . 0.37 110.356 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.45 156.59 48.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.29 -0.414 . . . . 1.74 110.638 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.8 mmpt? -82.0 161.01 23.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 1.23 110.624 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 1.7 t -84.3 -118.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.029 0.443 . . . . 0.39 110.146 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 17.3 t0 -171.91 -63.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.194 -0.669 . . . . 1.66 109.194 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.735 ' HG3' ' H ' ' B' ' 13' ' ' LEU . 4.2 pt-20 -169.59 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.909 . . . . 1.91 110.41 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.735 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -61.01 -29.64 69.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.405 -0.816 . . . . 0.72 112.564 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.88 -9.78 0.31 Allowed Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.992 -1.099 . . . . 0.31 112.974 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.1 mtt180 -60.78 106.0 0.52 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.02 0.378 . . . . 0.75 112.02 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 9.7 p -100.99 142.1 16.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.146 -0.479 . . . . 1.04 109.734 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.65 108.98 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.601 -0.272 . . . . 0.25 111.162 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 43' ' ' ILE . 3.4 mt -85.17 138.31 36.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.092 -0.336 . . . . 0.55 110.092 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.677 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 62.2 Cg_exo -43.16 136.6 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.395 2.73 . . . . 0.28 113.89 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -56.03 -33.42 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.82 110.813 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.73 -22.75 59.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.394 -0.366 . . . . 1.35 110.38 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -82.04 -47.17 12.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.33 -0.619 . . . . 0.33 109.33 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -64.98 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.723 -0.843 . . . . 1.48 108.723 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.7 -36.65 81.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.737 -1.119 . . . . 2.77 110.635 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 76.7 m -63.45 -36.03 82.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.529 0.68 . . . . 0.31 110.526 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.932 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -89.7 -10.61 45.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.338 -0.846 . . . . 0.24 109.777 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.22 15.77 68.12 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.34 112.698 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' B' ' 26' ' ' LEU . 15.5 pt -98.15 168.81 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.818 0.342 . . . . 0.47 111.247 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.44 146.66 0.28 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.309 -0.86 . . . . 0.22 109.835 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.3 pt-20 37.47 -89.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.299 1.592 . . . . 1.12 115.299 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HB2' ' B' ' 30' ' ' GLU . 10.8 mmpt? -75.23 4.91 6.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.515 0.561 . . . . 0.65 112.515 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -97.25 -177.99 4.02 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.086 -0.646 . . . . 1.37 110.896 -175.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -126.47 153.61 44.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.235 1.198 . . . . 0.22 114.235 -171.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' B' ' 47' ' ' LYS . 19.5 mt -127.02 153.68 45.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.186 -1.37 . . . . 1.23 108.024 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -106.41 104.76 14.53 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.204 -0.665 . . . . 1.4 109.204 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.631 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.94 124.5 45.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.52 0.676 . . . . 0.29 111.748 -175.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -126.46 162.95 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.079 -0.964 . . . . 4.28 108.658 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.27 140.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.019 0.437 . . . . 0.28 111.338 -171.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.31 78.87 1.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.588 . . . . 1.12 109.59 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.71 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.504 -1.225 . . . . 1.64 111.216 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -128.71 -13.62 4.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 2.81 110.391 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 24.0 mtpt -85.27 143.87 28.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.504 . . . . 0.98 109.748 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 26' ' ' LEU . 26.5 mt -104.25 132.5 50.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.927 -0.768 . . . . 0.42 108.927 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 44' ' ' ILE . 15.5 mm -120.53 108.89 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.1 -0.333 . . . . 0.25 110.1 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.631 ' HB3' HG13 ' B' ' 36' ' ' ILE . 0.1 OUTLIER -118.81 108.79 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.352 0.596 . . . . 1.29 110.629 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 28.7 ttpt -90.34 156.06 18.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.776 -1.194 . . . . 1.22 107.776 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' B' ' 34' ' ' LEU . 24.1 pttm -63.53 159.67 18.15 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.023 -0.671 . . . . 2.5 109.338 173.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 116.379 -0.373 . . . . 3.39 110.026 178.211 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 44.0 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.461 0.648 . . . . 0.48 112.102 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.7 m 71.73 60.58 0.15 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.749 -1.114 . . . . 0.48 111.382 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.09 36.29 3.2 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.439 -0.8 . . . . 0.32 112.131 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tp -105.15 134.92 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.905 0.383 . . . . 0.49 110.128 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 13.1 p -93.41 129.51 43.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.112 0.482 . . . . 0.37 111.36 -176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -129.81 165.82 21.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.96 110.814 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' B' ' 32' ' ' ASP . 7.5 tppt? -87.84 159.79 18.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.629 -0.714 . . . . 1.16 109.825 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.0 t -82.05 -118.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.716 -0.846 . . . . 0.44 108.716 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 20.3 t0 -174.79 -69.3 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.647 -0.501 . . . . 1.32 109.647 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.897 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.2 OUTLIER -154.98 -78.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.393 -0.821 . . . . 1.39 110.349 174.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.6 pt? -81.85 0.02 41.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.827 -1.079 . . . . 0.6 112.511 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.81 -21.05 3.59 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 120.076 -1.059 . . . . 0.34 113.143 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.1 mtt180 -53.49 106.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.066 0.433 . . . . 1.26 111.961 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 12.1 p -102.3 142.83 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.283 -0.417 . . . . 1.04 110.063 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' B' ' 15' ' ' ARG . 51.9 t -76.87 102.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.415 . . . . 0.25 111.939 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -70.67 132.36 87.26 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.62 110.414 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 99.3 Cg_exo -47.76 141.92 15.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.019 2.479 . . . . 0.31 113.016 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.35 -32.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.681 . . . . 0.86 110.117 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.53 -24.45 61.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.02 0.438 . . . . 1.73 110.146 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.6 mt -83.12 -48.69 10.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.504 -0.554 . . . . 0.44 109.504 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 22.6 ptt85 -64.5 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.408 -0.96 . . . . 1.92 108.408 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.5 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 14.4 ttt180 -58.88 -43.62 90.94 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.14 -0.936 . . . . 2.94 110.75 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -61.05 -32.76 72.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.34 110.31 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 2.5 mt -92.98 -9.53 39.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.003 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 28.01 69.61 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.28 112.635 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.713 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.2 pt -107.0 167.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.117 0.484 . . . . 0.43 111.626 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.54 150.89 1.44 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.1 -0.955 . . . . 0.26 110.2 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.856 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.2 pt-20 35.12 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.723 1.749 . . . . 1.22 115.723 173.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -80.01 5.63 13.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.022 0.749 . . . . 0.85 113.022 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.7 OUTLIER -81.73 177.81 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.866 0.365 . . . . 1.54 111.422 -177.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.36 151.33 42.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.993 -0.549 . . . . 0.23 112.151 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.7 mp -126.63 157.28 39.34 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.433 -0.951 . . . . 1.15 108.433 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -111.37 105.86 14.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.295 -0.632 . . . . 1.28 109.295 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.717 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -90.09 125.14 42.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.201 -0.909 . . . . 0.29 111.484 -176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.9 m-85 -114.55 173.97 6.19 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.459 -1.311 . . . . 4.3 107.459 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.85 142.2 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.563 -0.455 . . . . 0.26 110.294 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.85 77.23 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.885 -0.326 . . . . 1.15 110.435 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t70 57.79 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.619 1.199 . . . . 1.83 112.655 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.431 ' OE2' ' HG3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -117.19 7.16 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.52 -0.309 . . . . 2.54 111.351 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' B' ' 46' ' ' LYS . 35.6 mtmm -127.04 162.87 25.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.138 0.494 . . . . 0.87 111.41 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.653 HD13 HD12 ' B' ' 18' ' ' ILE . 54.0 mt -106.68 138.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.428 -0.805 . . . . 0.34 109.294 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' B' ' 44' ' ' ILE . 16.8 mm -125.78 106.13 15.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 109.705 -0.48 . . . . 0.2 109.705 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.5 OUTLIER -123.04 128.09 49.68 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.293 -0.963 . . . . 1.3 111.474 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' B' ' 42' ' ' LYS . 38.1 ttpt -121.96 145.94 47.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.999 -1.001 . . . . 1.41 108.328 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 60.2 pttt -48.41 143.04 5.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.114 0.259 . . . . 2.68 110.847 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.3 t80 . . . . . 0 N--CA 1.448 -0.53 0 N-CA-C 108.865 -0.791 . . . . 3.55 108.865 177.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 70.5 m . . . . . 0 N--CA 1.45 -0.469 0 CA-C-O 121.665 0.745 . . . . 0.46 112.128 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 7.8 m 66.82 66.16 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.651 -1.159 . . . . 0.41 111.302 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.64 34.45 4.97 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.606 -0.725 . . . . 0.32 112.403 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 tp -102.39 134.12 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.967 0.413 . . . . 0.52 110.342 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.2 p -94.66 127.03 46.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.129 0.49 . . . . 0.37 111.614 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.54 166.96 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.141 -0.481 . . . . 1.74 110.52 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.83 161.85 16.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 1.23 109.79 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 2.2 t -81.06 -109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.498 ' HB2' ' NE ' ' A' ' 15' ' ' ARG . 24.5 t70 176.65 -79.0 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.453 -0.573 . . . . 1.66 109.453 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.6 pt-20 -154.92 -81.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.521 -0.763 . . . . 1.91 110.024 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.603 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -65.49 -29.9 70.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.34 -0.845 . . . . 0.72 112.102 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.72 -9.81 0.32 Allowed Glycine 0 C--O 1.223 -0.587 0 C-N-CA 119.685 -1.245 . . . . 0.31 112.888 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 9.6 mtt180 -54.9 105.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.0 0.37 . . . . 0.75 112.0 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 12.7 p -98.72 141.44 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 1.04 110.132 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 15' ' ' ARG . 42.4 t -77.28 101.1 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.25 111.74 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 43' ' ' ILE . 26.0 mm -67.17 135.51 93.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.876 -0.602 . . . . 0.55 110.708 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' B' ' 22' ' ' LEU . 89.2 Cg_exo -49.85 137.64 35.02 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.846 2.364 . . . . 0.28 112.62 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 tt -57.86 -33.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.82 110.344 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -69.94 -27.34 64.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 1.35 110.276 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.3 mt -82.03 -48.41 11.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.33 109.457 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -68.29 -25.84 65.34 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.225 -1.028 . . . . 1.48 108.225 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.91 -37.48 75.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.619 -0.719 . . . . 2.77 110.742 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 98.2 m -61.35 -35.59 77.87 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.419 0.628 . . . . 0.31 110.503 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -89.27 -11.11 44.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.395 -0.82 . . . . 0.24 109.864 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.18 22.59 69.16 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.551 -0.75 . . . . 0.34 112.872 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.4 pt -101.95 167.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.173 0.511 . . . . 0.47 111.579 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.25 150.77 1.54 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.22 110.262 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.897 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.0 -89.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.725 1.75 . . . . 1.12 115.725 172.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.7 mmpt? -79.58 7.98 7.29 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.225 0.824 . . . . 0.65 113.225 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 71.6 m-20 -88.96 176.6 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.036 0.38 . . . . 1.37 111.06 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -121.43 150.91 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.536 0.684 . . . . 0.22 112.632 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.8 mp -123.02 156.21 35.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.964 -1.016 . . . . 1.23 109.256 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 43.7 mt-10 -108.77 105.42 14.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.805 -0.634 . . . . 1.4 109.385 175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.02 124.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.301 -0.863 . . . . 0.29 111.351 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 17.0 m-85 -113.57 174.78 5.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.517 -1.29 . . . . 4.28 107.517 172.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.45 142.96 42.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.598 -0.441 . . . . 0.28 110.158 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.58 78.12 1.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 1.12 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 60.02 -75.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.627 -1.169 . . . . 1.64 112.618 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -107.43 -25.58 11.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.957 0.408 . . . . 2.81 111.033 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 24.8 pttm -116.3 162.45 17.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.167 0.508 . . . . 0.98 111.919 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.858 ' HB ' HD12 ' A' ' 45' ' ' LEU . 59.9 mt -106.04 139.03 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.39 -0.823 . . . . 0.42 110.169 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -118.11 109.66 27.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 116.081 -0.509 . . . . 0.25 109.754 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.501 HD11 ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.39 116.88 28.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.433 -0.507 . . . . 1.29 110.146 -176.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.665 ' HB2' ' HG2' ' A' ' 42' ' ' LYS . 38.5 ttpt -116.88 139.8 50.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.702 -0.851 . . . . 1.22 108.702 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 63.2 pttt -47.69 147.59 1.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.202 0.314 . . . . 2.5 110.939 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 78.6 t80 . . . . . 0 C--N 1.324 -0.504 0 N-CA-C 109.112 -0.699 . . . . 3.39 109.112 176.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.592 0.71 . . . . 0.48 112.32 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.654 HG23 ' HD1' ' B' ' 37' ' ' TYR . 25.1 m 72.0 71.6 0.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.573 -1.194 . . . . 0.48 111.313 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.42 38.99 6.09 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.332 -0.849 . . . . 0.32 111.879 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.51 136.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.706 -0.479 . . . . 0.49 109.706 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 11.2 p -95.84 127.3 48.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.902 0.382 . . . . 0.37 110.938 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -125.96 161.13 28.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.344 -0.389 . . . . 1.96 110.671 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -81.45 161.09 23.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.218 -0.66 . . . . 1.16 109.218 175.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.0 t -80.21 -108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.564 -0.532 . . . . 0.44 109.564 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.491 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 26.9 t70 175.26 -67.29 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.02 -0.733 . . . . 1.32 109.02 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.4 pt-20 -158.47 -86.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.939 -1.028 . . . . 1.39 109.986 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.604 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -77.24 -27.73 53.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.6 112.112 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.49 -0.33 0.06 OUTLIER Glycine 0 C--O 1.225 -0.464 0 C-N-CA 119.483 -1.342 . . . . 0.34 114.461 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.9 ttt180 -66.81 99.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.495 1.148 . . . . 1.26 111.578 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 19.0 m -96.46 144.58 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 1.04 110.386 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' B' ' 15' ' ' ARG . 41.4 t -82.0 107.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.302 -0.408 . . . . 0.25 111.178 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' O ' ' B' ' 14' ' ' GLY . 3.6 mt -79.9 139.24 53.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 110.186 -0.302 . . . . 0.62 110.186 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 70.8 Cg_exo -46.33 140.03 11.82 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.422 2.748 . . . . 0.31 113.839 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 6.7 tp -58.19 -32.84 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.86 110.443 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -72.81 -23.03 60.73 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.406 -0.361 . . . . 1.73 110.419 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.705 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.3 mt -83.37 -46.48 12.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.297 0.57 . . . . 0.44 109.858 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -64.13 -31.37 72.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 1.92 108.011 176.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -38.48 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.966 -1.016 . . . . 2.94 111.605 173.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -60.66 -36.54 78.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.542 0.687 . . . . 0.34 110.473 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.942 HD11 HD11 ' B' ' 43' ' ' ILE . 1.9 mt -89.28 -9.22 51.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.464 -0.789 . . . . 0.26 109.713 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.13 29.37 70.91 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.257 -0.883 . . . . 0.28 112.118 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.3 pt -110.12 167.29 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.189 0.518 . . . . 0.43 111.124 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -179.68 154.87 0.62 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.727 -1.124 . . . . 0.26 109.22 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.1 pt-20 37.82 -89.46 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.904 1.446 . . . . 1.22 114.904 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.1 5.11 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.493 0.553 . . . . 0.85 112.493 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.537 ' O ' HG23 ' B' ' 10' ' ' VAL . 2.7 m-20 -87.67 172.73 9.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.81 0.338 . . . . 1.54 110.419 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -117.37 149.04 41.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.353 0.597 . . . . 0.23 111.692 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 47' ' ' LYS . 14.1 tp -126.21 149.33 49.12 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.984 -1.117 . . . . 1.15 107.984 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -107.03 106.03 16.35 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.209 0.528 . . . . 1.28 110.049 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 1.017 HG13 HD22 ' A' ' 45' ' ' LEU . 1.7 mp -94.14 125.73 46.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.29 111.312 -173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.737 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -126.97 160.97 29.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.453 -0.794 . . . . 4.3 109.555 175.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.83 138.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.84 0.352 . . . . 0.26 110.794 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.59 81.69 2.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.788 -0.449 . . . . 1.15 109.788 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 2.5 t70 58.55 -82.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.704 -1.135 . . . . 1.83 111.454 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 24.3 mt-10 -114.08 -19.62 11.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 2.54 111.018 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -92.73 159.03 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.87 110.242 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.868 HD11 HD11 ' B' ' 26' ' ' LEU . 26.7 mt -110.28 133.54 55.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.843 -0.617 . . . . 0.34 109.367 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.737 ' HB ' ' HD1' ' A' ' 37' ' ' TYR . 17.9 mm -121.21 115.44 46.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.829 -0.434 . . . . 0.2 109.829 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.03 118.91 35.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.546 -0.538 . . . . 1.3 109.546 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 30.7 ttpt -112.35 148.65 33.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.117 -1.438 . . . . 1.41 107.117 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.837 ' HA ' HD12 ' A' ' 34' ' ' LEU . 84.5 tttt -56.69 149.66 17.44 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.491 -0.559 . . . . 2.68 109.491 174.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 33' ' ' ALA . 17.3 p90 . . . . . 0 N--CA 1.448 -0.528 0 N-CA-C 108.38 -0.97 . . . . 3.55 108.38 177.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 46.8 m . . . . . 0 N--CA 1.451 -0.387 0 CA-C-O 121.488 0.661 . . . . 0.46 112.497 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 37' ' ' TYR . 25.0 m 71.94 70.58 0.16 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.638 -1.164 . . . . 0.41 111.79 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.39 39.18 6.05 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.32 111.796 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.41 137.23 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.374 -0.602 . . . . 0.52 109.374 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.527 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 10.0 p -95.61 127.99 47.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 120.958 0.408 . . . . 0.37 110.41 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.66 159.93 30.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.155 -0.475 . . . . 1.74 110.316 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -81.42 157.55 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.926 -0.768 . . . . 1.23 108.926 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 32' ' ' ASP . 3.1 t -76.73 -104.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.577 -0.527 . . . . 0.39 109.577 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.414 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 23.5 t0 170.2 -71.04 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.879 -0.786 . . . . 1.66 108.879 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.1 pt-20 -154.45 -83.51 0.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 1.91 110.173 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.5 pt? -84.13 -22.33 31.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.38 -0.827 . . . . 0.72 112.434 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 159.42 -4.74 0.11 Allowed Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.477 -1.344 . . . . 0.31 113.871 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 2.1 ttt180 -66.77 96.98 0.43 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.926 0.863 . . . . 0.75 111.513 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 24.7 m -94.42 144.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.012 -0.54 . . . . 1.04 110.43 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 15' ' ' ARG . 46.4 t -81.75 107.75 14.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.342 -0.39 . . . . 0.25 111.073 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.534 HD13 HD13 ' A' ' 43' ' ' ILE . 8.6 mt -82.14 138.16 45.83 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.485 -0.325 . . . . 0.55 110.611 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.51 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 70.6 Cg_exo -44.67 140.44 6.48 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.61 2.873 . . . . 0.28 113.969 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 5.3 tp -57.68 -34.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.105 -0.952 . . . . 0.82 110.611 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . 0.433 ' O ' ' HB3' ' B' ' 24' ' ' ARG . 7.8 pt-20 -71.11 -24.29 62.26 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 109.962 -0.384 . . . . 1.35 109.962 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.0 mt -83.51 -46.35 12.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.33 109.708 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' B' ' 28' ' ' ILE . 2.9 ppt_? -64.73 -31.57 72.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.866 -1.161 . . . . 1.48 107.866 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 31.3 ttt180 -59.29 -46.73 87.76 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 114.81 -1.086 . . . . 2.77 111.164 170.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.1 m -58.49 -35.33 72.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.313 0.578 . . . . 0.31 111.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -90.22 -10.33 44.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.488 -0.778 . . . . 0.24 109.917 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.22 63.66 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.531 -0.758 . . . . 0.34 112.768 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.678 HG12 ' HB2' ' B' ' 26' ' ' LEU . 13.3 pt -101.49 167.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.408 . . . . 0.47 111.126 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . 0.45 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -178.03 152.71 0.75 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.102 -0.953 . . . . 0.22 109.548 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.8 pt-20 34.36 -90.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.126 1.528 . . . . 1.12 115.126 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -75.89 5.07 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.985 0.735 . . . . 0.65 112.985 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.0 m-20 -91.76 176.41 6.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.891 -0.506 . . . . 1.37 111.335 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -116.65 150.68 37.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.639 -0.709 . . . . 0.22 112.167 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 47' ' ' LYS . 14.0 tp -128.36 150.67 50.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.219 -1.03 . . . . 1.23 108.219 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -106.35 107.25 18.16 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.607 -0.516 . . . . 1.4 109.607 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 1.033 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -94.53 124.1 46.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.992 -0.549 . . . . 0.29 111.291 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.825 ' HD2' ' HB ' ' B' ' 44' ' ' ILE . 0.3 OUTLIER -123.58 159.61 28.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.639 -0.71 . . . . 4.28 109.513 175.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.89 136.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.954 0.407 . . . . 0.28 110.622 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.47 79.9 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 1.12 109.557 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 57.02 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.858 -1.064 . . . . 1.64 111.507 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.63 -3.33 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.964 -0.562 . . . . 2.81 111.104 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -102.82 158.76 16.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.58 -0.526 . . . . 0.98 109.58 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 26' ' ' LEU . 22.7 mt -111.8 133.51 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.431 -0.581 . . . . 0.42 109.431 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HD2' ' B' ' 37' ' ' TYR . 18.3 mm -123.99 116.1 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.765 -0.458 . . . . 0.25 109.765 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.71 117.57 30.65 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.565 -0.454 . . . . 1.29 109.942 -177.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 18.8 ttpt -111.25 142.03 44.0 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.224 -1.028 . . . . 1.22 108.224 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' B' ' 34' ' ' LEU . 79.3 tttt -49.97 141.95 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.227 -0.286 . . . . 2.5 110.227 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 11.8 p90 . . . . . 0 C--O 1.234 0.289 0 N-CA-C 109.614 -0.513 . . . . 3.39 109.614 -177.482 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m . . . . . 0 N--CA 1.442 -0.871 0 CA-C-O 121.456 0.646 . . . . 0.48 111.065 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' HD1' ' B' ' 37' ' ' TYR . 11.5 m 70.79 68.22 0.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.903 -1.044 . . . . 0.48 111.683 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' B' ' 35' ' ' GLU . . . 91.89 37.66 5.99 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.31 -0.859 . . . . 0.32 111.894 174.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tp -104.14 135.76 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.767 -0.457 . . . . 0.49 109.767 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.615 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.8 p -90.67 124.79 43.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.996 0.427 . . . . 0.37 110.797 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.69 159.58 27.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.277 -0.419 . . . . 1.96 110.525 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 1.1 tpmt? -83.58 158.32 21.98 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.89 -0.781 . . . . 1.16 108.89 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.4 t -78.61 -105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.055 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.578 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 14.4 t70 175.32 -78.03 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.448 -0.575 . . . . 1.32 109.448 -173.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER -161.59 -77.71 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 1.39 109.679 172.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.7 pt? -72.66 -18.37 61.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.036 -0.984 . . . . 0.6 112.358 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.86 -21.32 1.0 Allowed Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.018 -1.087 . . . . 0.34 113.76 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.705 ' HD3' ' HB2' ' B' ' 11' ' ' ASP . 6.8 ttm180 -51.92 104.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.381 0.591 . . . . 1.26 112.433 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 14.9 p -97.11 143.22 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.951 -0.389 . . . . 1.04 109.951 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.2 t -77.14 105.9 6.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.25 111.597 -175.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.477 HD12 HG21 ' B' ' 43' ' ' ILE . 35.8 mm -77.42 134.82 65.93 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.62 110.218 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' HD12 ' A' ' 22' ' ' LEU . 87.3 Cg_exo -48.81 140.45 23.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.122 2.548 . . . . 0.31 113.199 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.4 tt -60.76 -33.3 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.86 110.339 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.04 -24.41 63.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.166 0.508 . . . . 1.73 109.725 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.78 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mt -82.05 -49.81 9.79 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.792 -0.64 . . . . 0.44 109.415 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -64.88 -34.6 78.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.624 -0.88 . . . . 1.92 108.624 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -44.36 85.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.241 -0.89 . . . . 2.94 111.129 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.2 m -63.14 -33.15 74.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.309 0.576 . . . . 0.34 110.956 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.845 HD11 HD11 ' B' ' 43' ' ' ILE . 3.1 mt -88.09 -12.91 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.918 -0.583 . . . . 0.26 110.036 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.56 76.71 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.28 112.17 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.692 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.3 pt -108.13 167.34 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.43 111.26 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.55 152.67 0.66 Allowed 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 0.26 109.674 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.826 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.3 pt-20 37.65 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.566 1.691 . . . . 1.22 115.566 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.445 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.17 7.02 12.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.704 0.631 . . . . 0.85 112.704 -172.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' B' ' 10' ' ' VAL . 28.6 m-20 -87.27 177.89 7.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 1.54 111.433 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -121.57 146.89 46.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.226 0.824 . . . . 0.23 113.226 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.0 mp -124.16 156.48 36.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 1.15 108.455 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.69 107.61 18.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.583 -0.525 . . . . 1.28 109.583 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.981 HG13 HD12 ' A' ' 45' ' ' LEU . 1.8 mp -90.3 120.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.599 0.714 . . . . 0.29 110.698 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.742 ' HD1' HG23 ' B' ' 4' ' ' THR . 1.0 OUTLIER -123.14 158.13 31.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.094 -0.957 . . . . 4.3 109.012 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.73 137.72 45.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.26 110.779 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 83.04 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 1.15 110.857 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 t70 63.53 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.793 -1.094 . . . . 1.83 111.817 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.33 9.62 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.006 -0.543 . . . . 2.54 111.255 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -118.84 158.64 25.25 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.322 -0.399 . . . . 0.87 109.978 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 26' ' ' LEU . 15.9 mt -110.06 138.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.263 -0.426 . . . . 0.34 109.89 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 44' ' ' ILE . 11.4 mm -122.79 115.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.443 -0.344 . . . . 0.2 110.268 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -114.36 117.08 30.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.876 -0.73 . . . . 1.3 109.092 176.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -107.62 126.8 53.02 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.028 -0.73 . . . . 1.41 109.028 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 59.3 pttt -44.71 139.48 2.92 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.255 0.347 . . . . 2.68 111.148 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 t80 . . . . . 0 N--CA 1.447 -0.588 0 N-CA-C 108.71 -0.848 . . . . 3.55 108.71 173.147 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 75.2 m . . . . . 0 C--O 1.233 0.187 0 N-CA-C 108.858 -0.793 . . . . 0.46 108.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' THR . . . . . 0.742 HG23 ' HD1' ' A' ' 37' ' ' TYR . 35.4 m 64.68 70.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.594 0.711 . . . . 0.41 111.317 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.08 38.15 5.49 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.773 -0.727 . . . . 0.32 112.255 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tp -104.6 133.81 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.628 -0.508 . . . . 0.52 109.628 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 11.0 p -92.0 117.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.529 0.68 . . . . 0.37 111.486 -172.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -109.73 159.61 17.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 1.74 110.209 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 155.93 20.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.233 -1.025 . . . . 1.23 108.233 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 34' ' ' LEU . 2.2 t -78.24 -111.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.497 -0.557 . . . . 0.39 109.497 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ASP . . . . . 0.705 ' HB2' ' HD3' ' A' ' 15' ' ' ARG . 26.4 t0 179.88 -68.94 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.4 -0.592 . . . . 1.66 109.4 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' GLU . . . . . 0.826 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.3 pt-20 -160.38 -83.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.819 . . . . 1.91 110.563 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' LEU . . . . . 0.545 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -74.45 -16.13 60.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.031 -0.986 . . . . 0.72 112.198 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.22 -16.79 1.16 Allowed Glycine 0 C--O 1.221 -0.66 0 C-N-CA 119.911 -1.137 . . . . 0.31 113.05 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.9 mtt180 -52.48 111.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.788 0.294 . . . . 0.75 111.75 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.5 p -105.14 142.09 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.721 -0.474 . . . . 1.04 109.721 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' VAL . . . . . 0.479 ' HB ' ' HG2' ' B' ' 8' ' ' ARG . 48.6 t -77.65 108.53 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 0.25 112.019 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.561 HD12 HD13 ' A' ' 43' ' ' ILE . 19.9 mm -76.28 135.65 69.35 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.942 -0.572 . . . . 0.55 110.422 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' PRO . . . . . 0.714 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.06 139.89 25.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.987 2.458 . . . . 0.28 113.215 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.579 HG13 ' HE ' ' B' ' 23' ' ' ARG . 12.3 tt -59.87 -33.6 53.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.587 -0.733 . . . . 0.82 110.707 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.55 -22.98 59.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.105 0.478 . . . . 1.35 110.251 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.2 mt -80.38 -48.47 12.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.957 -0.757 . . . . 0.33 108.957 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ARG . . . . . 0.579 ' HE ' HG13 ' B' ' 20' ' ' ILE . 15.0 ptt180 -65.58 -33.71 76.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.936 -0.765 . . . . 1.48 108.936 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ARG . . . . . 0.457 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 33.9 ttp180 -64.78 -37.83 88.93 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.409 -0.814 . . . . 2.77 110.495 175.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 95.7 m -63.83 -34.34 77.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.31 110.422 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 43' ' ' ILE . 3.1 mt -88.72 -10.36 48.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.48 0.657 . . . . 0.24 109.572 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.27 77.06 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 114.889 -1.051 . . . . 0.34 112.282 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ILE . . . . . 0.641 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.0 pt -111.67 166.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.932 0.396 . . . . 0.47 111.196 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.85 148.67 0.54 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.224 -0.898 . . . . 0.22 110.182 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.0 pt-20 35.85 -87.23 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.293 1.59 . . . . 1.12 115.293 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -75.04 5.11 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.075 0.769 . . . . 0.65 113.075 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ASP . . . . . 0.579 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 3.2 m-20 -86.67 173.74 9.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 1.37 111.636 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -118.28 144.86 45.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.621 -0.718 . . . . 0.22 112.401 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' LEU . . . . . 0.831 HD23 ' HA ' ' B' ' 47' ' ' LYS . 15.9 mt -124.77 152.27 44.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.846 -1.168 . . . . 1.23 107.846 174.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 19.3 tt0 -106.78 104.84 14.62 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.167 -0.679 . . . . 1.4 109.167 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ILE . . . . . 0.951 HG13 HD12 ' B' ' 45' ' ' LEU . 1.9 mp -90.26 121.39 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.346 0.593 . . . . 0.29 110.971 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' TYR . . . . . 0.601 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -127.21 158.64 36.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.358 -0.837 . . . . 4.28 109.498 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.0 p -110.94 138.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.626 -0.429 . . . . 0.28 111.221 -173.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.47 77.94 1.78 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.12 110.336 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 t70 58.56 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.504 -1.225 . . . . 1.64 112.384 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -115.58 -10.74 11.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 2.81 110.924 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -109.84 157.6 19.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.98 110.667 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 26' ' ' LEU . 12.1 mt -109.84 137.5 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.016 -0.538 . . . . 0.42 109.83 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 44' ' ' ILE . 10.1 mm -123.61 115.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.457 -0.338 . . . . 0.25 110.214 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' LEU . . . . . 0.951 HD12 HG13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -112.9 111.94 23.05 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.29 108.886 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.31 128.65 47.37 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.084 -0.71 . . . . 1.22 109.084 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LYS . . . . . 0.831 ' HA ' HD23 ' B' ' 34' ' ' LEU . 55.0 pttt -44.86 138.92 3.29 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.281 0.363 . . . . 2.5 111.407 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 t80 . . . . . 0 N--CA 1.447 -0.596 0 N-CA-C 108.853 -0.795 . . . . 3.39 108.853 173.723 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.2 mmt . . . . . 0 N--CA 1.481 1.109 0 N-CA-C 109.648 -0.501 . . . . 4.93 109.648 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.877 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -131.26 -85.6 0.5 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 120.994 -0.282 . . . . 1.67 111.585 179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.877 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 75.7 m -147.51 -170.9 3.67 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.818 -0.808 . . . . 0.48 108.818 -177.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.655 HG23 ' HD1' ' B' ' 37' ' ' TYR . 59.4 m 63.32 75.41 0.4 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.813 0.815 . . . . 0.48 111.311 177.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 84.61 35.97 12.82 Favored Glycine 0 N--CA 1.438 -1.203 0 CA-C-N 115.271 -0.877 . . . . 0.32 111.339 174.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 tp -104.71 134.54 45.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 109.745 -0.465 . . . . 0.49 109.745 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -86.99 125.66 40.88 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 CA-C-O 120.988 0.423 . . . . 0.37 111.384 -173.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -123.44 155.86 36.63 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.369 -0.378 . . . . 1.96 110.863 177.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.636 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.1 mmpt? -82.34 162.57 22.19 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.881 -0.414 . . . . 1.16 109.881 177.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.531 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.5 t -85.05 -108.83 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 120.772 -0.371 . . . . 0.44 110.231 177.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.583 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 19.5 t70 177.26 -74.65 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.326 0 N-CA-C 108.98 -0.748 . . . . 1.32 108.98 -174.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.921 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.9 OUTLIER -161.57 -80.55 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.942 -1.026 . . . . 1.39 109.686 171.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.535 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -68.4 -32.78 73.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.774 -1.103 . . . . 0.6 111.302 -177.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.78 -16.31 0.11 Allowed Glycine 0 C--O 1.221 -0.659 0 C-N-CA 119.879 -1.153 . . . . 0.34 113.947 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.649 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.36 103.09 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 117.584 0.692 . . . . 1.26 111.867 -176.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.714 HG11 HD13 ' B' ' 45' ' ' LEU . 13.4 p -96.55 140.24 17.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.866 -0.42 . . . . 1.04 109.866 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.497 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.4 t -77.76 101.75 3.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.267 -0.424 . . . . 0.25 111.323 -176.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 32.8 mm -71.7 129.06 88.89 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-N 115.818 -0.628 . . . . 0.62 110.229 174.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.683 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 57.2 Cg_exo -45.5 139.09 10.08 Favored 'Trans proline' 0 C--O 1.237 0.449 0 C-N-CA 123.387 2.725 . . . . 0.31 113.407 174.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.675 ' HA ' ' HE ' ' A' ' 23' ' ' ARG . 8.6 tt -57.03 -33.26 42.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.757 -0.656 . . . . 0.86 110.827 176.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -73.2 -24.86 60.58 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.098 0.475 . . . . 1.73 110.472 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.701 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 10.5 mt -81.49 -48.09 12.3 Favored 'General case' 0 N--CA 1.443 -0.776 0 N-CA-C 109.402 -0.592 . . . . 0.44 109.402 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HE ' ' HA ' ' A' ' 20' ' ' ILE . 12.2 ptt180 -64.7 -33.81 76.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.083 -0.71 . . . . 1.92 109.083 177.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 29.5 ttm180 -61.76 -40.38 94.96 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-N 115.281 -0.872 . . . . 2.94 110.677 174.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 97.6 m -61.12 -38.36 86.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.205 0.526 . . . . 0.34 110.634 177.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.739 HD11 HD11 ' B' ' 43' ' ' ILE . 2.2 mt -87.14 -10.67 52.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.697 -0.683 . . . . 0.26 109.704 -174.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.98 25.83 71.02 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 115.377 -0.829 . . . . 0.28 112.466 -174.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.683 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.5 pt -106.71 167.0 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.134 0.493 . . . . 0.43 111.606 -177.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.476 ' H ' ' HB2' ' A' ' 32' ' ' ASP . . . -177.32 152.84 0.88 Allowed 'General case' 0 CA--C 1.51 -0.57 0 CA-C-N 114.883 -1.053 . . . . 0.26 109.549 176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.0 pt-20 32.4 -89.47 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 115.779 1.77 . . . . 1.22 115.779 174.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.7 mmpt? -77.27 -0.43 25.34 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 112.746 0.647 . . . . 0.85 112.746 -171.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.51 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.9 OUTLIER -81.94 174.67 11.05 Favored 'General case' 0 CA--C 1.513 -0.47 0 CA-C-O 121.007 0.432 . . . . 1.54 110.535 -178.68 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.93 152.59 42.28 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.405 0.621 . . . . 0.23 112.499 -177.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.3 mp -120.04 152.51 37.43 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.91 -1.041 . . . . 1.15 109.204 175.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -101.53 100.14 10.53 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 108.514 -0.921 . . . . 1.28 108.514 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.611 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -91.13 123.74 43.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.347 0.594 . . . . 0.29 111.352 -174.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.665 ' HD1' HG23 ' B' ' 4' ' ' THR . 3.4 t80 -126.24 163.4 23.27 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.317 -0.856 . . . . 4.3 108.721 175.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.3 p -119.91 139.25 47.85 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 C-N-CA 120.706 -0.398 . . . . 0.26 110.686 -173.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -127.4 81.26 2.01 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.345 -0.388 . . . . 1.15 110.335 -178.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 23.4 t70 55.26 -80.73 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.535 0 CA-C-N 114.637 -1.165 . . . . 1.83 112.843 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.54 3.68 19.7 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.08 0.4 . . . . 2.54 112.08 -173.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -143.38 170.79 15.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.365 0.602 . . . . 0.87 112.611 179.45 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HD11 ' B' ' 26' ' ' LEU . 31.5 mt -106.58 139.06 29.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 114.973 -1.012 . . . . 0.34 110.257 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.655 HD12 HD12 ' B' ' 44' ' ' ILE . 22.4 mm -121.64 107.07 19.26 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 N-CA-C 109.458 -0.571 . . . . 0.2 109.458 -178.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.611 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -122.6 118.55 28.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.912 0.863 . . . . 1.3 111.362 -178.349 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.493 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 32.9 ttpt -102.64 165.43 11.08 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 114.197 -1.365 . . . . 1.41 107.932 175.282 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 57.5 pttt -66.43 147.91 52.62 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.524 -0.917 . . . . 2.68 108.524 170.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -65.2 137.57 57.69 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 120.173 -0.611 . . . . 3.55 109.402 178.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.573 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.52 111.28 7.65 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.576 -0.527 . . . . 3.38 109.576 -178.473 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.573 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 92.0 Cg_endo -74.33 119.13 5.64 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.505 2.137 . . . . 1.58 112.211 -175.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -86.71 77.69 9.27 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.46 0.648 . . . . 3.85 109.33 177.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.442 ' HG2' ' HB2' ' A' ' 50' ' ' PRO . 79.0 mmm -117.03 122.65 44.79 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.409 -0.814 . . . . 5.0 109.705 -176.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.249 1.065 0 CA-C-O 119.21 -0.424 . . . . 6.13 110.133 179.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.48 1.074 0 CA-C-O 120.803 0.335 . . . . 5.41 111.461 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.466 ' HE3' ' HB2' ' B' ' 2' ' ' LYS . 15.1 ptmt -103.04 -163.77 1.02 Allowed 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.027 -0.731 . . . . 1.29 109.027 171.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -67.31 -177.67 0.73 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-O 121.615 0.722 . . . . 0.46 112.255 179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.665 HG23 ' HD1' ' A' ' 37' ' ' TYR . 60.9 m 78.79 72.61 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 114.283 -1.326 . . . . 0.41 111.345 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 85.92 36.53 10.12 Favored Glycine 0 N--CA 1.441 -1.031 0 CA-C-N 114.983 -1.008 . . . . 0.32 111.28 174.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.8 tp -107.3 137.6 37.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.102 0.477 . . . . 0.52 109.931 -177.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 6.6 p -88.17 129.39 39.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 116.278 -0.419 . . . . 0.37 111.163 -173.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.418 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 2.5 mpt_? -126.43 155.91 41.44 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.729 -0.214 . . . . 1.74 111.074 175.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.691 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.4 mmpt? -81.28 162.38 23.51 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.847 -0.427 . . . . 1.23 109.847 176.052 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.516 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 2.5 t -86.16 -103.05 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 CA-C-O 121.117 0.484 . . . . 0.39 110.513 178.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.516 ' H ' ' HB ' ' B' ' 10' ' ' VAL . 6.6 t70 172.91 -76.1 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.794 -0.817 . . . . 1.66 108.794 -171.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.2 pt-20 -166.65 -76.8 0.03 OUTLIER 'General case' 0 CA--C 1.506 -0.722 0 CA-C-N 114.693 -1.14 . . . . 1.91 108.754 170.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.655 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.3 pp -76.8 -6.16 51.16 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.435 -1.711 . . . . 0.72 112.644 -175.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 136.35 -16.02 3.89 Favored Glycine 0 C--O 1.221 -0.657 0 C-N-CA 119.317 -1.421 . . . . 0.31 113.692 172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.666 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 4.4 ttt180 -56.17 99.93 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 117.334 0.567 . . . . 0.75 111.6 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.0 p -93.83 139.89 17.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.159 -0.473 . . . . 1.04 109.955 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.448 HG22 ' HG3' ' A' ' 15' ' ' ARG . 25.6 t -79.99 100.52 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 120.903 0.383 . . . . 0.25 111.63 -173.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 43' ' ' ILE . 36.8 mm -68.74 131.94 91.02 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 115.877 -0.601 . . . . 0.55 110.79 175.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.539 ' HD2' HD12 ' B' ' 22' ' ' LEU . 93.5 Cg_exo -48.23 139.03 22.23 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 123.269 2.646 . . . . 0.28 113.279 173.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 14.3 tt -58.03 -32.17 43.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 0.82 110.851 176.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' B' ' 2' ' ' LYS . 18.1 pt-20 -72.43 -25.05 61.32 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.149 0.499 . . . . 1.35 110.037 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.772 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -81.81 -48.41 11.62 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-N 115.84 -0.618 . . . . 0.33 109.537 -176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.95 -30.34 71.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.847 -0.797 . . . . 1.48 108.847 177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 42.7 ttm180 -68.04 -39.34 83.09 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.264 -0.88 . . . . 2.77 111.217 174.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 96.7 m -60.71 -38.09 83.88 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-O 121.391 0.615 . . . . 0.31 110.417 176.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.772 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -87.44 -10.71 51.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.44 -0.8 . . . . 0.24 109.742 -174.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 30.52 75.11 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.217 -0.901 . . . . 0.34 112.647 -174.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.663 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.9 pt -110.75 166.91 5.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-O 121.094 0.474 . . . . 0.47 111.141 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.41 150.71 1.47 Allowed 'General case' 0 CA--C 1.508 -0.643 0 CA-C-N 114.978 -1.01 . . . . 0.22 110.391 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.921 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.6 pt-20 34.65 -87.3 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.437 0 N-CA-C 115.43 1.641 . . . . 1.12 115.43 171.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -70.41 -11.88 61.21 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.485 0.55 . . . . 0.65 112.485 -173.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.531 ' O ' HG23 ' A' ' 10' ' ' VAL . 18.9 m-20 -78.75 177.13 8.91 Favored 'General case' 0 CA--C 1.515 -0.399 0 CA-C-O 121.165 0.507 . . . . 1.37 111.443 -173.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -125.18 155.47 39.95 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 121.675 0.75 . . . . 0.22 112.577 -178.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.8 mp -121.99 154.85 36.68 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.63 -1.168 . . . . 1.23 108.8 173.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.843 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 40.6 mt-10 -102.48 104.3 14.73 Favored 'General case' 0 C--N 1.315 -0.927 0 N-CA-C 109.169 -0.678 . . . . 1.4 109.169 174.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.989 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -89.83 123.29 41.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.857 -0.61 . . . . 0.29 110.953 -174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.655 ' HD1' HG23 ' A' ' 4' ' ' THR . 3.8 t80 -124.3 158.82 31.67 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 109.115 -0.698 . . . . 4.28 109.115 176.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.8 p -115.29 137.18 49.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 C-N-CA 120.811 -0.356 . . . . 0.28 110.495 -174.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . 0.537 ' HB3' ' HG3' ' B' ' 42' ' ' LYS . 37.0 t70 -128.76 82.46 2.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.122 0.487 . . . . 1.12 111.108 -176.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 8.3 t70 61.19 -85.92 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.949 -1.023 . . . . 1.64 112.322 176.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.44 9.46 15.52 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.579 -0.737 . . . . 2.81 111.042 -175.515 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.657 ' HD2' HD11 ' B' ' 44' ' ' ILE . 0.0 OUTLIER -138.41 169.16 18.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-N 116.139 -0.482 . . . . 0.98 111.206 -177.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.739 HD11 HD11 ' A' ' 26' ' ' LEU . 17.3 mt -115.26 139.47 41.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.643 -0.708 . . . . 0.42 110.625 179.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.657 HD11 ' HD2' ' B' ' 42' ' ' LYS . 19.6 mm -117.71 116.0 50.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 109.527 -0.545 . . . . 0.25 109.527 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.989 HD22 HG13 ' B' ' 36' ' ' ILE . 1.0 OUTLIER -115.89 110.41 18.97 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.287 -0.565 . . . . 1.29 109.806 -179.603 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -95.83 162.06 13.75 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.0 -1.111 . . . . 1.22 108.0 172.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 56.5 pttt -66.82 148.27 52.16 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 108.813 -0.81 . . . . 2.5 108.813 169.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.843 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 76.3 t80 -65.82 125.69 26.13 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.673 -0.862 . . . . 3.39 108.673 173.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.844 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -68.4 112.5 11.21 Favored Pre-proline 0 N--CA 1.45 -0.465 0 N-CA-C 109.722 -0.473 . . . . 3.18 109.722 -179.454 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.844 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 76.6 Cg_endo -73.35 124.41 9.41 Favored 'Trans proline' 0 N--CA 1.455 -0.769 0 C-N-CA 122.695 2.263 . . . . 1.56 112.375 -174.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -89.87 76.95 7.06 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.794 -0.639 . . . . 3.92 109.474 177.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 97.1 mmm -123.1 113.83 19.53 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.874 -0.603 . . . . 5.19 110.458 -177.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 3.5 t . . . . . 0 C--O 1.247 0.927 0 CA-C-N 116.057 -0.52 . . . . 6.34 110.233 -179.838 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' O ' ' HB3' ' A' ' 2' ' ' LYS . 23.4 mmt . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 110.054 -0.35 . . . . 4.93 110.054 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.439 ' HB3' ' O ' ' A' ' 1' ' ' MET . 11.2 tptm 69.9 144.6 0.05 Allowed 'General case' 0 C--O 1.234 0.239 0 O-C-N 123.866 0.729 . . . . 1.67 110.879 -176.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 43.4 m -72.54 -163.59 0.13 Allowed 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.506 -0.77 . . . . 0.48 111.066 179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.0 m 68.86 56.18 0.43 Allowed 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.18 -0.918 . . . . 0.48 110.931 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.58 34.32 2.48 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.462 -0.79 . . . . 0.32 112.362 176.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.5 tp -105.19 136.68 38.02 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.752 0 CA-C-O 120.928 0.394 . . . . 0.49 110.086 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.528 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.2 p -90.67 128.5 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-O 120.946 0.403 . . . . 0.37 110.691 -176.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.8 mpt_? -125.96 157.12 38.59 Favored 'General case' 0 C--N 1.326 -0.423 0 O-C-N 122.171 -0.33 . . . . 1.96 110.497 176.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 1.6 tpmt? -93.35 158.39 15.76 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.123 -0.325 . . . . 1.16 110.123 -178.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.547 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.3 t -82.93 -143.43 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 N-CA-C 109.031 -0.729 . . . . 0.44 109.031 174.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.4 ' H ' HG12 ' A' ' 10' ' ' VAL . 14.7 t0 -153.96 -62.5 0.14 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.443 -0.577 . . . . 1.32 109.443 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.584 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.3 pt-20 -157.2 -85.34 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.131 -0.94 . . . . 1.39 109.775 175.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -74.18 -15.47 61.01 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.768 -1.105 . . . . 0.6 111.759 -173.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 152.68 -20.74 0.8 Allowed Glycine 0 C--O 1.222 -0.647 0 C-N-CA 119.853 -1.165 . . . . 0.34 114.063 178.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.645 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 4.3 ttt180 -52.9 106.41 0.16 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.104 0.952 . . . . 1.26 111.976 -174.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -101.84 141.6 17.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.395 -0.82 . . . . 1.04 109.433 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.559 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.55 100.08 3.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 116.305 -0.407 . . . . 0.25 111.452 -175.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 45.7 mm -69.07 133.43 89.84 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 116.11 -0.495 . . . . 0.62 110.582 175.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.605 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 76.7 Cg_exo -46.61 140.67 11.99 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 123.297 2.664 . . . . 0.31 113.243 173.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.3 tt -63.21 -30.09 48.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.028 -0.533 . . . . 0.86 110.129 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' OE2' ' HD2' ' A' ' 2' ' ' LYS . 11.8 pt-20 -69.63 -26.16 64.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.998 -0.546 . . . . 1.73 110.142 178.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.757 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 9.3 mt -82.74 -47.99 11.35 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.883 -0.599 . . . . 0.44 109.657 -174.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.92 -33.94 76.85 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.432 -0.951 . . . . 1.92 108.432 178.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 37.9 ttm180 -61.37 -42.94 99.52 Favored 'General case' 0 CA--C 1.528 0.102 0 CA-C-N 115.121 -0.945 . . . . 2.94 111.653 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 99.3 m -61.54 -33.75 74.38 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-O 121.132 0.491 . . . . 0.34 110.829 177.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.757 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 2.6 mt -89.55 -9.1 51.13 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.015 -0.539 . . . . 0.26 109.744 -176.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.14 32.7 76.96 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.419 -0.81 . . . . 0.28 112.52 -173.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.673 HG12 ' HB2' ' A' ' 26' ' ' LEU . 21.8 pt -113.55 166.98 6.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 120.985 0.422 . . . . 0.43 111.403 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -171.4 152.01 3.19 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.11 -0.95 . . . . 0.26 109.863 176.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.762 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 4.3 pt-20 31.05 -89.4 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 115.901 1.815 . . . . 1.22 115.901 175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.9 mmpt? -78.76 6.73 8.3 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 113.468 0.914 . . . . 0.85 113.468 -171.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.508 ' O ' HG23 ' B' ' 10' ' ' VAL . 10.9 m-20 -87.39 175.16 8.12 Favored 'General case' 0 C--N 1.331 -0.228 0 O-C-N 122.071 -0.393 . . . . 1.54 110.494 178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.498 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.59 154.05 41.25 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.653 0.739 . . . . 0.23 112.72 -175.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.462 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.6 mp -122.94 154.97 37.67 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.461 -1.245 . . . . 1.15 108.28 176.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -106.35 104.22 13.87 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.269 -0.641 . . . . 1.28 109.269 177.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.55 122.98 42.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 121.341 0.591 . . . . 0.29 111.561 -174.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.535 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 2.2 m-85 -113.1 171.89 7.27 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.821 -1.177 . . . . 4.3 107.821 170.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.407 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.0 p -124.59 142.9 39.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 C-N-CA 120.519 -0.472 . . . . 0.26 110.651 177.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 38.1 t70 -133.48 90.96 2.79 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.285 -0.416 . . . . 1.15 110.115 178.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 56.88 -96.45 0.06 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 115.606 -0.725 . . . . 1.83 111.393 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -116.02 11.81 15.47 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.412 -0.813 . . . . 2.54 110.229 -176.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 20.3 mtpt -113.99 156.39 24.16 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.304 -0.407 . . . . 0.87 110.03 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.697 HD13 HD12 ' B' ' 18' ' ' ILE . 46.4 mt -108.36 138.36 35.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.914 0 N-CA-C 109.221 -0.659 . . . . 0.34 109.221 175.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' B' ' 44' ' ' ILE . 17.4 mm -124.55 107.53 18.57 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.421 -0.585 . . . . 0.2 109.421 -178.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.3 OUTLIER -121.33 110.99 16.79 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 122.225 1.012 . . . . 1.3 111.057 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.41 ' HG2' ' N ' ' A' ' 47' ' ' LYS . 30.4 ttpt -93.36 165.86 12.57 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 113.74 -1.573 . . . . 1.41 108.156 177.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.707 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 61.5 pttt -63.75 148.37 49.35 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.394 -0.595 . . . . 2.68 109.394 169.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 23.1 t80 -68.19 160.15 29.71 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.458 -0.571 . . . . 3.55 109.458 176.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -66.77 112.57 9.94 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.579 -0.282 . . . . 3.38 110.926 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -80.06 100.79 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.327 2.018 . . . . 1.58 111.971 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -85.01 105.28 15.66 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.144 -0.48 . . . . 3.85 109.744 178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . 0.425 ' O ' HG23 ' A' ' 53' ' ' THR . 23.1 mmt -102.44 107.38 18.34 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.721 -0.391 . . . . 5.0 110.166 179.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 52' ' ' MET . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.03 0 C-N-CA 125.348 1.459 . . . . 6.13 108.626 178.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.482 ' O ' ' HB3' ' B' ' 2' ' ' LYS . 21.2 mmt . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 110.415 -0.217 . . . . 5.41 110.415 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.502 ' HD2' ' OE2' ' B' ' 21' ' ' GLU . 15.5 tptm 73.61 148.16 0.09 Allowed 'General case' 0 N--CA 1.464 0.244 0 O-C-N 123.945 0.778 . . . . 1.29 110.264 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 49.1 m -72.24 -165.64 0.2 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.571 -0.741 . . . . 0.46 111.732 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.535 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 9.2 m 69.59 63.94 0.26 Allowed 'General case' 0 N--CA 1.446 -0.647 0 CA-C-N 114.61 -1.177 . . . . 0.41 111.193 -179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.03 37.45 4.13 Favored Glycine 0 N--CA 1.441 -1.016 0 CA-C-N 115.269 -0.878 . . . . 0.32 112.196 175.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.2 tp -106.2 135.47 44.39 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 CA-C-O 121.053 0.454 . . . . 0.52 109.898 178.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.498 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.3 p -87.74 126.64 41.29 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 CA-C-O 120.923 0.392 . . . . 0.37 111.066 -176.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.576 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 2.1 mpt_? -123.3 154.08 39.35 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 122.282 -0.261 . . . . 1.74 110.514 177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 32' ' ' ASP . 2.0 tpmt? -89.51 159.99 16.95 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.639 -0.504 . . . . 1.23 109.639 179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.0 t -82.85 -117.32 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 110.067 -0.345 . . . . 0.39 110.067 178.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.479 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 35.9 t0 -178.25 -67.23 0.01 OUTLIER 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 109.558 -0.534 . . . . 1.66 109.558 -178.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.762 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.7 pt-20 -161.18 -84.48 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.253 -0.885 . . . . 1.91 110.381 176.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.515 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -68.52 -33.42 74.09 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.42 -0.809 . . . . 0.72 111.459 -177.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 163.74 -9.8 0.08 OUTLIER Glycine 0 C--O 1.222 -0.6 0 C-N-CA 119.654 -1.26 . . . . 0.31 113.393 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.639 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.0 mtt180 -54.65 104.85 0.12 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.183 0.492 . . . . 0.75 111.967 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.645 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.7 p -100.3 141.02 17.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.341 -0.614 . . . . 1.04 109.341 178.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.576 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 39.3 t -79.6 101.89 5.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 120.968 0.413 . . . . 0.25 111.206 -175.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.697 HD12 HD13 ' A' ' 43' ' ' ILE . 26.1 mm -66.64 136.67 94.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 116.05 -0.523 . . . . 0.55 110.175 174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.588 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.2 138.42 28.88 Favored 'Trans proline' 0 N--CA 1.459 -0.538 0 C-N-CA 122.633 2.222 . . . . 0.28 112.321 170.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.1 tt -61.6 -30.6 48.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.004 -0.544 . . . . 0.82 110.143 178.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.502 ' OE2' ' HD2' ' B' ' 2' ' ' LYS . 14.6 pt-20 -70.11 -28.07 65.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.589 -0.732 . . . . 1.35 110.55 177.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.733 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 6.4 mt -80.02 -46.83 15.9 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.38 0.609 . . . . 0.33 109.515 -174.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.446 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 32.8 ptt85 -66.49 -33.0 74.72 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 108.622 -0.881 . . . . 1.48 108.622 178.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.446 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 11.8 ttm180 -61.5 -38.61 87.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.684 -0.689 . . . . 2.77 110.781 172.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 99.2 m -63.42 -35.94 82.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.39 0.614 . . . . 0.31 110.629 177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.779 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 2.7 mt -88.71 -5.96 57.76 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.506 -0.77 . . . . 0.24 109.364 -176.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.62 28.64 65.57 Favored Glycine 0 N--CA 1.449 -0.478 0 CA-C-N 115.028 -0.987 . . . . 0.34 112.47 -174.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.697 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.0 pt -109.9 167.47 4.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.346 0.593 . . . . 0.47 111.504 -178.283 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -173.51 151.62 1.98 Allowed 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.782 -1.099 . . . . 0.22 109.468 175.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.584 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.1 pt-20 36.11 -86.76 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 115.415 1.635 . . . . 1.12 115.415 171.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.5 mmpt? -79.86 5.05 14.75 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 113.156 0.799 . . . . 0.65 113.156 -172.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.547 ' O ' HG23 ' A' ' 10' ' ' VAL . 28.8 m-20 -89.28 173.21 8.52 Favored 'General case' 0 C--N 1.324 -0.522 0 C-N-CA 120.496 -0.482 . . . . 1.37 110.486 -178.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.528 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.81 154.38 38.29 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.335 0.588 . . . . 0.22 112.099 -177.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.6 mp -122.25 153.74 38.47 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.946 -1.025 . . . . 1.23 108.996 175.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.456 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 21.7 mt-10 -101.74 108.01 19.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.4 -0.593 . . . . 1.4 109.4 173.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.451 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.9 mp -95.08 122.19 46.32 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-O 121.641 0.734 . . . . 0.29 111.546 -176.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 14.5 m-85 -113.07 171.94 7.24 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 107.613 -1.255 . . . . 4.28 107.613 172.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . 0.449 HG12 ' OG1' ' A' ' 4' ' ' THR . 10.5 p -128.18 142.96 42.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.161 -0.616 . . . . 0.28 110.68 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -134.0 91.04 2.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.126 -0.488 . . . . 1.12 110.053 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 60.99 -91.28 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 115.62 -0.718 . . . . 1.64 111.817 -178.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.2 10.84 8.11 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.808 -0.633 . . . . 2.81 110.281 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 4.8 mtpt -114.57 154.16 28.81 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 109.125 -0.695 . . . . 0.98 109.125 175.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.861 ' HB ' HD12 ' A' ' 45' ' ' LEU . 46.5 mt -107.58 137.84 36.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 109.996 -0.372 . . . . 0.42 109.996 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.574 HD12 HD12 ' A' ' 44' ' ' ILE . 17.5 mm -113.52 118.24 57.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 N-CA-C 109.176 -0.675 . . . . 0.25 109.176 -177.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.509 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.4 OUTLIER -123.99 107.82 11.74 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-O 121.546 0.689 . . . . 1.29 109.933 -179.2 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.42 ' HE2' ' HB3' ' B' ' 46' ' ' LYS . 31.9 ttpt -96.62 163.13 13.15 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.731 -1.211 . . . . 1.22 107.731 175.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.779 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 24.4 pttm -71.11 150.24 45.67 Favored 'General case' 0 C--N 1.31 -1.144 0 N-CA-C 108.855 -0.795 . . . . 2.5 108.855 171.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.456 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 46.2 t80 -61.03 147.84 42.26 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.3 -0.629 . . . . 3.39 109.3 176.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.426 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.4 tppt? -66.79 110.7 5.35 Favored Pre-proline 0 N--CA 1.45 -0.472 0 CA-C-O 120.758 0.314 . . . . 3.18 110.572 -179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.426 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 56.8 Cg_endo -71.66 110.65 2.94 Favored 'Trans proline' 0 N--CA 1.46 -0.467 0 C-N-CA 122.722 2.281 . . . . 1.56 112.193 -176.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -85.89 102.37 13.67 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.976 -0.556 . . . . 3.92 109.703 177.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 26.0 mmt -103.73 108.57 19.92 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.624 -0.51 . . . . 5.19 109.624 177.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 42.5 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.268 -0.872 . . . . 6.34 109.26 -179.373 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtt . . . . . 0 N--CA 1.481 1.123 0 CA-C-O 120.518 0.199 . . . . 4.93 110.71 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.873 ' HG3' ' H ' ' A' ' 3' ' ' SER . 14.3 ptmt -118.04 -81.33 0.62 Allowed 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 121.093 -0.243 . . . . 1.67 110.836 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.873 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 72.3 m -155.98 -163.42 1.48 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.901 0.382 . . . . 0.48 111.436 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.609 ' H ' ' HA ' ' B' ' 37' ' ' TYR . 5.8 m 62.27 55.55 2.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.091 -0.959 . . . . 0.48 110.776 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 98.89 35.89 4.69 Favored Glycine 0 N--CA 1.438 -1.175 0 CA-C-N 115.489 -0.778 . . . . 0.32 112.159 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.556 ' O ' ' HA ' ' B' ' 35' ' ' GLU . 10.2 tp -93.43 160.24 2.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 107.946 -1.131 . . . . 0.49 107.946 175.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.454 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 7.2 p -124.67 126.65 71.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 N-CA-C 109.792 -0.447 . . . . 0.37 109.792 -176.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.506 ' CZ ' ' HG3' ' A' ' 19' ' ' PRO . 9.7 mtt-85 -137.17 170.73 15.61 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.758 0.314 . . . . 1.96 110.806 179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.592 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 10.9 mmpt? -91.8 162.6 14.38 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.976 -0.556 . . . . 1.16 111.273 -176.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.479 HG22 HD11 ' B' ' 34' ' ' LEU . 1.4 t -85.08 -133.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.051 -1.092 . . . . 0.44 108.051 168.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -162.92 -67.67 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.698 -0.482 . . . . 1.32 109.698 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.622 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 3.0 pt-20 -140.9 -94.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.346 -0.388 . . . . 1.39 111.515 169.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.578 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -66.1 -28.22 68.65 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 112.397 0.518 . . . . 0.6 112.397 -172.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.51 -5.56 0.05 OUTLIER Glycine 0 C--O 1.222 -0.616 0 C-N-CA 119.782 -1.199 . . . . 0.34 114.158 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.602 ' HG3' HG22 ' B' ' 17' ' ' VAL . 31.9 mtt180 -58.56 104.94 0.25 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 118.073 0.936 . . . . 1.26 111.708 178.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.699 HG11 HD22 ' B' ' 45' ' ' LEU . 7.2 p -96.14 138.14 22.28 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 N-CA-C 108.995 -0.743 . . . . 1.04 108.995 174.275 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.566 HG22 ' HG3' ' B' ' 15' ' ' ARG . 25.5 t -79.0 100.62 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.47 -0.332 . . . . 0.25 111.263 -174.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.1 mm -67.67 128.71 93.53 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.328 -0.396 . . . . 0.62 110.147 172.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.821 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 87.8 Cg_exo -47.72 141.92 15.07 Favored 'Trans proline' 0 C--O 1.237 0.435 0 C-N-CA 123.256 2.637 . . . . 0.31 113.17 173.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.436 ' HA ' ' HG2' ' A' ' 23' ' ' ARG . 10.5 tt -59.28 -34.67 54.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.19 -0.459 . . . . 0.86 110.795 177.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -70.45 -27.93 64.63 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.384 0.611 . . . . 1.73 110.256 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.821 ' HG ' ' HB2' ' A' ' 19' ' ' PRO . 5.0 mt -80.45 -46.93 15.11 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.537 -0.756 . . . . 0.44 109.141 -173.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HB2' HG13 ' A' ' 28' ' ' ILE . 13.3 ptt180 -65.37 -32.38 73.98 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.31 -0.996 . . . . 1.92 108.31 178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.493 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 2.3 tmt_? -65.05 -35.81 82.35 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 115.077 -0.965 . . . . 2.94 110.272 175.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.2 m -64.73 -37.02 86.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.337 0.589 . . . . 0.34 110.463 177.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.696 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -89.25 -14.11 36.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.51 -0.768 . . . . 0.26 109.886 -175.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.4 30.73 77.1 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.262 -0.881 . . . . 0.28 112.387 -172.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.553 HG13 ' HB2' ' A' ' 23' ' ' ARG . 14.0 pt -103.98 165.97 3.14 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.343 0 CA-C-O 120.984 0.421 . . . . 0.43 111.229 178.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.45 146.87 0.49 Allowed 'General case' 0 CA--C 1.508 -0.668 0 CA-C-N 114.929 -1.032 . . . . 0.26 109.773 176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.433 ' O ' ' HB ' ' B' ' 10' ' ' VAL . 2.9 pt-20 35.0 -89.67 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 115.447 1.647 . . . . 1.22 115.447 171.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.4 mmpt? -80.86 5.49 15.91 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.28 0.845 . . . . 0.85 113.28 -172.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.72 176.75 9.09 Favored 'General case' 0 CA--C 1.513 -0.447 0 C-N-CA 120.14 -0.624 . . . . 1.54 110.429 -178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.504 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.19 146.12 48.06 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.111 -0.95 . . . . 0.23 112.213 -176.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.5 mp -121.48 151.54 40.13 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.088 -0.96 . . . . 1.15 108.793 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 48' ' ' TYR . 11.2 tt0 -108.31 106.45 16.61 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.994 -0.743 . . . . 1.28 108.994 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.712 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.9 mp -90.1 126.59 42.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 114.811 -1.086 . . . . 0.29 112.023 -175.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.618 ' HA ' ' H ' ' B' ' 4' ' ' THR . 8.0 t80 -119.14 159.87 23.17 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.074 -1.084 . . . . 4.3 108.074 171.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -119.95 143.09 32.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 O-C-N 121.833 -0.542 . . . . 0.26 110.731 -175.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -134.67 82.32 1.96 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.24 0.543 . . . . 1.15 110.653 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.41 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 17.0 t70 55.8 -90.56 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 114.573 -1.194 . . . . 1.83 112.641 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.41 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 10.7 mt-10 -88.86 -23.03 22.89 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.468 -0.787 . . . . 2.54 110.349 -174.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.805 ' HE2' HD11 ' A' ' 44' ' ' ILE . 20.1 pttm -119.32 158.12 26.73 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.463 -0.79 . . . . 0.87 112.236 -167.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.692 HD11 HD11 ' B' ' 26' ' ' LEU . 49.7 mt -110.36 139.06 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.265 -0.879 . . . . 0.34 109.547 -178.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.805 HD11 ' HE2' ' A' ' 42' ' ' LYS . 13.4 mm -118.26 120.41 64.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-N 116.013 -0.54 . . . . 0.2 109.593 -176.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.712 ' HB3' HG13 ' A' ' 36' ' ' ILE . 0.4 OUTLIER -130.46 123.94 30.9 Favored 'General case' 0 C--N 1.316 -0.868 0 C-N-CA 119.44 -0.904 . . . . 1.3 111.886 176.746 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 41' ' ' GLU . 38.6 ttpt -115.59 170.23 8.58 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 108.011 -1.107 . . . . 1.41 108.011 175.115 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.459 ' HG3' ' CG2' ' A' ' 28' ' ' ILE . 44.5 tttm -63.81 146.05 54.65 Favored 'General case' 0 C--N 1.31 -1.121 0 N-CA-C 109.496 -0.557 . . . . 2.68 109.496 173.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.431 ' HA ' ' HB2' ' A' ' 35' ' ' GLU . 67.0 t80 -60.65 157.06 15.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.563 -0.29 . . . . 3.55 110.764 178.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 12.3 tppt? -66.85 112.57 10.01 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 115.868 -0.605 . . . . 3.38 111.24 -174.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -76.77 -54.07 0.07 OUTLIER 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 122.806 2.338 . . . . 1.58 111.951 179.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 51.2 t30 -101.07 130.91 47.17 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.898 -0.592 . . . . 3.85 109.745 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 22.2 ptp -80.25 123.48 27.99 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.108 0.48 . . . . 5.0 110.438 -177.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.5 p . . . . . 0 C--O 1.247 0.946 0 CA-C-N 115.688 -0.687 . . . . 6.13 110.34 -177.155 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.522 ' HG2' HD11 ' B' ' 6' ' ' ILE . 55.2 mtt . . . . . 0 N--CA 1.478 0.966 0 CA-C-O 120.539 0.209 . . . . 5.41 110.56 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.956 ' HG3' ' H ' ' B' ' 3' ' ' SER . 0.0 OUTLIER -108.69 -83.42 0.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.511 -0.313 . . . . 1.29 111.775 -176.507 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.956 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 73.4 m -157.74 -167.32 2.22 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.802 0.441 . . . . 0.46 110.0 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.618 ' H ' ' HA ' ' A' ' 37' ' ' TYR . 25.7 m 62.84 63.26 0.98 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.865 0.84 . . . . 0.41 110.783 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 91.95 38.37 5.77 Favored Glycine 0 N--CA 1.437 -1.241 0 CA-C-N 115.188 -0.915 . . . . 0.32 111.95 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . 0.522 HD11 ' HG2' ' B' ' 1' ' ' MET . 11.1 tp -108.91 138.39 36.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.164 0.507 . . . . 0.52 110.547 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.504 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.8 p -94.64 134.21 32.88 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-O 121.109 0.481 . . . . 0.37 112.028 -174.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.452 HH11 ' HG2' ' B' ' 8' ' ' ARG . 0.6 OUTLIER -136.6 174.46 10.59 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.954 -0.566 . . . . 1.74 110.178 171.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 9.2 mmpt? -98.27 160.29 14.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.211 -0.45 . . . . 1.23 110.363 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.436 HG22 ' CD1' ' A' ' 34' ' ' LEU . 0.6 OUTLIER -82.36 -133.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.686 -1.598 . . . . 0.39 106.686 166.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.418 ' HB2' ' O ' ' B' ' 10' ' ' VAL . 28.2 t70 -177.95 -51.47 0.01 OUTLIER 'General case' 0 CA--C 1.508 -0.654 0 CA-C-O 121.301 0.572 . . . . 1.66 110.883 166.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -125.32 -124.85 0.25 Allowed 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.354 -0.839 . . . . 1.91 111.408 -178.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -70.45 -8.65 52.65 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.815 -0.63 . . . . 0.72 112.377 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.41 -8.86 0.32 Allowed Glycine 0 C--O 1.219 -0.804 0 C-N-CA 119.749 -1.215 . . . . 0.31 112.535 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.625 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 39.4 mtt180 -58.96 100.24 0.06 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.918 0.39 . . . . 0.75 111.595 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 8.9 p -94.33 137.85 22.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 1.04 109.092 176.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 15' ' ' ARG . 44.0 t -79.66 101.15 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.246 -0.434 . . . . 0.25 111.535 -172.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . . . . . . . . . 35.1 mm -68.69 132.16 91.02 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.333 -0.394 . . . . 0.55 110.512 174.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.614 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 91.0 Cg_exo -47.88 140.41 18.18 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 123.155 2.57 . . . . 0.28 113.125 174.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.417 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 8.9 tt -57.91 -35.15 50.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.978 -0.555 . . . . 0.82 110.73 177.076 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -73.05 -23.91 60.63 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.219 0.533 . . . . 1.35 110.506 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 10.6 mt -82.68 -47.75 11.67 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 109.299 -0.63 . . . . 0.33 109.299 -177.08 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' B' ' 20' ' ' ILE . 4.4 ppt_? -65.81 -28.21 68.83 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.433 -0.951 . . . . 1.48 108.433 178.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -62.48 -47.65 83.04 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 114.979 -1.009 . . . . 2.77 111.027 171.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.4 m -57.17 -37.84 72.71 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.522 0.677 . . . . 0.31 110.874 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.7 mt -85.91 -19.77 30.02 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.415 -0.811 . . . . 0.24 109.922 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.46 33.07 71.95 Favored Glycine 0 N--CA 1.446 -0.642 0 CA-C-N 115.704 -0.68 . . . . 0.34 112.249 -171.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.528 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.2 pt -110.91 166.38 5.57 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.277 0 CA-C-O 120.685 0.279 . . . . 0.47 110.84 177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.35 150.69 0.58 Allowed 'General case' 0 CA--C 1.512 -0.518 0 O-C-N 124.29 0.994 . . . . 0.22 110.192 174.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.622 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.15 -89.6 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 115.549 1.685 . . . . 1.12 115.549 173.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.401 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.5 mmpt? -82.43 4.98 22.01 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 112.978 0.733 . . . . 0.65 112.978 -172.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -77.63 171.15 15.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.952 0.406 . . . . 1.37 110.83 -179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.75 144.72 46.09 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.366 0.603 . . . . 0.22 111.882 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.479 HD11 HG22 ' A' ' 10' ' ' VAL . 6.4 mp -118.55 149.74 40.83 Favored 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.179 -0.919 . . . . 1.23 108.917 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.556 ' HA ' ' O ' ' A' ' 6' ' ' ILE . 7.5 tt0 -104.45 101.44 11.12 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-N 115.544 -0.753 . . . . 1.4 108.99 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.526 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.0 mp -90.71 126.39 43.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.671 0.748 . . . . 0.29 112.016 -175.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.609 ' HA ' ' H ' ' A' ' 4' ' ' THR . 2.1 t80 -118.04 160.42 21.52 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.836 -1.172 . . . . 4.28 107.836 171.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -119.92 140.87 42.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 C-N-CA 120.53 -0.468 . . . . 0.28 110.301 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -136.88 86.84 2.24 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.123 0.487 . . . . 1.12 110.592 -177.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 64.17 -97.77 0.06 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.026 -0.988 . . . . 1.64 112.402 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.429 ' O ' ' HG3' ' A' ' 46' ' ' LYS . 36.1 mt-10 -102.88 -4.6 24.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.589 -0.732 . . . . 2.81 110.417 -175.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.472 ' HD2' ' CG2' ' A' ' 44' ' ' ILE . 26.0 pttm -124.03 159.09 30.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.361 0.6 . . . . 0.98 112.0 -174.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.706 ' HB ' HD12 ' A' ' 45' ' ' LEU . 60.2 mt -111.31 138.98 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.254 -0.885 . . . . 0.42 109.725 -178.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.785 HD12 HD12 ' A' ' 44' ' ' ILE . 18.7 mm -115.05 121.43 67.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 CA-C-N 115.621 -0.718 . . . . 0.25 109.3 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.699 HD22 HG11 ' A' ' 16' ' ' VAL . 0.0 OUTLIER -127.05 111.46 14.07 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 122.077 0.942 . . . . 1.29 110.937 179.118 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 34.1 ttpt -104.75 169.75 8.27 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 113.826 -1.534 . . . . 1.22 107.806 177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.427 ' N ' ' HG2' ' B' ' 46' ' ' LYS . 60.3 tttm -73.85 145.26 45.04 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 109.591 -0.522 . . . . 2.5 109.591 172.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -60.77 146.96 44.14 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 110.145 -0.317 . . . . 3.39 110.145 178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.565 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 17.3 tppt? -66.61 112.71 10.17 Favored Pre-proline 0 N--CA 1.447 -0.599 0 CA-C-N 115.828 -0.623 . . . . 3.18 111.56 -176.362 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.565 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 73.6 Cg_endo -76.71 -48.83 0.12 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.455 2.104 . . . . 1.56 112.088 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -94.66 124.75 38.88 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.513 -0.551 . . . . 3.92 109.513 179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.4 ptp -80.86 111.18 17.08 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.522 0.677 . . . . 5.19 110.942 -175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 p . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.269 -0.872 . . . . 6.34 110.461 177.861 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.9 mtt . . . . . 0 N--CA 1.479 1.008 0 CA-C-O 120.884 0.374 . . . . 4.93 110.079 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.916 ' HG3' ' H ' ' A' ' 3' ' ' SER . 0.0 OUTLIER -93.61 -84.28 0.31 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.137 0.494 . . . . 1.67 110.582 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.916 ' H ' ' HG3' ' A' ' 2' ' ' LYS . 75.1 m -143.27 -167.33 2.53 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 108.847 -0.798 . . . . 0.48 108.847 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.623 HG23 ' HD1' ' B' ' 37' ' ' TYR . 15.2 m 66.85 69.39 0.4 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.362 0.601 . . . . 0.48 111.692 173.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.62 42.07 5.87 Favored Glycine 0 N--CA 1.44 -1.045 0 C-N-CA 120.705 -0.759 . . . . 0.32 111.638 174.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.6 tp -115.64 141.93 30.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.156 0.503 . . . . 0.49 110.514 179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.569 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.3 p -88.35 129.59 39.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.042 -0.526 . . . . 0.37 111.303 -173.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.46 ' HB2' HD13 ' B' ' 36' ' ' ILE . 3.2 mpt_? -127.26 163.34 24.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.65 -0.25 . . . . 1.96 110.378 174.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HE2' ' HA ' ' A' ' 9' ' ' LYS . 9.9 mmpt? -89.54 162.09 15.86 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.501 -0.318 . . . . 1.16 110.654 179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.484 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.6 t -86.77 -132.86 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 108.757 -0.831 . . . . 0.44 108.757 172.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.589 ' HB2' ' HE ' ' B' ' 15' ' ' ARG . 25.4 t70 -159.6 -66.14 0.08 Allowed 'General case' 0 CA--C 1.512 -0.509 0 N-CA-C 108.699 -0.852 . . . . 1.32 108.699 176.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.858 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.7 pt-20 -153.47 -84.7 0.07 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.02 -0.991 . . . . 1.39 110.254 168.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.552 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -75.98 -14.92 60.23 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 114.89 -1.05 . . . . 0.6 112.492 -172.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 157.46 -11.2 0.25 Allowed Glycine 0 C--O 1.22 -0.778 0 C-N-CA 119.513 -1.327 . . . . 0.34 114.546 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.734 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.7 ttt180 -66.13 99.66 0.54 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 118.54 1.17 . . . . 1.26 112.131 -177.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.752 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 20.8 m -95.97 141.61 15.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.836 -0.62 . . . . 1.04 110.428 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.498 HG22 ' HG3' ' B' ' 15' ' ' ARG . 46.4 t -79.29 103.61 6.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.379 -0.373 . . . . 0.25 110.777 -177.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.693 HG21 HD13 ' B' ' 43' ' ' ILE . 21.0 mt -85.38 133.89 41.51 Favored Pre-proline 0 C--N 1.319 -0.745 0 CA-C-N 116.294 -0.412 . . . . 0.62 110.335 175.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.644 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 43.9 Cg_exo -40.87 138.32 1.61 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 124.094 3.196 . . . . 0.31 114.405 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 13.4 tt -58.42 -31.41 42.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.463 -0.79 . . . . 0.86 110.285 175.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' OE2' ' HB2' ' A' ' 2' ' ' LYS . 12.3 pt-20 -70.67 -26.76 63.58 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.765 -0.652 . . . . 1.73 110.238 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.653 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 8.2 mt -81.11 -47.34 13.64 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.995 -0.548 . . . . 0.44 109.774 -174.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.592 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 1.9 ptt180 -63.28 -35.78 81.49 Favored 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.051 -1.092 . . . . 1.92 108.051 177.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.592 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 3.1 tmt_? -61.94 -37.31 84.24 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 114.731 -1.122 . . . . 2.94 110.893 175.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 63.4 m -63.58 -34.8 78.62 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.344 0.592 . . . . 0.34 110.549 175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.832 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.6 mt -87.89 -9.05 54.88 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.825 -0.625 . . . . 0.26 109.793 -176.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.83 25.89 66.36 Favored Glycine 0 N--CA 1.45 -0.411 0 CA-C-N 115.275 -0.875 . . . . 0.28 112.269 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.602 HD13 HD11 ' A' ' 34' ' ' LEU . 2.4 pp -112.07 169.7 4.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.726 0.298 . . . . 0.43 111.257 178.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 179.67 157.31 0.63 Allowed 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 115.441 -0.8 . . . . 0.26 110.171 178.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 35.22 -90.22 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 115.378 1.621 . . . . 1.22 115.378 174.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -75.56 -4.5 40.29 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 112.882 0.697 . . . . 0.85 112.882 -172.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.457 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.2 OUTLIER -85.49 -178.44 6.69 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.508 -0.477 . . . . 1.54 111.409 -172.066 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.537 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -125.91 152.46 45.57 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.704 0.764 . . . . 0.23 112.842 -174.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.602 HD11 HD13 ' A' ' 28' ' ' ILE . 7.1 mp -127.94 156.89 41.92 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 114.477 -1.238 . . . . 1.15 107.855 175.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -105.83 107.6 18.68 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 109.117 -0.697 . . . . 1.28 109.117 178.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.519 HG13 HD23 ' A' ' 45' ' ' LEU . 1.8 mp -92.79 122.85 44.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.639 -0.71 . . . . 0.29 111.217 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.691 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.8 OUTLIER -124.44 159.94 29.35 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.207 -0.906 . . . . 4.3 108.79 175.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -116.1 135.66 55.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 C-N-CA 120.754 -0.379 . . . . 0.26 110.524 -174.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -133.04 96.07 3.69 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.977 -0.379 . . . . 1.15 109.977 -176.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 64.71 -97.48 0.06 Allowed 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.13 -0.941 . . . . 1.83 110.783 -175.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -124.04 10.86 8.84 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.085 -0.961 . . . . 2.54 109.489 -178.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 22.7 mtmm -111.17 156.52 21.27 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-N 115.382 -0.826 . . . . 0.87 109.586 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.963 ' HB ' HD12 ' B' ' 45' ' ' LEU . 38.0 mt -110.21 133.4 55.71 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 116.115 -0.493 . . . . 0.34 109.838 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' B' ' 44' ' ' ILE . 15.8 mm -117.45 112.71 40.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.406 -0.59 . . . . 0.2 109.406 -173.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.612 HD22 HG21 ' B' ' 16' ' ' VAL . 0.0 OUTLIER -121.19 108.97 14.42 Favored 'General case' 0 C--N 1.315 -0.929 0 C-N-CA 120.266 -0.573 . . . . 1.3 109.505 -177.876 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt -107.05 141.18 38.69 Favored 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 108.012 -1.107 . . . . 1.41 108.012 176.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.832 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 20.9 ptmt -47.8 139.16 7.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 117.914 0.324 . . . . 2.68 110.375 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -70.32 135.91 49.31 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 108.899 -0.778 . . . . 3.55 108.899 177.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.506 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.78 111.95 9.88 Favored Pre-proline 0 C--N 1.322 -0.597 0 N-CA-C 109.539 -0.541 . . . . 3.38 109.539 -178.689 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 80.6 Cg_endo -72.85 128.52 13.33 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.513 2.142 . . . . 1.58 111.486 -176.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -98.99 107.17 19.53 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.039 0.447 . . . . 3.85 110.154 -177.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 20.8 ptp -113.89 138.53 50.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.89 -0.596 . . . . 5.0 110.438 -177.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.0 t . . . . . 0 C--O 1.25 1.108 0 CA-C-O 118.176 -0.916 . . . . 6.13 109.474 -179.562 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 120.951 0.405 . . . . 5.41 110.602 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.899 ' HG3' ' H ' ' B' ' 3' ' ' SER . 10.9 ptmt -71.54 -85.58 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.786 -0.643 . . . . 1.29 111.765 -177.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.899 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 66.2 m -138.31 -166.08 1.92 Allowed 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.31 -0.626 . . . . 0.46 109.31 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.691 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.6 m 64.78 67.07 0.56 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 121.703 0.763 . . . . 0.41 111.466 173.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.95 38.53 5.14 Favored Glycine 0 N--CA 1.438 -1.167 0 CA-C-N 115.284 -0.871 . . . . 0.32 111.975 175.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.8 tp -106.16 139.03 28.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.493 -0.558 . . . . 0.52 109.493 178.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.537 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.7 p -90.1 125.52 42.99 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-O 120.971 0.415 . . . . 0.37 110.81 -176.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.526 ' HG2' ' O ' ' B' ' 17' ' ' VAL . 1.2 tpt180 -124.18 160.06 28.69 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.433 -0.349 . . . . 1.74 110.345 178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.541 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.2 mmpt? -87.26 163.12 17.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.415 -0.357 . . . . 1.23 110.65 178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.2 t -86.42 -108.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 110.049 -0.352 . . . . 0.39 110.049 176.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.531 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 26.9 t70 173.11 -68.97 0.01 OUTLIER 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.969 -0.752 . . . . 1.66 108.969 -173.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.8 pt-20 -166.56 -85.82 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 114.751 -1.113 . . . . 1.91 109.872 171.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.675 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -64.2 -35.36 80.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.318 -0.856 . . . . 0.72 112.155 -176.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.413 ' HA3' ' O ' ' A' ' 18' ' ' ILE . . . 164.35 -3.13 0.06 OUTLIER Glycine 0 C--O 1.224 -0.475 0 C-N-CA 119.617 -1.278 . . . . 0.31 113.442 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.752 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 1.7 ttt180 -65.67 97.61 0.33 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 117.101 0.451 . . . . 0.75 111.764 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.734 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 18.5 m -94.12 144.35 9.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 120.708 0.289 . . . . 1.04 110.32 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.526 ' O ' ' HG2' ' B' ' 8' ' ' ARG . 40.8 t -81.84 104.53 10.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.36 -0.382 . . . . 0.25 110.873 -177.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.726 HG21 HD13 ' A' ' 43' ' ' ILE . 2.3 mt -80.68 138.96 50.6 Favored Pre-proline 0 C--N 1.324 -0.502 0 N-CA-C 110.308 -0.256 . . . . 0.55 110.308 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.647 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 59.1 Cg_exo -42.96 135.3 5.33 Favored 'Trans proline' 0 N--CA 1.462 -0.368 0 C-N-CA 123.449 2.766 . . . . 0.28 113.809 173.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 12.8 tt -55.69 -32.22 30.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.471 -0.786 . . . . 0.82 110.727 174.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.591 ' OE2' ' HE3' ' B' ' 2' ' ' LYS . 18.4 pt-20 -72.96 -23.46 60.67 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.132 0.492 . . . . 1.35 110.499 -179.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.714 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -81.9 -46.99 13.32 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.161 -0.472 . . . . 0.33 109.769 -175.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.59 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 6.9 ptt180 -63.41 -35.47 80.53 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 108.174 -1.047 . . . . 1.48 108.174 176.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.59 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 51.2 ttt180 -56.98 -44.92 83.18 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 114.555 -1.202 . . . . 2.77 110.821 173.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 89.7 m -59.29 -37.31 77.38 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.762 -0.654 . . . . 0.31 110.615 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.858 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 3.2 mt -86.74 -8.41 57.41 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.376 -0.829 . . . . 0.24 109.759 -175.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 62.41 31.96 81.3 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.311 -0.859 . . . . 0.34 112.133 -174.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.801 HG12 ' HB2' ' B' ' 26' ' ' LEU . 10.9 pt -120.43 169.09 12.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.98 0.419 . . . . 0.47 111.007 -179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.77 157.46 1.21 Allowed 'General case' 0 CA--C 1.506 -0.74 0 CA-C-N 114.951 -1.022 . . . . 0.22 110.172 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.858 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.7 pt-20 39.65 -92.38 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 115.381 1.623 . . . . 1.12 115.381 172.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.2 mmpt? -81.49 6.79 13.66 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 112.681 0.622 . . . . 0.65 112.681 -173.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 10' ' ' VAL . 57.8 m-20 -86.02 176.67 7.9 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.882 0.373 . . . . 1.37 110.951 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.569 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -124.38 152.98 42.55 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.656 0.741 . . . . 0.22 112.936 -175.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 5.4 mp -124.53 157.09 36.18 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.69 -1.141 . . . . 1.23 109.143 174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.574 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 46.5 mt-10 -102.9 105.47 15.84 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.874 -0.603 . . . . 1.4 109.392 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.725 HG13 ' HB3' ' B' ' 45' ' ' LEU . 1.9 mp -91.89 122.51 43.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.282 0.563 . . . . 0.29 111.207 -176.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.623 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.4 OUTLIER -124.38 161.04 26.79 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.488 -0.778 . . . . 4.28 108.961 175.284 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 p -116.56 136.26 54.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.845 -0.342 . . . . 0.28 110.605 -174.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -128.23 89.21 2.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.828 0.347 . . . . 1.12 110.077 -176.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 60.42 -90.36 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.334 -0.848 . . . . 1.64 111.041 -172.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -124.51 7.34 8.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.867 -0.606 . . . . 2.81 110.427 -178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 26.7 mtmm -104.31 158.23 16.6 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 109.648 -0.501 . . . . 0.98 109.648 176.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.693 HD13 HG21 ' A' ' 18' ' ' ILE . 28.5 mt -109.13 134.49 50.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 109.059 -0.719 . . . . 0.42 109.059 175.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.824 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -123.23 108.73 21.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.373 -0.603 . . . . 0.25 109.373 -175.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.963 HD12 ' HB ' ' A' ' 43' ' ' ILE . 0.2 OUTLIER -120.88 110.96 16.94 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 122.177 0.989 . . . . 1.29 111.03 -179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.464 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 30.0 ttpt -90.71 161.33 15.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 113.747 -1.57 . . . . 1.22 107.843 175.073 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.858 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 45.9 pttt -64.19 137.99 58.22 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 109.849 -0.426 . . . . 2.5 109.849 171.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.574 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 88.0 t80 -65.99 131.84 47.17 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.183 -0.673 . . . . 3.39 109.183 175.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.51 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -67.93 111.17 6.96 Favored Pre-proline 0 C--N 1.323 -0.574 0 N-CA-C 109.539 -0.541 . . . . 3.18 109.539 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.51 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 74.3 Cg_endo -72.88 131.92 17.69 Favored 'Trans proline' 0 N--CA 1.458 -0.607 0 C-N-CA 122.745 2.297 . . . . 1.56 111.816 -174.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -92.85 115.9 28.54 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.65 -0.5 . . . . 3.92 109.65 -178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 22.7 ptp -120.71 144.43 48.24 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.857 -0.61 . . . . 5.19 110.238 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.0 t . . . . . 0 C--O 1.248 0.976 0 N-CA-C 109.686 -0.487 . . . . 6.34 109.686 179.115 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.2 tpt . . . . . 0 N--CA 1.48 1.062 0 CA-C-O 120.733 0.302 . . . . 4.93 111.142 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.585 ' HA ' ' OE2' ' A' ' 21' ' ' GLU . 2.1 tmtt? -80.42 148.38 30.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.53 0.681 . . . . 1.67 112.205 -169.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.447 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 67.4 m -73.39 -162.4 0.12 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.55 -1.204 . . . . 0.48 111.741 -178.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.59 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 3.9 m 65.88 65.26 0.53 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.019 -0.991 . . . . 0.48 111.452 178.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.42 37.2 3.84 Favored Glycine 0 N--CA 1.44 -1.059 0 CA-C-N 114.944 -1.026 . . . . 0.32 111.932 174.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.0 tp -107.29 138.89 31.09 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.969 -0.382 . . . . 0.49 109.969 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.508 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.4 p -89.13 127.78 41.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-O 120.898 0.38 . . . . 0.37 111.0 -177.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 8' ' ' ARG . 1.0 OUTLIER -123.57 164.8 18.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.515 -0.311 . . . . 1.96 110.492 175.161 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . . . . . . . . . 29.6 mmmt -98.95 158.62 15.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.447 -0.342 . . . . 1.16 110.317 -178.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.507 HG23 ' O ' ' B' ' 32' ' ' ASP . 1.4 t -82.58 -136.51 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 N-CA-C 108.988 -0.745 . . . . 0.44 108.988 174.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.538 ' C ' ' HA ' ' B' ' 30' ' ' GLU . 20.8 t70 -155.6 -66.01 0.12 Allowed 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.957 -0.757 . . . . 1.32 108.957 176.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.919 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.4 pt-20 -156.01 -82.82 0.07 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 114.698 -1.137 . . . . 1.39 109.098 168.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.6 pt? -60.16 -38.13 82.21 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.383 -0.826 . . . . 0.6 111.62 -178.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 166.44 -15.19 0.08 OUTLIER Glycine 0 C--O 1.22 -0.755 0 C-N-CA 119.572 -1.299 . . . . 0.34 114.552 -178.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.629 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 5.7 ttt180 -53.96 104.39 0.1 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 118.251 1.025 . . . . 1.26 111.637 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.637 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.6 p -101.38 141.7 17.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.773 -0.649 . . . . 1.04 109.692 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.501 HG22 ' HG3' ' B' ' 15' ' ' ARG . 45.1 t -78.84 108.65 12.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.262 -0.426 . . . . 0.25 111.39 -175.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.1 mm -74.26 132.94 78.46 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.148 -0.478 . . . . 0.62 110.89 176.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.598 ' HD2' HD12 ' A' ' 22' ' ' LEU . 77.8 Cg_exo -46.93 140.83 12.8 Favored 'Trans proline' 0 C--N 1.347 0.5 0 C-N-CA 123.403 2.735 . . . . 0.31 113.298 173.392 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.961 HD12 ' HD2' ' A' ' 23' ' ' ARG . 4.2 tp -60.49 -32.73 52.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.606 -0.724 . . . . 0.86 110.132 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 2' ' ' LYS . 6.6 pt-20 -70.67 -26.29 63.37 Favored 'General case' 0 CA--C 1.522 -0.126 0 CA-C-O 121.128 0.489 . . . . 1.73 109.934 179.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 12.3 mt -82.1 -47.96 11.94 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 109.321 -0.622 . . . . 0.44 109.321 -174.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.961 ' HD2' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -64.31 -32.12 73.59 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.606 -0.887 . . . . 1.92 108.606 177.824 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.1 tmt_? -63.74 -42.7 97.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.314 -0.857 . . . . 2.94 111.397 172.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.3 m -61.41 -35.28 77.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.383 0.611 . . . . 0.34 110.75 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' A' ' 22' ' ' LEU . 1.7 mt -91.09 -10.53 41.68 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.452 -0.795 . . . . 0.26 109.446 -176.529 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 59.2 34.7 81.12 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.449 -0.796 . . . . 0.28 112.22 -172.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.526 HG12 ' HB2' ' A' ' 26' ' ' LEU . 13.9 pt -106.86 163.86 4.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 121.372 0.606 . . . . 0.43 111.665 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.97 148.96 1.07 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.462 -1.245 . . . . 0.26 109.373 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.9 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 2.5 pt-20 33.07 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 115.62 1.711 . . . . 1.22 115.62 175.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.6 mmpt? -76.04 4.9 7.48 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.509 0.929 . . . . 0.85 113.509 -171.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.518 ' O ' HG23 ' B' ' 10' ' ' VAL . 22.2 m-20 -85.78 171.47 11.54 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.578 -0.449 . . . . 1.54 110.112 -178.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.493 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -124.03 153.26 41.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.527 0.68 . . . . 0.23 112.16 -179.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.493 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.4 mp -123.09 153.38 40.0 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 114.813 -1.085 . . . . 1.15 108.22 177.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -107.6 106.16 16.38 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.717 -0.846 . . . . 1.28 108.717 177.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.803 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -89.8 124.42 42.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.292 -0.867 . . . . 0.29 111.365 -174.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.7 m-85 -115.06 172.8 6.84 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 107.471 -1.307 . . . . 4.3 107.471 171.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -126.55 141.19 46.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.911 0 C-N-CA 120.693 -0.403 . . . . 0.26 110.173 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -129.32 76.84 1.75 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.13 0.491 . . . . 1.15 110.19 -179.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 20.4 t0 54.03 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 114.254 -1.339 . . . . 1.83 113.001 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.8 mt-10 -105.03 -13.43 15.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.978 -0.556 . . . . 2.54 110.777 -174.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 6.1 mtpt -115.25 158.73 21.91 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.973 -0.558 . . . . 0.87 110.932 -174.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.72 HD11 HD11 ' B' ' 26' ' ' LEU . 59.0 mt -104.37 137.86 31.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.842 -0.799 . . . . 0.34 108.842 173.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' B' ' 44' ' ' ILE . 15.9 mm -123.88 105.46 15.55 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.818 0 N-CA-C 109.614 -0.513 . . . . 0.2 109.614 -177.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.876 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.4 OUTLIER -119.62 118.71 31.69 Favored 'General case' 0 C--N 1.318 -0.804 0 C-N-CA 119.316 -0.953 . . . . 1.3 111.185 179.902 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -102.88 165.13 11.22 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 113.97 -1.468 . . . . 1.41 107.882 177.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HB2' ' HB3' ' A' ' 26' ' ' LEU . 81.8 tttt -65.22 137.02 57.32 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 109.064 -0.717 . . . . 2.68 109.064 171.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -60.32 154.36 20.38 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 109.371 -0.603 . . . . 3.55 109.371 176.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 16.2 mmmt -66.94 115.74 28.27 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.118 0.485 . . . . 3.38 110.652 -177.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.66 -29.13 9.18 Favored 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 122.899 2.399 . . . . 1.58 113.049 -169.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -69.43 134.72 49.32 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 121.267 0.556 . . . . 3.85 110.277 176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -94.11 146.89 23.65 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.856 -0.611 . . . . 5.0 109.812 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.247 0.956 0 CA-C-N 116.185 -0.462 . . . . 6.13 110.047 179.791 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 14.4 tpt . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 120.642 0.258 . . . . 5.41 111.512 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.429 ' HE2' ' OE2' ' B' ' 21' ' ' GLU . 0.4 OUTLIER -81.84 142.89 32.14 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.485 0.66 . . . . 1.29 111.764 -168.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 52.6 m -70.79 -162.53 0.07 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.488 -1.233 . . . . 0.46 112.002 178.21 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 3.9 m 69.33 59.37 0.32 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.703 -1.135 . . . . 0.41 111.337 177.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.76 35.89 3.14 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.501 -0.772 . . . . 0.32 112.282 175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 9.7 tp -109.52 136.92 43.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.975 0.417 . . . . 0.52 110.761 -179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.3 p -88.94 125.37 42.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.982 0.42 . . . . 0.37 111.688 -174.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 2.7 mpt_? -120.94 165.93 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.509 -0.314 . . . . 1.74 110.321 175.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -96.04 162.54 13.51 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.974 -0.38 . . . . 1.23 109.974 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.7 t -82.34 -108.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.798 -0.361 . . . . 0.39 110.293 177.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.56 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 7.0 t70 175.17 -77.8 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.107 -0.701 . . . . 1.66 109.107 -171.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.9 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.5 OUTLIER -159.27 -71.61 0.08 Allowed 'General case' 0 CA--C 1.506 -0.738 0 CA-C-N 115.045 -0.979 . . . . 1.91 108.832 168.541 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.669 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.4 pt? -77.74 -29.07 50.95 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 114.58 -1.191 . . . . 0.72 111.271 -175.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.46 -11.86 0.18 Allowed Glycine 0 C--O 1.219 -0.835 0 C-N-CA 119.206 -1.473 . . . . 0.31 114.011 177.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.637 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.9 ttt180 -56.61 99.94 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.628 0.714 . . . . 0.75 111.741 -178.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.629 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.6 p -95.01 141.83 14.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.777 -0.453 . . . . 1.04 109.777 -179.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 47.3 t -78.38 109.44 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.306 -0.406 . . . . 0.25 111.071 -176.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.5 HD12 HD13 ' A' ' 43' ' ' ILE . 30.8 mm -75.34 134.48 73.53 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.155 -0.475 . . . . 0.55 110.701 175.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.64 ' HD2' HD12 ' B' ' 22' ' ' LEU . 92.9 Cg_exo -48.46 141.12 20.08 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 123.087 2.525 . . . . 0.28 113.044 173.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.566 HD12 ' HD2' ' B' ' 23' ' ' ARG . 6.5 tp -59.93 -32.83 50.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.937 -0.574 . . . . 0.82 110.222 178.124 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.429 ' OE2' ' HE2' ' B' ' 2' ' ' LYS . 8.9 pt-20 -73.47 -23.62 60.1 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-O 121.172 0.51 . . . . 1.35 110.328 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.8 mt -81.36 -48.19 12.28 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 109.417 -0.586 . . . . 0.33 109.417 -176.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.566 ' HD2' HD12 ' B' ' 20' ' ' ILE . 0.1 OUTLIER -64.15 -33.48 75.87 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.154 -1.054 . . . . 1.48 108.154 177.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.45 -47.11 85.07 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 115.191 -0.913 . . . . 2.77 111.289 171.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 86.9 m -60.77 -35.14 75.69 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.358 0.599 . . . . 0.31 111.045 -179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.766 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 2.5 mt -90.36 -10.9 42.27 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.709 -0.678 . . . . 0.24 109.785 -176.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.71 24.72 64.66 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.337 -0.847 . . . . 0.34 112.298 -172.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.55 HG12 ' HB2' ' B' ' 26' ' ' LEU . 12.3 pt -96.98 166.53 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.554 0 CA-C-O 121.293 0.568 . . . . 0.47 111.048 -179.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.87 152.69 1.58 Allowed 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.548 -1.206 . . . . 0.22 109.111 176.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.919 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.5 pt-20 33.78 -90.67 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 115.778 1.77 . . . . 1.12 115.778 169.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.465 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.0 mmpt? -83.98 7.19 19.21 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 113.01 0.744 . . . . 0.65 113.01 -171.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.507 ' O ' HG23 ' A' ' 10' ' ' VAL . 1.4 m-20 -84.48 174.54 9.96 Favored 'General case' 0 C--N 1.33 -0.26 0 O-C-N 122.129 -0.357 . . . . 1.37 110.57 178.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.508 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -122.7 152.97 40.03 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.481 0.658 . . . . 0.22 112.453 -177.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.457 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.5 mp -120.92 151.88 39.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 114.935 -1.03 . . . . 1.23 108.979 175.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -104.18 102.35 12.08 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 108.652 -0.869 . . . . 1.4 108.652 177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.433 HG13 ' HG ' ' B' ' 45' ' ' LEU . 1.8 mp -90.07 124.88 42.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.391 0.615 . . . . 0.29 111.68 -174.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.59 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 7.3 m-85 -114.16 175.13 5.61 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.012 -1.107 . . . . 4.28 108.012 171.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 11.6 p -127.25 143.11 41.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 N-CA-C 110.008 -0.367 . . . . 0.28 110.008 176.115 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -132.94 77.13 1.72 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.827 0.346 . . . . 1.12 110.628 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 t70 56.14 -75.95 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 114.565 -1.198 . . . . 1.64 113.05 176.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mt-10 -103.17 -25.44 13.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.125 -0.489 . . . . 2.81 110.81 -175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.455 ' HE2' ' HB2' ' B' ' 42' ' ' LYS . 1.0 OUTLIER -111.62 160.06 17.58 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.857 -0.611 . . . . 0.98 111.127 -173.633 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.876 ' HB ' HD12 ' A' ' 45' ' ' LEU . 68.0 mt -105.58 138.16 32.0 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 115.459 -0.792 . . . . 0.42 109.351 174.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.598 HD12 HD12 ' A' ' 44' ' ' ILE . 16.9 mm -114.64 112.69 41.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.491 -0.559 . . . . 0.25 109.491 -175.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.499 HD12 ' N ' ' B' ' 45' ' ' LEU . 0.5 OUTLIER -118.92 108.97 15.43 Favored 'General case' 0 C--N 1.315 -0.903 0 C-N-CA 119.938 -0.705 . . . . 1.29 110.247 -178.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.445 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 35.4 ttpt -96.23 164.96 12.44 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 174.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.556 ' HB2' ' HB3' ' B' ' 26' ' ' LEU . 82.9 tttt -70.48 139.06 51.6 Favored 'General case' 0 C--N 1.311 -1.093 0 N-CA-C 108.769 -0.826 . . . . 2.5 108.769 168.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -61.26 147.47 44.33 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 108.823 -0.806 . . . . 3.39 108.823 175.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -67.5 114.84 21.45 Favored Pre-proline 0 CA--C 1.512 -0.508 0 CA-C-O 121.366 0.603 . . . . 3.18 110.664 -177.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -75.31 -27.95 9.1 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.936 2.424 . . . . 1.56 113.288 -168.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -70.75 122.11 19.23 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.719 0.295 . . . . 3.92 110.217 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 1.1 pmm? -91.92 110.43 21.78 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.498 0.666 . . . . 5.19 111.349 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 51.2 m . . . . . 0 C--O 1.248 0.974 0 CA-C-N 115.468 -0.787 . . . . 6.34 109.367 172.215 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.1 mtp . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 110.244 -0.28 . . . . 4.93 110.244 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HA ' ' HD2' ' A' ' 2' ' ' LYS . 31.8 tptt -105.36 154.51 20.19 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.962 0.41 . . . . 1.67 110.732 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.1 m -85.73 -167.56 1.9 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.498 -0.774 . . . . 0.48 111.539 176.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HD1' ' B' ' 37' ' ' TYR . 49.2 m 72.15 72.59 0.16 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.999 -1.0 . . . . 0.48 112.574 173.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.22 40.02 7.13 Favored Glycine 0 N--CA 1.442 -0.911 0 CA-C-N 115.405 -0.816 . . . . 0.32 111.756 170.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.6 tp -111.47 139.7 34.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.052 0.453 . . . . 0.49 110.1 -179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.512 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 10.9 p -94.04 132.37 38.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.306 -0.406 . . . . 0.37 111.205 -174.021 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 3.2 mpt_? -134.14 164.85 26.44 Favored 'General case' 0 CA--C 1.515 -0.37 0 CA-C-N 116.251 -0.431 . . . . 1.96 110.498 176.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.485 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 0.8 OUTLIER -83.69 161.12 21.16 Favored 'General case' 0 C--N 1.321 -0.63 0 CA-C-N 115.923 -0.58 . . . . 1.16 109.611 179.676 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.578 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.8 t -79.35 -102.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 110.022 -0.362 . . . . 0.44 110.022 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.515 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 17.2 t0 174.48 -73.01 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.712 -0.847 . . . . 1.32 108.712 -177.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.875 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.3 pt-20 -164.78 -80.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.398 -1.274 . . . . 1.39 109.43 174.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.69 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.7 pt? -65.81 -31.48 72.46 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.053 -0.976 . . . . 0.6 112.032 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 157.62 -19.81 0.38 Allowed Glycine 0 C--O 1.221 -0.719 0 C-N-CA 119.783 -1.198 . . . . 0.34 113.816 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.647 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.3 ttt180 -49.49 105.8 0.09 Allowed 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 117.386 0.593 . . . . 1.26 112.385 -175.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.644 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.0 p -97.39 141.99 14.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.175 -0.466 . . . . 1.04 109.941 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 46.6 t -78.19 110.92 14.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.25 111.8 -175.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.542 HD12 HG21 ' B' ' 43' ' ' ILE . 40.7 mm -80.95 134.49 52.94 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 115.605 -0.725 . . . . 0.62 110.597 176.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.654 ' HD2' HD12 ' A' ' 22' ' ' LEU . 80.4 Cg_exo -49.99 141.11 30.33 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.275 2.65 . . . . 0.31 113.533 174.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 11.6 tt -60.59 -33.3 54.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.651 -0.704 . . . . 0.86 110.689 176.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -70.89 -23.54 62.31 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.155 0.503 . . . . 1.73 109.747 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.703 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.7 mt -82.22 -49.51 10.02 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.838 -0.619 . . . . 0.44 109.875 -175.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -65.29 -31.31 72.39 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.73 -0.841 . . . . 1.92 108.73 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.56 -39.54 94.66 Favored 'General case' 0 C--O 1.23 0.073 0 CA-C-N 115.525 -0.761 . . . . 2.94 110.895 173.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 98.3 m -62.59 -33.28 74.66 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.672 0.749 . . . . 0.34 110.254 177.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.849 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 1.9 mt -88.43 -11.25 46.58 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.422 -0.808 . . . . 0.26 109.573 -177.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.03 24.39 66.92 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.252 -0.886 . . . . 0.28 112.401 -172.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.82 HG12 ' HB2' ' A' ' 26' ' ' LEU . 18.5 pt -107.71 166.55 4.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-O 121.291 0.567 . . . . 0.43 111.467 -176.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.38 146.39 0.63 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.812 -1.085 . . . . 0.26 109.807 175.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.993 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.4 pt-20 37.5 -85.08 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 115.33 1.604 . . . . 1.22 115.33 174.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.452 ' HE3' ' HB2' ' A' ' 30' ' ' GLU . 11.0 mmpt? -71.51 -1.42 13.3 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 112.91 0.707 . . . . 0.85 112.91 -173.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.466 ' O ' HG23 ' B' ' 10' ' ' VAL . 9.2 m-20 -86.59 175.98 8.03 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 120.99 0.424 . . . . 1.54 111.428 -177.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.546 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -122.8 152.33 40.78 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.626 -0.715 . . . . 0.23 112.59 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.461 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.8 mp -124.69 156.95 36.75 Favored 'General case' 0 CA--C 1.513 -0.459 0 N-CA-C 107.344 -1.354 . . . . 1.15 107.344 175.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.622 ' HB3' ' HG2' ' A' ' 46' ' ' LYS . 26.4 tt0 -108.03 107.96 18.87 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 109.204 -0.665 . . . . 1.28 109.204 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.64 HG13 HD12 ' A' ' 45' ' ' LEU . 2.0 mp -92.8 123.21 44.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.618 -0.719 . . . . 0.29 111.282 -174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.659 ' HD2' ' HB ' ' A' ' 44' ' ' ILE . 0.3 OUTLIER -127.05 162.56 25.75 Favored 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 115.201 -0.909 . . . . 4.3 109.092 177.197 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 15.0 p -121.42 139.89 47.16 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.688 0 CA-C-O 120.989 0.423 . . . . 0.26 110.611 -174.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -129.06 80.17 1.96 Allowed 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.233 0.539 . . . . 1.15 110.243 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 1.1 t70 61.94 -77.38 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.419 0 CA-C-N 114.353 -1.294 . . . . 1.83 111.459 -178.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -112.28 -31.47 6.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.237 -0.438 . . . . 2.54 110.639 -178.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.729 ' HE2' HD11 ' A' ' 44' ' ' ILE . 25.2 pttm -96.8 156.34 16.39 Favored 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 120.196 -0.601 . . . . 0.87 111.46 -172.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HD11 ' B' ' 26' ' ' LEU . 13.8 mt -107.06 137.67 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 CA-C-N 115.462 -0.79 . . . . 0.34 109.575 -176.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' B' ' 44' ' ' ILE . 15.1 mm -124.24 109.62 23.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.2 110.112 -175.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.764 HD21 HD11 ' B' ' 45' ' ' LEU . 0.0 OUTLIER -117.77 113.84 22.41 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 119.897 -0.721 . . . . 1.3 109.51 176.64 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.622 ' HG2' ' HB3' ' A' ' 35' ' ' GLU . 12.7 ptpt -91.98 162.57 14.33 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 107.647 -1.242 . . . . 1.41 107.647 173.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 51.4 pttt -65.97 148.01 52.46 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.82 -0.807 . . . . 2.68 108.82 168.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 37.6 t80 -60.82 126.72 28.44 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.712 -1.218 . . . . 3.55 107.712 173.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.7 tppt? -66.93 119.61 65.33 Favored Pre-proline 0 C--N 1.322 -0.609 0 N-CA-C 109.674 -0.491 . . . . 3.38 109.674 -171.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -59.5 107.02 0.34 Allowed 'Trans proline' 0 N--CA 1.461 -0.434 0 C-N-CA 122.726 2.284 . . . . 1.58 112.36 -172.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -109.34 96.94 6.63 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.564 -0.744 . . . . 3.85 109.55 179.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 26.8 ptm -104.21 145.7 29.84 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 116.048 -0.524 . . . . 5.0 110.082 178.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 23.6 p . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.564 -0.731 . . . . 6.13 110.783 -179.981 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 87.0 mtp . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.459 0.171 . . . . 5.41 111.161 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . . . . . . . . . 33.8 tptt -76.41 150.64 36.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.394 0.616 . . . . 1.29 112.096 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . . . . . . . . . 23.7 m -81.4 -164.52 0.78 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 114.825 -1.079 . . . . 0.46 110.973 175.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.538 HG23 ' HD1' ' A' ' 37' ' ' TYR . 20.8 m 74.16 71.36 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.269 -0.878 . . . . 0.41 111.98 173.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 87.73 39.13 7.22 Favored Glycine 0 N--CA 1.443 -0.891 0 CA-C-N 115.199 -0.91 . . . . 0.32 111.812 170.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.9 tp -109.67 138.71 35.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 121.164 0.506 . . . . 0.52 110.029 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.546 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 7.4 p -93.37 129.34 43.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.941 0 CA-C-N 116.114 -0.494 . . . . 0.37 111.244 -173.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ALA . 1.5 mpt_? -131.03 163.54 27.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.391 -0.368 . . . . 1.74 110.574 176.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.1 tpmt? -82.67 161.22 22.23 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.364 -0.606 . . . . 1.23 109.364 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 32' ' ' ASP . 2.8 t -78.99 -103.74 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 120.806 -0.357 . . . . 0.39 110.251 177.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.664 ' H ' ' HA ' ' A' ' 30' ' ' GLU . 17.4 t70 175.42 -77.01 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 109.173 -0.677 . . . . 1.66 109.173 -175.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.993 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -160.57 -73.25 0.07 Allowed 'General case' 0 CA--C 1.51 -0.559 0 CA-C-N 114.965 -1.016 . . . . 1.91 108.626 172.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.472 ' H ' HD23 ' B' ' 13' ' ' LEU . 2.5 pt? -80.12 -23.1 41.42 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.394 -1.275 . . . . 0.72 111.534 -174.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 153.9 -18.95 0.66 Allowed Glycine 0 C--O 1.221 -0.665 0 C-N-CA 119.557 -1.306 . . . . 0.31 113.553 177.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.644 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.4 ttt180 -50.12 105.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 112.312 0.486 . . . . 0.75 112.312 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.647 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 11.5 p -97.94 142.98 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.238 -0.437 . . . . 1.04 109.906 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 54.4 t -78.47 111.46 15.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.025 0.44 . . . . 0.25 111.889 -174.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.646 HD12 HD13 ' A' ' 43' ' ' ILE . 25.1 mm -78.34 132.51 65.93 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 115.642 -0.708 . . . . 0.55 110.777 175.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.617 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 88.8 Cg_exo -48.73 140.27 22.95 Favored 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.233 2.622 . . . . 0.28 113.291 172.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.8 tt -60.11 -33.01 51.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.76 -0.655 . . . . 0.82 110.961 176.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -70.83 -25.49 62.87 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.932 0.396 . . . . 1.35 110.264 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.766 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.7 mt -80.54 -48.79 12.22 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.808 -0.633 . . . . 0.33 109.608 -175.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.503 ' HG3' ' N ' ' B' ' 24' ' ' ARG . 0.3 OUTLIER -65.44 -33.22 75.42 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.381 -0.97 . . . . 1.48 108.381 178.593 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.503 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 5.7 tmm_? -59.57 -42.4 92.36 Favored 'General case' 0 CA--C 1.517 -0.317 0 CA-C-N 115.261 -0.881 . . . . 2.77 109.844 173.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 80.3 m -60.96 -38.15 84.91 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.677 0.751 . . . . 0.31 110.465 179.217 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.843 ' HB3' ' HB3' ' B' ' 47' ' ' LYS . 4.9 mt -85.72 -11.26 54.12 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 114.994 -1.003 . . . . 0.24 109.789 -173.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.78 33.86 86.71 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.294 -0.866 . . . . 0.34 111.782 -174.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.549 HG13 ' HB2' ' B' ' 26' ' ' LEU . 2.7 pp -122.15 167.23 15.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 CA-C-O 120.917 0.389 . . . . 0.47 111.345 -178.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.444 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -174.13 154.93 2.35 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 115.164 -0.926 . . . . 0.22 109.432 177.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.4 pt-20 36.2 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.522 0 N-CA-C 115.419 1.637 . . . . 1.12 115.419 170.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.447 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.8 mmpt? -79.45 6.91 9.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.822 0.675 . . . . 0.65 112.822 -173.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.578 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.9 OUTLIER -92.9 176.73 6.32 Favored 'General case' 0 CA--C 1.516 -0.328 0 O-C-N 122.223 -0.298 . . . . 1.37 110.94 178.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.512 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -123.01 153.33 39.95 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 113.168 0.803 . . . . 0.22 113.168 -175.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . . . . . . . . . 6.9 mp -124.71 155.94 38.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.377 -1.283 . . . . 1.23 107.557 172.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -108.16 107.37 17.98 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-O 121.257 0.551 . . . . 1.4 109.768 178.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.716 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.3 124.7 44.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.259 -0.882 . . . . 0.29 111.432 -173.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.595 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.7 OUTLIER -127.0 164.49 21.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.195 -0.911 . . . . 4.28 108.827 176.028 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 13.0 p -123.38 139.91 48.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 C-N-CA 120.988 -0.285 . . . . 0.28 110.874 -175.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -129.73 89.37 2.81 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 120.642 -0.423 . . . . 1.12 110.333 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.0 t70 63.88 -81.07 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 115.001 -1.0 . . . . 1.64 111.396 -178.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.14 4.77 4.1 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.274 -0.876 . . . . 2.81 110.604 -177.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -103.79 155.13 18.84 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.704 -0.48 . . . . 0.98 109.704 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.742 HD11 HD11 ' A' ' 26' ' ' LEU . 13.0 mt -109.6 134.13 52.66 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.811 0 N-CA-C 109.454 -0.573 . . . . 0.42 109.454 174.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.763 HD12 HD12 ' A' ' 44' ' ' ILE . 11.7 mm -125.65 106.13 15.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.322 -0.399 . . . . 0.25 110.382 -172.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.764 HD11 HD21 ' A' ' 45' ' ' LEU . 0.0 OUTLIER -120.08 116.04 24.91 Favored 'General case' 0 C--N 1.32 -0.688 0 C-N-CA 119.758 -0.777 . . . . 1.29 110.067 178.857 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -94.42 163.47 13.4 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 108.087 -1.079 . . . . 1.22 108.087 172.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.843 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 62.1 pttt -63.18 151.32 40.62 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.179 -0.674 . . . . 2.5 109.179 169.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -60.83 132.03 52.57 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.131 -1.062 . . . . 3.39 108.131 172.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.472 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.3 tppt? -65.48 118.65 52.75 Favored Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 109.897 -0.409 . . . . 3.18 109.897 -175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.472 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 22.8 Cg_endo -61.74 106.48 0.44 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.486 2.124 . . . . 1.56 112.094 -174.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -98.25 104.71 16.76 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.403 -0.817 . . . . 3.92 109.044 178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.8 ptm -115.33 117.5 30.63 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.211 -0.449 . . . . 5.19 110.465 -177.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.456 -0.783 . . . . 6.34 110.215 177.366 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.481 1.109 0 CA-C-O 121.337 0.589 . . . . 4.93 110.68 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.29 -158.68 0.74 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.49 -0.777 . . . . 1.67 110.209 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 51.8 m -66.2 -175.41 0.33 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.797 0.808 . . . . 0.48 112.854 -176.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.594 HG23 ' HD1' ' B' ' 37' ' ' TYR . 17.8 m 72.11 67.74 0.14 Allowed 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 114.28 -1.327 . . . . 0.48 111.409 176.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.88 43.85 4.97 Favored Glycine 0 N--CA 1.437 -1.254 0 CA-C-N 115.349 -0.841 . . . . 0.32 111.438 174.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 tp -108.15 137.63 38.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.587 -0.445 . . . . 0.49 109.968 176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.544 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 9.8 p -98.67 124.23 51.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-O 120.907 0.384 . . . . 0.37 110.652 -175.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' B' ' 33' ' ' ALA . 0.5 OUTLIER -128.7 163.84 24.24 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.497 -0.32 . . . . 1.96 111.297 -178.39 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.491 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -80.86 162.98 23.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.918 -0.583 . . . . 1.16 110.645 178.591 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.3 t -86.75 -109.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 116.272 -0.422 . . . . 0.44 109.975 176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.492 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 16.7 t0 179.11 -67.3 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 109.044 -0.725 . . . . 1.32 109.044 -177.447 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.628 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 1.1 pt-20 -168.15 -83.83 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.92 -1.036 . . . . 1.39 110.255 175.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.3 pt? -80.52 -0.64 38.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.555 -1.202 . . . . 0.6 112.326 -171.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.569 ' O ' HG13 ' B' ' 18' ' ' ILE . . . 144.35 -22.75 2.05 Favored Glycine 0 C--O 1.222 -0.652 0 C-N-CA 119.744 -1.217 . . . . 0.34 113.967 177.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.722 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.6 ttt180 -58.12 106.82 0.41 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 117.436 0.618 . . . . 1.26 112.466 -174.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.725 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 13.4 p -98.3 140.07 18.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.753 -0.462 . . . . 1.04 109.753 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' HG3' ' B' ' 15' ' ' ARG . 40.7 t -79.8 101.71 5.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-O 120.8 0.333 . . . . 0.25 110.867 -178.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.682 HD13 HD13 ' B' ' 43' ' ' ILE . 10.4 mt -81.04 135.1 51.67 Favored Pre-proline 0 C--N 1.322 -0.614 0 CA-C-N 116.313 -0.403 . . . . 0.62 110.264 175.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.508 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 54.4 Cg_exo -42.85 136.0 4.88 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.494 2.796 . . . . 0.31 113.663 176.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 15.8 tt -59.06 -29.3 41.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.612 -0.722 . . . . 0.86 109.98 175.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.416 ' HG2' ' HB3' ' A' ' 19' ' ' PRO . 11.6 pt-20 -68.87 -27.38 65.76 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.929 -0.578 . . . . 1.73 110.047 177.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.721 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.3 mt -82.91 -47.01 12.27 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 116.01 -0.541 . . . . 0.44 109.675 -174.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.1 ptt180 -65.69 -30.65 71.37 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.604 -0.888 . . . . 1.92 108.604 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 68.7 ttt180 -62.44 -42.18 99.27 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.602 -0.726 . . . . 2.94 110.846 172.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.9 m -60.81 -35.64 77.0 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.244 0.545 . . . . 0.34 111.039 177.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.852 HD11 HD11 ' B' ' 43' ' ' ILE . 1.3 mt -90.3 -9.71 46.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.818 -0.628 . . . . 0.26 109.719 -176.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.26 34.91 86.6 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.241 -0.89 . . . . 0.28 112.099 -173.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.563 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.6 pt -115.41 165.96 9.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.104 0.478 . . . . 0.43 111.096 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -176.1 154.81 1.47 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.943 -1.026 . . . . 0.26 109.593 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.56 ' HG3' ' H ' ' A' ' 31' ' ' LYS . 4.6 pt-20 37.83 -89.71 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 115.356 1.613 . . . . 1.22 115.356 173.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.56 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.8 mmpt? -76.15 -1.61 27.05 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.818 0.673 . . . . 0.85 112.818 -173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' O ' HG23 ' B' ' 10' ' ' VAL . 37.2 m-20 -85.87 174.05 9.56 Favored 'General case' 0 CA--C 1.514 -0.425 0 C-N-CA 120.672 -0.411 . . . . 1.54 110.307 -176.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.18 153.38 40.14 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.746 0.784 . . . . 0.23 113.061 -175.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.668 HD23 ' HA ' ' A' ' 47' ' ' LYS . 18.5 mt -124.47 153.34 42.15 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-N 114.398 -1.274 . . . . 1.15 107.598 173.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -106.82 105.39 15.4 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 109.324 -0.621 . . . . 1.28 109.324 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.89 HG13 HD22 ' A' ' 45' ' ' LEU . 1.8 mp -90.37 123.39 42.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-N 115.473 -0.785 . . . . 0.29 111.06 -173.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.71 ' HD1' HG23 ' B' ' 4' ' ' THR . 0.2 OUTLIER -124.92 158.85 32.55 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.716 -0.846 . . . . 4.3 108.716 175.545 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.427 HG12 ' OG1' ' B' ' 4' ' ' THR . 9.7 p -112.56 139.48 37.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 C-N-CA 120.68 -0.408 . . . . 0.26 110.795 -172.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -135.48 82.15 1.93 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.381 -0.372 . . . . 1.15 110.109 -178.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 63.17 -85.24 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.531 0 CA-C-N 115.357 -0.838 . . . . 1.83 111.511 -175.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -121.28 -15.35 8.15 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.62 -0.718 . . . . 2.54 110.038 -179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 16.2 mtpt -85.21 144.45 28.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.789 -0.642 . . . . 0.87 110.344 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.932 HD11 HD11 ' B' ' 26' ' ' LEU . 18.4 mt -106.05 131.58 55.29 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 115.431 -0.804 . . . . 0.34 108.929 177.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' B' ' 44' ' ' ILE . 17.9 mm -119.32 112.25 36.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 116.389 -0.369 . . . . 0.2 110.054 -171.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.89 HD22 HG13 ' A' ' 36' ' ' ILE . 0.1 OUTLIER -117.03 108.74 16.12 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.483 -0.562 . . . . 1.3 109.483 -178.039 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.414 ' HB2' ' HG2' ' B' ' 42' ' ' LYS . 31.9 ttpt -103.18 134.89 45.84 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.813 -0.81 . . . . 1.41 108.813 176.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.668 ' HA ' HD23 ' A' ' 34' ' ' LEU . 60.3 pttt -47.51 144.85 2.84 Favored 'General case' 0 C--O 1.238 0.492 0 O-C-N 123.064 0.227 . . . . 2.68 110.623 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -60.4 144.69 50.32 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 110.108 -0.33 . . . . 3.55 110.108 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.788 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.88 114.69 24.64 Favored Pre-proline 0 N--CA 1.447 -0.599 0 N-CA-C 109.575 -0.528 . . . . 3.38 109.575 -179.042 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.788 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 58.0 Cg_endo -69.5 110.03 2.4 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.581 2.187 . . . . 1.58 111.17 -176.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -81.8 151.72 27.27 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.092 -0.504 . . . . 3.85 110.816 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.83 145.8 51.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.133 0.492 . . . . 5.0 110.983 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.389 -0.815 . . . . 6.13 110.423 178.52 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.682 ' HG2' ' H ' ' B' ' 2' ' ' LYS . 12.9 ttt . . . . . 0 N--CA 1.48 1.048 0 N-CA-C 109.474 -0.565 . . . . 5.41 109.474 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.757 ' HD3' ' H ' ' B' ' 3' ' ' SER . 0.0 OUTLIER -89.36 -95.42 0.1 Allowed 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.941 1.089 . . . . 1.29 113.941 -170.092 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.757 ' H ' ' HD3' ' B' ' 2' ' ' LYS . 69.1 m -130.44 -174.29 3.3 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.659 0.266 . . . . 0.46 111.162 -173.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.71 HG23 ' HD1' ' A' ' 37' ' ' TYR . 27.9 m 65.73 69.3 0.46 Allowed 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.403 -0.817 . . . . 0.41 111.005 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.75 41.54 4.38 Favored Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.021 -0.99 . . . . 0.32 111.721 175.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.5 tp -105.44 137.21 36.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.664 -0.495 . . . . 0.52 109.664 177.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.503 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 12.5 p -96.99 128.31 48.32 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-O 120.967 0.413 . . . . 0.37 110.356 -177.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.45 156.59 48.31 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.29 -0.414 . . . . 1.74 110.638 -178.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . 0.596 ' HA ' ' HE2' ' B' ' 9' ' ' LYS . 10.8 mmpt? -82.0 161.01 23.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.52 -0.309 . . . . 1.23 110.624 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.486 ' HB ' ' H ' ' B' ' 11' ' ' ASP . 1.7 t -84.3 -118.1 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.365 0 CA-C-O 121.029 0.443 . . . . 0.39 110.146 178.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.564 ' HB2' ' HE ' ' A' ' 15' ' ' ARG . 17.3 t0 -171.91 -63.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.194 -0.669 . . . . 1.66 109.194 178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.735 ' HG3' ' H ' ' B' ' 13' ' ' LEU . 4.2 pt-20 -169.59 -86.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.201 -0.909 . . . . 1.91 110.41 175.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.735 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.7 pt? -61.01 -29.64 69.83 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.405 -0.816 . . . . 0.72 112.564 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.88 -9.78 0.31 Allowed Glycine 0 C--O 1.225 -0.449 0 C-N-CA 119.992 -1.099 . . . . 0.31 112.974 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.725 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 5.1 mtt180 -60.78 106.0 0.52 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.02 0.378 . . . . 0.75 112.02 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.722 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 9.7 p -100.99 142.1 16.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.146 -0.479 . . . . 1.04 109.734 176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . . . . . . . . . 58.6 t -80.65 108.98 14.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.601 -0.272 . . . . 0.25 111.162 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.573 HG21 HD13 ' A' ' 43' ' ' ILE . 3.4 mt -85.17 138.31 36.82 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 110.092 -0.336 . . . . 0.55 110.092 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.677 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 62.2 Cg_exo -43.16 136.6 5.28 Favored 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 123.395 2.73 . . . . 0.28 113.89 174.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 6.6 tt -56.03 -33.42 35.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 115.357 -0.838 . . . . 0.82 110.813 174.769 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -73.73 -22.75 59.78 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.394 -0.366 . . . . 1.35 110.38 -177.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.4 mt -82.04 -47.17 12.95 Favored 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 109.33 -0.619 . . . . 0.33 109.33 -176.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 18.0 ptt85 -64.98 -35.66 81.89 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.723 -0.843 . . . . 1.48 108.723 177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -61.7 -36.65 81.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 114.737 -1.119 . . . . 2.77 110.635 173.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . 0.405 ' HB ' ' O ' ' B' ' 22' ' ' LEU . 76.7 m -63.45 -36.03 82.39 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 121.529 0.68 . . . . 0.31 110.526 176.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.932 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -89.7 -10.61 45.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.338 -0.846 . . . . 0.24 109.777 -175.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.22 15.77 68.12 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.549 -0.75 . . . . 0.34 112.698 -175.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.601 HG12 ' HB2' ' B' ' 26' ' ' LEU . 15.5 pt -98.15 168.81 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.818 0.342 . . . . 0.47 111.247 -178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -179.44 146.66 0.28 Allowed 'General case' 0 CA--C 1.508 -0.667 0 CA-C-N 115.309 -0.86 . . . . 0.22 109.835 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.628 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.3 pt-20 37.47 -89.59 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 115.299 1.592 . . . . 1.12 115.299 173.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HB2' ' B' ' 30' ' ' GLU . 10.8 mmpt? -75.23 4.91 6.17 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.515 0.561 . . . . 0.65 112.515 -172.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.433 ' O ' HG23 ' A' ' 10' ' ' VAL . 0.5 OUTLIER -97.25 -177.99 4.02 Favored 'General case' 0 CA--C 1.512 -0.508 0 C-N-CA 120.086 -0.646 . . . . 1.37 110.896 -175.298 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.544 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -126.47 153.61 44.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 114.235 1.198 . . . . 0.22 114.235 -171.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' B' ' 47' ' ' LYS . 19.5 mt -127.02 153.68 45.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 114.186 -1.37 . . . . 1.23 108.024 173.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 13.8 tt0 -106.41 104.76 14.53 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 109.204 -0.665 . . . . 1.4 109.204 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.631 HG13 ' HB3' ' B' ' 45' ' ' LEU . 2.1 mp -92.94 124.5 45.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.52 0.676 . . . . 0.29 111.748 -175.168 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.594 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -126.46 162.95 24.42 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.079 -0.964 . . . . 4.28 108.658 175.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 8.2 p -115.27 140.69 35.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.019 0.437 . . . . 0.28 111.338 -171.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -131.31 78.87 1.86 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.336 0.588 . . . . 1.12 109.59 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 62.71 -77.7 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 114.504 -1.225 . . . . 1.64 111.216 -174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -128.71 -13.62 4.7 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.822 -0.627 . . . . 2.81 110.391 -177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.414 ' HG2' ' HB2' ' A' ' 46' ' ' LYS . 24.0 mtpt -85.27 143.87 28.46 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.09 -0.504 . . . . 0.98 109.748 174.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.852 HD11 HD11 ' A' ' 26' ' ' LEU . 26.5 mt -104.25 132.5 50.64 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 N-CA-C 108.927 -0.768 . . . . 0.42 108.927 177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.705 HD12 HD12 ' A' ' 44' ' ' ILE . 15.5 mm -120.53 108.89 24.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 110.1 -0.333 . . . . 0.25 110.1 -172.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.631 ' HB3' HG13 ' B' ' 36' ' ' ILE . 0.1 OUTLIER -118.81 108.79 15.27 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.352 0.596 . . . . 1.29 110.629 -178.526 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.413 ' HB3' ' HE2' ' B' ' 46' ' ' LYS . 28.7 ttpt -90.34 156.06 18.52 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.776 -1.194 . . . . 1.22 107.776 173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.71 ' HA ' HD23 ' B' ' 34' ' ' LEU . 24.1 pttm -63.53 159.67 18.15 Favored 'General case' 0 C--N 1.312 -1.04 0 C-N-CA 120.023 -0.671 . . . . 2.5 109.338 173.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -59.64 149.4 30.49 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.379 -0.373 . . . . 3.39 110.026 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.723 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -68.93 116.08 37.89 Favored Pre-proline 0 C--N 1.322 -0.602 0 N-CA-C 108.988 -0.745 . . . . 3.18 108.988 173.692 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.723 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 60.5 Cg_endo -71.01 109.74 2.63 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.504 2.136 . . . . 1.56 111.278 -176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -78.86 152.16 31.43 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.876 -0.602 . . . . 3.92 110.528 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.36 149.19 50.63 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.025 -0.534 . . . . 5.19 110.402 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 C--O 1.248 0.992 0 CA-C-O 118.217 -0.897 . . . . 6.34 110.957 -179.098 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.482 1.148 0 N-CA-C 110.349 -0.241 . . . . 4.93 110.349 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.417 ' HD3' ' N ' ' A' ' 3' ' ' SER . 6.1 tmtt? -139.24 156.88 46.76 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 1.67 109.859 177.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.417 ' N ' ' HD3' ' A' ' 2' ' ' LYS . 44.0 m -72.79 -167.65 0.39 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.461 0.648 . . . . 0.48 112.102 -177.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.585 ' HA ' ' HA ' ' B' ' 37' ' ' TYR . 4.7 m 71.73 60.58 0.15 Allowed 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.749 -1.114 . . . . 0.48 111.382 177.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 104.09 36.29 3.2 Favored Glycine 0 N--CA 1.44 -1.053 0 CA-C-N 115.439 -0.8 . . . . 0.32 112.131 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 tp -105.15 134.92 45.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 CA-C-O 120.905 0.383 . . . . 0.49 110.128 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.558 ' HA ' ' O ' ' B' ' 34' ' ' LEU . 13.1 p -93.41 129.51 43.75 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.112 0.482 . . . . 0.37 111.36 -176.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.439 HH12 ' HA ' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -129.81 165.82 21.19 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.034 -0.53 . . . . 1.96 110.814 176.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.6 ' HD3' ' O ' ' B' ' 32' ' ' ASP . 7.5 tppt? -87.84 159.79 18.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.629 -0.714 . . . . 1.16 109.825 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.528 HG23 ' O ' ' B' ' 32' ' ' ASP . 2.0 t -82.05 -118.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 108.716 -0.846 . . . . 0.44 108.716 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.556 ' HB2' ' NE ' ' B' ' 15' ' ' ARG . 20.3 t0 -174.79 -69.3 0.01 OUTLIER 'General case' 0 CA--C 1.512 -0.482 0 N-CA-C 109.647 -0.501 . . . . 1.32 109.647 176.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.897 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.2 OUTLIER -154.98 -78.52 0.09 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.393 -0.821 . . . . 1.39 110.349 174.325 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.556 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.6 pt? -81.85 0.02 41.44 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 114.827 -1.079 . . . . 0.6 112.511 -171.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 135.81 -21.05 3.59 Favored Glycine 0 C--O 1.219 -0.795 0 C-N-CA 120.076 -1.059 . . . . 0.34 113.143 178.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.684 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 6.1 mtt180 -53.49 106.41 0.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 117.066 0.433 . . . . 1.26 111.961 -177.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.679 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 12.1 p -102.3 142.83 15.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.283 -0.417 . . . . 1.04 110.063 179.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.508 HG22 ' HG3' ' B' ' 15' ' ' ARG . 51.9 t -76.87 102.98 3.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.415 . . . . 0.25 111.939 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 37.6 mm -70.67 132.36 87.26 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 116.071 -0.513 . . . . 0.62 110.414 173.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.582 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 99.3 Cg_exo -47.76 141.92 15.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 123.019 2.479 . . . . 0.31 113.016 174.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 12.0 tt -61.35 -32.91 54.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-N 115.703 -0.681 . . . . 0.86 110.117 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -71.53 -24.45 61.95 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 121.02 0.438 . . . . 1.73 110.146 179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.723 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.6 mt -83.12 -48.69 10.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.504 -0.554 . . . . 0.44 109.504 -174.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.5 ' HG3' ' N ' ' A' ' 24' ' ' ARG . 22.6 ptt85 -64.5 -33.4 75.8 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.408 -0.96 . . . . 1.92 108.408 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.5 ' N ' ' HG3' ' A' ' 23' ' ' ARG . 14.4 ttt180 -58.88 -43.62 90.94 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.14 -0.936 . . . . 2.94 110.75 172.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.9 m -61.05 -32.76 72.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.435 -0.802 . . . . 0.34 110.31 178.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.822 ' HB3' ' HB3' ' A' ' 47' ' ' LYS . 2.5 mt -92.98 -9.53 39.57 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.472 -0.785 . . . . 0.26 110.003 -177.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.94 28.01 69.61 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.448 -0.796 . . . . 0.28 112.635 -174.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.713 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.2 pt -107.0 167.1 3.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.117 0.484 . . . . 0.43 111.626 -177.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.54 150.89 1.44 Allowed 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 115.1 -0.955 . . . . 0.26 110.2 177.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.856 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.2 pt-20 35.12 -89.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 115.723 1.749 . . . . 1.22 115.723 173.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -80.01 5.63 13.58 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 113.022 0.749 . . . . 0.85 113.022 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.474 ' O ' HG23 ' B' ' 10' ' ' VAL . 0.7 OUTLIER -81.73 177.81 8.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.866 0.365 . . . . 1.54 111.422 -177.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.466 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -123.36 151.33 42.64 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.993 -0.549 . . . . 0.23 112.151 -177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 6.7 mp -126.63 157.28 39.34 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.433 -0.951 . . . . 1.15 108.433 176.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -111.37 105.86 14.62 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.295 -0.632 . . . . 1.28 109.295 178.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.717 HG13 ' HB3' ' A' ' 45' ' ' LEU . 1.8 mp -90.09 125.14 42.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.201 -0.909 . . . . 0.29 111.484 -176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.537 ' HA ' ' HA ' ' B' ' 4' ' ' THR . 1.9 m-85 -114.55 173.97 6.19 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.459 -1.311 . . . . 4.3 107.459 171.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.7 p -126.85 142.2 44.03 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 C-N-CA 120.563 -0.455 . . . . 0.26 110.294 176.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -126.85 77.23 1.71 Allowed 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.885 -0.326 . . . . 1.15 110.435 178.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.6 t70 57.79 -76.99 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.619 1.199 . . . . 1.83 112.655 179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.431 ' OE2' ' HG3' ' A' ' 42' ' ' LYS . 0.0 OUTLIER -117.19 7.16 12.9 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.52 -0.309 . . . . 2.54 111.351 -176.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.665 ' HG2' ' HB2' ' B' ' 46' ' ' LYS . 35.6 mtmm -127.04 162.87 25.02 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.138 0.494 . . . . 0.87 111.41 178.207 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.653 HD13 HD12 ' B' ' 18' ' ' ILE . 54.0 mt -106.68 138.64 31.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.428 -0.805 . . . . 0.34 109.294 173.164 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' B' ' 44' ' ' ILE . 16.8 mm -125.78 106.13 15.64 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.801 0 N-CA-C 109.705 -0.48 . . . . 0.2 109.705 -176.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.858 HD12 ' HB ' ' B' ' 43' ' ' ILE . 0.5 OUTLIER -123.04 128.09 49.68 Favored 'General case' 0 C--N 1.317 -0.816 0 C-N-CA 119.293 -0.963 . . . . 1.3 111.474 -179.279 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HB2' ' HB3' ' B' ' 42' ' ' LYS . 38.1 ttpt -121.96 145.94 47.63 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.999 -1.001 . . . . 1.41 108.328 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.822 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 60.2 pttt -48.41 143.04 5.11 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.114 0.259 . . . . 2.68 110.847 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -60.44 140.4 57.26 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.865 -0.791 . . . . 3.55 108.865 177.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.729 ' HD3' ' HD2' ' A' ' 50' ' ' PRO . 17.2 tppt? -65.88 121.06 73.9 Favored Pre-proline 0 N--CA 1.441 -0.907 0 CA-C-N 116.206 -0.452 . . . . 3.38 110.546 -174.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.729 ' HD2' ' HD3' ' A' ' 49' ' ' LYS . 37.7 Cg_endo -66.16 102.65 0.57 Allowed 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.143 1.896 . . . . 1.58 110.856 178.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 41.3 t30 -97.61 110.73 23.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.644 -0.707 . . . . 3.85 110.399 -173.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 45.5 tpp -134.4 122.71 22.94 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.875 -0.602 . . . . 5.0 110.386 -178.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 27.7 p . . . . . 0 C--O 1.252 1.205 0 CA-C-O 118.095 -0.955 . . . . 6.13 112.318 179.626 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 72.0 mtm . . . . . 0 N--CA 1.482 1.126 0 N-CA-C 110.239 -0.282 . . . . 5.41 110.239 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.49 ' HA ' ' OE1' ' B' ' 21' ' ' GLU . 3.9 tmtt? -162.41 148.35 12.84 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.144 -0.687 . . . . 1.29 109.144 174.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.431 ' N ' ' HD3' ' B' ' 2' ' ' LYS . 70.5 m -69.36 -166.05 0.09 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.665 0.745 . . . . 0.46 112.128 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.537 ' HA ' ' HA ' ' A' ' 37' ' ' TYR . 7.8 m 66.82 66.16 0.44 Allowed 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.651 -1.159 . . . . 0.41 111.302 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.64 34.45 4.97 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.606 -0.725 . . . . 0.32 112.403 174.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 5.8 tp -102.39 134.12 44.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.967 0.413 . . . . 0.52 110.342 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 34' ' ' LEU . 7.2 p -94.66 127.03 46.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.129 0.49 . . . . 0.37 111.614 -176.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -127.54 166.96 17.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.141 -0.481 . . . . 1.74 110.52 175.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 1.2 tpmt? -88.83 161.85 16.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 1.23 109.79 -179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 30' ' ' GLU . 2.2 t -81.06 -109.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 N-CA-C 109.59 -0.522 . . . . 0.39 109.59 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.498 ' HB2' ' NE ' ' A' ' 15' ' ' ARG . 24.5 t70 176.65 -79.0 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.296 0 N-CA-C 109.453 -0.573 . . . . 1.66 109.453 -175.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.856 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 2.6 pt-20 -154.92 -81.85 0.08 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.521 -0.763 . . . . 1.91 110.024 173.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.603 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -65.49 -29.9 70.61 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.34 -0.845 . . . . 0.72 112.102 -178.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 155.72 -9.81 0.32 Allowed Glycine 0 C--O 1.223 -0.587 0 C-N-CA 119.685 -1.245 . . . . 0.31 112.888 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 9.6 mtt180 -54.9 105.18 0.14 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.0 0.37 . . . . 0.75 112.0 179.046 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.684 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 12.7 p -98.72 141.44 16.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 116.38 -0.373 . . . . 1.04 110.132 179.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.482 HG22 ' HG3' ' A' ' 15' ' ' ARG . 42.4 t -77.28 101.1 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.968 0.413 . . . . 0.25 111.74 -174.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.653 HD12 HD13 ' A' ' 43' ' ' ILE . 26.0 mm -67.17 135.51 93.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.876 -0.602 . . . . 0.55 110.708 174.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.553 ' HD2' HD12 ' B' ' 22' ' ' LEU . 89.2 Cg_exo -49.85 137.64 35.02 Favored 'Trans proline' 0 C--O 1.234 0.306 0 C-N-CA 122.846 2.364 . . . . 0.28 112.62 171.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . . . . . . . . . 11.4 tt -57.86 -33.21 45.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.008 -0.542 . . . . 0.82 110.344 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' B' ' 2' ' ' LYS . 12.3 pt-20 -69.94 -27.34 64.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.255 -0.43 . . . . 1.35 110.276 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.746 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.3 mt -82.03 -48.41 11.44 Favored 'General case' 0 N--CA 1.446 -0.665 0 CA-C-N 115.775 -0.648 . . . . 0.33 109.457 -174.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . . . . . . . . . 4.6 ppt_? -68.29 -25.84 65.34 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 108.225 -1.028 . . . . 1.48 108.225 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -69.91 -37.48 75.96 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 115.619 -0.719 . . . . 2.77 110.742 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 98.2 m -61.35 -35.59 77.87 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 121.419 0.628 . . . . 0.31 110.503 175.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.746 ' HG ' ' O ' ' B' ' 22' ' ' LEU . 3.1 mt -89.27 -11.11 44.46 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.395 -0.82 . . . . 0.24 109.864 -175.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.18 22.59 69.16 Favored Glycine 0 N--CA 1.452 -0.244 0 CA-C-N 115.551 -0.75 . . . . 0.34 112.872 -174.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.674 HG12 ' HB2' ' B' ' 26' ' ' LEU . 17.4 pt -101.95 167.97 2.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.173 0.511 . . . . 0.47 111.579 -177.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -174.25 150.77 1.54 Allowed 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 114.871 -1.059 . . . . 0.22 110.262 174.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.897 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 3.0 pt-20 36.0 -89.56 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 115.725 1.75 . . . . 1.12 115.725 172.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . 0.409 ' H ' ' HG3' ' B' ' 30' ' ' GLU . 11.7 mmpt? -79.58 7.98 7.29 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 113.225 0.824 . . . . 0.65 113.225 -171.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.6 ' O ' ' HD3' ' A' ' 9' ' ' LYS . 71.6 m-20 -88.96 176.6 6.94 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 118.036 0.38 . . . . 1.37 111.06 -177.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.495 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -121.43 150.91 40.84 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.536 0.684 . . . . 0.22 112.632 -176.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 7' ' ' VAL . 6.8 mp -123.02 156.21 35.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 114.964 -1.016 . . . . 1.23 109.256 173.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.521 ' HG3' ' HA ' ' B' ' 48' ' ' TYR . 43.7 mt-10 -108.77 105.42 14.99 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.805 -0.634 . . . . 1.4 109.385 175.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . . . . . . . . . 1.8 mp -90.02 124.78 42.85 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.301 -0.863 . . . . 0.29 111.351 -175.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.585 ' HA ' ' HA ' ' A' ' 4' ' ' THR . 17.0 m-85 -113.57 174.78 5.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 107.517 -1.29 . . . . 4.28 107.517 172.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.6 p -130.45 142.96 42.37 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 C-N-CA 120.598 -0.441 . . . . 0.28 110.158 176.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -130.58 78.12 1.82 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.107 -0.497 . . . . 1.12 110.554 -179.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 1.7 t70 60.02 -75.55 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.627 -1.169 . . . . 1.64 112.618 176.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -107.43 -25.58 11.35 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.957 0.408 . . . . 2.81 111.033 -175.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 24.8 pttm -116.3 162.45 17.48 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.167 0.508 . . . . 0.98 111.919 -173.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.858 ' HB ' HD12 ' A' ' 45' ' ' LEU . 59.9 mt -106.04 139.03 28.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.39 -0.823 . . . . 0.42 110.169 -177.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.645 HD12 HD12 ' A' ' 44' ' ' ILE . 15.6 mm -118.11 109.66 27.97 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.559 0 CA-C-N 116.081 -0.509 . . . . 0.25 109.754 -176.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.501 HD11 ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -117.39 116.88 28.06 Favored 'General case' 0 C--N 1.317 -0.805 0 C-N-CA 120.433 -0.507 . . . . 1.29 110.146 -176.335 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.665 ' HB2' ' HG2' ' A' ' 42' ' ' LYS . 38.5 ttpt -116.88 139.8 50.2 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.702 -0.851 . . . . 1.22 108.702 177.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.696 ' HB3' ' HB3' ' B' ' 26' ' ' LEU . 63.2 pttt -47.69 147.59 1.81 Allowed 'General case' 0 N--CA 1.467 0.415 0 O-C-N 123.202 0.314 . . . . 2.5 110.939 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . 0.521 ' HA ' ' HG3' ' B' ' 35' ' ' GLU . 78.6 t80 -59.79 139.7 57.11 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.112 -0.699 . . . . 3.39 109.112 176.661 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.54 ' HD3' ' HD2' ' B' ' 50' ' ' PRO . 16.0 tppt? -65.46 121.05 72.91 Favored Pre-proline 0 N--CA 1.445 -0.698 0 CA-C-N 116.32 -0.4 . . . . 3.18 110.462 -176.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.54 ' HD2' ' HD3' ' B' ' 49' ' ' LYS . 39.9 Cg_endo -66.56 98.83 0.41 Allowed 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.349 2.033 . . . . 1.56 110.961 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 38.0 t30 -89.62 108.39 19.64 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.493 -0.776 . . . . 3.92 110.569 -174.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 46.6 tpp -115.78 151.43 35.18 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.623 -0.717 . . . . 5.19 109.239 177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.252 1.203 0 CA-C-O 118.339 -0.838 . . . . 6.34 111.448 179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.98 0 N-CA-C 111.108 0.04 . . . . 4.93 111.108 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.493 ' HG2' ' OE2' ' A' ' 21' ' ' GLU . 0.0 OUTLIER -150.13 162.42 40.48 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 121.076 -0.25 . . . . 1.67 110.424 -178.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -80.83 -166.56 1.14 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.592 0.71 . . . . 0.48 112.32 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.654 HG23 ' HD1' ' B' ' 37' ' ' TYR . 25.1 m 72.0 71.6 0.16 Allowed 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.573 -1.194 . . . . 0.48 111.313 176.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.42 38.99 6.09 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.332 -0.849 . . . . 0.32 111.879 173.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 9.1 tp -105.51 136.76 38.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.706 -0.479 . . . . 0.49 109.706 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.549 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 11.2 p -95.84 127.3 48.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-O 120.902 0.382 . . . . 0.37 110.938 -174.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -125.96 161.13 28.21 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.344 -0.389 . . . . 1.96 110.671 178.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.42 ' HA ' ' HE3' ' A' ' 9' ' ' LYS . 0.5 OUTLIER -81.45 161.09 23.82 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.218 -0.66 . . . . 1.16 109.218 175.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.501 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.0 t -80.21 -108.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 109.564 -0.532 . . . . 0.44 109.564 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.491 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 26.9 t70 175.26 -67.29 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.364 0 N-CA-C 109.02 -0.733 . . . . 1.32 109.02 -178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.829 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 2.4 pt-20 -158.47 -86.91 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.939 -1.028 . . . . 1.39 109.986 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.604 ' H ' ' HG3' ' A' ' 12' ' ' GLU . 2.5 pt? -77.24 -27.73 53.4 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.786 -0.643 . . . . 0.6 112.112 -175.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 162.49 -0.33 0.06 OUTLIER Glycine 0 C--O 1.225 -0.464 0 C-N-CA 119.483 -1.342 . . . . 0.34 114.461 -178.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' B' ' 16' ' ' VAL . 2.9 ttt180 -66.81 99.65 0.64 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 118.495 1.148 . . . . 1.26 111.578 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 19.0 m -96.46 144.58 10.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.369 -0.378 . . . . 1.04 110.386 177.138 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.582 HG22 ' HG3' ' B' ' 15' ' ' ARG . 41.4 t -82.0 107.22 13.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 116.302 -0.408 . . . . 0.25 111.178 -176.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.546 HG13 ' O ' ' B' ' 14' ' ' GLY . 3.6 mt -79.9 139.24 53.61 Favored Pre-proline 0 C--N 1.326 -0.422 0 N-CA-C 110.186 -0.302 . . . . 0.62 110.186 173.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HB2' ' HG ' ' A' ' 22' ' ' LEU . 70.8 Cg_exo -46.33 140.03 11.82 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.422 2.748 . . . . 0.31 113.839 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.478 ' O ' ' HG3' ' A' ' 23' ' ' ARG . 6.7 tp -58.19 -32.84 45.44 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.52 -0.764 . . . . 0.86 110.443 175.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.493 ' OE2' ' HG2' ' A' ' 2' ' ' LYS . 20.5 pt-20 -72.81 -23.03 60.73 Favored 'General case' 0 C--O 1.225 -0.193 0 CA-C-N 116.406 -0.361 . . . . 1.73 110.419 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.705 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 6.3 mt -83.37 -46.48 12.51 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.297 0.57 . . . . 0.44 109.858 -175.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.525 HH11 ' HB2' ' A' ' 29' ' ' ALA . 0.0 OUTLIER -64.13 -31.37 72.54 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.011 -1.107 . . . . 1.92 108.011 176.572 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -65.64 -38.48 89.48 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 114.966 -1.016 . . . . 2.94 111.605 173.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.8 m -60.66 -36.54 78.95 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.542 0.687 . . . . 0.34 110.473 175.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.942 HD11 HD11 ' B' ' 43' ' ' ILE . 1.9 mt -89.28 -9.22 51.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.464 -0.789 . . . . 0.26 109.713 -175.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 61.13 29.37 70.91 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.257 -0.883 . . . . 0.28 112.118 -173.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.652 HG12 ' HB2' ' A' ' 26' ' ' LEU . 9.3 pt -110.12 167.29 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 CA-C-O 121.189 0.518 . . . . 0.43 111.124 179.049 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.525 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -179.68 154.87 0.62 Allowed 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 114.727 -1.124 . . . . 0.26 109.22 175.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.638 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.1 pt-20 37.82 -89.46 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 114.904 1.446 . . . . 1.22 114.904 171.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.1 5.11 17.66 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.493 0.553 . . . . 0.85 112.493 -172.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.537 ' O ' HG23 ' B' ' 10' ' ' VAL . 2.7 m-20 -87.67 172.73 9.49 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.81 0.338 . . . . 1.54 110.419 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -117.37 149.04 41.17 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.353 0.597 . . . . 0.23 111.692 -179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.837 HD12 ' HA ' ' A' ' 47' ' ' LYS . 14.1 tp -126.21 149.33 49.12 Favored 'General case' 0 N--CA 1.44 -0.975 0 N-CA-C 107.984 -1.117 . . . . 1.15 107.984 176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.5 tt0 -107.03 106.03 16.35 Favored 'General case' 0 C--N 1.308 -1.204 0 CA-C-O 121.209 0.528 . . . . 1.28 110.049 -177.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 1.017 HG13 HD22 ' A' ' 45' ' ' LEU . 1.7 mp -94.14 125.73 46.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 0.29 111.312 -173.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.737 ' HD1' ' HB ' ' A' ' 44' ' ' ILE . 0.4 OUTLIER -126.97 160.97 29.47 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.453 -0.794 . . . . 4.3 109.555 175.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.83 138.82 47.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 120.84 0.352 . . . . 0.26 110.794 -175.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -125.59 81.69 2.0 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.788 -0.449 . . . . 1.15 109.788 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.403 ' HB3' ' H ' ' A' ' 41' ' ' GLU . 2.5 t70 58.55 -82.61 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.704 -1.135 . . . . 1.83 111.454 -174.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.403 ' H ' ' HB3' ' A' ' 40' ' ' ASP . 24.3 mt-10 -114.08 -19.62 11.3 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.838 -0.619 . . . . 2.54 111.018 -176.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -92.73 159.03 15.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.034 0.445 . . . . 0.87 110.242 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.868 HD11 HD11 ' B' ' 26' ' ' LEU . 26.7 mt -110.28 133.54 55.33 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.843 -0.617 . . . . 0.34 109.367 175.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.737 ' HB ' ' HD1' ' A' ' 37' ' ' TYR . 17.9 mm -121.21 115.44 46.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 N-CA-C 109.829 -0.434 . . . . 0.2 109.829 -174.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' B' ' 45' ' ' LEU . 0.7 OUTLIER -114.03 118.91 35.41 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 109.546 -0.538 . . . . 1.3 109.546 -178.216 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.44 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 30.7 ttpt -112.35 148.65 33.81 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 107.117 -1.438 . . . . 1.41 107.117 173.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.837 ' HA ' HD12 ' A' ' 34' ' ' LEU . 84.5 tttt -56.69 149.66 17.44 Favored 'General case' 0 C--N 1.313 -1.002 0 N-CA-C 109.491 -0.559 . . . . 2.68 109.491 174.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.451 ' HD1' ' O ' ' A' ' 33' ' ' ALA . 17.3 p90 -59.16 146.12 40.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.38 -0.97 . . . . 3.55 108.38 177.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.926 ' HD2' ' HD2' ' A' ' 50' ' ' PRO . 0.0 OUTLIER -68.53 115.19 27.53 Favored Pre-proline 0 C--N 1.321 -0.641 0 C-N-CA 120.309 -0.557 . . . . 3.38 109.754 -177.259 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.926 ' HD2' ' HD2' ' A' ' 49' ' ' LYS . 32.2 Cg_endo -62.48 117.04 3.91 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 C-N-CA 122.644 2.229 . . . . 1.58 112.292 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.1 t-20 -87.93 99.32 12.05 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.228 -0.896 . . . . 3.85 109.831 178.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 14.3 tpt -127.55 124.32 37.91 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.461 -0.791 . . . . 5.0 109.733 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.248 1.0 0 CA-C-N 115.94 -0.573 . . . . 6.13 110.893 -179.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.201 0 CA-C-O 120.469 0.176 . . . . 5.41 110.773 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.451 ' HG2' ' OE2' ' B' ' 21' ' ' GLU . 0.1 OUTLIER -160.27 162.14 33.56 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.908 -0.404 . . . . 1.29 109.908 -178.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.439 ' N ' ' HD3' ' B' ' 2' ' ' LYS . 46.8 m -79.47 -167.26 1.15 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 123.4 0.68 . . . . 0.46 112.497 -176.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.619 HG23 ' HD2' ' A' ' 37' ' ' TYR . 25.0 m 71.94 70.58 0.16 Allowed 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 114.638 -1.164 . . . . 0.41 111.79 174.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.39 39.18 6.05 Favored Glycine 0 N--CA 1.441 -0.986 0 CA-C-N 115.193 -0.912 . . . . 0.32 111.796 174.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 8.6 tp -103.41 137.23 32.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.374 -0.602 . . . . 0.52 109.374 177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.527 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 10.0 p -95.61 127.99 47.17 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-O 120.958 0.408 . . . . 0.37 110.41 -176.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -125.66 159.93 30.96 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.155 -0.475 . . . . 1.74 110.316 179.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 2.7 tpmt? -81.42 157.55 24.91 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 108.926 -0.768 . . . . 1.23 108.926 175.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 32' ' ' ASP . 3.1 t -76.73 -104.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 109.577 -0.527 . . . . 0.39 109.577 175.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.414 ' C ' ' HA ' ' A' ' 30' ' ' GLU . 23.5 t0 170.2 -71.04 0.0 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.879 -0.786 . . . . 1.66 108.879 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.638 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.1 pt-20 -154.45 -83.51 0.07 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 114.877 -1.056 . . . . 1.91 110.173 175.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.546 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.5 pt? -84.13 -22.33 31.1 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.38 -0.827 . . . . 0.72 112.434 -173.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . 0.546 ' O ' HG13 ' A' ' 18' ' ' ILE . . . 159.42 -4.74 0.11 Allowed Glycine 0 C--O 1.222 -0.596 0 C-N-CA 119.477 -1.344 . . . . 0.31 113.871 -178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 2.1 ttt180 -66.77 96.98 0.43 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 117.926 0.863 . . . . 0.75 111.513 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.696 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 24.7 m -94.42 144.11 10.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.012 -0.54 . . . . 1.04 110.43 177.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.429 HG22 ' HG3' ' A' ' 15' ' ' ARG . 46.4 t -81.75 107.75 14.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.342 -0.39 . . . . 0.25 111.073 -176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.534 HD13 HD13 ' A' ' 43' ' ' ILE . 8.6 mt -82.14 138.16 45.83 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.485 -0.325 . . . . 0.55 110.611 175.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.51 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 70.6 Cg_exo -44.67 140.44 6.48 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.61 2.873 . . . . 0.28 113.969 175.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.433 ' O ' ' HG3' ' B' ' 23' ' ' ARG . 5.3 tp -57.68 -34.26 47.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.105 -0.952 . . . . 0.82 110.611 174.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' B' ' 2' ' ' LYS . 7.8 pt-20 -71.11 -24.29 62.26 Favored 'General case' 0 N--CA 1.459 0.023 0 N-CA-C 109.962 -0.384 . . . . 1.35 109.962 -179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.728 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 8.0 mt -83.51 -46.35 12.54 Favored 'General case' 0 N--CA 1.447 -0.584 0 CA-C-N 116.004 -0.544 . . . . 0.33 109.708 -174.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.557 ' HD3' ' O ' ' B' ' 28' ' ' ILE . 2.9 ppt_? -64.73 -31.57 72.86 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.866 -1.161 . . . . 1.48 107.866 176.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' B' ' 21' ' ' GLU . 31.3 ttt180 -59.29 -46.73 87.76 Favored 'General case' 0 C--O 1.23 0.072 0 CA-C-N 114.81 -1.086 . . . . 2.77 111.164 170.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 91.1 m -58.49 -35.33 72.04 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.313 0.578 . . . . 0.31 111.042 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.868 HD11 HD11 ' A' ' 43' ' ' ILE . 2.1 mt -90.22 -10.33 44.76 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.488 -0.778 . . . . 0.24 109.917 -175.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.72 18.22 63.66 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.531 -0.758 . . . . 0.34 112.768 -173.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.678 HG12 ' HB2' ' B' ' 26' ' ' LEU . 13.3 pt -101.49 167.22 2.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.958 0.408 . . . . 0.47 111.126 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . 0.45 ' H ' ' HB2' ' B' ' 32' ' ' ASP . . . -178.03 152.71 0.75 Allowed 'General case' 0 CA--C 1.509 -0.608 0 CA-C-N 115.102 -0.953 . . . . 0.22 109.548 176.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.829 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.8 pt-20 34.36 -90.13 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 115.126 1.528 . . . . 1.12 115.126 173.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.3 mmpt? -75.89 5.07 6.94 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.985 0.735 . . . . 0.65 112.985 -173.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 10' ' ' VAL . 16.0 m-20 -91.76 176.41 6.54 Favored 'General case' 0 CA--C 1.515 -0.397 0 O-C-N 121.891 -0.506 . . . . 1.37 111.335 -177.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.549 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -116.65 150.68 37.72 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.639 -0.709 . . . . 0.22 112.167 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.854 HD12 ' HA ' ' B' ' 47' ' ' LYS . 14.0 tp -128.36 150.67 50.0 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.219 -1.03 . . . . 1.23 108.219 173.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -106.35 107.25 18.16 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.607 -0.516 . . . . 1.4 109.607 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 1.033 HG13 HD22 ' B' ' 45' ' ' LEU . 1.7 mp -94.53 124.1 46.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.992 -0.549 . . . . 0.29 111.291 -174.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.825 ' HD2' ' HB ' ' B' ' 44' ' ' ILE . 0.3 OUTLIER -123.58 159.61 28.84 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.639 -0.71 . . . . 4.28 109.513 175.196 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 12.7 p -116.89 136.04 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.954 0.407 . . . . 0.28 110.622 -176.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -122.47 79.9 1.67 Allowed 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.557 -0.534 . . . . 1.12 109.557 -176.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 57.02 -87.53 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 114.858 -1.064 . . . . 1.64 111.507 -172.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -115.63 -3.33 12.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.964 -0.562 . . . . 2.81 111.104 -176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.0 mtpt -102.82 158.76 16.04 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.58 -0.526 . . . . 0.98 109.58 176.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.942 HD11 HD11 ' A' ' 26' ' ' LEU . 22.7 mt -111.8 133.51 57.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.431 -0.581 . . . . 0.42 109.431 175.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.825 ' HB ' ' HD2' ' B' ' 37' ' ' TYR . 18.3 mm -123.99 116.1 46.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.765 -0.458 . . . . 0.25 109.765 -174.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 1.08 HD11 HD11 ' A' ' 45' ' ' LEU . 0.7 OUTLIER -115.71 117.57 30.65 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 120.565 -0.454 . . . . 1.29 109.942 -177.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . 0.675 ' HE3' ' O ' ' B' ' 47' ' ' LYS . 18.8 ttpt -111.25 142.03 44.0 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 108.224 -1.028 . . . . 1.22 108.224 174.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.854 ' HA ' HD12 ' B' ' 34' ' ' LEU . 79.3 tttt -49.97 141.95 9.93 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 110.227 -0.286 . . . . 2.5 110.227 175.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -59.87 148.74 33.73 Favored 'General case' 0 C--O 1.234 0.289 0 N-CA-C 109.614 -0.513 . . . . 3.39 109.614 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.596 ' HD2' ' HD2' ' B' ' 50' ' ' PRO . 0.0 OUTLIER -67.12 113.14 12.1 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.377 -0.601 . . . . 3.18 109.377 -174.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . 0.596 ' HD2' ' HD2' ' B' ' 49' ' ' LYS . 39.9 Cg_endo -66.19 113.97 2.84 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 122.817 2.345 . . . . 1.56 111.768 -174.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -81.49 106.1 13.18 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.575 -0.739 . . . . 3.92 109.445 179.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 14.8 tpt -137.63 116.14 12.03 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.571 -0.741 . . . . 5.19 109.893 -177.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 11.1 p . . . . . 0 C--O 1.246 0.875 0 CA-C-O 118.634 -0.698 . . . . 6.34 110.993 -178.681 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.7 ptp . . . . . 0 N--CA 1.482 1.156 0 CA-C-O 120.908 0.385 . . . . 4.93 110.902 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -97.61 -152.36 0.39 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.235 -0.439 . . . . 1.67 110.069 -178.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.9 m -68.47 -170.44 0.2 Allowed 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.456 0.646 . . . . 0.48 111.065 172.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.601 HG23 ' HD1' ' B' ' 37' ' ' TYR . 11.5 m 70.79 68.22 0.18 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 114.903 -1.044 . . . . 0.48 111.683 171.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.409 ' HA2' ' HG2' ' B' ' 35' ' ' GLU . . . 91.89 37.66 5.99 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.31 -0.859 . . . . 0.32 111.894 174.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.9 tp -104.14 135.76 40.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 109.767 -0.457 . . . . 0.49 109.767 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.615 ' CG2' ' HB1' ' B' ' 33' ' ' ALA . 7.8 p -90.67 124.79 43.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.993 0 CA-C-O 120.996 0.427 . . . . 0.37 110.797 -175.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -122.69 159.58 27.64 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.277 -0.419 . . . . 1.96 110.525 175.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HE2' ' O ' ' B' ' 32' ' ' ASP . 1.1 tpmt? -83.58 158.32 21.98 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.89 -0.781 . . . . 1.16 108.89 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.487 HG23 ' O ' ' B' ' 32' ' ' ASP . 3.4 t -78.61 -105.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.055 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.578 ' H ' ' HA ' ' B' ' 30' ' ' GLU . 14.4 t70 175.32 -78.03 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.291 0 N-CA-C 109.448 -0.575 . . . . 1.32 109.448 -173.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.883 ' HA ' ' HB3' ' B' ' 30' ' ' GLU . 0.7 OUTLIER -161.59 -77.71 0.05 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.511 -0.768 . . . . 1.39 109.679 172.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.49 ' H ' HD23 ' A' ' 13' ' ' LEU . 2.7 pt? -72.66 -18.37 61.56 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.036 -0.984 . . . . 0.6 112.358 -176.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 150.86 -21.32 1.0 Allowed Glycine 0 C--O 1.221 -0.714 0 C-N-CA 120.018 -1.087 . . . . 0.34 113.76 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.705 ' HD3' ' HB2' ' B' ' 11' ' ' ASP . 6.8 ttm180 -51.92 104.87 0.09 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 117.381 0.591 . . . . 1.26 112.433 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.691 ' O ' ' HA ' ' B' ' 15' ' ' ARG . 14.9 p -97.11 143.22 12.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 109.951 -0.389 . . . . 1.04 109.951 179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' B' ' 15' ' ' ARG . 48.2 t -77.14 105.9 6.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.155 0.502 . . . . 0.25 111.597 -175.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.477 HD12 HG21 ' B' ' 43' ' ' ILE . 35.8 mm -77.42 134.82 65.93 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 115.78 -0.645 . . . . 0.62 110.218 173.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.614 ' HD2' HD12 ' A' ' 22' ' ' LEU . 87.3 Cg_exo -48.81 140.45 23.08 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.122 2.548 . . . . 0.31 113.199 175.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 9.4 tt -60.76 -33.3 54.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.915 -0.584 . . . . 0.86 110.339 176.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -70.04 -24.41 63.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.166 0.508 . . . . 1.73 109.725 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.78 ' O ' ' HG ' ' A' ' 26' ' ' LEU . 7.9 mt -82.05 -49.81 9.79 Favored 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.792 -0.64 . . . . 0.44 109.415 -175.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.2 ptt180 -64.88 -34.6 78.77 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.624 -0.88 . . . . 1.92 108.624 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.66 -44.36 85.66 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 115.241 -0.89 . . . . 2.94 111.129 172.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 96.2 m -63.14 -33.15 74.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.309 0.576 . . . . 0.34 110.956 178.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.845 HD11 HD11 ' B' ' 43' ' ' ILE . 3.1 mt -88.09 -12.91 42.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.918 -0.583 . . . . 0.26 110.036 -176.075 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.62 22.56 76.71 Favored Glycine 0 N--CA 1.446 -0.651 0 CA-C-N 115.443 -0.799 . . . . 0.28 112.17 -174.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.692 HG12 ' HB2' ' A' ' 26' ' ' LEU . 11.3 pt -108.13 167.34 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-O 120.993 0.425 . . . . 0.43 111.26 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -178.55 152.67 0.66 Allowed 'General case' 0 CA--C 1.507 -0.677 0 CA-C-N 114.749 -1.114 . . . . 0.26 109.674 174.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.826 ' HB3' ' HA ' ' B' ' 12' ' ' GLU . 3.3 pt-20 37.65 -89.3 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 115.566 1.691 . . . . 1.22 115.566 172.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.445 ' H ' ' HG3' ' A' ' 30' ' ' GLU . 11.5 mmpt? -81.17 7.02 12.13 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 112.704 0.631 . . . . 0.85 112.704 -172.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.467 ' O ' HG23 ' B' ' 10' ' ' VAL . 28.6 m-20 -87.27 177.89 7.02 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 1.54 111.433 -178.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' ' CG2' ' B' ' 7' ' ' VAL . . . -121.57 146.89 46.5 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.226 0.824 . . . . 0.23 113.226 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' B' ' 7' ' ' VAL . 5.0 mp -124.16 156.48 36.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.01 -0.995 . . . . 1.15 108.455 172.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -105.69 107.61 18.69 Favored 'General case' 0 C--N 1.314 -0.974 0 N-CA-C 109.583 -0.525 . . . . 1.28 109.583 176.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.981 HG13 HD12 ' A' ' 45' ' ' LEU . 1.8 mp -90.3 120.6 39.41 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-O 121.599 0.714 . . . . 0.29 110.698 -175.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.742 ' HD1' HG23 ' B' ' 4' ' ' THR . 1.0 OUTLIER -123.14 158.13 31.42 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.094 -0.957 . . . . 4.3 109.012 178.118 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.73 137.72 45.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 C-N-CA 120.551 -0.46 . . . . 0.26 110.779 -175.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -131.06 83.04 2.08 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.048 0.451 . . . . 1.15 110.857 -178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.4 t70 63.53 -83.13 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 114.793 -1.094 . . . . 1.83 111.817 178.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -128.33 9.62 6.15 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.006 -0.543 . . . . 2.54 111.255 -178.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -118.84 158.64 25.25 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.322 -0.399 . . . . 0.87 109.978 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.818 HD11 HD11 ' B' ' 26' ' ' LEU . 15.9 mt -110.06 138.31 38.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.263 -0.426 . . . . 0.34 109.89 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' B' ' 44' ' ' ILE . 11.4 mm -122.79 115.44 45.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.443 -0.344 . . . . 0.2 110.268 -175.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.981 HD12 HG13 ' A' ' 36' ' ' ILE . 0.0 OUTLIER -114.36 117.08 30.06 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.876 -0.73 . . . . 1.3 109.092 176.124 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 36.3 ttpt -107.62 126.8 53.02 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 109.028 -0.73 . . . . 1.41 109.028 176.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.648 ' HB3' ' HB3' ' A' ' 26' ' ' LEU . 59.3 pttt -44.71 139.48 2.92 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 123.255 0.347 . . . . 2.68 111.148 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 48.6 t80 -60.88 138.2 58.16 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.71 -0.848 . . . . 3.55 108.71 173.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 51' ' ' ASN . 13.5 tppt? -67.74 110.61 5.72 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 123.198 0.311 . . . . 3.38 110.348 -176.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.88 -40.12 17.62 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.586 2.191 . . . . 1.58 112.406 -175.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.429 ' O ' ' HG3' ' A' ' 49' ' ' LYS . 45.6 t30 -94.86 144.09 25.93 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 108.85 -0.796 . . . . 3.85 108.85 174.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' MET . . . . . . . . . . . . . 23.5 ptm -79.98 147.42 31.58 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.976 0.417 . . . . 5.0 110.231 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 11.6 t . . . . . 0 C--O 1.252 1.237 0 CA-C-O 118.003 -0.999 . . . . 6.13 108.74 179.085 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . . . . . . . . . 24.7 ptp . . . . . 0 N--CA 1.482 1.153 0 N-CA-C 111.505 0.187 . . . . 5.41 111.505 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' LYS . . . . . 0.771 ' HG3' ' H ' ' B' ' 3' ' ' SER . 13.6 ptmt -124.76 -84.26 0.64 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 121.398 -0.121 . . . . 1.29 111.131 -178.078 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' SER . . . . . 0.771 ' H ' ' HG3' ' B' ' 2' ' ' LYS . 75.2 m -128.85 -173.25 2.92 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.858 -0.793 . . . . 0.46 108.858 177.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' THR . . . . . 0.742 HG23 ' HD1' ' A' ' 37' ' ' TYR . 35.4 m 64.68 70.52 0.48 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.594 0.711 . . . . 0.41 111.317 175.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.08 38.15 5.49 Favored Glycine 0 N--CA 1.439 -1.147 0 C-N-CA 120.773 -0.727 . . . . 0.32 112.255 174.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' ILE . . . . . . . . . . . . . 7.3 tp -104.6 133.81 47.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.628 -0.508 . . . . 0.52 109.628 178.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' VAL . . . . . 0.571 ' CG2' ' HB1' ' A' ' 33' ' ' ALA . 11.0 p -92.0 117.31 35.06 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-O 121.529 0.68 . . . . 0.37 111.486 -172.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ARG . . . . . 0.563 ' HB2' HD13 ' A' ' 36' ' ' ILE . 1.0 OUTLIER -109.73 159.61 17.02 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.509 -0.769 . . . . 1.74 110.209 -178.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.64 155.93 20.22 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.233 -1.025 . . . . 1.23 108.233 171.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' VAL . . . . . 0.504 HG22 HD11 ' A' ' 34' ' ' LEU . 2.2 t -78.24 -111.26 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.497 -0.557 . . . . 0.39 109.497 176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ASP . . . . . 0.705 ' HB2' ' HD3' ' A' ' 15' ' ' ARG . 26.4 t0 179.88 -68.94 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 109.4 -0.592 . . . . 1.66 109.4 179.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' GLU . . . . . 0.826 ' HA ' ' HB3' ' A' ' 30' ' ' GLU . 1.3 pt-20 -160.38 -83.97 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.397 -0.819 . . . . 1.91 110.563 177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' LEU . . . . . 0.545 ' H ' ' HG3' ' B' ' 12' ' ' GLU . 2.6 pt? -74.45 -16.13 60.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.031 -0.986 . . . . 0.72 112.198 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 149.22 -16.79 1.16 Allowed Glycine 0 C--O 1.221 -0.66 0 C-N-CA 119.911 -1.137 . . . . 0.31 113.05 178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ARG . . . . . 0.691 ' HA ' ' O ' ' A' ' 16' ' ' VAL . 7.9 mtt180 -52.48 111.56 0.66 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.788 0.294 . . . . 0.75 111.75 -179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' VAL . . . . . 0.669 ' O ' ' HA ' ' A' ' 15' ' ' ARG . 14.5 p -105.14 142.09 19.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 109.721 -0.474 . . . . 1.04 109.721 177.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' VAL . . . . . 0.479 ' HB ' ' HG2' ' B' ' 8' ' ' ARG . 48.6 t -77.65 108.53 11.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 0.25 112.019 -173.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.561 HD12 HD13 ' A' ' 43' ' ' ILE . 19.9 mm -76.28 135.65 69.35 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.942 -0.572 . . . . 0.55 110.422 174.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' PRO . . . . . 0.714 ' HB2' ' HG ' ' B' ' 22' ' ' LEU . 92.8 Cg_exo -49.06 139.89 25.51 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.987 2.458 . . . . 0.28 113.215 170.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.579 HG13 ' HE ' ' B' ' 23' ' ' ARG . 12.3 tt -59.87 -33.6 53.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.767 0 CA-C-N 115.587 -0.733 . . . . 0.82 110.707 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -73.55 -22.98 59.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.105 0.478 . . . . 1.35 110.251 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' LEU . . . . . 0.765 ' O ' ' HG ' ' B' ' 26' ' ' LEU . 7.2 mt -80.38 -48.47 12.87 Favored 'General case' 0 N--CA 1.443 -0.805 0 N-CA-C 108.957 -0.757 . . . . 0.33 108.957 -176.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ARG . . . . . 0.579 ' HE ' HG13 ' B' ' 20' ' ' ILE . 15.0 ptt180 -65.58 -33.71 76.54 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.936 -0.765 . . . . 1.48 108.936 179.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ARG . . . . . 0.457 ' N ' ' HG3' ' B' ' 23' ' ' ARG . 33.9 ttp180 -64.78 -37.83 88.93 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.409 -0.814 . . . . 2.77 110.495 175.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' THR . . . . . . . . . . . . . 95.7 m -63.83 -34.34 77.7 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.969 -0.56 . . . . 0.31 110.422 177.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' LEU . . . . . 0.818 HD11 HD11 ' A' ' 43' ' ' ILE . 3.1 mt -88.72 -10.36 48.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.48 0.657 . . . . 0.24 109.572 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . 63.36 30.27 77.06 Favored Glycine 0 N--CA 1.446 -0.633 0 CA-C-N 114.889 -1.051 . . . . 0.34 112.282 -174.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ILE . . . . . 0.641 HG12 ' HB2' ' B' ' 26' ' ' LEU . 14.0 pt -111.67 166.87 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.932 0.396 . . . . 0.47 111.196 -179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ALA . . . . . . . . . . . . . . . -177.85 148.67 0.54 Allowed 'General case' 0 CA--C 1.511 -0.526 0 CA-C-N 115.224 -0.898 . . . . 0.22 110.182 176.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' A' ' 12' ' ' GLU . 2.0 pt-20 35.85 -87.23 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 115.293 1.59 . . . . 1.12 115.293 174.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' LYS . . . . . . . . . . . . . 11.7 mmpt? -75.04 5.11 5.59 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 113.075 0.769 . . . . 0.65 113.075 -174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ASP . . . . . 0.579 ' O ' ' HE2' ' A' ' 9' ' ' LYS . 3.2 m-20 -86.67 173.74 9.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.933 0.397 . . . . 1.37 111.636 -176.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' ALA . . . . . 0.615 ' HB1' ' CG2' ' A' ' 7' ' ' VAL . . . -118.28 144.86 45.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.621 -0.718 . . . . 0.22 112.401 -177.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' LEU . . . . . 0.831 HD23 ' HA ' ' B' ' 47' ' ' LYS . 15.9 mt -124.77 152.27 44.07 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.846 -1.168 . . . . 1.23 107.846 174.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLU . . . . . 0.409 ' HG2' ' HA2' ' A' ' 5' ' ' GLY . 19.3 tt0 -106.78 104.84 14.62 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 109.167 -0.679 . . . . 1.4 109.167 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ILE . . . . . 0.951 HG13 HD12 ' B' ' 45' ' ' LEU . 1.9 mp -90.26 121.39 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.346 0.593 . . . . 0.29 110.971 -173.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' TYR . . . . . 0.601 ' HD1' HG23 ' A' ' 4' ' ' THR . 0.3 OUTLIER -127.21 158.64 36.59 Favored 'General case' 0 C--N 1.316 -0.881 0 CA-C-N 115.358 -0.837 . . . . 4.28 109.498 178.107 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' VAL . . . . . . . . . . . . . 10.0 p -110.94 138.81 37.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 C-N-CA 120.626 -0.429 . . . . 0.28 111.221 -173.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -127.47 77.94 1.78 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.008 -0.542 . . . . 1.12 110.336 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASP . . . . . . . . . . . . . 7.1 t70 58.56 -79.16 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 114.504 -1.225 . . . . 1.64 112.384 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLU . . . . . 0.414 ' H ' ' HG3' ' B' ' 41' ' ' GLU . 0.0 OUTLIER -115.58 -10.74 11.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 2.81 110.924 -176.169 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -109.84 157.6 19.03 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.979 -0.555 . . . . 0.98 110.667 -176.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.845 HD11 HD11 ' A' ' 26' ' ' LEU . 12.1 mt -109.84 137.5 41.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.016 -0.538 . . . . 0.42 109.83 177.143 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ILE . . . . . 0.828 HD12 HD12 ' A' ' 44' ' ' ILE . 10.1 mm -123.61 115.6 45.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.457 -0.338 . . . . 0.25 110.214 -176.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' LEU . . . . . 0.951 HD12 HG13 ' B' ' 36' ' ' ILE . 0.0 OUTLIER -112.9 111.94 23.05 Favored 'General case' 0 CA--C 1.511 -0.55 0 N-CA-C 108.886 -0.783 . . . . 1.29 108.886 175.214 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LYS . . . . . . . . . . . . . 39.6 ttpt -101.31 128.65 47.37 Favored 'General case' 0 C--N 1.31 -1.12 0 N-CA-C 109.084 -0.71 . . . . 1.22 109.084 175.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LYS . . . . . 0.831 ' HA ' HD23 ' B' ' 34' ' ' LEU . 55.0 pttt -44.86 138.92 3.29 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 123.281 0.363 . . . . 2.5 111.407 178.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -61.53 138.48 58.29 Favored 'General case' 0 N--CA 1.447 -0.596 0 N-CA-C 108.853 -0.795 . . . . 3.39 108.853 173.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.442 ' HA ' ' HD3' ' B' ' 49' ' ' LYS . 12.8 tppt? -67.68 113.99 17.4 Favored Pre-proline 0 C--N 1.321 -0.651 0 N-CA-C 110.145 -0.317 . . . . 3.18 110.145 -176.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.99 -40.28 9.46 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.594 2.196 . . . . 1.56 112.177 -175.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ASN . . . . . 0.435 ' O ' ' HG3' ' B' ' 49' ' ' LYS . 48.1 t30 -108.23 135.3 49.8 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 109.253 -0.647 . . . . 3.92 109.253 176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' MET . . . . . . . . . . . . . 21.6 ptm -81.23 115.87 20.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.307 0.575 . . . . 5.19 111.214 -175.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' THR . . . . . . . . . . . . . 6.9 t . . . . . 0 C--O 1.248 1.021 0 CA-C-N 115.556 -0.747 . . . . 6.34 110.459 -178.511 . . . . . . . . 0 0 . 1 stop_ save_